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  In response to osmotic or heat stress, marine hyperthermophiles (thriving 
optimally at or above 80ºC) accumulate ionic compatible solutes such as α-D-
mannosyl-D-glycerate (MG). It has been proposed that these hypersolutes 
stabilise intracellular components, such as proteins and enzymes, allowing 
them to withstand high growth temperatures. Actually, the efficacy of these 
solutes in the stabilisation of a number of model proteins has been 
demonstrated in vitro. Since several human pathologies such as Alzheimer’s, 
Creutzfeldt-Jacob’s, cystic fibrosis and Parkinson’s diseases have been 
associated with the structural instability of proteins, and consequent protein 
aggregation, the development of reliable strategies to improve protein stability 
is of great importance and could lead to several pharmaceutical and 
biotechnological applications. 
  The main goals of this doctoral work were the development of strategies for 
the synthesis of newly isolated natural solutes, such as α-D-mannopyranosyl-
(1→2)- α-D-glucopyranosyl-(1→2)-D-glycerate (MGG) and (2R)-2-(1- α-D-
mannopyranosyl)-3-(1-O-α-D-glucopyranosyl)-glycerate (MGlyG), and the 
construction of a solute library inspired by the structure of natural 
hypersolutes, mainly MG. 
  Hypersolutes are present in limited quantities in their natural producers and 
chemical synthesis was considered a convenient method to obtain, study and 
confirm the structure of the isolated compounds. The most challenging feature 
in carbohydrate chemistry is the stereoselective introduction of the glycosidic 
bond, hence, to enhance the anomeric selectivity of the glycosylation reaction 
for the preparation of these compounds new synthetic methodologies for the 
synthesis of 1,2-cis glycosides were developed. In this work, several 
galactose, glucose and glucosamine thioglycosides were prepared and used 
as donors. The influence of the nature of the protective groups on different 
positions of the donor, solvent and temperature on the stereochemical 
outcome of these glycosylation reactions was studied using a wide range of 
acceptors, ranging from unhindered linear primary alcohols to other sugars, 
using NIS/TfOH as activator. The results showed that for the studied hexoses, 
the presence of a strong electron withdrawing group at the C-6 position of the 
donors had an influence in the anomeric selectivity, favouring the formation of 
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1,2-cis glycosides. In the case of galactose this effect could be enhanced by 
the presence of an additional ester group at the C-4 position of the donor. 
  In the present work, the natural MGG was efficiently synthesised in solution 
and on solid support in a stereocontrolled manner. Different strategies using 
two different thioglucosides bearing a free C-2 hydroxyl group were designed 
and tested in solution. These thioglucosides were used as glycosyl acceptors 
in the first glycosylation reaction with the tetraacetylmannosyl 
trichloroacetimidate, and as donors in the second glycosylation reaction with 
the glycerate acceptor. The glycosylation reactions with both thioglucosides 
were highly stereoselective affording exclusively the α-anomer. For the solid 
supported synthesis, a thioglucoside was efficiently immobilized on the solid 
support (Tentagel MB-NH2) by the C-6 hydroxyl group using a succinate 
linker, and successfully used in the synthesis of MGG. The stereoselectivity of 
the glycosylation reactions was reproducible on solid support, affording the 
desired α-product. Characterisation of the products while attached to the solid 
support was performed using HR-MAS NMR. 
  A synthetic strategy for the synthesis of the recently isolated MGlyG was 
successfully developed based on the glycosylation reaction of ethyl 6-O-
acetyl-2,3,4-tri-O-benzyl-1-thio-α/β-D-glucopyranoside donor with a partially 
protected mannosyl glycerate acceptor. Optimisation studies were performed 
changing the solvent and temperature for these reaction in order to improve 
the 1,2-cis stereoselectivity. The effectiveness of MGlyG for the protection of 
model enzymes against heat induced inactivation was evaluated, using 
differential scanning fluorimetry (DSF). For comparison, the protection 
induced by natural compatible solutes, like MG, GG or GGG, was assessed 
by the same method. The results demonstrated that for the studied enzymes 
(malate dehydrogenase, staphylococcal nuclease and lysozyme) MGlyG was 
the best stabiliser, and that the extent of protein stabilisation rendered by the 
solute depends on the specific solute/enzyme examined. 
  The mechanisms that govern protein stabilisation by hypersolutes are still 
unclear and a subject of interest for the literature. To understand what are the 
structural features of these compounds that are determinant for stabilisation, a 
solute library was developed in this work. Twenty-one new synthetic 
analogues derived from different hexoses, such as glucose, galactose, 
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mannose and glucosamine have been synthesised and their 
thermostabilisation properties assessed using DSF. The comparative analysis 
of the results obtained reinforces the idea of the importance of charge for the 
stabilisation effect, and that the extent of stabilisation is determined by 
specific interactions between solutes and proteins. Furthermore, the 
importance of the nature of the sugar and the non-glycosidic moiety of the 
molecule for the stabilisation effect were studied, and results suggested that 
the structure of the non-glycosidic moiety had more influence on the 
stabilisation effect than the nature of the hexose. 
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  Hipertermófilos marinhos capazes de proliferar optimamente  acima dos 
80ºC acumulam solutos compatíveis iónicos (hipersolutos), tais como o α-D-
manosil-D-glycerato (MG), como resposta a condições de stress osmótico e 
de temperatura. Dada a capacidade destes hipersolutos de estabilizarem  
componentes intracelulares, nomeadamente  proteínas, foi proposta a 
acumulação destes compostos intracelularmente como estratégia destes 
organismos para suportar temperaturas elevadas. Para além disso, testes in 
vitro demonstraram a capacidade estabilizadora destes solutos numa 
variedade de proteínas modelo. Uma vez que a instabilidade estrutural das 
proteínas e a sua consequente agregação tem sido associada  a uma série 
de doenças humanas, tais como a Alzheimer, a doença Creutzfeldt-Jacob, a 
fibrose quística e a doença de Parkinson, o desenvolvimento de estratégias 
que visam o aumento da estabilidade das proteínas é de grande interesse e 
poderá ter inúmeras aplicações farmacêuticas e biotecnológicas. 
  Os principais objectivos desta tese de doutoramento foram o 
desenvolvimento de estratégias para a síntese de compostos naturais 
recentemente isolados, tais como o α-D-manosil-(1→2)-α-D-glucosil-(1→2)-D-
glicerato (MGG) e (2R)-2-(1-O-α-D-manosil)-3-(1-O-α-D-glucosil)-glicerato 
(MGlyG), e a construção de uma biblioteca de compostos baseada na 
estrutura de solutos produzidos naturalmente  pelos hipertermófilos, 
nomeadamente o MG. 
  Uma vez que estes hipersolutos ocorrem em baixas concentrações nos 
produtores naturais , o método mais conveniente para os obter, estudar e 
confirmar a sua estrutura é a síntese química. Um dos maiores desafios da 
síntese de açúcares é a introdução estereosselectiva da ligação glicosídica; 
por isso, para melhorar a selectividade anomérica da reacção de glicosilação 
na síntese destes compostos foram desenvolvidas novas metodologias para 
a obtenção de 1,2-cis glicósidos. Neste trabalho foram sintetizados e 
utilizados vários tioglucósidos derivados da glucose, galactose e 
glucosamina. Utilizando diversos aceitadores glicosídicos a influência da 
natureza dos grupos protectores em diferentes posições do dador, bem como 
o solvente e a temperatura, na selectividade da reacção de glicosilação foi 
avaliada utilizando o sistema NIS/TfOH como activador. Os resultados 
obtidos para as hexoses estudadas demonstram que grupos electroatractores 
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na posição C-6 dos dadores têm uma influência directa na selectividade 
anomérica da reacção, favorecendo a formação de 1,2-cis glicósidos. No 
caso da galactose, este efeito pode ser acentuado pela presença adicional de  
um grupo éster na posição C-4 do dador glicosídico. 
  No presente trabalho, o soluto natural MGG foi eficientemente e 
esterosselectivamente sintetizado em solução e em suporte sólido. Foram 
desenvolvidas e testadas duas vias de síntese em solução utilizando dois 
dadores tioglucosídicos contendo o grupo hidroxilo do C-2 livre. Estes 
tioglucósidos foram utilizados como aceitadores numa primeira glicosilação 
com o dador tetraacetilmanosil tricloroacetamidato, e posteriormente como 
dadores na reacção de glicosilação com o glicerato como aceitador. As 
reacções de glicosilação com ambos os tioglucósidos foram 
estereosselectivas, tendo-se formado exclusivamente o anómero α. A síntese 
em suporte sólido foi conseguida com sucesso através da imobilização do 
tioglucósido na resina Tentagel MB-NH2 através do C-6 e utilizando como 
“linker” o succinato. A estereosselectividade das reacções em solução foi 
reproductível em suporte sólido, tendo-se obtido exclusivamente o produto α 
pretendido. A caracterização dos compostos em suporte sólido foi realizada 
através de RMN HR-MAS. 
  Para a síntese do recentemente isolado MGlyG foi desenvolvida uma 
estratégia  tendo como base a reacção de glicosilação entre o dador etil 6-O-
acetil-2,3,4-tri-O-benzil-1-tio- α/β-D-glucopiranósido e o manosil glicerato 
parcialmente protegido como aceitador. Uma vez que a reacção de 
glicosilação não foi estereosselectiva, foi necessário proceder-se à realização 
de um estudo para optimização das condições de reacção (solvente e 
temperatura). A capacidade termoestabilizadora do MGlyG foi avaliada 
através de fluorimetria diferencial de varrimento (DSF) em três enzimas 
modelo (malato desidrogenase, staphylococcal nuclease e lisozima). Como 
termo de comparação foi também avaliada pelo mesmo método a capacidade 
termoestabilisadora de alguns solutos compatíveis naturais, tais como o MG, 
o GG ou GGG. Os resultados obtidos para as três enzimas em estudo 
demonstraram que o MGlyG é o melhor termoestabilisador, e que o grau de 
estabilização conferido pelos solutos depende de interacções específicas 
entre o par soluto/enzima em questão. 
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  Uma vez que os mecanismos que controlam a estabilização de proteínas 
pelos hipersolutos são ainda desconhecidos , para compreender quais os 
determinantes estruturais destes compostos para a estabilização foi 
desenvolvida uma biblioteca de solutos análogos aos produzidos na natureza 
pelos hipertermófilos. Para a construção da biblioteca foram sintetizados 21 
novos análogos derivados de diferentes hexoses, tais como a glucose, 
galactose, manose e glucosamina, e as suas propriedades 
termoestabilisadoras avaliadas em proteínas modelo. A análise  comparativa 
dos resultados obtidos reforça o conceito da importância da carga eléctrica 
dos compostos para o efeito de estabilização, e de que o grau de 
estabilização conferido é determinado por interacções específicas entre os 
solutos e as proteínas. Neste trabalho foi ainda estudado o modo como a 
estrutura da hexose, bem como da parte não glicosídica da molécula 
influenciam o efeito de estabilização, sendo que os resultados sugerem que a 
estrutura da parte não glicosídica tem maior relevância do que a estrutura da 
hexose. 
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Hypersolutes	  
 
  Halotolerant and moderately halophilic microorganisms accumulate 
compatible solutes in the cytoplasm to face fluctuations in the osmotic 
pressure of their environment.1 Compatible solutes are low molecular weight 
and highly soluble organic compounds, namely amino acids and derivatives, 
sugars and polyols that are able to protect cell structures under stress 
conditions and do not interfere with normal cell function. 
  In response to osmotic or heat stress, marine hyperthermophiles 
(microorganisms thriving optimally at or above 80ºC) use the same strategy 
and accumulate ionic compatible solutes also known as hypersolutes.1 In 
contrast with neutral or zwitterionic compounds, more commonly found in 
mesophiles, hypersolutes are in general negatively charged and most fall into 
two categories: hexose derivatives, like α-D-mannosyl-D-glycerate (MG) and 
polyol-phosphodiesters such as di-myo-inositol phosphate (DIP) (Figure 1).1 
Although the preference for the accumulation of negatively charged 
compounds is still unclear, in vitro studies have proved not only the efficacy of 
these solutes in the stabilisation of a number of model proteins, but also that 
charged compounds rendered better protection against aggregation, unfolding 
and inactivation of proteins than neutral compounds.2-5 The increase in the  
concentration of these solutes not only with the increase of the osmotic 
pressure of the medium but also with the growth temperature led to the 
proposal that they would play a role in thermoadaptation by stabilising 
intracellular components, such as proteins and enzymes, allowing them to 
withstand high growth temperatures.1, 6  
  MG is one of the most widespread6 solutes in hyper/thermophilic organisms 
and the efficacy of this natural solute in the protection of protein structures 
has been amply illustrated2, 4. Due to the small amounts of these 
hypersolutes available from their natural sources, chemical synthesis was 
considered the best route to obtain, study and confirm the structure of the 
isolated compounds. More recently, other isolated natural solutes, like α-D-
glucosyl-D-glycerate (GG) and α-D-glucopyranosyl-(1→6)-α-D-
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glucopyranosyl-(1→2)-D-glucopyranosyl-(1→2)-D-glycerate (GGG) (Figure 1) 
with a more complex structure, have been synthesised.7 
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Figure 1. Examples of natural compatible solutes and analogues. 
 
  Protein stability can be defined in a very simplistic way as the capacity of the 
polypeptide chain to maintain a specific three-dimensional conformation that 
allows it to perform a given function, and results of the equilibrium between 
folding and unfolding forces, which is highly influenced on the interactions 
between the protein and the solvent. Although the principles underlying the 
stabilisation effect of compatible solutes are still unknown, it is accepted to be 
a consequence of the alteration of the environment that surrounds the protein. 
More specifically, the solvent (in this case water) physicochemical properties.8 
In the presence of the solute, the hydrated tertiary native structure of the 
protein in aqueous solution suffers a structural compaction and rigidification.9 
This concept is supported by the study of the effect of MG in the internal 
motions of the hyperstable staphylococcal nuclease (SNase), where it was 
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shown that, in the presence of the solute, the protein backbone motions were 
restricted in a concentration-dependent manner.10 Also, the fact that different 
solutes stabilise proteins to different extents suggests the presence of weak 
interactions between the solutes and the protein surface9, without interfering 
with the biological function of the protein. 
  The success of many industrial and pharmaceutical processes is highly 
dependent on the preservation of the native structure and activity of enzymes 
and other proteins. Moreover, since several afflicting human pathologies have 
been associated with structural instability of proteins, and consequent protein 
aggregation, like Alzheimer’s, Creutzfeldt-Jacob’s, Huntington’s, cystic fibrosis 
and Parkinson’s, the development of reliable strategies to improve protein 
stability is of great importance.  
  Some classical compatible solutes from mesophiles, like trehalose11, that 
are able to sustain and preserve a wide array of biological molecules have 
been used as stabilisers in several commercially available therapeutic 
products, food and cosmetic products. Based on the proposed role of 
hypersolutes as thermoprotectors and on their superior stabilisation properties 
against denaturation, aggregation and inactivation effects several 
biotechnological applications can be considered. Furthermore, since 
enhanced stability of proteins to high temperature usually implies improved 
resistance to other types of stress conditions, such as pH, freezing, radiation, 
dehydration, oxidation and other chemical modifications, suggests that the 
use of hypersolutes can be considered for the global enhancement of protein 
stability.8, 12 In fact, MG is one of the most studied hypersolutes with respect 
to its protein stabilising properties and has been successfully used with this 
purpose in different types of applications, for example: in the quality 
improvement of DNA microarrays13; in the inhibition of aggregation of proteins 
involved in Alzheimer’s14, Parkinson’s15 and Huntington’s16 disease; and in 
the stability improvement of the retro and adenoviral vectors17 allowing long-
term storage (half-life >1 year). In addition, its high compatibility and lack of 
toxicity has made it a very promising candidate for several industrial 
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applications as stabilising agent of biomaterials, which have been disclosed in 
a number of patent applications18-21. 
  Recently in another study3, several molecules chemically related to MG were 
synthesised and in some cases (like α-D-mannosyl-(S)-lactate (ML), Figure 1) 
showed a superior ability to protect model enzymes against heat-induced 
denaturation, aggregation and inactivation. This finding showed that an 
apparently small structural change, the glycerate moiety being replaced by a 
lactate, had positive effect in the protein thermostabilisation and has 
stimulated the production of new synthetic analogues. The possibilities of 
solute engineering having MG as the reference compound are very large, so 
in this work a solute library was constructed, and the diversity of these 
analogue structures was introduced in three levels: the nature of the sugar 
(mannose, glucose, galactose and glucosamine), both anomers for each 
sugar and the glycosyl acceptor (like, for example methyl (2R)-D-glycerate, 
methyl (S)-lactate, glycerol, methyl glycolate, methyl butyrate or dimethyl 
malate) used in the glycosylation reaction. The solute library provided a wide 
range of structurally different sugar derivatives that could give insight into the 
key features necessary for protein stabilization, and synthetic analogues with 
improved stabilisation properties. 
 
Carbohydrates	  Synthesis	  
 
  Carbohydrates play an important role in many biological processes and can 
be found in nature in various forms, from simple monosaccharides to more 
complex polysaccharides, glycoconjugates or glycosides in which a 
monosaccharide is joined by glycosidic bonds to other monosaccharides or 
other functional groups. From the three major classes of biopolymers - 
oligonucleotides, oligopeptides and oligosaccharides (Figure 2) - the 
synthesis of oligosaccharides is the most challenging and has been less 
explored than that of other biomolecules. Compared with other biopolymers 
such as nucleic acids, proteins and peptides, in which their biological activity 
depends on the sequence of nucleotides or amino acids, in the case of 
oligosaccharides, the situation is more complex. For oligosaccharides, 
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besides the sequence of the monomeric structures, other aspects such as the 
functional groups and their stereochemistry, the conformation of the sugars 
and the stereoselective formation of glycosidic linkages must be considered. 
  In order to perform biophysical and biochemical studies of biologically active 
carbohydrates to understand their biological function, sufficient quantities of 
defined oligosaccharides are required and which are difficult to obtain from 
their natural sources due to their microheterogeneity and low concentrations 
and low biomass yields. The chemical synthesis of oligosaccharides for 
biological studies is a powerful tool to provide pure, structurally defined and 
homogeneous samples in substantial quantity, and simultaneously allows for 
synthesising several structures including non-natural ones. 
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Figure 2. The three major classes of biooligomers. 
 
  The structural complexity of carbohydrates can be translated in two major 
chemical challenges: the multitude of functional groups with similar reactivity 
that need to be distinguished, and the creation of a new stereogenic center 
when the glycosidic bond is formed. 
  The development of stereoselective methods for the introduction of the 
glycosidic bond between the monosaccharide units during the glycosylation 
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reaction plays a central role in carbohydrates chemistry. The glycosidic bond 
is formed by a nucleophilic attack by an alcohol (R’OH), or by the hydroxyl 
group of a partially protected sugar moiety – the glycosyl acceptor - to the 
anomeric center of the glycosyl donor often through a unimolecular SN1 
mechanism. The reaction is generally performed in the presence of an 
activator called promoter (E) that assists the departure of the leaving group 
(X) and in some cases, other additives such as molecular sieves or any base 
that may act as acid scavenger are used (Scheme 1).22 
 
O
X
RO
O
RO
E+ R'OH
O
OR'
RO
 
Scheme 1. Glycosylation reaction.  
 
  Despite the glycosylation reaction being known for centuries and the 
existence of many glycosylation methods available for glycosidic bond 
formation, none of them is general, as there are many factors to take in 
consideration. Although 1,2-trans glycosides (Table 1) can be 
stereoselectively prepared in the classical manner by using the C-2 acyl 
neighbouring group participation, the stereoselective formation of 1,2-cis 
glycosides (Table 1), like α-glucopyranosides, α-galactopyranosides and β-
mannopyranosides, still represents a challenge and proceeds with poorer 
stereocontrol, which results in mixtures of diastereomers. 
 
Table 1. Stereochemistry of the anomeric bond. 
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  For example, this can be easily illustrated by comparing the selectivities 
obtained for the synthesis of the 1,2-cis glucosides, GG (>10:1 1,2-cis/1,2-
trans isomers) and GL (4:1 1,2-cis/1,2-trans isomers), which are difficult to 
attain in a stereocontrolled manner, with the selectivities obtained for the 
synthesis of the 1,2-trans mannosides, MG and ML (1:0 1,2-trans/1,2-cis 
isomers).3, 7  
  Many factors, such as the nature of the leaving and protective groups on the 
donor, the steric hindrance of the glycosyl acceptor, the reaction solvent, 
temperature, and the promoting system can influence the outcome of the 
reaction and should be taken into account.22 So improved and more general 
methods for the control of the 1,2-cis stereoselectivity of the glycosylation 
reaction are needed. 
  When planning a synthetic strategy for carbohydrates synthesis another 
crucial task is the preparation of properly functionalized building blocks and 
deprotection strategies. This involves the use of multistep transformations for 
differentiation of functional groups (amino and hydroxyl) of similar reactivity 
and, in most cases, purification by chromatography is needed after each step. 
In order to simplify the labour-intensive, time consuming and expensive 
solution phase synthesis of these compounds, many research efforts have 
been directed towards the development of efficient strategies and 
methodologies for solid phase synthesis. 
  Although the solid phase synthesis was initially almost exclusively dedicated 
to oligopeptides and provided the basis for automated peptide synthesis, the 
use of functionalised solid supports has been extended to the synthesis of 
oligonucleotides and oligosaccharides, proving to be a powerful tool for 
combinatorial chemistry in the preparation of compound libraries. However, 
the solid phase synthesis of oligosaccharides and oligosaccharide libraries, 
for the reasons mentioned above, is much more demanding than the 
synthesis of peptides or nucleic acids and therefore less developed and 
automatised than the other two. The automation of solid phase 
oligosaccharide synthesis holds great promise for the future, and is expected 
to simplify the synthesis of biologically relevant sugar structures. 
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  Using solid supports for the synthesis of compatible solutes will allow a more 
efficient preparation of these compounds in a relatively short time, essentially 
by using well established solution phase reactions and taking advantage of 
the main feature of solid supports - the purification step, which can be 
accomplished by a simple filtration, allowing the use of excess reagents to 
drive reactions to completion. 
  The development of improved and more efficient chemical synthesis of these 
compounds is crucial for the expansion of the industrial applications of 
hypersolutes. 
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Abstract	  
 
  Thioglycosides are extremely versatile and have been widely employed in 
the synthesis of complex carbohydrates and carbohydrate libraries. Since 
obtaining high stereoselectivity in 1,2-cis glycosylation reactions is challenging 
in this chapter the use of thioglycosides as donors in this reaction was 
explored. In order to improve the α anomeric selectivity of the glycosylation 
reaction different thioglucosides, thiogalactosides and 2-azido-2-
deoxythioglucosides were prepared as donors and the NIS/TfOH system used 
as the promoter. The influence of the nature of the protective groups on 
different positions of the donor, solvent and temperature in this reaction was 
studied using a wide range of acceptors (from unhindered primary hydroxyl 
groups to other sugars). Studies showed that the α-stereoselectivity of 
thioglucosides and 2-azido-2-deoxythioglucosides could be improved by the 
use of an electron-withdrawing group (acetyl or acyl) at the C-6 position of 
these donors, and in the case of thiogalactosides by the use of an acyl group 
both at the C-4 and C-6 position. In general, it was observed that donors 
possessing stronger electron-withdrawing groups at these positions have a 
higher α-directing effect. Glycosylations of the different thioglycosides with 
several acceptors showed that careful optimisation of the solvent system and 
temperature is a powerful way to obtain high yields and α-stereoselectivity. 
These glycosides are key intermediates for the synthesis of new analogues of 
compatible solutes. 
 
Introduction	  
 
  The key step in the synthesis of carbohydrates is the stereoselective 
introduction of the glycosidic bond between the monosaccharide units during 
the glycosylation reaction. The glycosylation is a complex phenomenon which 
detailed mechanism is still unknown and subject of several studies1-3. It is 
commonly accepted that involves the nucleophilic attack by an alcohol (ROH) 
– the glycosyl acceptor - to the anomeric center of the glycosyl donor in the 
presence of the promoter (E). Regarding the mechanism, the reaction cannot 
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be considered simply in terms of pure unimolecular (SN1) or pure bimolecular 
mechanism (SN2), and was described by Crich
2 as “continuum of 
mechanisms” ranging between the pure SN2 mechanism at the one extreme 
and the SN1 mechanism with free oxocarbenium ions at the other (Scheme 2). 
Where according to a given donor-acceptor pair, the reaction conditions may 
favour either a bimolecular or a monomolecular rate-determining step 
(Scheme 2).2 
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Scheme 2. Full spectrum of mechanisms from SN2 all the way to pure SN1.
2  
 
  When considering that the new glycosidic linkage creates a chirality center, 
many factors influence the stereochemical outcome of this reaction, like: 
• the nature of the protecting groups, specially the group bound to the 
C-2 of the sugar ring;  
• the reactivity of the anomeric centre of the glycosyl donor, the 
acceptor and the promoter;  
• the solvent; 
• the steric hindrance of the acceptor; 
• the temperature at which the reaction takes place; 
need to be taken into account when designing the glycosidic donors to 
accomplish the desired product.  
  The choice of the proper protecting groups has great influence in the 
reactivity of the donor - they affect the nucleophilicity of the anomeric function 
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and thereby the rate of attack of the anomeric group on the electrophilic 
promoter species. And they determine the stability of the partial positive 
charge on the anomeric center, which develops upon expulsion of the 
anomeric leaving group. A glycoside donor is deactivated by electron-
withdrawing protecting groups (such as acyl functions) and termed 
“disarmed”, since they decrease the electron density, therefor, the 
nucleophilicity of the anomeric function and destabilise the oxocarbenium ion 
transition state.3 Whereas electron releasing protective groups (such as aryl 
or alkyl functions) are more reactive and described “armed”. 
  The protecting group on C-2, adjacent to the anomeric center, has the 
highest impact in the outcome of the glycosylation reaction as it can 
participate by formation of an intermediate if it is an ester (like acetyl, benzoyl, 
2-phthalimido, Scheme 3. a), or not if it is an ether (Scheme 3. b).1  
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Scheme 3. Glycosylation Reaction: a) C-2 Group Participation – Disarmed donor; b) 
C-2 Non-participative Group - Armed donor. 
 
  The most commonly applied nonparticipating groups are benzyl for neutral 
sugars and azide for 2-amino-2-deoxy sugars, but other protective groups 
have also been used. In this case, since the nucleophilic attack would be 
almost equally possible from either the upper (β product) or the bottom face (α 
product) of the sugar ring and although the α-product is thermodynamically 
favoured by the anomeric effect, the kinetic β-product is often obtained 
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(Scheme 3. b)). This is why the formation of 1,2-trans glycosides can easily 
be accomplished by neighbouring group participation of the 2-acyl group, 
while 1,2-cis glycosides it is far more complicated. 
  Even though the effect of substituents remote to the anomeric center is less 
important for the stereochemical outcome of the glycosylation reaction than 
those at C-2, their significant contribution needs to be addressed.1 Several 
reports have been speculating about remote group participation by esters 
from C-34-7, C-45, 6, 8-11 (axial and equatorial) and C-64, 9, 10 positions. These 
assumptions are mostly based on the observation of changes in 
stereoselectivity when esters replace ethers at those positions. Distinguish 
between the electron-withdrawing effect from the effect of remote participation 
of the protecting groups on the outcome of the reaction is a controversial and 
a non-unanimous subject.2, 4, 11, 12 
  In a recent study, several molecules chemically related to MG were 
synthesised and in some cases showed a superior ability to protect model 
enzymes against heat-induced denaturation, aggregation and inactivation.13 
This finding has stimulated the production of new synthetic analogues from 
different hexoses, such as mannose, glucose, galactose and glucosamine. In 
this work, although it would be interesting to test both anomers of each solute 
analogue, since in nature these compounds are present in the α-form the 
main challenge would be the stereoselective synthesis of the α-glucosides, 
the α-galactosides and the α-glucosamine analogues. 
  Despite the several methods available for the formation of 1,2-cis glycosides 
none of them is general and when applied to different acceptors the 
stereoselectivity is not predictable in many cases. Lemieux14 and Crich15 
have both developed methods using “armed” donors - benzyl ethers - bearing 
non-participative groups on C-2 and obtained preferentially the 1,2-cis 
isomers. Crich’s method15 is based on the use of thioglucosides that upon 
treatment and activation with triflic anhydride lead to the formation of triflate 
intermediates (Scheme 4). He proposed the existence of a system where the 
α− and β-triflates are in dynamic equilibrium and since the β-triflate is less 
stable, more reactive, reacts faster with the glycosyl acceptor by nucleophilic 
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substitution. This leads to the formation of the α-glucoside and directs the 
system equilibrium in that direction. Crich also found that size and steric 
hindrance of the acceptor had a great influence in this reaction. With smaller 
and less hindered glycosyl acceptors, like methanol, a α/β mixture 
 is obtained, which can be explained by the fast direct displacement of the α-
triflate (more stable) that directs the system equilibrium in that direction. 
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ROH ROH
Promoter, TfO-
 
Scheme 4. Glycosylation reaction scheme according to Crich.15 
 
  More recently, in the synthesis of GG and GGG16, thioglucoside 1 (Scheme 
6) was used as the glucosidic donor and in both glycosylation reactions the α-
anomer was the major product (α/β >10:1), using the NIS/TfOH system as the 
promoter. The presence of an acetate group at C-6 position of the 
thioglucoside 1 should favor the formation of the α-product because of the 
disarming effect of this electron-withdrawing group, lowering the reactivity of 
the donor when compared with the tetrabenzylated thioglucoside.17 In 
addition, bulky or strong electron-withdrawing substituents at the C-6 position 
can influence the outcome of the reaction by electronically shielding the upper 
face of sugar ring, favoring the nucleophilic attack from the opposite side and 
therefore the formation of 1,2-cis glycosides.18 However, when the same 
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thioglucoside 1 was used for the synthesis of the GG analogue, GL, under the 
same conditions with a less bulky, more reactive acceptor, like (S)-lactate, a 
α/β ratio of 4:1 was obtained.13 Reactive alcohols are stronger nucleophiles 
and react faster, which turns difficult to control the selectivity and tend to give 
lower 1,2-cis stereoselectivity.1 
  The importance of solvents for the stereochemical outcome of the 
glycosylation reaction is well known in literature.1 In general, polar solvents 
have a tendency to direct the glycosylation in an β-selective way while non-
polar solvents, like dichloromethane or toluene, increase the proportion of α-
glycoside. Moreover there are other contributions that can be manipulated in 
order to favour the synthesis of the desired products, like the participating 
properties of some ethereal and nitrile solvents. In the case of diethyl ether, a 
β−diethyl oxonium-ion intermediate may be formed due to steric reasons, 
which after nucleophilic displacement with inversion of configuration would 
give α-product (Scheme 5).1 When using nitrile solvents, on contrary, the 
nitrilium cation formed in situ adopts axial orientation, leading towards the 
formation of the β-glycosides (Scheme 5).1 
 
O
RO
O
RO O
O
RO
OR'
R'OHEt2O
MeCN O
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N
O
RO OR'
R'OH
 
Scheme 5. Solvent coordination to the glycosyl donor. 
 
  Boons and co-workers19 studied the α-directing effect of ethers as solvents 
in the glycosylation of a armed tetrabenzylated β-thioglucoside, and found that 
by performing the reaction in a mixture of toluene:1,4-dioxane obtained higher 
α-selectivities (α/β 15.3:1). Ethyl ether was tested in mixtures with 
dichloromethane and toluene, but even though the results were better in 
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toluene than in dichloromethane, were worst than with 1,4-dioxane. 
Dichloromethane was the worst solvent affording more β-anomer (α/β 0.7:1) 
and THF was not used in this study.  
  Bonnaffé and co-workers20 performed an optimisation study of the solvent 
system for the α-selective glycosylation reaction of a 2-azido 
trichloroacetimidate disaccharide derived from glucose. Ethyl ether and 
dichloromethane showed the worst results both in terms of diastereoselectivity 
(α/β 70:30) and yield (<74%). They found that THF enhanced the α-
stereoselectivity (α/β 93:7) and lowered the yield (66%) of the reaction, but 
when used as mixture THF/Et2O (9:1) they obtained the best results (α/β 92:8, 
90%). 
  In another study, Ito and co-workers21 described the optimisation of the 
solvent system during the construction of three sequential α-glucosidic bonds 
using 4,6-O-cyclohexylidene-protected thioglucoside donors. It was shown 
that the best solvent systems were 1:1 mixtures of CHCl3/Et2O and 
CHCl3/CPME. 
  A common point in these studies is that all of the acceptors used were other 
glycosides, mono and higher saccharides, and no smaller or more reactive 
alcohols were studied. 
In order to improve the α-selectivity of the glycosylation reaction for the 
synthesis of new synthetic 1,2-cis analogues from glucose, galactose and 
glucosamine, several thioglycosides were prepared as donors. Using the 
NIS/TfOH16 system as the promoter, the influence of the nature of the 
protective groups on different positions of the donor, as well as the solvent 
and the temperature on these glycosylations, were studied using a wide range 
of acceptors. 
 
Results	  and	  Discussion	  
1,2-cis Stereoselective Glucosylations 
 
  Following the same line of research used for the synthesis of the natural 
compatible solutes GG and GGG16, thioglucoside 1 (Scheme 6) was prepared 
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according to literature in 3 steps from methyl glucose and used to study the 
influence of the solvent and temperature on the glycosylation reaction. To 
further investigate the influence of protecting groups thioglucoside donor 3 
was synthesised with a more electron-withdrawing group at the 6-position 
(chloroacetyl) from donor 1 (Scheme 6). 
 
O
BnO
BnO
OAcCl
SEtBnO
OBnO
BnO
OH
SEtBnO
O
BnO
BnO
OAc
SEtBnO
a
1 2
b
3
a) NaOMe, MeOH, 0ºC, 96%. b) Chloroacetyl chloride, Py, 0ºC, 86%. 	  
Scheme 6. Synthesis of thioglucosyl donor 3. 
 
CO2Me
OH
CO2Me
OH
CO2Bn
OH
CO2Me
OH
TBDPSO
CO2Me
OTBDMS
HO
HO CO2Me
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Methyl (S)-lactate
7
Methyl glycolate
8
Methyl (2R)-O-tert-butyldimethylsilyl-
2,3-dihydroxipropanoate
5
Methyl (R)-lactate
6
Benzyl (S)-lactate
9
Methyl (2R)-3-O-tert-butyldiphenylsilyl-
2,3-hidroxypropanoate  
Figure 3. Glycosyl acceptors. 
 
  Based on the work of Boons19, Bonnaffée20 and Ito21, a series of 
experiments changing the solvent system and the temperature was 
conducted. The results of the glycosylation reaction of donor 1 and 3 with a 
series of small and reactive glycosyl acceptors (Figure 3) using NIS/TfOH16 
system in the presence of 4Å MS are described in Table 2. 
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Table 2. Effect of solvent and temperature on the stereoselectivity of the glycosylation 
of donors 1 and 3. 
NIS, TfOH, 4A MSO
BnO
BnO
OR
SEtBnO
R'OH
O
BnO
BnO
OR
OR'BnO
1: R=Ac
3: R=AcCl  
Entry R’OH T (ºC) Solvent 
Donor 1 Donor 3 
Product 
(Yield,%) 
t 
(mn) α /β  
Product 
(Yield,%) 
t 
(mn) α /β  
1 
4 
0 
CH2Cl2 10 (91) 10 4:1 16 (90) 5 5.5:1 
2 CH2Cl2  (THF, 2 eq) 10 (83) 10 4:1    
3 Tol/Dioxane (1:3) 10 (43) 
a 80 6:1    
4 Tol/Dioxane (1:3)b 10 (78) 20 6.3:1 16 (85) 5 7.8:1 
5 THF/Et2O (1:9) 10 (87) 10 6:1    
6 THF/Et2O (9:1) 10 (60) 10 5.8:1    
7 Et2O 10 (85) 10 7.5:1 16 (90) 5 9.3:1 
8 THF 10 (72) 45 6.5:1 16 (85) 5 6.8:1 
9 
-60 
CH2Cl2 10 (83) 10 7:1 16 (94) 20 8.5:1 
10 Et2O 10 (81) 45 9:1 16 (90) 25 14.2:1 
11 
5 
0 
CH2Cl2 11 (85) 10 4:1    
12 Et2O 11 (76) 15 7.9:1    
13 
-60 
CH2Cl2 11 (82) 10 6.5:1    
14 Et2O 11 (83) 45 8.3:1    
15 
6 
0 
CH2Cl2 12 (93) 10 4:1    
16 Et2O 12 (82) 15 8.3:1    
17 -60 CH2Cl2 12 (97) 10 6.1:1    
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18 Et2O 12 (81) 45 10:1 17 (85) 20 11:1 
7 
7 
0 
CH2Cl2 13 (93) 10 4.2:1    
20 Et2O 13 (85) 45 4.4:1    
21 
-60 
CH2Cl2 13 (96) 10 4.2:1    
22 Et2O 13 (88) 45 13:1 18 (70) 20 11:1 
23 8 -60 Et2O 14 (30) b,c 45 1:0    
24 
9 
0 CH2Cl2 15 (96) 30 >10:1    
25 0 Et2O 15 (94) 45 1:0    
a Hydrolysis product also recovered. b TMSTOf was used instead of TfOH. 
c Initial donor was recovered. 
 
  As expected, ethereal solvents like ethyl ether, 1,4-dioxane and THF, gave 
higher α-selectivity than dichloromethane that is a halogenated solvent. This 
study showed that by using the standard glycosylation conditions - 
dichloromethane at 0ºC - the worst results were obtained in terms of 
selectivity for the two donors with all of the acceptors. 
  Glycosylation of donor 1 with methyl (S)-lactate 4 in the toluene/dioxane 
(1:3) mixture used by Boons19 improved the α/β ratio (6:1), however the 
reaction was slower (80 min), we obtained only 43% yield and recovered the 
corresponding reducing monosaccharide as by-product (Table 2, entry 3). 
Changing the promoter to NIS/TMSOTf increased the yield (78%), but the α/β 
ratio remained almost the same (α/β 6.3:1, Table 2, entry 4). 
  The THF/Et2O (9:1) mixture employed by Bonnaffé
20 was not beneficial in 
this case and resulted in a 5.8:1 α/β ratio and only 60% yield (Table 2, entry 
6). By reversing the proportions of both solvents in the mixture, THF/Et2O 
(1:9), the yield was enhance to 87% still the α/β ratio remained almost 
unchanged (α/β 6:1, Table 2, entry 5). Performing the reaction in ethyl ether a 
higher anomeric ratio of 7.5:1 α/β and 85% yield was obtained (Table 2, entry 
Stereoselective 1,2-cis Glycosylations 
	  
	  
	  
29 
7). However, when using only THF both selectivity and yield were lower, and 
the reaction was slower (Table 2, entry 8). 
  Concerning the study of the effect of temperature, conducting the reaction in 
dichloromethane and ethyl ether at -60ºC afforded in both cases an enhance 
in the α-anomeric selectivity (Table 2, entries 9 and 10). In the case of 
dichloromethane (α/β 7:1) the yield was slightly lower (83%) but the reaction 
time remained the same (10 min) (Table 2, entry 9). With ethyl ether the donor 
was consumed more slowly (45 min) but this was compensated by 
improvement of the α/β ratio 9:1 and the good yield (81%, Table 2, entry 10). 
Regarding the glycosylation with methyl (R)-lactate 5 in dichloromethane and 
ethyl ether both at 0 and 60ºC (Table 2, entries 11-14) the results were very 
similar to those obtained for methyl (S)-lactate 4. With the bulkier benzyl (S)-
lactate 6 the highest α-anomeric selectivity was achieved in ethyl ether at -
60ºC (α/β 10:1, Table 2, entry 18). When comparing the α/β ratio obtained for 
the glycosylation reaction in dichloromethane at 0ºC using methyl (S)-lactate 
4, methyl (R)-lactate 5 and benzyl (S)-lactate 6 as acceptors the results were 
the same (α/β 4:1, Table 2, entry 1, 11 and 15), meaning that under this 
conditions neither the (R),(S)-stereochemistry and bulkiness of the ester 
moiety of the lactate acceptor was relevant for the anomeric selectivity. 
  Glycosylation with the primary hydroxyl group of the small methyl glycolate 7 
acceptor in ethyl ether at -60ºC afforded excellent results both in terms of α/β 
ratio (13:1) and yield (88%, Table 2, entry 22). Reaction with primary hydroxyl 
group of methyl glycerate 8 was attempted and even though only the α-
anomer was isolated the yield was low and initial donor 1 was recovered 
(Table 2, entry 23). On contrary, glycosylation with the sterically hindered 
secondary hydroxyl group of methyl glycerate 9 afforded a good α/β ratio 
(>10:1) and yield both in dichloromethane and ethyl ether at 0ºC (Table 2, 
entries 24 and 25). Methyl glycerate acceptor 9 was prepared according to 
literature16, 22, and acceptor 8 prepared from 9 using standard 
protection/deprotection reactions (Scheme 7). Although the synthesis of 
methyl glycerate acceptor 8 seems straightforward, the low yield (16%) is due 
to the migration of the protecting group on the secondary hydroxyl group after 
deprotection of the primary hydroxyl. When using acetate to protect the 
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secondary hydroxyl group total migration occurs, and the same phenomenon 
was observed when using a benzoyl group at this position.  
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a) Ac2O, Py, DMAP, 0ºC-r.t., 94%. b) TBAF, THF, 0ºC-r.t., 75%.   c) TBDMSCl, imidazole, 
DMF, 0ºC-r.t., 74%. d) NaOMe, MeOH, 0ºC, 16% 8, 76% 8a.
CO2Me
OH
TBDMSO+
8a
 
Scheme 7. Synthesis of methyl (2R)-O-tert-butyldimethylsilyl-2,3-dihydroxipropanoate 
8. 
 
  Concerning the influence of protecting groups at the 6-position for most of 
the cases donor 3 showed a slightly higher α-selectivity than donor 1, which is 
an evidence of the importance for the anomeric selectivity of a more electron-
withdrawing group at this position. 
 
1,2-cis Stereoselective Galactosylations 
 
  Aiming to determine the importance of the sugar structure for the protein 
stabilisation effect, the synthesis of analogues from galactose was attempted. 
In general, glycosylations of thiogalactosides afford lower 1,2-cis selectivities 
and are less studied. This lack of selectivity can be explained by a higher 
reactivity due to unfavorable steric effects of the axially oriented substituent at 
C-4. 
  Using the same methodology used for glucose, thiogalactosides 19 and 21 
(Scheme 8) were synthesised from methyl D-galactopyranoside, and 
conducted a series of experiments changing the solvent system and the 
temperature. 
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a, b, c
a) BnBr, NaH, DMF, 0ºC-r.t., 90%. b) Ac2O/AcOH, H2SO4, 0ºC, 75%, α/β=3.7:1.  c) EtSH, BF3.Et2O, 
CH2Cl2, 0ºC, 91%, α/β=2.4:1. d) NaOMe, MeOH, 0ºC, 81%. e) Chloroacetyl anhydride, Py, 0ºC, 90%. 	  
Scheme 8.Synthesis of thiogalactosyl donors 19 and 21. 
 
  In this study not only small and reactive alcohols (Figure 3) were chosen as 
acceptors but also other molecules with a more complex structure, like lipids, 
aminoacids, steroids, other sugars and bulkier alcohols (Figure 4). 
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H
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Figure 4. Glycosyl acceptors. 
 
  The results of the glycosylation reaction of donor 19 and 21 using NIS/TfOH 
system in the presence of 4Å MS are described in Table 3. 
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Table 3. Effect of solvent and temperature on the stereoselectivity of the glycosylation 
of donor 19 and 21. 
NIS, TfOH, 4A MSO
BnO
BnO
OR
SEtBnO
R'OH
O
BnO
BnO
OR
OR'BnO
19: R=Ac
21: R=AcCl 	  
	  
Entry R’OH T (ºC) Solvent 
Donor 19 Donor 21 
Product 
(Yield,) 
t 
(mn) α /β  
Product 
(Yield,%) 
t 
(mn) α /β  
1 
4 
r.t. CH2Cl2    36 (76) 5 3.8:1 
2 
0 
CH2Cl2 32 (87) 5 3:1 36 (95) 5 3.4:1 
3 CH2Cl2 32 (68) 30 2.6:1    
4 THF 32 (15) a 60 5:1    
5 Et2O 32 (70) 40 3:1    
6 Tol:Dioxane (1:3) 32 (54) 
b 10 2.5:1    
7 
-60 
CH2Cl2 32 (83) 5 1.5:1 36 (81) 15 1.8:1 
8 Et2O 32 (40) 86 2.2:1    
9 
6 
0 
CH2Cl2 33 (92) 5 2.8:1    
10 Et2O 33 (84) 40 2.7:1    
11 
-60 
CH2Cl2 33 (82) 10 1.7:1    
12 Et2O 33 (86) 40 4:1    
13 
7 
0 
CH2Cl2 34 (87) 5 3:1 37 (80) c 5 3:1 
14 Et2O 34 (92) 15 2.2:1    
15 
-60 
CH2Cl2 34 (96) 5 1.2:1    
16 Et2O 34 (95) 15 1.4:1    
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17 9 
0 CH2Cl2 
35 (70) 5 2.4:1 38 (86) 5 2.6:1 
18 22    39 (68) 5 2.4:1 
19 23    40 (63) 5 1:2.3 
20 24    41 (70) 5 1.4:1 
21 25    42 (57) 5 1:1.7 
22 26    43 (82) 5 1:1.3 
23 27    44 (70) 5 1:0 
24 28    45 (97) c 30 1:1 
25 29    46 (85) 5 1:1.5 
26 30    47 (93) 5 1:1.2 
27 31    48 (91) 5 2:1 
a 43% of starting material and 38% of the hydrolysis product were recovered. b 18% of the 
hydrolysis product was recovered. c More equivalents of TfOH were added during the reaction. 
 
  Contrary to what happened with the glucose donors, glycosylation with 
methyl (S)-lactate using dichloromethane (Table 3, entry 2) as solvent gave 
better results than ethereal solvents. Also when using dichloromethane the 
reaction times were shorter and by leaving the reaction longer, the anomeric 
selectivity and the yield were decreased (Table 3, entry 3). Galactosylation in 
THF afforded the highest selectivity (α/β 5:1, Table 3, entry 4) but 
unfortunately the reaction time was longer, the yield was only 15% and we 
recovered 43% of starting material and 38% of the hydrolysis product.	  
  The toluene/dioxane (1:3) mixture, employed by Boons and co-workers19, 
afforded not only the lowest selectivity but also low yield (α/β 2.5:1, 54%, 
Table 3, entry 6). When using diethyl ether the same α/β ratio 3:1 was 
obtained as in dichloromethane but the reaction time was longer and the yield 
was lower (Table 3, entry 5).	  
  When comparing the results obtained for the galactosylation reaction at 
different temperatures, the temperature dependence is obvious and that the 
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higher α-selectivites were obtained at higher reaction temperatures (Table 3, 
entries 1-2 and 7). This effect has been attributed to the fact that the addition 
to the donor at low temperatures (-60ºC) is subjected to kinetic control, and 
when the temperature is increased the effect of the remote neighbouring 
group at C-6 is enhanced.9 
  Experiments with the bulkier benzyl (S)-lactate in dichloromethane did not 
improve the anomeric selectivity (Table 3, entries 9 and 11), but when using 
ethyl ether as solvent at -60ºC the α/β ratio increased to 4:1 (Table 3, entry 
12). Reaction with the primary hydroxyl group of methyl glycolate in 
dichloromethane at 0ºC afforded  a α/β ratio of 3:1 (Table 3, entry 13) and 
worst results were obtained when other conditions were tested (Table 3, 
entries 14-16). 
  Having found that the best solvent for the glycosylation reaction of 
thiogalactoside donor 19 was dichloromethane, a series of experiments were 
performed with thiogalactoside donor 21 in order to assess if a more electron-
withdrawing group at the C-6 position of the donor would have a dramatic 
effect on the selectivity of the reaction. 
  The results of the glycosylation reaction of donor 21 with methyl (S)-lactate 
in dichloromethane at different temperatures (Table 3, entries 1-2 and 6), 
confirmed the temperature dependence. The lower the reaction temperature 
the lower the anomeric selectivity, and the higher the reaction temperature the 
lower the yield of the reaction.	  
  When comparing the results obtained for the two donors (19 and 21), we 
found that using the chloroacetyl thiogalactoside 21 with the small and 
reactive acceptors did not improve the anomeric selectivity and the reaction 
time remained the same (Table 3, entries 2, 7, 13 and 17). However, in the 
case of benzyl (S)-mandelate it was obtained exclusively the α-anomer (Table 
3, entry 23). 
  Contrary to what was expected, glycosylation of donor 21 with bulkier and 
less reactive acceptors (Table 3, entries 18-22 and 24-25) afforded lower 
anomeric selectivity, with more β anomer being obtained. 
  As predictable, thiogalactoside donors were more reactive and less selective 
than the corresponding thioglucosides. These results were in accordance with 
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the work of Wong and co-workers23 who studied the structural effect of 
monosaccharides on the reactivity of the glycosylation reaction by comparing 
reaction rates of several thioglycoside donors with MeOH using NIS/TfOH 
system. In this study, for example, the perbenzylated tolylthiogalactoside 
reacts 6.4 times faster than the corresponding thioglucoside, which was 
explained by the stereo and inductive effects and possible involvement of the 
axial 4-O lone-pair electrons in the stabilization of the oxocarbenium ion 
intermediate. 
  The concept of an axial polar substituent stabilizing a positive charge to a 
higher degree than the corresponding equatorial equivalent explains these 
findings, and is the concept behind the idea of very reactive super-armed 
glycosyl donors developed by Bols and co-workers24. Super-armed donors 
are synthesised by forcing conformational changes, in this case forcing the 
oxygen substituents into an axial position by choosing bulky silyl protecting 
groups. 
  Since changing the solvent system and temperature were unable to improve 
the selectivity of the glycosylation reaction for the synthesis of galactosyl 
derivatives, based on the work of Bols24 a super-armed thiogalactosyl donor 
50 (Scheme 9) was designed, synthesised and studied. Super armed donor 
50 was synthesised in five steps from D-galactose, which after selective 
protection of the primary hydroxyl group at C-6 position of the ethyl β-D-
thiogalactoside in the form of trityl ether25 49 was silylated with TBDMSOTf 
according to literature24. When protected with bulky silyl groups, donor 50 
(Scheme 9) would suffer a conformational change to a more “axial-rich” 
conformation that would enhance their reactivity. 
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Scheme 9. Synthesis of super armed thiogalactosyl donor 50. 
 
  Since in solution donor 50 is in slow equilibrium between several conformers 
the peaks on 1H NMR spectra were broad and complex. The quality of the 
spectra could be improved by cooling the samples in CDCl3 to -30°C where 
the equilibration was slow and the different conformers gave sharper signals. 
To test the donor, the glycosylation reaction was performed using the 
NIS/TfOH system as the promoter in dichloromethane at -78ºC, and as 
acceptors methyl (S)-lactate 4 and methyl glycerate 9 (Scheme 10). 
 
O
TBDMSO
TBDMSO
TBDMSO
SEt
OTr
a O
TBDMSO
TBDMSO
TBDMSOOR
OTr
50
a) ROH: 4 or 9, NIS, TfOH, 4A MS, CH2Cl2, -78ºC.
51, R: (S)-CH(CH3)CO2Me , 48%, α/β=1:0.
52, R: (R)-CH(CH2OTBDPS)CO2Me, 22%, α/β=1:0.
 
Scheme 10. Glycosylation reaction of super armed thiogalactosyl donor 50. 
	  
  Despite the fact of the good 1,2-cis selectivities achieved for both acceptors, 
the yields obtained were disappointing (Scheme 10) due to degradation of the 
initial donor. Examples in literature24 show higher yields when other sugars 
are used as acceptors, which are not comparable to our relatively small and 
reactive alcohols with few functional groups. Possibly with less reactive 
acceptors this would be an efficient approach. Moreover, the super armed 
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thiogalactosyl donor used in literature bears a benzyl group at the C-6 
position, the acid lability of the trityl group of donor 50 can also explain the 
differences in the yields obtained. 
  Aiming for a selective and efficient method to obtain the α-galactosyl 
derivatives, based on works reported on literature5, 6, 8-10, the influence of 
remote neighbouring group at C-4 position of the donor was studied. 
  Boons and co-workers8 observed the effect of having a participating 
neighboring group at C-4 position of thiogalactosyl donors for the 
stereochemical outcome of glycosylations. They tested several tribenzylated 
thiogalactosides bearing different groups at C-4 position, and obtained high α-
anomeric selectivity when using electron-donating groups (like esters) in a 
1,4-dioxane/toluene solvent system. Kalikanda et al.5 followed the same 
rationale and tested a dibenzylated thiogalactoside donor bearing acetate 
groups at C-3 and C-4 positions using the NIS/TfOH promoter system in 
dichloromethane. Excellent α-selectivity was observed in all test reactions 
using other glycosides as glycosyl acceptors and a superior stereoselectivity 
was observed when compared with tetrabenzyl protected galactose donor. 
  This C-4 participating neighboring group effect was also found in studies with 
other types of donors, for example Lin and co-workers9 reported that 
galactosyl phosphite donors bearing acyl remote participating groups 
(benzoyl) at C-4 and C-6 positions promoted high α-anomeric selectivities in 
glycosylations with primary and secondary hydroxyl acceptors. In a more 
recent study, Matta and coworkers10 compared the use of dibenzoyl esters to 
benzylidene as protective groups at C-4 and C-6 positions of 
trichloroacetimidate donors with 2-naphtylmethyl (NAP) non-participating 
group at C-2, and the higher α-selectivities in the glycosylations were 
obtained with the dibenzoyl trichloroacetimidate donor.  
  Based on these studies, thiogalactoside donors 57 and 58 were synthesised 
with a further acetate or chloroacetyl group respectively at C-4 position. The 
diacetate thiogalactosyl donor 57 was prepared in seven steps according to 
the literature26,27,28 from D-galactose (Scheme 11) using standard protection 
and deprotection steps. The dichloroacetyl thiogalactosyl donor 58 was 
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prepared in the same manner from diol 56 after esterification with chloroacetic 
anhydride (Scheme 11). 
 
 
57: R: Ac (100%)
58: R: AcCl (69%)
53
56
54
55
O
HO
HO
OH
OHHO
O
HO
HO
OH
SPh
HO
D-Galactose
a, b, c d O
O
HO
O
SPh
HO
Ph
O
O
BnO
O
SPh
BnO
Ph
e
O
HO
BnO
OH
SPh
BnO
O
RO
BnO
OR
SPh
BnO
f g
a) Ac2O, DMAP, Py, 0ºC-r.t. b) PhSH, BF3.Et2O, CH2Cl2, reflux, over-night. (90% in two steps.) c) NaOMe,
MeOH, 0ºC-r.t., 98%. d) PhCH(OMe)2, CSA, THF, reflux, 90%. e) BnBr, NaH, DMF, 0ºC, 86%. f) MeOH: CH2Cl2 
(2:1), p-TSOH (cat.), r.t., 88%. g) Ac2O or Chloroacetic anhydride, Py, 0ºC. 	  
Scheme 11. Synthesis of thiogalactosyl donors 57 and 58. 
 
 
  Donors 57 and 58 were used in the glycosylation study with several 
acceptors (Figure 3, Figure 4) at different temperatures using the NIS/TfOH 
system in dichloromethane, the solvent in which previously we obtained the 
best results for thiogalactoside donors 19 and 21. The results are presented in 
Table 4.  
  When comparing the results obtained with the thiogalactosyl donors 57 and 
58 (Table 4) to the ones obtained previously with donor 21 (Table 3) the di-
acetyl donors gave, in general, significant higher α-anomeric selectivities for 
almost all of the acceptors. As expected, dichloroacetyl donor 58 provided 
higher α selectivity than the diacetate donor 57, which can be explained by 
having stronger electron-withdrawing esters. Also diethyl ether proved to be, 
once more, a worst solvent than dichloromethane for the glycosylations with 
galactose. 
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Table 4. Effect of solvent and temperature on the stereoselectivity of the glycosylation 
of donor 57 and 58. 
NIS, TfOH, 4A MSO
RO
BnO
OR
SEtBnO
R'OH
O
RO
BnO
OR
OR'BnO
57: R=Ac
58: R=AcCl 	  
Entry R’OH T (ºC) Solvent 
Donor 57 Donor 58 
Product 
(Yield,%) 
t 
(mn) α/β 
Product 
(Yield,%) 
t 
(mn) α/β 
1 
4 
r.t. CH2Cl2 59 (96) 5 10:1 72 (67) 5 1:0 
2 
0 
CH2Cl2 59 (80) 5 10:1 72 (74) 5 1:0 
3 Et2O 
59 (56) 
a, b 110 6.7:1 
72 (20) 
a, c 110 1:0 
4 -60 CH2Cl2 59 (91) 15 8.6:1 72 (63) d 15 1:0 
5 7 
0 CH2Cl2 
60 (84) a 15 6.3:1 73 (63) a 5 7.5:1 
6 9 61 (90) 5 1:0 74 (86) 5 1:0 
7 22 62 (86) 5 1:0 75 (69) 5 1:0 
8 23 63 (77) 5 1.2:0 76 (63) 5 1.5:1 
9 24 64 (69) 15 1:0 77 (89) 15 1:0 
10 25 65 (91) 5 2.2:1 78 (41) 15 3.8:1 
11 26 66 (91) 5 6.5:1 79 (89) 5 6.2:1 
12 27 67 (68) 5 1:0 80 (79) 5 1:0 
13 28 68 (99) a 40 1.9:1 81 (99) a 60 1.5:1 
14 29 69 (85) 5 2.7:1 82 (94) 5 3.4:1 
15 30 70 (78) a 50 1.1:1 83 (87) 5 2.5:1 
16 31 71 (69) e 5 2:1 84 (73) f 5 2:1 
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Caption of Table 4: a More equivalents of TfOH were added during the reaction. a 15% of starting 
material was recovered. b 50% of starting material was recovered. d 19% of the hydrolysis product 
was recovered. e 21% of starting material was recovered. f 20% of starting material was 
recovered. 
 
  Galactosylation with more hindered small acceptors afforded higher 
anomeric selectivities (Table 4, entries 1-7 and 12). When methyl (R)-
glycerate 9 and the glycerol 22 (Table 4, entries 6 and 7) were used as 
acceptors both donors 57 and 58 provided only the α-anomer. In the case of 
the small and reactive methyl (S)-lactate 4, the α-anomer was exclusively 
obtained when using thiogalactosyl donor 58 (Table 4, entries 1-4). 
Glycosylation with benzyl (S)-mandelate, as it was previously seen with donor 
21, also afforded only the α-galactoside. 
  In most of the studies found in the literature that showed good α-selectivities 
the acceptors used were other glycosides, mono or higher saccarides, and 
the same happened when another sugar was used as the acceptor, the α-
anomer was formed exclusively (Table 4, entry 9). 
  In some cases, like when using EPA 25, adamantanol 26 and menthol 29 as 
acceptors, even though the improvement was not as significant as in other 
cases, the selectivity of the reaction was inversed (Table 4, entries 10-11 and 
14) when compared with the results obtained with donor 21 (Table 3, entries 
21-22 and 25). In the case of the reaction with the EPA acceptor (Table 4, 
entry 10) a superior stereoselectivity was obtained (donor 57 α/β 2.2:1, donor 
58 α/β 3.8:1) when compared with the results obtained in literature29 for the 
tetrabenzyl protected galactose donor with cholestanol a very similar molecule 
to EPA (α/β 1:1). 
  The lipophilic primary alcohols, 23 and 28 (Table 4, entries 8 and 13), with 
both donors gave the worst α/β ratios showing no selectivity and no tendency 
for improvement. This lack of stereocontrol can be explained by the tendency 
of lipids to aggregate and hence change reactivity.30 
  In the case of N-Boc serine methyl ester 31 there was no improvement 
(Table 4, entry 16), the α/β ratio (2:1) was the same as with donor 21 (Table 
3, entry 27). A low α-selectivity for the glycosylation of N-acylated β-hydroxy 
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amino acids have been explained in the literature31 by a decrease in the 
nucleophilicity of the glycosyl acceptor due to hydrogen-bonding between the 
OH and NH groups of the acceptor. Also, the use of Fmoc as the amine 
protecting group instead of Boc, and the use of a benzyl ester instead of 
methyl ester as the carboxyl protecting group have both proven to improve the 
α-selectivity of the reaction31,32. However, this was not attempted in this 
study. 
  The results obtained undoubtedly confirm the importance of the ester 
functionality at the C-4 position of the thiogalactosyl donor for the 
stereoselectivity of the glycosylation reaction. Although the 4-O-chloroacetyl 
group could disarm the system slightly, the higher α-stereoselectivity can be 
attributed to a remote stereocontrol and electronic effect of the C-4 ester in 
the galactoside donor. Boons8, Kalikanda5, Lin9 and Matta10 have suggested 
the possibility of remote group participation by axial carboxylated esters on C-
4 position leading to improved synthesis of α-galactosides. This hypothesis 
was studied by Crich and co-workers2, 12 who found no experimental 
evidence in support of neighbouring group participation at this position and at 
the C-6 position. Crich defends that no single effect is responsible for these 
results and the mechanism for this remote stereocontrol is still unknown. The 
remarkable α-anomeric selectivities obtained with donors 57 and 58 cannot 
be explained by neighbouring group participation of the esters at C-4 and C-6, 
but to stereoelectronic and conformational influences. The preferential 
formation of the α-anomer can be explained based on the system proposed 
by Crich15 (Scheme 4) and on the reactivity of the respective triflate 
intermediates, where the β-triflate, being unstable and more reactive shifts the 
equilibrium towards the formation of the α-galactoside by nucleophilic 
substitution by the alcohol in an SN2 manner. 
1,2-cis Stereoselective 2-Azido-2-DeoxyGlucosylations 
 
  Glucosamine is one of the most abundant monosaccharides and an 
important building block present in many natural molecules involved in a 
number of biological processes. Although structurally similar to glucose it 
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possesses an amine group in the C-2 position that in solution and according 
to pH can be charged. In order to study the effect of an amine group, 
glucosamine analogues were synthesised. Synthesis of 1,2-trans 2-amino-2-
deoxy-glycosides can be achieved by applying the C-2 neighbouring group 
participation methodology, however 1,2-cis 2-amino-2-deoxy-glycosides face 
the same problems that we presented for 1,2-cis glucosides and galactosides. 
  For the synthesis of the α-glucosamine analogues, the most common way is 
to protect the amino functionality by masking it in the form of an azide at C-2 
position of the donor. The use of 2-azido-2-deoxyglucosyl the 
trichloroacetimidate donors for the synthesis of α-glucosamine compounds 
have been widely reported, due to the non-participating nature of the azide 
group and subsequent convenient conversion to the amine. Similar 
glycosylations using thioglycosides have been less studied. 
  Several 2-azido-2-deoxythioglucosides were prepared from the readily 
available glucosamine hydrochloride salt that after treatment with imidazole-1-
sulfonyl azide hydrochloride salt, followed by acetylation, produced per-O-
acetyl 2-azido-2-deoxyglucosyl acetate (Scheme 12).33 Thioglucoside 
formation with the respective thiol in the presence of boron trifluoride–diethyl 
ether was sluggish and 20-30% of the initial acetate was recovered. In the 
future the solution to this problem could be the use of sonication34, 35, 
however we did not test this method. Thioglycosides 85 and 86 were 
deacetylated by the Zemplé method and the primary hydroxyl group 
selectively silylated before benzylation of the secondary hydroxyl groups. The 
2-azidoper-O-benzyl-2-deoxythioglucoside donor 92 (Scheme 12) was 
obtained as a by-product of the benzylation reaction of compound 87 in 7% 
yield. After deprotection of the silyl group, esterification with acetic or 
chloroacetic anhydride gave donors 89-91. 
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O
AcO
AcO
SR1N3
OAc
OHO
HO
OHHCl.H2N
OH
a,b
e,f,g O
BnO
BnO
SR1N3
OR2
c,d
O
HO
HO
SR1N3
OTBDPS
85 R1= Ph (77%)
86 R1= Tol (60%)
a) (i) K2CO3, CuSO4.5H2O, imidazole-1-sulfonyl azide hydrochloride, MeOH, r.t. (ii) Ac2O, Py, DMAP, r.t.,
82% (over two steps). b) PhSH or TolSH, BF3.OEt2, CH2Cl2, 0ºC-r.t. c) NaOMe, MeOH, 0ºC-r.t. d)
TBDPSCl, Py, DMAP, r.t. e) NaH, BnBr, DMF, 0ºC-r.t. f) TBAF, THF, r.t. g) Ac2O or ClAc2O, Py, DMAP, r.t.
D-Glucosamine
hydrochloride
87 R1= Ph (90%)
88 R1= Tol (98%)
89 R1= Ph; R2= Ac (68%)
90 R1= Ph; R2= AcCl (66%)
91 R1= Tol; R2= AcCl (82%)
92 R1= SPh; R2= Bn
 
Scheme 12. Synthesis of 2-azido-2-deoxythioglucoside donors 89-92. 
 
 
  Following our line of work and aiming to determine the best conditions to 
obtain the new synthetic 1,2-cis glucosamine analogues, the influence of the 
different protecting groups at the 6-position of the donor, as well as the 
solvent and the temperature on these glycosylations, were studied. Using the 
NIS/TfOH system as the promoter and methyl (S)-lactate 4 as the acceptor. 
These results are presented in Table 5. 
  Since most common solvents found in literature for these donors are 
dichloromethane and diethyl ether, initial studies of the reactivity of the donors 
were done in dichloromethane. The selectivities were generally lower than 
those for the corresponding thioglucosides donors and lowering the 
temperature showed no great impact on the selectivity, however the reaction 
time increased considerably (Table 5, entries 7 and 12). Contrary to what 
happened with thioglucoside donors, when using ethyl ether as solvent 2-
azido-2-deoxythioglucosides donors did not react and the initial donor was 
recovered (Table 5, entries 5 and 10).  
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Table 5. Effect of solvent, temperature and protecting groups on the stereoselectivity 
of the glycosylation of donors 89-92. 
OBnO
BnO
SR1N3
OR2
O
BnO
BnO
ON3
OR2
NIS, TfOH,
4Å MS
89-92
CO2Me
OH
CO2Me
	  
Entry R1 R2 T (ºC) Solvent 
Product 
(Yield,%) 
t 
(mn) α /β  
1 
Ph 
Bn 
 -10 
CH2Cl2 93 (73) 10 1:1 
2 CH2Cl2:Et2O (1:1.8) a 93 (78) 120 2.6:1 
3 
Ac 
 
r.t. CH2Cl2 94 (87) 5 3:1 
4 
-10 
CH2Cl2 94 (90) 10 3.5:1 
5 Et2O 94 (0) b 90 - 
6 CH2Cl2:Et2O (1:1.8) a 94 (96) 120 7.3:1 
7 -78 CH2Cl2 94 (98) 120 2.5:1 
8 
AcCl 
 
r.t. CH2Cl2 95 (96) 5 3.6:1 
9 
-10 
CH2Cl2 95 (85) 10 4.2:1 
10 Et2O 95 (0) b 90 - 
11 CH2Cl2:Et2O (1:2) a 95 (84) 120 8.7:1 
12 -78 CH2Cl2 95 (87) 120 4.2:1 
13 
Tol AcCl  
-10 
CH2Cl2 95 (93) 10 4:1 
14 CH2Cl2:Et2O (1:2) a 95 (99) 120 10.3:1 
15 -78 CH2Cl2:Et2O (1:2) a 95 (99) 120 8:1 
a Adition of NIS(2 eq.)/TfOH system in solution. 
b Recovery of the initial donor. 
 
  Wong and co-workers36 reported the use of a solvent mixture of CH2Cl2/Et2O 
(1:4) with the NIS/TfOH system for obtaining α-2-azido-2-deoxyglucosides 
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from a tribenzylated 2-azido-2-deoxythioglucoside 92. The selectivity obtained 
for the glycosylation using 2-deoxystreptamine as acceptor was in the range 
of 10:1 α/β ratio and 58% yield. The use of diethyl ether as cosolvent was 
fundamental to this selectivity because when the reaction was performed in 
dichloromethane at -78°C the α/β ratio was only 2.5:1. Using the CH2Cl2/Et2O 
(1:4) solvent combination employed by Wong36 and direct addition of the 
NIS/TfOH system to the reaction mixture, did not afford any improvement and 
we recovered the initial donor. However, when using this solvent combination 
and adding the NIS/TfOH system in solution to the reaction mixture there was 
a remarkable improvement of the α-selectivity for almost all of the donors 
(Table 5, entries 6, 11 and 14). Performing the reaction at a lower 
temperature lowered the selectivity from 10.3:1 α/β ratio at 0ºC to 8:1 at -78ºC 
(Table 5, entries 14 and15). 
  Other important aspect is that when using these conditions but only one 
equivalent of NIS, the reaction was incomplete and the initial donor was 
recovered. This problem was overcome by the addition of two equivalents of 
NIS. Although the influence of the anomeric thio-group for the stereoselectivity 
of the glycosylation has been reported in literature37, in this case this effect is 
less obvious since phenyl and tolyl are both bulky thio-groups with similar 
properties. 
  Comparing the results obtained with different protecting groups at the 6-
position of the donors it is evident that the presence of an ester-protecting 
group at this position influences the stereoselectivity of the reaction. Donors 
89, 90 and 91 showed higher α-selectivity than 92. 
  Since the best results for the glycosylation reaction with methyl (S)-lactate 
were obtained using a mixture of CH2Cl2/Et2O (1:4) at -10ºC with donor 91 
(Table 5, entry 14), these conditions were selected to study the selectivity of 
the reaction using a wide range of acceptors (Figure 3, Figure 4) under these 
conditions. The results are presented on Table 6. 
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Table 6. Glycosylation of donor 91 with different acceptors. 
O
BnO
BnO
STolN3
OAcCl
O
BnO
BnO
ORN3
OAcCl
NIS, TfOH, 4Å MS, 
CH2Cl2:Et2O (1:4),
-10ºC
ROH
91 	  
	  
Entry R3OH Product (Yield,%) 
t 
(mn) α /β  
1 HO CO2Me   
7 
96 (76) 180 12:1 
2 CO2Me
OH
TBDPSO
  
9 
97 (84) 120 >10:1 
3 
OBnO
BnO
O
BnO
OH
CO2Me
OTBDPS
  
24 
98 (42)(a) 120 5:1 
4 
OH
  
26 
99 (50) 120 6.2:1 
5 
HO
O
H
H
H H
 
25 
100 (46)(a) 120 3.2:1 
a	  Recovery of the initial donor.	  
 
 
  Glycosylation with small and reactive donors, such as methyl glycolate 7 and 
methyl glycerate 9, gave better α-selectivities and better yields (Table 6, entry 
1 and 2). When the acceptor was bulkier the stereoselectivity of the reaction 
was lower, so were the yields and non-reacted initial donor was recovered 
(Table 6, entry 3-5). 
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Conclusion	  
 
  The determinant step during the synthesis of any oligosaccharide, 
glycoconjugates or glycosides is the control of the anomeric stereochemistry 
during the course of the glycosylation reaction. 
  In this study, several thioglycosides derived from glucose, galactose and 
glucosamine were synthesised in order to determine the best reaction 
conditions to obtain stereoselectively 1,2-cis glycosides. Since the 
stereoselectivity of the glycosylation reaction is dependent of many factors, 
the influence of solvent, temperature and reactivity of its components (like 
nature and position of protecting groups, and different acceptors) were 
studied. All synthesised thioglycoside donors were stable to many different 
chemical manipulations, and under the presence of soft electrophilic reagents, 
such as the NIS/TfOH promoter system, afforded clean glycosylations. 
  As expected, the best results for the synthesis of 1,2-cis glucosides with the 
thioglucosides 1 and 3 were obtained when using ethyl ether as the solvent 
for all the small and reactive acceptors tested. Also, the α-selectivity could be 
further improved by lowering the reaction temperature to -60ºC. The presence 
of the ester group at the C-6 position proved to be important for the 
stereoselectivity and this effect can be enhanced by the presence of a 
stronger electron-withdrawing group at this position. 
  Using the same conditions for the synthesis of 1,2-cis galactosides, 
glycosylations with the thiogalactosides 19 and 21 produced lower 
stereoselectivities, which could not be improved by changing the solvent or 
the temperature. These findings could be explained by the higher reactivity 
and shorter reaction times of thiogalactoside donors when compared to the 
corresponding thioglucosides. Nevertheless the conditions that showed best 
α-selectivities were dichloromethane at -10ºC. Trying to develop an efficient 
method for the synthesis of 1,2-cis galactosides, a super-armed thiogalactosyl 
donor 50 was synthesised and tested. Although glycosylation with the small 
and reactive acceptors gave only the desired α-products, the yields were 
poor.  
  The influence of the nature of the protecting group at the C-4 position of 
galactosyl donors on the stereochemical outcome of the glycosylation reaction 
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was studied. Thiogalactosyl donors bearing acetyl and chloroacetyl groups 
both on C-4 and C-6 positions were synthesised, and higher α-selectivities 
were obtained with almost all the acceptors tested in this reaction, proving the 
α-directing effect of ester functionalities at the C-4 position of galactosyl 
donors. In addition, comparing the results obtain for the two donors (57 and 
58) led to the conclusion that stronger electron-withdrawing groups gave 
better results, in our case the dichloroacetyl thiogalactosyl donor 58. 
  For the synthesis of the α-glucosamine analogues, several 2-azido-2-
deoxythioglucoside donors were synthesised, with the amine group 
conveniently protected in the form of a non-participating azide, which 
afterwards could be converted to the amine. Performing the glycosylation 
reaction at -10 ºC and the use of a mixture of CH2Cl2:Et2O (1:4) as solvent 
improved the anomeric selectivity favoring the α product. Glycosylation with 
small and reactive acceptors gave better results than the ones obtained with 
bulkier and less reactive alcohols. 
  Regarding the results obtained for each hexose, reactivity is dependent on 
their structure and of the protecting groups used. Each hexose needs to be 
considered independently and the conditions of the reaction optimized 
according to it.  
  In these studies with the different hexoses, when comparing different 
acceptors it is clear that the reactivity and structure of the acceptors plays an 
important role on the stereoselectivity of the glycosylation reaction. In most of 
the studies described in the literature the acceptors are other sugars or bulkier 
molecules that can interact in several ways with the donor, so the results 
cannot be compared to the small reactive acceptors that we used. Moreover, 
alcohol reactivity is typically known to be inversely correlated with the 1,2-cis 
stereoselectivity meaning that, most reactive hydroxyls are stronger 
nucleophiles, giving faster reactions which being difficult to control produce 
lower α-selectivities. Acknowledging this, the good results obtained in some 
cases with the small reactive acceptors were highly rewarding. 
  In summary, although many factors that influence stereoselectivity have 
been object of study for many years, it is still difficult to find a general method 
to obtain 1,2-cis glycosides or predict the α stereoselectivity when using 
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different acceptors. Furthermore, full understanding of the mechanisms 
involved in the glycosylation reaction would provide insight for the 
development of methodologies to control anomeric stereochemistry. In this 
study, different methods were developed to enhance the α-selectivity for the 
synthesis of 1,2-cis glucosides, galactosides and glucosamines that are 
intermediates in the synthesis of several analogues of hypersolutes. The 
methods developed can be very useful for the efficient synthesis of higher 
saccharides.  
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Abstract	  
 
  An efficient and stereocontrolled synthesis of the recently isolated and rare 
natural solute α-D-mannopyranosyl-(1→2)-α-D-glucopyranosyl-(1→2)-D-
glycerate potassium salt (MGG) was achieved in solution and on solid 
support. Different strategies using two thioglucosides bearing a free C-2 
hydroxyl group were tested in solution. These thioglucosides were used as 
glycosyl acceptors in the first glycosylation reaction with the 
tetraacetylmannosyl trichloroacetimidate, and as donors in the second 
glycosylation reaction with the glycerate acceptor. The glycosylation reactions 
with both thioglucosides were highly stereoselective affording exclusively the 
α-anomer. For the solid supported synthesis the thioglucoside donor/acceptor 
was efficiently immobilized on the solid support (Tentagel MB-NH2) by the C-6 
hydroxyl group using a succinate linker, and successfully used in the 
synthesis of MGG. 
	  
	  
Introduction	  
 
  The study of the intracellular accumulation of organic solutes in Petrotoga 
miotherma1 led to the identification of a new solute, α-D-mannopyranosyl-
(1→2)-α-D-glucopyranosyl-(1→2)-D-glycerate (MGG, Figure 5), which more 
recently was also isolated from Petrotoga mobilis2. While in Petrotoga 
miotherma1, MGG is accumulated during low-level of osmotic adaptation and 
it is not used against oxidative or heat stress, in Petrotoga mobilis2 it is the 
major compatible solute under osmotic and thermal stress. The ability of MGG 
to protect malate dehydrogenase (pig heart MDH), a model enzyme, against 
heat inactivation and freeze-drying led to a patent for the stabilization and 
preservation of biomaterials.1 Until the present date, these are the only two 
organisms known to accumulate MGG. 
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Figure 5. MGG, 101. 
 
  The structure of the novel MGG which was established to be (2R)-2-O-α-D-
mannopyranosyl-(1→2)-α-D-glucopyranosyl-2,3-dihydroxypropanoate,  is 
related to the compatible solutes α-D-mannosyl-D-glycerate (MG), α-D-
glucosyl-D-glycerate (GG) and  α-D-glucopyranosyl-(1→6)-α-D-
glucopyranosyl-(1→2)-D-glycerate (GGG) (Figure 1), where a hexose moiety 
is α-lynked to the C-2 of a glyceric unit. Since this hypersolute is available in 
very small amounts from its natural sources, chemical synthesis was 
considered the best route to obtain, study and confirm the structure of the 
isolated compound.  
  Chemical synthesis of carbohydrates normally includes time-consuming 
protecting group manipulations to differentiate several hydroxyl groups of 
similar reactivity, complicated stereoselective glycosylations and long overall 
routes. Impelled by the automated solid phase oligopeptide and 
oligonucleotide synthesis different strategies for the assembly of 
oligosaccharides on solid supports have been developed to allow a more 
efficient preparation of these compounds in a relatively short time.3, 4 
  The use of polymer bound scaffolds has attractive advantages, like: better 
yields due to the use of excess reagents; simpler, easier and faster 
purification steps, since excess reagents and non-bound by-products are 
removed by washing the solid support; and it is a 
chemically/environmentally/economically sustainable process, because even 
though excess reagents are used there is less use of solvents. 
When planning the synthesis of oligosaccharides on solid support some 
considerations need to be taken, such as: the design of an overall synthetic 
strategy (protective groups, experimental conditions and the stereospecificity 
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of the glycosylation reaction); the selection of a suitable solid support and 
linker; and how the reactions are monitored. 
  In general, there are two main strategies for the solid supported synthesis of 
these molecules: attachment of the glycosyl donor to the polymeric support 
via an anchoring group (donor-bound strategy, Scheme 13), or attachment of 
the glycosyl acceptor by fixing the anomeric position to the support (acceptor-
bound strategy, Scheme 13). Alternatively, mixed strategies of these two have 
been explored leading to a bidirectional synthesis approach, where a glycosyl 
donor/acceptor is immobilised to the solid support bearing at the same time a 
suitably differentiated acceptor site and an anomeric donor function for chain 
elongation in two directions (Scheme 13).  
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Scheme 13. Solid support synthetic strategies (X, Y: leaving group). 
 
  Selection of the solid support is determinant for the synthesis design since it 
limits the use of reagents and reaction conditions. In this case, a commercially 
available copolymer of polyethylene glycol (PEG) and polysterene (PS), 
known as Tentagel-NH2, was used as solid support. Even though, these 
copolymers have amphiphilic properties the presence of 50-70% of PEG 
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chains determines the properties they exhibit. The possibility of using a wide 
range of solvents, from protic to aprotic, is one of the biggest advantages of 
this type of resins. The localisation of the reactive site at the end of the long 
PEG flexible spacer well separated from the PS backbone, allows the high 
mobility of these chains and the immobilised molecules to exhibit a “solution-
like” behaviour5, 6, which is the reason for the successful use of Tentagel 
resins in oligosaccharide synthesis7, 8. Flexibility, mobility, accessibility and 
solvation properties allow the reaction to be conducted almost as in a 
homogenous solution. However, when compared with other resins, Tentagel 
resins are less stable, more expensive and have lower loading capacity. 
  Other determinant step when planning the synthesis is the choice of the 
appropriate linker between the solid support and first monosaccharide, since it 
will determine all other protecting-group and coupling manipulations. The 
linker can be considered as a protecting group that is attached to the solid 
support, but is essential that the linker forms stable linkages with both the 
resin and the donor, to be inert to all reaction conditions and easily cleaved at 
the end of the synthesis. 
  Although, solid supported synthesis has been successfully used in 
oligopeptide and oligonucleotide synthesis, oligosaccharide synthesis often 
affords lower overall yields, since efficiency of glycosylations on solid support 
are significantly lower (50-90%) than that of peptide bond formation (>95%)4. 
This can be explained by the existence of highly reactive and unstable 
intermediary species giving rise to different by-products. 
  The use of solid supported synthesis is also limited due to: the need for well 
established reaction conditions; the reactivity of the molecules attached to the 
solid support may be different than in solution; the high cost of some solid 
supports; and difficulty in monitoring the reaction and characterising products 
or intermediates during the course of the synthesis. 
  The present work describes the synthesis of the MGG using two different 
strategies, one in solution and other using a solid support.  
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Results	  and	  Discussion	  
	  
Solution-phase Synthesis 
 
  The main challenges in the synthesis of MGG 101 were the need for the C-2 
hydroxyl group of glucose to be free in order to form a glycosidic bond with 
mannose, and the stereoselective formation of the 1,2-cis glucosidic bond 
with glycerate. 
  For the synthesis of MGG in solution, a strategy was developed based on 
thioglycoside 1029 bearing a free hydroxyl group at C-2, and at the same time 
similar to the donor developed by Crich et al.10, 11 which have proved to 
provide α-glucosides with high stereoselectivity. Thioglucoside 102 would act 
first as a glycosyl acceptor in the reaction with the mannosyl 
trichloroacetimidate donor 103, and afterwards could be activated as a donor 
in the glycosylation reaction with the glycerate derivative 912 (Scheme 14). 
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Scheme 14. Glycosylation reactions for the solution phase synthesis of MGG, 105. 
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  The first glycosylation reaction between mannose trichloroacetimidate donor 
10313 and the thioglucoside 102 as the acceptor, using TMSOTf as the 
promoter, afforded as expected by the use of C-2 acyl neighboring group 
participation strategy exclusively the α-mannoside 104 in 74% yield. 
Glycosylation between thioglucoside 104 and methyl 3-O-tert-
butyldiphenylsilylglycerate acceptor 9, using the NIS/TMSOTf system as the 
promoter, gave the desired product 105 and no β-anomer was detected by 
NMR (Scheme 14). Although, the second glycosylation was highly selective 
the yield was only 40% due to the lability of the benzylidene-protecting group. 
The use of TMSOTf instead of TfOH was unable overcome this issue and 
23% of the deprotected product 106 was recovered. However, since the next 
step would be the deprotection of the benzylidene this was not a major 
problem. 
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Scheme 15. Deprotection strategy to obtain MGG, 101. 
	  
  Hydrolysis of the benzylidene-protecting group of fully protected MGG 105 
furnished the diol 106 (91%, Scheme 15). Selective fluorolysis of the silyl 
ether with tetrabutylammonium fluoride (TBAF, 80%), followed by 
deacetylation by Zemplé method and hydrogenolysis of the benzyl group 
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afforded the fully unprotected MGG 109 (Scheme 15). After the final 
hydrolysis of the methyl ester, MGG 101 (Scheme 15) was obtained in the 
form of the potassium salt with 34% overall yield (calculated from the first 
glycosylation reaction). The NMR data (Table 7) of the synthetic product were 
identical to those described in literature1 for the natural product. 
	  
Table 7. Comparison of 13C NMR chemical shifts for the synthetic potassium salt of 
MGG 101 with data from the natural product1. 
13C, 
δ (ppm) 
α (1→2) mannosyl moiety 
C-1 C-2 C-3 C-4 C-5 C-6 
Natural 99.90 72.53 72.88 69.33 75.47 63.50 
Synthetic 100.1 72.7 73.1 70.6 75.7 63.9 
 
13C, 
δ (ppm) 
α (1→2) glucosyl moiety 
C-1 C-2 C-3 C-4 C-5 C-6 
Natural 96.60 76.76 73.85 72.24 74.62 63.30 
Synthetic 96.8 76.9 74.1 72.5 74.8 63.5 
 
13C, 
δ (ppm) 
Gliceryl moiety 
C-1 C-2 C-3 
Natural 179.2 81.0 65.7 
Synthetic 179.5 81.3 65.9 
 
Solid-supported Synthesis 
 
  The use of a bidirectional approach (Scheme 13) for the solid-supported 
synthesis of MGG 101 required the development of a new synthetic strategy, 
where the donor with the C-2 free hydroxyl group would be linked to the resin 
through the C-6 position. A new thioglycoside 111 was designed bearing the 
C-2 and C-6 hydroxyl groups free for manipulation (Scheme 16). Butane-2,3-
bis-acetals have been widely used in carbohydrates synthesis for the 
selective protection of vicinal diequatorial diols14, 15. Treatment of phenyl 
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thioglucopyranoside 11010 with 2,2,3,3-tetramethoxybutane afforded a 
separable mixture of 1:1 of the bisacetals 111 and 112 (Scheme 16)16, 17. The 
undesired isomer 112 could be recycled afterwards by overnight reflux in 
methanol with a catalytic amount of CSA, affording once again a 1:1 mixture 
of isomers that increased the yield of the desired isomer 111 to 70%. 
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Scheme 16. Synthesis of thioglucoside 111. 
 
  The tuning of the reaction conditions for maximum yields and anomeric 
selectivity for the synthesis of MGG 101 was first carried out using solution 
phase reactions (Scheme 17). In order to block the C-6 position selective 
silylation of the primary hydroxyl group of 111 was accomplished using tert-
butyldiphenylsilyl chloride and imidazole with 89% yield.  
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Scheme 17. Optimisation for the solid supported synthesis of MGG. 
	  
  Glycosylation of the mannose donor 103 and thioglucoside 113 as the 
acceptor, using TMSOTf as the promoter, afforded the α-product 114 in 58% 
yield. The second glycosylation reaction between disaccharide donor 114 and 
methyl 3-O-tert-butyldiphenylsilylglycerate 9, in the presence of the promoter 
NIS/TMSOTf, afforded exclusively the desired α-glucoside 115 (Scheme 17). 
The use of 6-O-bulky protecting groups on the donor, like TBDPS, for long-
range stereocontrol of 1,2-cis glucosylations has been reported in the 
literature18. Although both glycosylation reactions were highly selective the 
reason for the moderate yields was the partial hydrolysis of the acetal under 
the glycosylation conditions. 
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Scheme 18. Deprotection strategy for the synthesis of MGG, 101. 
 
  Removal of the silyl ethers of 115 with TBAF (71%), followed by hydrolysis of 
the acetal with TFA in dichloromethane/water (60%), deacetylation by the 
Zemplé method of the acetates, and final hydrolysis of the methyl ester of the 
glycerate afforded the final product MGG 101 in the form of the potassium salt 
(Scheme 18). With the strategy tested and optimized in solution we were 
ready to proceed for the synthesis on solid support. 
  Several stereoselective glycosylation reactions on solid support have been 
reported in the literature3, 19, but the exact degree of stereoselectivity is not 
predictable and there is no guarantee that the stereochemical outcome 
observed in solution-phase chemistry can be reproduced in solid-phase 
synthesis. 
  In our synthetic strategy for the solid supported synthesis of MGG 101, 
immobilization of the thioglycoside 111 on the Tentagel MB-NH2 resin was 
accomplished through a succinate bridge, involving the C-6 hydroxyl group of 
the donor and the native amino function of the Tentagel resin (Scheme 19).7, 
8, 20, 21 The succinate ester was chosen as a linker to exert the same 
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orienting effect that is assigned in literature to the acetate group in the C-6 
position of the thioglucoside donor12, 22. 
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MS, CH2Cl2, 0ºC. e) NaOMe, MeOH, r.t. f) Ac2O, pyridine, DMAP, r.t., quant.
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Scheme 19. Solid supported synthesis of MGG. 
	  
  Selective formation of the hemisuccinic acid moiety on the primary C-6 
hydroxyl group of diol 111 was achieved under basic conditions using succinic 
anhydride in good yield (90%), leaving the C-2 hydroxyl group free (Scheme 
19). Thioglucoside donor 118 was successfully anchored to the solid support 
through the formation of an amide linkage between the carboxylic group of the 
succinic acid moiety and the amine active sites of the Tentagel resin, using 
standard carbodiimide coupling. Immobilisation was confirmed by HR-MAS 
NMR spectroscopy experiments (1H, 13C and HSQC) and an initial loading of 
0.32 mmol.g-1 of resin was estimated from the dry weight difference. 
  Using a bi-directional strategy the resin-bound thioglucoside 119 first acted 
as a glycosyl acceptor in the glycosylation reaction with 
mannosyltrichloroacetimidate donor 103 using TMSOTf7, 8 as in solution. 
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Afterwards, the resulting α-disaccharide 120 was used as a donor upon 
reaction with the glycerate acceptor 9 in the presence of the NIS/TMSOTf 
promoter system20, and HR-MAS NMR experiments confirmed formation of 
the 1,2-cis glucoside 121. This technique has proven to be an excellent tool 
for monitoring the reaction progress and quickly estimated the specificity of 
the coupling step without the need to cleave the product from the resin. The 
glycosylation reactions were as selective on solid support as in solution. The 
major advantage of performing the glycosylation reactions on the solid 
support was the purification step, where the excess of reagents was simply 
washed away by filtering the resin beads.  
  Treatment of the fully protected MGG 121 attached to the solid support with 
sodium methoxide in methanol, cleaved the product from the resin and 
hydrolysed the acetate groups from the mannose moiety (Scheme 19). 
Acetylation of the free hydroxyl groups was performed in order to better purify 
and characterize the crude obtained from the resin to confirm the success of 
the polymer-bound glycosylations. 
  Overall yield of the synthesis on solid support was disappointing, 18% based 
on calculated immobilised 118. Contrary to most procedures found in 
literature that remark the use of longer glycosylation times7, 8, 20 and the need 
to cap the unreacted sites with acetate7, 8 after each reaction on solid support, 
in the present case these strategies did not make any difference to the overall 
efficiency of the synthesis. 
 
Conclusion	  
 
  In this work, the natural compatible solute MGG was synthesised in solution 
and on a solid support. The synthetic challenges of MGG were the formation 
of the 1,2-cis glycosidic bond between glucose and the secondary hydroxyl 
group of glycerate, and the design of a thioglucoside donor bearing the C-2 
hydroxyl group free for coupling with the mannose donor.  
  Solution-phase synthesis using the benzylidene protected thioglucoside 
acceptor/donor 102 afforded the final product with the overall yield of 34% 
(calculated from the first glycosylation reaction). 
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  Thioglucoside donor 111 was designed to be used in the solid-phase 
synthesis in a bidirectional approach, bearing the C-6 hydroxyl group 
differentiated to be immobilised to the resin and the C-2 position free to react 
as an acceptor with mannose. In order to test and optimise the reaction 
conditions for the solid-phase synthesis, the synthesis of MGG 101 from 
thioglucoside donor 111 was first carried out in solution with an overall yield of 
15% (calculated from the first glycosylation reaction). Solution-phase 
glycosylations using both thioglucoside donors 102 and 113 were 
stereoselective affording exclusively the α-product.  
  A similar synthesis was carried out successfully with the thioglucoside donor 
111 immobilised on a solid support (Tentagel MB-NH2 resin) by a succinate 
linker, affording a partially deprotected product in 18% overall yield. The 
stereoselectivity of the glycosylation reactions was reproducible on solid 
support, affording at each step of the synthesis only the α-product. 
  Although solid-phase synthesis seems very promising in the construction of 
carbohydrate libraries and several advances have been made in this field for 
the synthesis of complex carbohydrates there are still obstacles to overcome, 
such as the need for reactions with high degree of efficiency. Reactions with 
low degree of efficiency after several couplings lead to low quality products 
and difficulties in their isolation due to simpler purification steps. Other major 
downsize is still the high price of these resins. HR-MAS NMR proved to be a 
powerful analytical tool for the characterisation of the products while attached 
to the solid support. 
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Abstract	  
 
 An efficient synthesis of the newly isolated and rare compatible solute (2R)-2-
(1-O-α-D-mannopyranosyl)-3-(1-O-α-D-glucopyranosyl)-glycerate (MGlyG) 
was accomplished. A tetraacetylmannosyl trichloroacetimidate was used first 
as a donor in the glycosylation reaction with the glycerate derivative and, after 
deprotection of the primary hydroxyl group of glycerate as the acceptor in the 
glycosylation reaction with the ethyl 6-O-acetyl-2,3,4-tri-O-benzyl-1-thio-α/β-D-
glucopyranoside. As expected the α-anomer was the only product of the first 
glycosylation reaction. Although the formation of the 1,2-cis glucoside was 
more challenging, after optimisation studies the α-anomer was obtained as 
the major product. 
 The effectiveness of MGlyG for the protection of model enzymes against heat 
induced inactivation was evaluated, using differential scanning fluorimetry 
(DSF). For comparison, the protection induced by natural compatible solutes, 
like MG, GG or GGG, was assessed by the same method. The results 
obtained demonstrated that for the studied enzymes (malate dehydrogenase, 
staphylococcal nuclease and lysozyme) MGlyG was the best stabiliser, and 
that the extent of protein stabilisation rendered by the solute depends on the 
specific solute/enzyme examined. 
 
Introduction	  
 
  The new compatible solute (2R)-2-(1-O-α-D-mannopyranosyl)-3-(1-O-α-D-
glucopyranosyl)-glycerate (MGlyG, Figure 6) has been recently isolated and 
characterised.1 
OHO
HO
HO
OH
O
CO2-K+
O
O
OH
OH
HO
OH
 
Figure 6. MGlyG, 124. 
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  Although, the position of the glyceric unit in bridge between the two hexoses 
has never been detected before, the newly isolated MGlyG is structurally 
related to the compatible solutes α-D-mannosyl-D-glycerate (MG, Figure 1) 
where a mannose moiety is α-lynked to the C-2 of a glyceric unit, and to the 
disaccharide α-D-mannopyranosyl-(1→2)-α-D-glucopyranosyl-(1→2)-
glycerate (MGG, Figure 5) which is composed by the same structural units – 
mannose, glucose and glyceric acid – lynked in a different manner. 
  To confirm the structure of the isolated MGlyG and study his biochemical 
properties it is required sufficient amounts of the pure compound, which is not 
possible from its natural source where it is available in low concentrations. 
Hence it was highly desirable to establish a methodology for the chemical 
synthesis of MGlyG. 
  In the present work the chemical synthesis of MGlyG was established and 
the ability of MGlyG to protect three model proteins - malate dehydrogenase 
(MDH), staphylococcal nuclease (SNase) and lysozyme - against heat 
denaturation was assessed using differential scanning fluorimetry (DSF). 
Differential scanning fluorimetry (DSF) also known as thermofluor, is a high-
throughput technique for monitoring thermal stability changes in proteins 
developed by Pantoliano et al.2 Initially developed as a high-throughput 
screen for buffer optimization and ligand-induced stabilisation in proteins, DSF 
has been successfully used in screening for ligands and small molecules. This 
technique determines the protein melting temperature (TM) by monitoring 
protein unfolding using a fluorescent reporter dye, which interacts with the 
hydrophobic regions of the protein that are exposed upon protein thermal 
denaturation. Although there are other methods available to determine the 
melting temperature of proteins, like differential scanning calorimetry (DSC) or 
circular dichroism (CD), the DSF is the most suitable for this work due to the 
need for only small amounts of protein (micrograms) and solutes (milligrams), 
and the ability to screen simultaneously different conditions. 
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Results	  and	  Discussion	  
Chemical Synthesis 
 
  The key step in the synthesis of MGlyG 124 is the selective formation of the 
1,2-cis glucosidic bond between glucose and the primary hydroxyl group of 
glycerate for which there are no general methods. The synthetic strategy was 
developed starting from the synthesis of α-mannosyl glycerate 126, that 
afterwards would act as acceptor in the glycosylation reaction with the 
thioglucoside 1. 
  For the synthesis of α-mannosyl glycerate acceptor 126, the α-mannose 
trichloroacetimidate derivative 1033 was used as donor in the glycosylation 
reaction with the methyl 3-O-tert-butyldiphenylsilylglycerate acceptor 9 
(Scheme 20). Methyl glycerate acceptor 9 was prepared according to 
experimental procedures described in literature4, 5. 1,2-Trans mannoside 125 
was exclusively obtained in 85% yield applying the C-2 acyl neighbouring 
group participation methodology, using acetates as protecting groups and 
under BF3.OEt2 activation. Removal of the silyl ether from the primary 
hydroxyl group of glycerate afforded the α-mannosyl glycerate 126 in 89% 
yield, and ready to be used as the acceptor in the next glycosylation step. 
 
OAcO
AcO
AcO
OAc
O
CCl3
NH
a
TBDPSO
CO2Me
OH OAcO
AcO
AcO
OAc
O
CO2Me
OTBDPS
OAcO
AcO
AcO
OAc
O
CO2Me
OH
b
103
9
125
126
a) BF3.OEt2, CH2Cl2, 0ºC-r.t., 85%. b) TBAF, THF, r.t., 89%. 	  
Scheme 20. Synthesis of partially protected MG, 126. 
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  Based on previous glycosylation studies (Chapter 2) thioglucoside 1, which 
is readily obtained in three steps from methyl glucose5, was chosen as donor 
for the second glycosylation reaction. In order to obtain high 1,2-cis 
stereoselectivity in this glycosylation reaction, a series of experiments 
changing the solvent, temperature and the activator were conducted. The 
results of the glycosylation reaction of donor 1 using NIS in the presence of 
4Å MS are described in  
Table 8. 
 
Table 8. Optimisation of the glycosylation reaction of acceptor 126. 
 
 
Entry Solvent Activator T (ºC) 
t 
(mn) 
Yield, 
(%) α /β  
1 
CH2Cl2 
TfOH 
-20 
15 84 1.7:1 
2 
TMSOTf 
15 73 1.7:1 
3 -60 30 90 2.1:1 
4 
Et2O 
TfOH 
-20 15 62 4:1 
5 
-60 
60 65 4.6:1 
6 TMSOTf 90a 47b 4.7:1 
a More equivalents of TMSOTf were added during the reaction. b Initial donor was recovered. 
 
  As expected from previous results (Chapter 2, Table 2), using an ethereal 
solvent like ethyl ether, gave higher α-selectivity than dichloromethane that is 
a halogenated solvent. Using dichloromethane gave the worst results in terms 
of selectivity, even at lower temperatures. The use of ethyl ether enhanced 
the α-selectivity, although in general, lowered the reaction yields. 
OAcO
AcO
AcO
OAc
O
CO2Me
O
O
OBn
OBn
BnO
OAc
OBnO
BnO
BnO
OAc
SEt
127
OAcO
AcO
AcO
OAc
O
CO2Me
OH
126
1
 NIS/activator,
solvent, 4A MS
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  Concerning the use of different activators, comparing the results obtained 
with TfOH and TMSOTf using dichloromethane (Table 8, entries 1 and 2) or 
ethyl ether (Table 8, entries 5 and 6) as solvent, it is clear that the activator 
has no influence on the selectivity of the glycosylation reaction. 
  Conducting the reaction at lower temperatures (-60ºC, Table 8, entries 3 and 
5-6) afforded only a minor improvement in the α-anomeric selectivity. When 
using ethyl ether at -60ºC the donor was consumed much slower (Table 8, 
entries 5 and 6), and when using TMSOTf the lowest reaction yield was 
obtained (43%, Table 8, entry 6). 
  Glycosylation with the thioglucoside donor 3 bearing a more electrophilic 
group at the C-6 position (chloroacetyl) used in Chapter 2 was also attempted 
to improve the α-selectivity (Scheme 21). The reaction conditions chosen 
were the ones that gave the best results with thioglucoside donor 1 - TfOH in 
Et2O at -60ºC (Table 8, entry 5). Although the α/ proportion have improved to 
6:1 the reaction yield dropped to 30%, with 60% recovery of the donor 3 and 
10% of the hydrolysed donor in the anomeric position.  
 
OAcO
AcO
AcO
OAc
O
CO2Me
O
O
OBn
OBn
BnO
OAcCl
OBnO
BnO
BnO
OAcCl
SEt
128
OAcO
AcO
AcO
OAc
O
CO2Me
OH
126
3
 NIS/TfOH, Et2O,
 -78ºC, 4A MS,
30%, α/β=6:1  
Scheme 21. Glycosylation of acceptor 126 with thioglucoside donor 3. 
 
  In light of the results obtained and aiming to develop the best route to 
efficiently obtain the MGlyG 124, changing the strategy to alter the 
glycosylations order was considered. The possibility of performing first the 
glycosylation of thioglucoside donor 1 with glycerate, followed by the 
glycosylation with the mannose donor 103 was studied. Glycosylation of 
thioglucoside donor 1 with different acceptors chemically related to methyl 
glycerate 9, but bearing the first hydroxyl group free and the secondary one 
protected was tested (Table 9). Acceptor 8 (Table 9, entry 1) was obtained as 
described in Chapter 2, and acceptor 129 (Table 9, entry 2) was obtained 
after benzylation of the methyl glycerate 9 with BnBr/NaH followed by 
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deprotection of the primary hydroxyl group with TBAF. Since the best results 
for the glycosylation reaction with methyl glycerate 9 were obtained with TfOH 
in Et2O at -60ºC (Table 8, entry 5) these conditions were selected to study the 
selectivity of the reaction using acceptors 8 and 129. The results obtained are 
summarised in Table 9. 
 
Table 9. Glycosylation of donor 1 with different acceptors. 
OBnO
BnO
BnO
OAc
SEt
NIS, TfOH,
4A MS, Et2O, -60ºC
ROH
OBnO
BnO
BnO
OAc
OR
1  
Entry ROH Product t (mn) 
Yield 
(%) α /β  
1 HO CO2Me
OTBDMS
 
8 
14 45 30a 1:0 
2 HO CO2Bn
OBn
 
129 
130 60 54 2.8:1 
a  64% of the initial donor was recovered. 
 
  Even though glycosylation with the primary hydroxyl group of methyl 
glycerate 8 afforded only the α-anomer, the yield was low (30%) and initial 
donor 1 was recovered (Table 9, entry 1). Glycosylation with the primary 
hydroxyl group of benzyl glycerate 129 gave worst results in terms of α/β ratio 
(2.8:1), but better yield (54%, Table 9, entry 2). These results can be 
explained by the difference in the steric hindrance of the protecting groups on 
the secondary hydroxyl group of glycerate. Benzyl ether being a smaller 
group, less sterically hindred than the tert-butyldimethylsilyl ether afforded 
worst results. Attempts were made with other protecting groups on the 
secondary hydroxyl group of methyl glycerate, such as THP but the reaction 
yields were lower than 12%. 
  Since the results obtained with this strategy were disappointing, the MGlyG 
synthesis was developed based on the first strategy and proceeded from the 
protected MGlyG 127 (Scheme 22). 
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a) NaOMe, MeOH, r.t., 90%. b) H2(g), Pd/C,AcOEt, r.t., 50 psi, quant. c) KOH, H2O, r.t., quant.
127
only the
α anomer
131
132 124
	  
Scheme 22. Deprotection scheme for the synthesis of MGlyG, 124. 
	  
  After methanolysis of the acetates from the fully protected MGlyG 127 (90%) 
followed by flash column chromatography, the mixture of the α/β anomers 
could be separated and the synthesis was carried on with only the α anomer 
(Scheme 22). Hydrogenolysis of the benzyl groups and finally hydrolysis of 
the methyl ester afforded the potassium salt of MGlyG 124 (Scheme 22). The 
synthesis overall yield calculated from the first glycosylation step was 36%. 
 
Performance of MGlyG as stabilizer for model enzymes 
 
  The stabilising effect of MGlyG 124 was assessed for three model enzymes - 
MDH, SNase and lysozyme – using DSF. The stabilising effect of MGlyG was 
compared with other natural compatible solutes that are structurally related to 
MGlyG, like MG, GG and GGG (Figure 1, Chapter 1).  
   The DSF based stability assays were performed at each protein working pH 
and the melting temperatures (TM) values determined in the absence (control 
experiments) and in the presence of solutes, and at different solute 
concentrations. 
  An example of the typical denaturation curve of SNase obtained from the 
fluorescence data is presented on Figure 7. The stabilisation effect of different 
concentrations of MGlyG (0.1 and 0.25 M) on SNase is described by the 
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positive shift of the protein-unfold transition slop relatively to the control 
experiment. 
 
 
Figure 7. Curves obtained for the fluorescence data of SNase, comparing the 
stabilisation effect of different concentrations of MGlyG - 0.1M (green) and 0.25 M 
(red) - with the control experiment (absence of solute (blue)). 
 
  The denaturation curves for each assay were analysed, and the melting 
temperatures determined by the calculation of the first derivative, which 
corresponds to the midpoint temperature of the protein-unfolding transition. In 
the absence of solutes, malate dehydrogenase (MDH), staphylococcal 
nuclease (SNase) and lysozyme have melting temperatures (TM) of 50, 52 
and 71ºC respectively. The unfolding temperature shifts (ΔTM) were calculated 
by comparing the TM values obtained in the presence of solutes with the TM 
values of the control experiments (absence of solutes). Positive ΔTM values 
correspond to an increase in the TM meaning that the protein is more stable 
and more energy (heat) is needed to unfold it. Negative ΔTM values 
correspond to a decrease in the TM meaning that the protein is less stable. 
The increment in the melting temperature (ΔTM) induced by the presence of 
MGlyG and the other natural structurally related solutes is depicted in Figure 
8. 
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Figure 8. Increment in the melting temperature (TM) of malate dehydrogenase (MDH, 
blue bars), staphylococcal nuclease (SNase, red bars) and lysozyme (green bars) in 
the presence of 0.25 M of different solutes. The melting temperatures (TM) in the 
absence of solutes were 50 ºC for MDH, 52 ºC for SNase and 71ºC for lysozyme. 
 
  As expected from previous results obtained using DSC for MG, GG6 and 
GGG7 all compounds had a stabilising effect on the tested proteins. However, 
this effect was not general, the degree of stabilisation of each solute, in most 
cases, was different for each protein. Meaning that the degree of stabilisation 
rendered by each solute is dependent on the specific protein/solute system 
studied. In fact, these findings support the hypothesis of the existence of 
specific weak interactions, or loci for preferential binding sites on the protein 
surface.8 
  The results obtained demonstrated that at 0.25 M, MGlyG was the best 
stabiliser for SNase and lysozyme. Comparing the results obtained with the 
disaccharides - GGG and MGlyG – with the monosaccharides - GG and MG – 
the fact that these compounds have an extra glycosyl unit brings no clear 
benefit for stabilisation. Except in the case of SNase, where MGlyG was 
clearly the best stabiliser. Also, the fact that MGlyG gave the best results and 
it is the only solute in which the primary hydroxyl group of the glyceric unit is 
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not free can probably indicate that the carboxylic acid group is more important 
than the alcohol for the stabilisation effect.  
  The dependence of the increment of TM (stabilisation) on the concentration 
of MGlyG was studied using MDH, SNase and Lysozyme (Figure 9), and also 
by comparing it with the effect of the other solutes on SNase (Figure 10). 
 
 
Figure 9. Dependece of MDH, SNase and lysozyme melting temperatures on the 
concentration of MGlyG. 
 
 
Figure 10. Dependece of SNase melting temperature on the concentration of MGlyG 
(squares), GGG (triangles), MG (circles) and GG (diamonds). 
 
  Although only two concentrations were tested, the stabilisation effect was 
directly proportional to the concentration of solute as expected, and MGlyG 
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was the best stabiliser for SNase. The concentration of MGlyG required to 
increase the TM of SNase by 4ºC was 0.1 M while for the others solutes the 
same increment was produced only at 0.25 M. 
 
Conclusion	  
 
  The efficient synthesis of the natural solute MGlyG has been achieved with 
36% overall yield (calculated from the first glycosylation step). The main 
challenge of the synthesis of MGlyG was to form the α-glycosidic bond 
between glucose and the primary hydroxyl group of glycerate, for which there 
are good procedures but still no general method. A synthetic strategy was 
designed starting with the synthesis of the partially protected MG acceptor 
126 to be used in the glycosylation reaction with the thiogluocoside donor. In 
order to obtain high 1,2-cis stereoselectivity in the glycosylation reaction 6-
acetoxy perbenzylated thioglucoside donor was used to optimise the reaction 
conditions. Although the reaction was not selective, ethyl ether at -60ºC and 
TfOH were found to be best conditions with α/β proportion of 4.6:1. Other 
synthetic strategies, like changing the order of glycosylations, using a different 
thioglucoside donor or different glycerate derivatives, were tried without much 
success. Although, the product was obtained as a mixture of anomers, after 
deprotection of the acetate groups the anomers could be separated and the 
desired final product obtained. 
  The effectiveness of the newly synthesised natural solute MGlyG for the 
protection of model enzymes against heat-induced denaturation was 
evaluated using DSF. For comparison, the protection induced by other natural 
compatible solutes, like MG, GG and GGG was assessed. The results 
obtained demonstrated that for SNase and lysozyme MGlyG was the best 
stabiliser and that the extent of protein stabilisation rendered by each solute 
depends on the specific solute/enzyme examined. 
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Abstract	  
 
  Mannosylglycerate (MG) is one of the most widespread solutes in 
hyper/thermophilic organisms, and its efficacy in the protection of protein 
structures has been amply illustrated. In the present work, several molecules 
inspired by the structure of natural compatible solutes, mainly 
mannosylglycerate, were synthesised. The diversity of the chemical library of 
new synthetic solutes was introduced in three levels: the nature of the sugar 
(glucose, galactose and mannose), both anomers for each sugar and the 
glycosyl acceptor (methyl (2R)-L-glycerate, methyl (2R)-D-glycerate, ethyl 3-
hydroxybutyrate, dimethyl (S)-malate, methyl (S)-lactate and methyl glycolate) 
used in the glycosylation reaction. The effectiveness of the 21 newly 
synthesised compounds as protein thermostabilisers was assessed using 
differential scanning fluorimetry (DSF). The importance of the nature of the 
sugar and the non-glucosidic moiety for the stabilisation effect was studied. 
 
Introduction	  
 
  In a recent study, several molecules chemically related to mannosylglycerate 
were synthesized and their effectiveness for the protection of model enzymes 
against heat-induced denaturation, aggregation and inactivation was 
evaluated.1 In this study, α-mannosyllactate (ML) (Figure 1, Chapter 1), a 
non-natural solute, proved to be superior to MG in the stabilisation rendered 
to model enzymes. The results showed that an apparently small structural 
change, the glycerate moiety being replaced by a lactate, which lacks the 
primary hydroxyl group and has the opposite configuration, had positive effect 
in the protein thermostabilisation. Thus, the possibilities of solute engineering 
having MG as the reference compound are very large. 
  Since several human pathologies such as Alzheimer’s, Creutzfeldt-Jacob’s, 
cystic fibrosis and Parkinson’s diseases, have been associated with the 
structural instability of proteins, and consequent protein aggregation, the 
development of reliable strategies to improve protein stability is of great 
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importance and could have several pharmaceutical and biotechnological 
applications. 
  With the objective of synthesising new organic compounds with increased 
protein stabilisation properties inspired by the structure of natural compatible 
solutes, a chemical library based on sugar derivatives was prepared. The 
diversity of the analogue structures was introduced by using different 
hexoses, such as glucose, galactose, mannose and glucosamine, and by 
using different glycosyl acceptors during the glycosylation reaction.  
  Although most common solutes derived from hexoses are mannosides and 
glucosides, galactose and glucosamine analogues were also synthesised in 
this work to assess the contribution of the sugar structure for the stabilisation 
effect. To our knowledge, only one galactose containing compatible solute 
has been isolated from hyperthermophiles, the β-galactopyranosyl-5-
hydroxylysine (GalHI) from Thermococcus litoralis (Figure 11). 
 
O
HO
HO O
HO
OH
NH3+
CO2-
+H3N
 
Figure 11. β-Galactopyranosyl-5-hydroxylysine (GalHI). 
	  
  Several amino acids, like glutamate, proline, and glutamine, can function as 
compatible solutes in many mesophilic organisms and both α- and β-amino 
acids are used for osmoadaptation.2 Amino acids are common compatible 
solutes, chargeable according to media pH, and it is known that charge is 
important for the stabilisation effect of hypersolutes. In order to determine if 
the amino group or the extra charge would enhance the stabilisation effect it is 
necessary to synthesise glucosamine derivatives. Glucosamine is an 
important building block present in many natural molecules involved in a 
number of biological processes. To our knowledge, only one glucosamine 
containing compatible solute has been isolated from hyperthermophiles, 
the di-N-acetyl-glucosamine phosphate (DAGAP) from Rubrobacter 
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xylanophilus (Figure 12).3 DAGAP is structurally similar to the phosphodiester 
compatible solutes found in hyperthermophiles, like DIP or DGP, however, the 
role as a compatible solute has been refuted due to the concentrations that 
are too low to contribute to the cell’s osmotic balance. 
 
OHO
HO
O
AcHN
OH
AcHN
O
OH
O
OH
OH
P
O
OH
 
Figure 12. Di-N-acetyl-glucosamine phosphate (DAGAP). 
 
  Since previous studies1 have proven the superiority of charged organic 
solutes as enzymes thermostabilisers, all of the acceptors chosen are 
charged and structurally related to glycerate with point modifications (Figure 
13), such as more or less carbon atoms, loss of a hydroxyl group, an 
additional carboxylic group and the configuration at the asymmetric center, 
when present. 
 
CO2Me
OH
CO2Me
OH
TBDPSO
HO CO2Me
4
Methyl (S)-lactate
7
Methyl glycolate
9
Methyl (2R)-3-O-tert-butyldiphenylsilyl-
2,3-hidroxypropanoate
CO2Me
OH
TBDPSO
135
Methyl (2S)-3-O-tert-butyldiphenylsilyl-
2,3-hidroxypropanoate
OH
EtO2C CO2Me
OH
MeO2C
133
Ethyl 3-hydroxybutyrate
134
Dimethyl (S)-malate
 
Figure 13.Glycosyl acceptors. 
 
  The solute library provided a wide range of structurally different sugar 
derivatives that could give insight into the key features necessary for protein 
stabilisation. 
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  The ability of the newly synthesised solutes to protect three model proteins - 
MDH, SNase and lysozyme - against heat denaturation was assessed using 
DSF. 
	  
Results	  and	  Discussion	  
	  
Synthesis of the New Analogues of Compatible Solutes  
 
  The design of the properly functionalized building blocks is a crucial step for 
the stereoselective introduction of the glycosidic linkage during the 
glycosylation reaction. 
  For the synthesis of the glucose and galactose derivatives thioglycoside 
donors were synthesised, and the method of choice for the formation of the 
thioglycosides 1 and 19 was oriented according to previous optimisation 
studies (Chapter 2), so that the configuration of the glycosidic linkage was 
preferentially α. The results obtained for the glycosylation reaction of donors 1 
and 19 with the glycosyl acceptors (Figure 13) using NIS/TfOH4 system in 
dichloromethane are described in Table 10. All acceptors were commercially 
available with exception of the methyl glycerate derivatives 9 and 135, which 
were synthesised according to the experimental procedures reported for D-
serine4, 5. 
  Although for most of the glycosyl acceptors the reaction gave a mixture of 
anomers, this was not a problem, since it would be interesting to test α and β 
anomers separately to determine the importance of the stereochemistry of the 
anomeric position for the stabilization effect. This was the case for the D/L-
glycerate and malate galactosyl derivatives. 
 
Table 10. Results obtained for the glycosylation reaction with the thioglycoside donors 
1 and 19. 
O
OAc
SEt
BnO
O
OAc
OR
BnO
ROH, TfOH/NIS,
CH2Cl2, 4Α MS 0ºC
1: Glucose
19: Galactose  
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ROH Donor                Product  
Yield 
(%) 
α /β  
4 
1 OBnO
BnO
BnO
OAc
O CO2Me  
10 91 4:1 
19 O
BnO
BnO
BnO
OAc
O CO2Me  
32 87 3:1 
7 
1 OBnO
BnO
BnO
OAc
O CO2Me  
13 93 4:1 
19 O
BnO
BnO
BnO
OAc
O CO2Me  
34 95 3:1 
9 19 O
BnO
BnO
BnO
OAc
O CO2Me
OTBDPS
 
35 88 2:1 
133 
1 OBnO
BnO
BnO
OAc
O
CO2Et
	  
136 84 9:1a 
19 O
BnO
BnO
BnO
OAc
O
CO2Et
 
137 95 3:1a 
134 
1 OBnO
BnO
BnO
OAc
O CO2Me
CO2Me
 
138 94 7:1 
19 O
BnO
BnO
BnO
OAc
O CO2Me
CO2Me
 
139 87 5:1 
135 
1 OBnO
BnO
BnO
OAc
O CO2Et
OTBDPS
 
140 98 >10:1 
19 O
BnO
BnO
BnO
OAc
O CO2Me
OTBDPS
 
141 88 2.6:1 
a Calculated after deprotection of the acetate group. 
 
  After the successive removal of the protective groups using common organic 
reactions, such as methanolysis of the acetates, fluorolysis of the silyl ether in 
the case of the glycerate analogues (compounds 35, 140 and 141) and 
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hydrolysis of the ester group (Scheme 23), the desired products were 
obtained (Table 11). 
 
b
O
O
OAc
CO2Me
R
BnO a
O
O
OH
CO2Me
R
BnO
O
O
OAc
BnO CO2Et
O
O
OH
CO2-K+HO
a, b, c
O
O
OH
CO2Me
R
cHO
O
O
OH
CO2-K+
R
HO
R: H, CH3, CH2OTBDPS, CH2CO2Me.
a) NaOMe, MeOH, 0ºC-r.t. b) H2(g), Pd/C, 50 psi, AcOEt, r.t. c) KOH/H2O, r.t.  
Scheme 23. General deprotection scheme for the glucose and galactose analogues. 
 
Table 11. Final products and overall yieldsa for glucose and galactose derivatives. 
Compound 
number 
            Final Product  
Yield 
(%)a 
10 OHO
HO
HO
OH
O CO2-K+  
142 78 
32 O
HO
HO
HO
OH
O CO2-K+  
143 83 
13 OHO
HO
HO
OH
O CO2-K+  
144 73 
34 O
HO
HO
HO
OH
O CO2-K+  
145 77 
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35 O
HO
HO
HO
OH
O CO2-K+
OH
 
146 α  
147 β  
61 
21 
136 
OHO
HO
HO
OH
O
CO2-K+
 
148 68 
137 O
HO
HO
HO
OH
O
CO2-K+
 
149 86 
138 OHO
HO
HO
OH
O CO2-K+
CO2-K+
 
150 42 
139 O
HO
HO
HO
OH
O CO2-K+
CO2-K+
 
151 α  
152 β  
57 
16 
140 
OHO
HO
HO
OH
O
CO2-K+
OH
 
153 60 
141 O
HO
HO
HO
OH
O CO2-K+
OH
 
154 α  
155 β  
43 
14 
a Calculated from the glycosylation reaction. 
 
  Overall the products were successfully obtained in good yields and the α 
anomer was the major product. Although in some cases a mixture of α and β 
anomers was obtained (enriched on the first), they were used for a preliminary 
screening where the most promising compounds would then be tested 
separately. The lowest yields were obtained for the derivatives of the dimethyl 
(S)-malate (150, 151 and 152, Table 11) due to the use of base in the removal 
of the acetates and in the hydrolysis of the methyl ester, which promoted the 
hydrolysis of the anomeric position, by elimination of the malate moiety. This 
problem has been reported in the literature in the synthesis of bacillithiol 
(BSH).6 To minimize the elimination of the malate moiety, careful ester 
hydrolysis left traces of the mono-ester in the final product. 
 
  For the synthesis of the 1,2-trans mannosides, the C-2 acyl neighboring 
group participation strategy was applied using acetates as protecting groups, 
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and trichloroacetamidates as glycosyl donors, which are relatively fast to 
prepare and unexpensive. Glycosylation reaction between the mannose 
trichloroacetimidate donor 103 and the glycosyl acceptors (Figure 13), using 
BF3.OEt2 as the promoter, afforded as expected exclusively the α-products. 
The results obtained for the glycosylation reaction with the mannose donor 
103 are presented on Table 12.  
 
Table 12. Results obtained for the glycosylation reaction with the mannose 
trichloroacetimidate donor 104. 
OAcO
AcO
AcO
OAc
O
CCl3
NH
OAcO
AcO
AcO
OAc
OR
ROH, BF3.OEt2,
CH2Cl2, 0ºC
103
	  
	  
ROH                  Product  
Yield 
(%) 
133 
OAcO
AcO
AcO
OAc
O
CO2Et
 
156 91 
134 
OAcO
AcO
AcO
OAc
O
MeO2C
CO2Me
 
157 88 
135 
OAcO
AcO
AcO
OAc
O
MeO2C
OTBDPS
 
158 73 
 
 
  Successive removal of the protective groups using common organic 
reactions (Scheme 24), afforded the desired products (Table 13) in good 
overall yields. 
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R: CH2OTBDPS, CH2CO2Me.
O
AcO
AcO
OAc
O
CO2Et
OAcO
AcO
AcO
OAc
O
CO2Me
R
AcO
a
a O
HO
HO
OH
O
CO2Et
OHO
HO
HO
OH
O
CO2Me
R
HO
b
b
O
HO
HO
OH
O
CO2-K+
OHO
HO
HO
OH
O
CO2-K+
R
HO
a) NaOMe, MeOH, 0ºC-r.t. b) KOH/H2O, r.t.  
Scheme 24. General deprotection scheme for the mannose analogues. 
	  
Table 13. Final products and overall yieldsa for mannose derivatives. 
Compound  
number 
               Final Product  
Overall 
Yield 
(%)a 
156 
OHO
HO
HO
OH
O
CO2-K+
 
159 73 
157 
OHO
HO
HO
OH
O
CO2-K+
CO2-K+
 
160 69 
158 
OHO
HO
HO
OH
O
CO2-K+
OH
 
161 50 
a Calculated from the glycosylation reaction. 
 
  Hydrolysis of the acetate groups and of the methyl ester of mannosyl 
dimethyl (S)-malate derivative presented the same problem described above 
for the glucose and galactose derivatives. 
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  The 1,2-cis glucosamine derivatives were synthesised from the 2-azido-2-
deoxythioglucoside donor 90 synthesised in Chapter 2, and the glycosylation 
reaction with the glycosyl acceptors from Figure 13 conducted in a mixture of 
CH2Cl2/Et2O (4:1) at -10ºC and using NIS/TfOH as promotor. The results are 
presented on Table 14. 
 
Table 14. Results obtained for the glycosylation reaction with the 2-azido-2-
deoxythioglucoside donor 90. 
O
BnO
BnO
STolN3
OAcCl
O
BnO
BnO
ORN3
OAcCl
NIS, TfOH, 4Å MS, 
CH2Cl2:Et2O (1:4),
-10ºC
ROH
90  
ROH Product  
Yield 
(%) 
α /β  
4 OBnO
BnO
N3
OAcCl
O CO2Me  
95 86 8.7:1 
7 OBnO
BnO
N3
OAcCl
O CO2Me  
96 76 12:1 
9 OBnO
BnO
N3
OAcCl
O CO2Me
OTBDPS
 
97 84 >10:1 
134 
O
BnO
BnO
O
N3
OAcCl
CO2Me
CO2Me
 
162 86 1:0 
 
  As expected from previous studies (Chapter 2) the α anomer was the major 
product for all of the acceptors used. After methanolysis of the acetate group 
and in the case of the glycerate derivative fluorolysis of the silyl ether, 
catalytic hydrogenation of the benzyl group with simultaneous reduction of the 
azide promoted the formation of an undesired cyclic amide (Scheme 25). This 
effect was only observed for the α anomers, and led to uncharged derivatives. 
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O
BnO
BnO
O
N3
OH
CO2Me
R
O
HO
HO
NH
OH
O
O
R
163: R=Me
164: R=H
165: R=CH2OH
166: R=CH2CO2Me
167: R=Me, 84%
168: R=H, 81%
169: R=CH2OH, 80%
170: R=CH2CO2H, 87%
H2(g), Pd/C,
EtOH/H2O (2:1),
50 psi, r.t.
 
Scheme 25. Hydrogenation of the 2-azido-2-deoxyglucoside derivatives. 
  Since it is known that charge is important for the stabilisation effect, to 
overcome this problem previous reduction of the azide using a Staudinger 
reaction, followed by protection of the resulting amine group with acetate 
(Scheme 26) blocked the amine and avoided cyclisation. After removal of the 
protecting groups and hydrolysis of the methyl ester the final N-acetyl 
glucosamine derivatives were obtained. 
 
O
BnO
BnO
ON3
OAcCl
CO2Me
R
95: R=Me
162: R=CH2CO2Me
O
BnO
BnO
OAcHN
OAcCl
CO2Me
R
171: R=Me
172: R=CH2CO2Me
O
HO
HO
OAcHN
OH
CO2-K+
Rb, c, d
173: R=Me, 46% (after 4 steps)
174: R=CH2CO2-K+, 33% (after 4 steps)
a) (i) Ph3P, THF, AcOH, 0ºC-r.t. (ii) Ac2O, 0ºC. b) NaOMe, MeOH, 0ºC. 
c) H2 (g), Pd/C, AcOEt, 50 psi, r.t. d) KOH/H2O, r.t.
a
 
Scheme 26. Synthesis of the N-acetyl glucosamine derivatives. 
	  
Assessment of the ability of the new analogues as thermostabilisers  
 
  The ability of the new synthetic analogues to stabilise three model proteins 
against thermal stress was assessed using DSF. Previous studies involved 
the use of differential scanning calorimetry (DSC)1 or the determination of 
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enzymatic activities7, however these methods are time consuming and large 
quantities of solutes and proteins are needed. DSF is a high-throughput 
method that allows the simultaneous screening of different conditions and 
requires low quantities of both solute and protein, which means fast access to 
information about the stabilising properties of the solutes. The careful analysis 
of the results can lead to the design of new structural modifications that will 
improve the properties of the compounds in order to produce better 
stabilisers. 
  In this study, MDH, SNase and lysozyme were used as model proteins, and 
the stabilising effect of the synthetic compounds was compared with the effect 
of natural solutes, like MG and GG as well as potassium chloride, and other 
previously synthesised non-natural solutes, like MGlyc and ML. All 
compounds tested are presented in Table 15 and Table 16. 
 
Table 15. Chemical structures of the natural and synthetic glucose, galactose and 
mannose derivatives tested in this study. 
Glucose derivatives Galactose derivatives Mannose derivatives 
OHO
HO
HO
OH
O CO2-K+  
GL, 142 
O
HO
HO
HO
OH
O CO2-K+  
GaL, 143 
OHO
HO
HO
OH
O CO2-K+  
ML, 175 
OHO
HO
HO
OH
O CO2-K+  
GGlyc, 144 
O
HO
HO
HO
OH
O CO2-K+  
GaGlyc, 145 
OHO
HO
HO
OH
O CO2-K+  
MGlyc, 176 
OHO
HO
HO
OH
O
CO2-K+
OH
 
GG (D), 177 
O
HO
HO
HO
OH
O CO2-K+
OH
 
GaG (α, D), 146 
GaG (β, D), 147 
OHO
HO
HO
OH
O
CO2-K+
OH
 
MG (D), 178 
OHO
HO
HO
OH
O
CO2-K+
 
GBut, 148 
O
HO
HO
HO
OH
O
CO2-K+
 
GaBut, 149 
OHO
HO
HO
OH
O
CO2-K+
 
MBut, 159 
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OHO
HO
HO
OH
O CO2-K+
CO2-K+
 
GMal, 150 
O
HO
HO
HO
OH
O CO2-K+
CO2-K+
 
GaMal (α), 151 
GaMal (β), 152 
OHO
HO
HO
OH
O
CO2-K+
CO2-K+
 
MMal, 160 
OHO
HO
HO
OH
O
CO2-K+
OH
 
GG (L), 153 
O
HO
HO
HO
OH
O CO2-K+
OH
 
GaG (α, L), 154 
GaG (β, L), 155 
OHO
HO
HO
OH
O
CO2-K+
OH
 
MG (L), 161 
 
 
Table 16. Chemical structures of the synthetic glucosamine and N-acetyl glucosamine 
derivatives tested in this study. 
Glucosamine derivatives 
N-Acetyl Glucosamine 
derivatives 
O
HO
HO
NH
OH
O
O
 
GNHL, 167 
O
HO
HO
OAcHN
OH
CO2-K+  
NAcGL, 173 
O
HO
HO
NH
OH
O
O
OH  
GNHG, 169 
O
HO
HO
OAcHN
OH
CO2-K+
CO2-K+
 
NAcGM, 174 
 
  The DSF based stability assays were performed at each protein working pH 
and the melting temperatures (TM) values determined in the absence (control 
experiments) and in the presence of solutes, at different solute 
concentrations. The denaturation curves for each assay were analysed, and 
the melting temperatures determined by the calculation of the first derivative, 
which corresponds to the midpoint temperature of the protein-unfolding 
transition. In the absence of solutes, MDH, SNase and lysozyme have melting 
temperatures (TM) of 50, 52 and 71ºC respectively. The unfolding temperature 
shifts (ΔTM) were calculated by comparing the TM values obtained in the 
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presence of solutes with the TM values of the control experiments (absence of 
solutes). Positive ΔTM values correspond to an increase in the TM meaning 
that the protein is more stable and more energy (heat) is needed to unfold it. 
Negative ΔTM values correspond to a decrease in the TM meaning that the 
protein is less stable. 
  The increment in the melting temperature (ΔTM) of the three enzymes 
induced by the presence of the synthetic and the natural solutes (Table 15, 
Table 16) is depicted in Figure 14. 
  From the analysis of the large data set presented in Figure 14 it is clear that 
the degree of stabilisation rendered by each compound is different for each 
protein. This reinforces the concept that the extent of thermoprotection 
provided by organic solutes depends on specific protein/solute interactions. 
This specificity has been reported in literature8, where the study of minimal 
alterations on the protein sequence produced considerable differences in the 
extent of stabilisation rendered by a given solute. 
  Also, the fact that GNHL 167 and GNHG 169 (cyclic glucosamine 
derivatives) were poor stabilisers was expected, since reported studies1 have 
demonstrated the superior thermostabilisation properties of charged solutes. 
When plotting the increment of the melting temperature of MDH versus those 
of SNase and lysozyme, a general view of the results arises. Although the 
results are quite disperse, it is clear that the non-charged solutes 167 and 
169, in opposition to the charged ones, are clustered in the lower-left corner of 
the graphic (Figure 15). However, charge alone cannot be responsible for the 
stabilisation, since KCl is a charged inorganic salt and its stabilisation effect is 
similar to the non-charged solutes, showing that the major contribution arises 
from the organic moiety of the solutes. 
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Figure 14. Increment in the melting temperature (TM) of malate dehydrogenase (MDH, 
red bars), staphylococcal nuclease (SNase, green bars) and lysozyme (blue bars) in 
the presence of 0.5 M of different solutes. The melting temperatures (TM) in the 
absence of solutes were 50 ºC for MDH, 52 ºC for SNase and 71ºC for lysozyme. 
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Figure 15. Stabilising effect of different compounds against thermal denaturation of 
malate dehydrogenase (MDH), staphylococcal nuclease (SNase) and lysozyme. In the 
abscissa axis the increment in the melting temperature of MDH induced by 0.5 M of 
several compounds, and in the ordinate axis the increment in the melting temperature 
of SNase (solid symbols) and Lysozyme (open symbols) are plotted. 
 
  In order to determine which are the structural features important for the 
stabilisation effect, different types of analysis were done based on the results 
obtained. However, since the degree of stabilisation depends on the protein 
studied, the rationalisation of the data becomes difficult. 
  Analysis of different glucose (Figure 17) and galactose (Figure 18) 
derivatives showed the importance of the non-glycosidic group attached to the 
hexose. By changing the nature of the group attached to the anomeric center 
of the hexose, a significant difference in the melting temperature of the 
proteins was observed. For both hexoses, malate derivatives were the best 
stabilisers, which can be explained by the presence of the extra charge in 
these molecules and reinforces the importance of charge for the stabilisation 
effect. These findings are in agreement with a study found in literature9 where 
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the stabilising effect of several carboxylic acids on four proteins increased 
with the number of carboxylic groups in the salt. Lactate derivatives were also 
good stabilisers, although when compared with the natural glycerate (R), 
lactate lacks the primary hydroxyl group and has the opposite configuration 
(S). In the case of glucose, GGlyc that lacks the CH2OH group and has lost 
the asymmetric center was the poorest stabiliser tested. This results and the 
fact that butyrate and the natural glycerate had a similar behaviour lead to the 
hypothesis that the primary hydroxyl group present in glycerate is not 
essential for the stabilising effect. Although the order of efficiency depends on 
the enzyme studied, for most cases, the following series was found: 
glycolate<glycerate<butyrate<lactate<malate. 
 
 
 
Figure 16. Stabilising effect of different glucose derivatives against thermal 
denaturation of malate dehydrogenase (MDH), staphylococcal nuclease (SNase) and 
lysozyme. In the abscissa axis the increment in the melting temperature of MDH 
induced by 0.5 M of several compounds, and in the ordinates axis the increment in the 
melting temperature of SNase (solid symbols) and Lysozyme (open symbols) are 
plotted. 
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Figure 17. Stabilising effect of different galactose derivatives against thermal 
denaturation of malate dehydrogenase (MDH), staphylococcal nuclease (SNase) and 
lysozyme. In the abscissa axis the increment in the melting temperature of MDH 
induced by 0.5 M of several compounds, and in the ordinates axis the increment in the 
melting temperature of SNase (solid symbols) and Lysozyme (open symbols) are 
plotted. 
 
  Concerning the importance of the sugar structure different lactate (Figure 18) 
and malate derivatives (Figure 19) were analysed. In the case of lactate 
derivatives (Figure 18), a small change in the stabilisation effect of the 
different hexoses was observed, with exception of MDH, where changing the 
structure of the hexose had a larger impact in the degree of stabilisation. In 
this case, N-acetyl glucosamine derivative was the poorest stabiliser, and 
glucose and galactose were better stabilisers than mannose. For malate 
derivatives (Figure 19) the sugar structure had a bigger impact in the 
stabilisation effect of the three proteins. α-Galactosyl malate was the best 
stabiliser, and mannosyl malate gave the lowest stabilisation effect. Although, 
the effect can not be generalised, from the results obtained glucose and 
galactose derivatives were better stabilisers than mannose derivatives. 
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Figure 18. Stabilising effect of different lactate derivatives against thermal 
denaturation of malate dehydrogenase (MDH), staphylococcal nuclease (SNase) and 
lysozyme. In the abscissa axis the increment in the melting temperature of MDH 
induced by 0.5 M of several compounds, and in the ordinate axis the increment in the 
melting temperature of SNase (solid symbols) and Lysozyme (open symbols) are 
plotted. 
 
 
Figure 19 Stabilising effect of different malate derivatives against thermal denaturation 
of malate dehydrogenase (MDH), staphylococcal nuclease (SNase) and lysozyme. In 
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the abscissa axis the increment in the melting temperature of MDH induced by 0.5 M 
of several compounds, and in the ordinate axis the increment in the melting 
temperature of SNase (solid symbols) and Lysozyme (open symbols) are plotted. 
 
  In nature hypersolutes are found in the α-anomeric configuration, to 
determine the importance of the glycosidic linkage of the sugar for the 
stabilisation effect, different α and β anomers of D and L-galactosyl glycerates 
were studied (Figure 20). Results obtained for the three enzymes showed that 
L-glycerates were better stabilisers than the natural D-glycerate derivatives, 
and that the α-anomers were better stabilisers than those with the 
β configuration.  
 
 
Figure 20. Stabilising effect of different galactosyl glycerate derivatives against 
thermal denaturation of malate dehydrogenase (MDH), staphylococcal nuclease 
(SNase) and lysozyme. In the abscissa axis the increment in the melting temperature 
of MDH induced by 0.5 M of several compounds, and in the ordinate axis the 
increment in the melting temperature of SNase (solid symbols) and Lysozyme (open 
symbols) are plotted. 
 
  In order to study the dependence of the increment of the melting 
temperature on the concentration of the solutes, the proteins were tested at 
different solute concentrations – 0.1, 0.25 and 0.5 M (Figure 21, Figure 22 
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and Figure 23). For the three proteins, results showed that independent of the 
degree of stabilisation, the stabilisation effect was directly proportional to the 
concentration of the solute. Although the results obtained seem to follow a 
general trend, when taking a closer look in the case of SNase (Figure 21) and 
lysozyme (Figure 23) α-galactosyl malate is clearly the best stabiliser. In the 
case of MDH the results show that glucosyl malate was the best stabiliser for 
this enzyme. 
 
 
Figure 21. Dependence of SNase melting temperature on the concentration of solutes. 
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Figure 22. Dependence of MDH melting temperature on the concentration of solutes. 
	  
 
Figure 23. Dependence of lysozyme melting temperature on the concentration of 
solutes. 
 
Conclusion	  
 
  In this work, 21 new analogues of hypersolutes were efficiently synthesised 
based on glucose, galactose, mannose and glucosamine. α-Manosides were 
selectively obtained from the tetraacetylmannosyl trichloroacetimidate donor, 
and glucosides and galactosides from the respective thioglycoside donors 
with high α-anomeric selectivity. After cleavage of the protecting groups the 
final products were obtained with good overall yields. α−Glucosamine 
analogues were prepared from the 2-azido-2-deoxythioglucoside donors and 
the α-product was obtained as the major product. Since the catalytic 
hydrogenation of the azide group promoted the formation of a cyclic amide 
between the amine and the carboxylic acid from non-sugar moiety, to 
overcome this problem N-acetyl glucosamine analogues were prepared.  
  The effectiveness of the new compounds in the protection of model proteins 
against heat-induced inactivation was assessed using DSF, and compared 
with the effect of natural solutes, like MG and GG as well as potassium 
chloride, and other previously synthesised non-natural solutes, like MGlyc and 
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ML. DSF proved to be an excellent high-throughput method to obtain rapid 
information about the stabilising properties of the molecules. However, in 
order to obtain more accurate results further improvements have to be made 
related to the quantification of these compounds and the presence of 
inorganic KCl salt that can interfere with the results.  
  Analysis of the results obtained showed that the stabilisation effect is not 
general, and strongly depends on specific protein-solute interactions. 
Although some solutes showed superior thermostabilisation properties, the 
degree of stabilisation is different for each protein. 
  The presence of charge is one the most important features for the 
stabilisation effect. Uncharged solutes, like the glucosamine cyclic derivatives, 
gave the lowest stabilisation, and malate derivatives, bearing a double 
charge, were the best stabilisers. 
  Concerning the use of different hexoses, glucose and galactose derivatives 
were better stabilisers than the respective mannose and N-acetylglucosamine 
derivatives. However, the results showed that the group attached to the sugar 
had more influence for the stabilisation effect than the nature of the sugar. 
  The results obtained with the α and β anomers of galactosyl glycerates, 
showed that the α derivatives were better stabilisers. To confirm this trend 
future tests should be made with other β derivatives. 
  In the future, it would be interesting to test the stabilization effect of these 
compounds in a wider range of proteins with biotechnological relevance, like 
biopharmaceuticals. Although, the possibilities for solute engineering are 
large, the results obtained in the current study have presented some 
guidelines for the design of new analogues. Since the negative charge is 
determinant for the stabilization effect, it would be interesting to add an 
additional negative charge to the sugar moiety, such as a phosphate, a 
sulphate or a carboxylic acid (uronic acid) groups. Also, using other alcohols 
as glycosyl acceptors, or the introduction of other modifications on the hexose 
or in the aglycon moiety, such as replacing the hydroxyl groups for fluorine, 
thiol or amine groups. 
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  In conclusion, this study provides structural insight for future modifications, 
as well as confirmation about the structural features that might play a role in 
the stabilisation effect rendered by hypersolutes. 
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  Compatible solutes isolated from hyperthermophiles have shown the ability 
to preserve cell components against heat induced inactivation, making them 
promising candidates for several biotechnological applications. Although 
these compounds have been known for a long time, the mechanism 
responsible for stabilisation is still unclear. To understand the molecular 
mechanism for protein stabilisation by hypersolutes, it is crucial to understand 
what are the structural features of these compounds that are important for this 
effect.  
  The main goals of this work were the synthesis and study of new isolated 
hypersolutes with challenging structures - MGG 101 and MGlyG 124 - and the 
development of a solute library inspired by the structure of natural 
hypersolutes, mainly MG.  
  Since the 1,2-cis equatorial relationship of the glycosidic bond found in the 
natural solutes is difficult to obtain in a stereocontrolled manner, the most 
challenging step for the synthesis of the new natural hypersolutes and the 
synthetic analogues is the glycosylation reaction. In this work, new 
methodologies were developed in order to efficiently obtain these compounds 
with high stereoselectivity. Several thioglycoside donors derived from glucose, 
galactose and glucosamine were synthesised and tested in the glycosylation 
reaction with a wide range of acceptors using NIS/TfOH system as the 
promoter. The reported studies showed that, although many factors influence 
stereoselectivity of the glycosylation reaction, careful design of the donors, 
optimisation of the solvent system and temperature are powerful tools to 
obtain high α-stereoselectivities and good yields. However, when applied to 
different acceptors the α stereoselectivity is not predictable in many cases. 
The influence of the nature of the protecting groups was found to be 
determinant for the stereoselectivity of the glycosylation reaction, such as the 
α-directing effect of ester functionalities at the C-6 position of the 
thioglycoside donors, and in the case of the thiogalactosides an additional 
ester group at the C-4 position had also a very important role. Particular 
relevance was given to the development of these donors that can be used as 
versatile building blocks for the efficient synthesis of higher saccharides. 
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  The newly isolated hypersolutes of more complex structure, MGG and 
MGlyG, were efficiently synthesised with high stereoselectivity. The 
challenging 1,2-cis linkages present in these molecules were introduced in a 
stereocontrolled manner applying the developed glycosylation methods for 
glucose. In this work, MGG was also synthesised on solid support using a 
bidirectional approach. Although, the solid supported synthesis of peptides is 
well establish and fully automated, the synthesis of carbohydrates is more 
complex due to the low efficiency of coupling reactions. In the solid supported 
synthesis of MGG, coupling to the solid support and the successive 
glycosylation reactions were successfully achieved with the desired 
stereoselectivity, however the overall yield was lower than in solution. The 
chemical synthesis has proven to be the method of choice to obtain and study 
the natural isolated compounds. 
  In search for better protein stabilisers, a chemical library inspired by the 
structure of natural compatible solutes was created. 21 new synthetic 
analogues derived from glucose, galactose, mannose and glucosamine using 
several glycosyl acceptors structurally related to the natural glycerate were 
synthesised with good overall yields. DSF has proved to be an excellent 
method for the fast screening of the newly synthesised compounds as protein 
thermostabilisers. Analysis of the results reinforced the concept that the 
degree of stabilisation rendered by each solute is not general, being 
dependent of the existence of specific solute/protein interactions, since the 
same solute can stabilise different proteins to very different extents. 
Additionally, the structural diversity of the solute library has provided insight 
about the influence of the structure of these molecules for the stabilisation 
effect. The careful analysis of the data set has provided two major 
conclusions about the structural features of these molecules: charge has 
proven to be one of the most important structural features for the stabilisation 
effect, malate glycosides bearing two negative charges being the best 
stabilisers; and that the structure of the glycosyl acceptor had more influence 
on the stabilisation effect than the nature of the hexose.  
  Protein stability is a subject of great importance for many biotechnological, 
industrial and pharmaceutical areas, where compounds with increased protein 
stabilisation properties would have several applications. In this work, new 
Conclusion 
	  
	  
	  
127 
methods were developed for the efficient synthesis and screening of natural 
and synthetical hypersolutes as protein thermostabilisers. These contributions 
can be a platform for the synthesis of other molecules of biological interest. 
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Chemical Synthesis 
 
Materials	  and	  Analysis	  
	  
  All the reactions were carried out under an inert atmosphere (argon), except 
when the solvents were not dried. Air sensitive materials were handed in a 
Braun MB 150-GI glove box. The synthesized compounds were purified by 
flash chromatography using Silica Gel Merck 60 (0.040-0.063 mm), and 
preparative TLC using Merck 60 F254 silica gel. Analytical TLC was 
performed on aluminum-backed Merck 60 F254 silica gel plates. 1H NMR 
spectra were obtained at 400 MHz in CDCl3 or D2O with chemical shift values 
(δ) in ppm downfield from tetramethylsilane in the case of CDCl3, and 13C 
NMR spectra were obtained at 100.61 MHz in CDCl3 or D2O. Assignments are 
supported by 2D correlation NMR studies and the peaks assigned when 
possible. Specific rotations ([α]20D) were measured by using a Perkin–Elmer 
D241 automatic polarimeter.  
	  
	  
Solvent	  and	  Reagent	  Purification	  
	  
Reagents and solvents were purified and dried according to Ref.1. 
	  
	  
Graphical	  Index	  of	  Compounds	  and	  Experiments	  
	  
	  
Table 17. Graphical Index of Compounds and Experiments. 
Compound 
number 
Compound Experiment Page 
1 OBnO
BnO
OAc
SEtBnO  
Experiment 1 150 
2 OBnO
BnO
OH
SEtBnO  
Experiment 2 150 
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3 OBnO
BnO
OAcCl
SEtBnO  
Experiment 3 151 
10 OBnO
BnO
OAc
OBnO
CO2Me
 
Experiment 5 152 
11 OBnO
BnO
OAc
OBnO
CO2Me
 
Experiment 6 153 
12 OBnO
BnO
OAc
OBnO
CO2Bn
 
Experiment 7 153 
13 OBnO
BnO
OBnO
OAc
CO2Me  
Experiment 8 154 
14 OBnO
BnO
O
BnO
OAc
CO2Me
OTBDMS
 
Experiment 9 154 
15 
OBnO
BnO
BnO
OAc
O
CO2Me
OTBDPS
 
Experiment 10 155 
16 
O
CO2MeOBnO
BnO
BnO
OAcCl
 
Experiment 11 156 
17 
O
CO2BnOBnO
BnO
BnO
OAcCl
 
Experiment 12 156 
18 OBnO
BnO
OBnO
OAcCl
CO2Me  
Experiment 13 157 
19 O
BnO
BnO
OAc
SEtBnO  
Experiment 14 157 
20 O
BnO
BnO
OH
SEtBnO  
Experiment 15 159 
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21 O
BnO
BnO
OAcCl
SEtBnO  
Experiment 16 160 
32 O
BnO
BnO
OBnO
OAc
CO2Me
 
Experiment 17 161 
33 O
BnO
BnO
OBnO
OAc
CO2Bn
 
Experiment 18 161 
34 O
BnO
BnO
BnO
OAc
O CO2Me  
Experiment 19 162 
35 O
BnO
BnO
OBnO
OAc
CO2Me
OTBDPS
 
Experiment 20 162 
36 O
BnO
BnO
OBnO
OAcCl
CO2Me
 
Experiment 21 163 
37 O
BnO
BnO
BnO
OAcCl
O CO2Me  
Experiment 22 163 
38 O
BnO
BnO
OBnO
OAcCl
CO2Me
OTBDPS
 
Experiment 23 164 
39 O
BnO
BnO
OBnO
OAcCl
OTBDPS
OTBDPS
 
Experiment 24 165 
40 O
BnO
BnO
OBnO
OAcCl
CO2Me
14
 
Experiment 25 165 
41 OBnO
BnO
O
BnO
O
CO2Me
OTBDPS
O
BnO
BnO
BnO
OAcCl
 
Experiment 26 166 
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42 O
BnO
BnO
OBnO
OAcCl
O
H  
Experiment 27 166 
43 
O
BnO
BnO
BnO
OAcCl
O
 
Experiment 28 167 
44 
O
BnO
BnO
O
BnO
OAcCl
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Experimental	  Procedures	  
	  
Experiment 1. Synthesis of Ethyl 6-O-acetyl-2,3,4-tri-O-benzyl-1-thio-α /β-
D-glucopyranoside (1) 
  The synthesis of compound 1 was carried out according to the procedure 
described in the literature2. 
 
Experiment 2. Synthesis of Ethyl 2,3,4-tri-O-benzyl-1-thio-α /β-D-
glucopyranoside (2) 
  A solution of NaOMe 1N (1.12 mL, 1.12 mmol) in MeOH was added to a 
stirred solution of 1 (1.0 g, 1.86 mmol) in MeOH (5 mL) at 0 ºC. After 1 hour 
the reaction mixture was neutralized with saturated aqueous NH4Cl. The 
aqueous phase was extracted with EtOAc (3x10 mL) and the combined 
organic extracts were dried (MgSO4), filtered and the solvent was removed. 
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The crude product was purified by flash column chromatography on silica gel 
(20:80, EtOAc/Hex) to afford the product 2 (0.90 g, 96%, α:β =2.6:1) as a 
white solid. FT-IR (KBr disk) υmáx.: 3370-3515 (O-H) cm-1. 1H RMN (CDCl3): 
δ 7.40-7.25 (m, Ph), 5.35 (d, J = 5.4 Hz, H-1 (α)), 4.97-4.84 (m, CH2Ph), 4.80-
4.71 (m, CH2Ph), 4.66-4.62 (m, CH2Ph), 4.50 (d, J = 9.8 Hz, H-1 (β)), 4.10-
4.09 (m), 3.88 (dt, J = 3.3 Hz, J = 10.0 Hz, H-5 (α)), 3.88 (t, J = 9.1 Hz), 3.79-
3.66 (m), 3.60-3.50 (m), 3.43-3.35 (m, H-2 (β), H-5 (β)), 2.82-2.62 (m, 
SCH2CH3 (β)), 2.60-2.45 (m, SCH2CH3 (α)), 1.33-1.25 (m, SCH2CH3) ppm. 13C 
RMN (CDCl3): δ 138.7, 138.2, 137.9, 137.8, 128.6-127.6, 86.5, 85.3 (C-1 (β)), 
83.0 (C-1 (α)), 82.4, 81.8  (C-2 (β)), 79.7 (C-2 (α)), 79.3 (C-5 (β)), 77.7, 77.2, 
75.7 (CH2Ph), 75.5 (CH2Ph (β)), 75.1 (CH2Ph (β)), 75.0 (CH2Ph (α)), 72.4 
(CH2Ph (α)), 71.1 (C-5 (α)), 62.2 (C-6 (β)), 62.0 (C-6 (α)), 25.2 (SCH2CH3 (β)), 
23.7 (SCH2CH3 (α)), 15.1 (SCH2CH3 (β)), 14.6 (SCH2CH3 (α)) ppm. 
 
Experiment 3. Synthesis of Ethyl 2,3,4-tri-O-benzyl-6-O-chloroacetyl-1-
thio-α /β-D-glucopyranoside (3) 
  To a stirred solution of 2 (1.05 g, 2.12 mmol) in pyridine (5 mL) at 0ºC was 
added chloroacetyl chloride (0.186 mL, 2.33 mmol), after 1 hour more 
chloroacetyl chloride (0.169 mL, 2.12 mmol) was added at 0ºC. After 
complete conversion of the starting material water was added. The mixture 
was extracted with EtOAc, dried (MgSO4) and concentrated to furnish a 
yellow viscous residue. Purification by flash column chromatography on silica 
gel (10:90, EtOAc/Hex) afforded the product 3 as viscous colourless foam 
(1.04 g, 86%). FT-IR (film) υmáx.: 1762, 1743 (C=O) cm-1. 1H RMN (CDCl3): 
δ 7.39-7.25 (m, Ph), 5.35 (d, J = 5.4 Hz, H-1 (α)), 4.98-4.94 (m, CH2Ph), 4.91-
4.83 (m, CH2Ph), 4.78-4.71 (m, CH2Ph), 4.64 (d, J = 11.7 Hz, CH2Ph (α)), 
4.60-4.56 (m, CH2Ph), 4.47 (d, J = 9.8 Hz, H-1 (β)), 4.44-4.41 (m, H-6 (β)), 
4.34-4.22 (m), 4.03-3.95 (m, AcCl), 3.91-3.86 (m, H-3 (α)), 3.79 (dd, J = 5.4 
Hz, J = 9.5 Hz, H-2 (α)), 3.70 (t, J = 8.7 Hz, H-3 (β)), 3.53-3.52 (m, H-4 (β)), 
3.48-3.40 (m, H-4 (α), H-2 (β)), 2.73-2.66 (m, SCH2CH3 (β)), 2.61-2.45 (m, 
SCH2CH3 (α)), 1.33-1.25 (m, SCH2CH3) ppm. 13C RMN (CDCl3): δ 166.97 
(COCH2Cl (β)), 166.95 (COCH2Cl (β)), 138.4, 138.2, 137.7, 137.6, 137.5, 
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128.5-127.7, 86.6 (C-3 (β)), 85.2 (C-1 (β)), 82.9 (C-1 (α)), 82.4 (C-3 (α)), 81.6 
(C-2 (β)), 79.4 (C-2 (α)), 76.5 (C-4), 75.8 (CH2Ph (β)), 75.7 (CH2Ph (α)), 75.5 
(CH2Ph (β)), 75.0 (CH2Ph (β)), 74.8 (CH2Ph (α)), 72.3 (CH2Ph (α)), 72.4 
(CH2Ph (α)), 68.6 (C-5), 64.8 (C-6 (β)), 64.7 (C-6 (α)), 40.68 (COCH2Cl (β)), 
40.62 (COCH2Cl (α)), 25.1 (SCH2CH3 (β)), 23.7 (SCH2CH3 (α)), 15.1 
(SCH2CH3 (β)), 14.7 (SCH2CH3 (α)) ppm. 
 
Experiment 4. General glycosylation procedure 
  A suspension of thioglycoside donor (0.15 mmol), acceptor (0.15 mmol) and 
4Å MS in the solvent/mixture of solvents indicated (1 mL) was stirred for 1 h at 
room temperature then cooled to 0°C. N-Iodosuccinimide (0.19 mmol) and 
TfOH (0.9 µL) were added at 0°C and when the reaction was complete (TLC), 
10% Na2S2O3 aqueous solution (2 mL) and saturated aqueous NaHCO3 (1 
mL) were added and the mixture was extracted with CH2Cl2 (3x5 mL); the 
combined organic phases were dried (MgSO4), filtered and the solvent was 
removed under vacuum. The crude product was purified by preparative TLC 
(3:7, EtOAc/Hex). The α/β ratio of the isolated product was measured by 1H 
NMR (400 MHz, CDCl3) spectra. 
 
Experiment 5. Synthesis of Methyl (2S)-2-(6-O-acetyl-2,3,4-tri-O-benzyl-
α /β-D-glucopyranosyl)propanoate (10) 
  The glycosylation reaction of donor 1 with acceptor 4 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 2, Chapter 1. FT-IR (film) υmáx.: 1743 (C=O) cm-1. 1H NMR 
(CDCl3): δ 7.42-7.24 (m, Ph), 5.14 (d, J = 8.6 Hz, CH2Ph), 5.01 (d, J = 8.6 Hz, 
CH2Ph), 4.96 (d, J = 8.6 Hz, CH2Ph), 4.89-4.70 (m, CH2Ph), 4.75 (d, J = 3.0 
Hz, H-1 (α)), 4.63 (d, J = 12.0 Hz, CH2Ph), 4.57 (d, J = 10.9 Hz, CH2Ph), 4.50 
(d, J = 6.2 Hz, H-1 (β)), 4.32 (dd, J = 12.2 Hz, J = 3.9 Hz, H-6), 4.15-4.02 (m, 
H-3, H-5, H-6, CHCH3), 3.71 (s, OMe (β)), 3.70 (s, OMe (α)), 3.55-3.48 (m, H-
2, H-4), 2.03 (s, Ac (β)), 2.00 (s, Ac (α)) 1.50 (d, J = 5.5 Hz, CH(CH3) (β)), 
1.44 (d, J = 5.4 Hz, CHCH3 (α)) ppm. 13C NMR (CDCl3): δ 172.9, 172.7, 
138.6, 138.5, 138.0, 135.6, 135.5, 132.8, 129.9, 129.8, 128.5–127.4, 102.4 
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(C-1 (β)), 97.8 (C-1 (α)), 84.3, 82.0, 81.6, 80.1, 75.7, 75.6, 75.1, 75.0, 74.6, 
74.4, 73.4, 72.8, 71.5, 62.0, 61.8, 52.1, 52.0, 19.1, 18.0 ppm. 
 
Experiment 6. Synthesis of Methyl (2R)-2-(6-O-acetyl-2,3,4-tri-O-benzyl-
α /β-D-glucopyranosyl)propanoate (11) 
  The glycosylation reaction of donor 1 with acceptor 5 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 2, Chapter 1.FT-IR (film) υmáx.: 1742 (C=O) cm-1. 1H NMR 
(CDCl3): δ 7.43–7.25 (m, Ph), 5.10 (d, J = 3.4 Hz, H-1(α)), 5.06 (d, J = 10.8 
Hz, CH2Ph), 4.89 (d, J = 11.9 Hz, 1H, CH2Ph), 4.88 (d, J = 10.7 Hz, CH2Ph), 
4.81 (d, J = 10.8 Hz, CH2Ph), 4.72 (d, J = 11.9 Hz, CH2Ph), 4.55 (d, J = 10.7 
Hz, CH2Ph), 4.48 (d, J = 7.7 Hz, H-1(β)), 4.37 (q, J = 7.0 Hz, CHCH3), 4.26 (d, 
J = 3.4 Hz, H-6), 4.08 (t, J = 9.2Hz, H-3), 3.83 (ddd, J = 3.2Hz, J=3.2Hz, J = 
10.0Hz, H-5), 3.76 (s, OMe (α)), 3.72 (s, OMe (β)), 3.58 (dd, J = 3.6 Hz, J = 
9.6 Hz, H-2), 3.48 (t, J = 9.7 Hz, H-4), 2.04 (s, Ac (β)), 2.02 (s, Ac (α)), 1.50 
(d, J = 7.0 Hz, CHCH3 (α)), 1.46 (d, J = 6.8 Hz, CHCH3 (β)) ppm. 13C NMR 
(CDCl3): δ 172.9 (β), 172.5 (α), 170.7 (β), 170.6 (α), 138.6 (α), 138.4 (β), 
138.2 (β), 137.9 (α), 137.6 (α), 137.5 (β), 128.5-127.6, 103.4 (C-1 (β)), 95.3 
(C-1 (α)), 84.5 (β), 81.8 (β), 81.5 (α), 78.9 (α), 77.1 (α), 75.7 (α), 75.6 (β), 
75.5 (β), 75.2 (α), 75.0 (β), 74.9 (β), 72.9 (β), 72.3 (α), 69.7 (α), 69.3 (α), 62.9 
(α), 62.8 (β), 51.9 (α), 20.7 (α), 18.4 (α), 18.2 (β) ppm. 
 
Experiment 7. Synthesis of Benzyl (2S)-2-(6-O-acetyl-2,3,4-tri-O-benzyl-
α /β-D-glucopyranosyl)propanoate (12) 
    The glycosylation reaction of donor 1 with acceptor 6 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 2, Chapter 1. FT-IR (film) υmáx.:1739 (C=O) cm-1. 1H NMR 
(CDCl3): δ 7.34–7.24 (m, Ph), 5.18–5.09 (m, CO2CH2Ph), 4.99 (d, J = 10.7 Hz, 
CH2Ph), 4.86 (d, J = 10.9 Hz, CH2Ph), 4.82 (d, J = 11.0 Hz, CH2Ph), 4.79 (d, J 
= 12.1 Hz, CH2Ph), 4.77 (d, J = 3.1 Hz, H-1 (α)), 4.63 (d, J = 12.0 Hz, CH2Ph), 
4.54 (d, J = 11.0 Hz, CH2Ph), 4.51 (d, J = 7.8 Hz, H-1 (β)), 4.20-4.09(m, H-5, 
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H-6, CHCH3), 4.06-3.99 (m, H-3, H-6), 3.54-3.47 (m, H-2, H-4), 2.01 (s, Ac 
(β)), 1.97 (s, Ac (α)), 1.51 (d, J = 6.8 Hz, CHCH3 (β)), 1.45 (d, J = 6.8 Hz, 
CHCH3 (α)) ppm. 13C NMR (CDCl3): δ 172.1 (β), 171.9 (α), 170.7 (β), 170.6 
(α), 138.6 (α), 138.5 (β), 138.4 (β), 138.1 (α), 138.0 (α), 137.7 (β), 135.4 (α), 
128.6–127.6, 102.4 (C-1 (β)), 97.3 (C-1 (α)), 84.4 (β), 81.8 (C-3 (α)), 79.9 (C-
2 (α)), 77.1 (β), 77.0 (C-4 (α)), 75.7 (α), 75.0 (β), 74.8 (α), 74.5 (β), 73.8 
(CHCO2CH3 (α)), 73.3 (α), 72.9 (β), 72.8 (β), 69.1 (C-5 (α)), 66.7 (α), 63.0 (β), 
62.7 (C-6 (α)), 20.8 (OCOCH3), 19.1 (CO2CH3 (β)), 17.8 (CO2CH3 (α)) ppm. 
 
Experiment 8. Synthesis of Methyl 2-(6-O-acetyl-2,3,4-tri-O-benzyl-α /β-D-
glucopyranosyl)acetate (13) 
    The glycosylation reaction of donor 1 with acceptor 7 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 2, Chapter 1. FT-IR (film) υmáx.:1742 (C=O) cm-1. 1H NMR 
(CDCl3): δ 7.32–7.25 (m, Ph), 5.05 (d, J = 4.0 Hz, H-1(α)), 5.03 (d, J = 11.2Hz, 
CH2Ph), 4.88 (d, J = 10.8Hz, CH2Ph), 4.86 (d, J = 11.9 Hz, CH2Ph), 4.81 (d, J 
= 10.8 Hz, CH2Ph), 4.77 (d, J = 11.9 Hz, CH2Ph), 4.55 (d, J = 10.9 Hz, 
CH2Ph), 4.51 (d, J = 7.7 Hz, H-1 (β)), 4.27 (d, J = 16.6 Hz, CH2CO2Me), 4.25-
4.24 (m, H-6), 4.15 (d, J = 16.6 Hz, CH2CO2Me), 4.06 (t, J = 9.2 Hz, H-3), 
3.91 (dt, J =  3.1 Hz, J = 10.1 Hz, H-5), 3.76 (s, CO2Me (α)), 3.75 (s, CO2Me 
(β)), 3.59 (dd, J = 3.6 Hz, J = 9.6 Hz, H-2 (α)), 3.54-3.50 (m, H-2 (β)), 3.48 
(dd, J = 9.2 Hz, J = 9.7 Hz, H-4), 2.03 (s, Ac (β)), 2.02 (s, Ac (α)) ppm. 13C 
NMR (CDCl3): δ 170.7, 170.0, 138.6, 137.9, 137.8, 128.5, 128.47, 128.45, 
128.3, 128.1, 128.0, 127.95, 127.92, 127.7, 103.2 (C-1 (β)), 96.3 (C-1 (α)), 
81.6, 79.3, 77.0, 75.8, 75.0, 72.7, 69.3, 63.3, 62.9, 51.9, 20.8 ppm. Anal. 
Calcd for C32H36O9: C, 68.07; H, 6.43. Found: C, 68.60, H, 6.54. 
 
Experiment 9. Synthesis of Methyl (2R)-tert-butyldimethylsilyl-3-(6-O-
acetyl-2,3,4-tri-O-benzyl-α-D-glucopyranosyl)-2,3-dihydroxypropanoate 
(14) 
    The glycosylation reaction of donor 1 with acceptor 8 was performed 
according to the procedure described in experiment 4. The results are 
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presented in Table 2, Chapter 1. FT-IR (film) υmáx.: 1744 (C=O) cm-1. 1H NMR 
(CDCl3): δ 7.38–7.25 (m, 15H, Ph), 4.95 (d, 1H, J = 10.8 Hz, CH2Ph), 4.88 (d, 
1H, J = 11.1 Hz, CH2Ph), 4.87 (d, 1H, J = 3.5 Hz, H-1), 4.77 (d, 1H, J = 10.8 
Hz, CH2Ph), 4.72-4.66 (m, 2H, CH2Ph), 4.56 (d, 1H, J = 11.1 Hz, CH2Ph), 
4.45 (dd, 1H, J = 4.4 Hz, J = 6.2 Hz, CH2CH(OTBDMS)CO2Me), 4.24-4.22 (m, 
2H, H-6), 4.00 (t, 1H, J = 9.2 Hz, H-3), 3.88 (dt, 1H, J = 3.0 Hz, J = 10.0 Hz, 
H-5), 3.81-3.75 (m, 1H, CH2CH(OTBDMS)CO2Me), 3.72-3.67 (m, 1H, 
CH2CH(OTBDMS)CO2Me), 3.70 (s, 3H, OMe), 3.54-3.44 (m, 2H, H-2, H-4), 
2.01 (s, 3H, Ac), 0.91 (s, 9H, t-But), 0.13 (s, 6H, SiMe2) ppm. 13C NMR 
(CDCl3): δ 172.2, 170.7, 138.6, 138.3, 138.1, 128.6-127.6, 97.1 (C-1), 81.7 
(C-3), 79.2 (C-2), 77.1 (C-4), 75.7 (CH2Ph), 74.8 (CH2Ph), 72.6 (CH2Ph), 72.0 
(CH2CH(OTBDMS)CO2Me)), 68.8 (CH2CH(OTBDMS)CO2Me), 65.0 (C-5), 
63.1 (C-6), 52.0 (CO2Me), 25.7 (SiC(CH3)3), 20.8 (COCH3), 18.3 (SiC(CH3)3), 
4.9 (Si(CH3)2) ppm. 
 
Experiment 10. Synthesis of Methyl 3-O-tert-butyldimethylsilyl-(2R)-2-O-
(6-O-acetyl-2,3,4-tri-O-benzyl-α-D-glucopyranosyl)-2,3-
dihydroxypropanoate (15) 
  The glycosylation reaction of donor 1 with acceptor 9 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 2, Chapter 1. Alpha anomer: [α]D20 +45.2 (c 1.45, 
CH2Cl2). FT-IR (film) υmáx.: 1744 (C=O) cm-1. 1H NMR (CDCl3): δ 7.38-7.37 
(5H, m), 7.37-7.22 (25H, m), 5.16 (1H, d, J = 3.6 Hz, H-1), 5.02 (1H, d, J = 
10.6 Hz), 4.89 (2H, dd, J = 11.9 Hz, J = 3.1 Hz), 4.76 (1H, d, J = 10.5Hz), 
4.70 (1H, d, J = 11.8Hz), 4.54 (1H, d, J = 11.2 Hz), 4.49 (1H, dd, J = 6.3 Hz, J 
= 4.3 Hz), 4.15-3.94 (6H, m), 3.73 (3H, s), 3.60 (1H, dd, J = 9.7 Hz, J = 3.5 
Hz), 3.48 (1H, t, J = 9.5 Hz), 1.99 (3H, s), 1.03 (9H, s) ppm. 13C NMR (CDCl3): 
δ 170.6, 170.2, 138.7, 138.1, 138.0, 135.6, 135.5, 133.0, 132.8, 129.8, 129.8, 
128.4, 128.3, 128.2, 128.2, 128.1, 127.8, 127.7, 127.6, 94.8 (C-1), 81.6, 75.8, 
74.8, 72.0, 71.9, 69.0, 65.8, 64.6, 62.9, 51.9, 26.7, 20.8, 19.1 ppm. HR-MS: 
calcd for C49H56O10Si [M]+: 559.2130; found: 559.2125. 
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Experiment 11. Synthesis of Methyl (2S)-2-(2,3,4-tri-O-benzyl-6-O-
chloroacetyl-α /β-D-glucopyranosyl)propanoate (16) 
  The glycosylation reaction of donor 3 with acceptor 4 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 2, Chapter 1. FT-IR (film) υmáx.: 1751 (C=O) cm-1. 1H NMR 
(CDCl3): δ 7.37-7.24 (m, Ph), 5.13 (d, J = 10.8 Hz, CH2Ph (β)), 5.00 (d, J = 
10.7 Hz, CH2Ph (α)), 4.96 (d, J = 11.0 Hz, CH2Ph (β)), 4.90-4.77 (m, CH2Ph), 
4.72 (d, J = 3.8 Hz, H-1 (α)), 4.68-4.55 (m, CH2Ph), 4.50 (d, J = 7.6 Hz, H-1 
(β)), 4.31-4.24 (m), 4.16-4.11 (m), 4.06-3.90 (m), 3.71 (s, OMe (β)), 3.70 (s, 
OMe (α)), 3.55-3.45 (m) ppm. 13C NMR (CDCl3): δ 172.6 (CO2Me), 166.9 
(COCH2Cl), 138.6, 138.1, 137.8, 128.5-128.0, 127.9, 127.7, 102.3 (C-1 (β)), 
97.5 (C-1 (α)), 84.4 (β), 81.3 (C-3 (α)), 80.0 (C-2 (α)), 75.7 (C-4 (α)), 74.8 
(CH2Ph), 74.6 (CH2Ph), 74.1 (CHCH3), 73.4 (CH2Ph), 72.8 (β), 72.5 (β), 69.0 
(C-5 (α)), 64.3 (C-6 (α)), 52.1 (OMe), 40.7 (COCH2Cl), 17.9 (CHCH3) ppm. 
 
Experiment 12. Synthesis of Benzyl (2S)-2-(2,3,4-tri-O-benzyl-6-O-
chloroacetyl-α /β-D-glucopyranosyl)propanoate (17) 
  The glycosylation reaction of donor 3 with acceptor 6 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 2, Chapter 1. FT-IR (film) υmáx.: 1745 (C=O) cm-1. 1H NMR 
(CDCl3): δ 7.34-7.27 (m, Ph), 5.13 (dd, J = 12.2 Hz, J = 23.8 Hz, CO2CH2Ph 
(α)), 5.00 (d, J = 10.7 Hz, CH2Ph (α)), 4.99 (d, J = 10.7 Hz, CH2Ph (α)), 4.87 
(d, J = 11.1 Hz, CH2Ph (α)), 4.82 (d, J = 10.8 Hz, CH2Ph (α)), 4.78 (d, J = 
12.1 Hz, CH2Ph (α)), 4.73 (d, J = 3.7 Hz, H-1 (α)), 4.61 (d, J = 12.0Hz, CH2Ph 
(α)), 4.57 (d, J = 11.2 Hz, CH2Ph (α)), 4.51 (d, J = 7.6 Hz, H-1 (β)), 4.19-4.06 
(m), 4.02 (t, J = 9.2 Hz, H-3 (α)), 3.90 (dd, J = 14.8 Hz, J = 21.1 Hz, AcCl), 
3.52-3.44 (m, H-2 (α), H-4 (α)), 1.45 (d, J = 6.7 Hz, CHCH3 (α)), 1.50 (d, J = 
6.9 Hz, CHCH3 (β)) ppm. 13C NMR (CDCl3): δ 171.9 (CO2Bn), 166.9 
(COCH2Cl), 138.6, 138.1, 138.0, 135.3, 128.9-127.7, 102.3 (C-1 (β)), 97.4 (C-
1 (α)), 81.8 (C-3 (α)), 79.9 (C-2 (α)), 76.6 (C-4 (α)), 75.8 (CH2Ph), 74.7 
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(CH2Ph), 74.0 (CHCH3), 73.4 (CH2Ph), 69.0 (C-5 (α)), 66.8 (CO2CH2Ph), 64.2 
(C-6 (α)), 40.6 (COCH2Cl), 17.9 (CHCH3) ppm. 
 
Experiment 13. Synthesis of Methyl 2-(2,3,4-tri-O-benzyl-6-O-
chloroacetyl-α /β-D-glucopyranosyl)acetate (18) 
  The glycosylation reaction of donor 3 with acceptor 7 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 2, Chapter 1. FT-IR (film) υmáx.: 1757 (C=O) cm-1. 1H NMR 
(CDCl3): δ 7.42-7.24 (m, Ph), 5.07 (d, J = 11,0 Hz, CH2Ph (β)), 5.03 (d, J = 
10.4 Hz, CH2Ph (α)), 5.02 (s, H-1 (α)), 4.97 (d, J = 10.9 Hz, CH2Ph (β)), 4.90-
4.71 (m, CH2Ph), 4.58 (d, J = 11.0 Hz, CH2Ph (α)), 4.51 (d, J = 7.6 Hz, H-1 
(β)), 4.38-4.23 (m), 4.16-4.00 (m), 3.98-3.92 (m), 3.76 (s, OMe), 3.67 (t, J = 
8.3 Hz, H-3 (β)), 3.57 (dd, J = 3.6 Hz, J = 9.6 Hz, H-2 (α)), 3.47 (t, J = 9.4 Hz, 
H-4 (α)) ppm. 13C NMR (CDCl3): δ 170.0 (CO2Me), 166.9 (COCH2Cl), 138.5, 
137.8, 137.7, 128.5-127.7, 96.3 (C-1 (α)), 81.6 (C-3 (α)), 79.3 (C-2 (α)), 76.5 
(C-4 (α)), 75.8 (CH2Ph), 74.9 (CH2Ph), 72.8 (CH2Ph), 69.1 (C-5 (α)), 64.4 (C-
6 (α)), 63.4 (OMe), 40.6 (COCH2Cl) ppm. 
 
Experiment 14. Synthesis of Ethyl 6-O-acetyl-2,3,4-tri-O-benzyl-1-thio-
α /β-D-galactopyranoside (19) 
  To a stirred solution of methyl α−D-galactopyranoside (2.0 g, 10.3 mmol) in 
DMF (20 mL) was added benzyl bromide (6.3 mL, 51.5 mmol). The mixture 
was cooled to 0ºC and sodium hydride (1.48 g, 61.8 mmol) was added 
portion-wise. The reaction was kept over-night at r.t. and after complete 
conversion of the starting material MeOH was added at 0ºC. The mixture was 
extracted with Et2O and the combined organic phases dried, filtered and 
concentrate. Purification by flash column chromatography on silica gel (10:90, 
EtOAc/Hex) afforded the product as a viscous colourless foam (5.14 g, 90%).  
  Concentrated sulphuric acid (1.0 mL) was added dropwise to a stirred 
solution of the methyl tetra-O-benzylgalactopyranoside (5.72 g, 10.7 mmol) in 
acetic acid/acetic anhydride (1:1, 50 mL) at 0ºC. After complete conversion of 
the starting material the reaction mixture was quenched with saturated 
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NaHCO3 solution and ice-cold distilled water until pH 7. The mixture was 
extracted with EtOAc (3x70 mL) and the combined organic dried, filtered and 
concentrated in vacuum. The residue was purified by flash column 
chromatography on silica gel (20:80, EtOAc/Hex) to give the diacetate (4.29 g, 
75%, α:β = 3.7:1) as a viscous colourless foam. FT-IR (film) υmáx.: 1745 (C=O) 
cm-1. 1H NMR (CDCl3): δ 7.40-7.26 (m, Ph), 6.39 (d, J = 2.5 Hz, H-1 (α)), 5.58 
(d, J = 5.0 Hz, H-1 (β)), 4.99-4.95 (m), 4.89-4.60 (m), 4.20-3.95 (m), 3.92-3.87 
(m), 3.83 (d, J = 2.0 Hz), 3.68 (t, J = 6.0 Hz), 3.62 (dd, J = 2.8 s Hz, J = 10.0 
Hz), 2.11 (s, Ac (α)), 2.04 (s, Ac (β)), 1.98 (s, Ac (α)), 1.96 (s, Ac (β)) ppm. 13C 
NMR (CDCl3): δ 170.5 (COCH3), 169.4 (COCH3), 138.5, 138.0, 137.9, 128.5-
127.4, 94.1 (C-1 (β)), 90.7 (C-1 (α)), 82.4 (β), 78.6 (α), 78.1 (β), 75.4 (α), 75.3 
(CH2Ph (β)), 74.7 (CH2Ph (α)), 74.4 (CH2Ph (β)), 74.3 (α), 73.44 (CH2Ph (α)), 
73.40 (CH2Ph (α)), 73.1 (CH2Ph (β)), 73.2 (β), 72.9 (β), 70.8 (α), 63.1 (C-6 
(α)), 62.9 (C-6 (β)), 21.1 (COCH3 (α)), 21.0 (COCH3 (β)), 20.8 (COCH3 (α)), 
20.7 (COCH3 (β)) ppm. HR-MS: calcd for C31H34O8Na+ [M+Na]+: 557.21459; 
found: 557.21447.  
  Ethanethiol (1.56 mL, 20.7 mmol) was added to a stirred solution of 
diacetate (3.69 g, 6.9 mmol) in DCM (30 ml). The reaction mixture was cooled 
to 0ºC and boron trifluoride diethyl etherate (1.31 mL, 10.35 mmol) added 
dropwise. After complete conversion of starting material the reaction mixture 
was diluted with CH2Cl2 (40 mL) and quenched with saturated NaHCO3 
solution until pH 7. The aqueous phase was extracted with CH2Cl2 (2×40 mL) 
and the combined organic extracts dried, filtered and concentrated in vacuum. 
The residue was purified by flash column chromatography (20:80, EtOAc/Hex) 
to give the thiogalactoside 19 (3.39 g, 91%, α/β=2.4:1) as a viscous 
colourless foam. Alpha product: [α]D20  +113.8 (c 2.32, CH2Cl2). FT-IR (film) 
υmáx.: 1743 (C=O) cm-1. 1H NMR (CDCl3): δ 7.40-7.27 (m, 15H, Ph), 5.49 (d, 
1H, J = 3.5 Hz, H-1), 4.95 (d, 1H, J = 7.0 Hz, CH2Ph), 4.86 (d, 1H, J = 7.5 Hz, 
CH2Ph), 4.76-4.66 (m, 3H, CH2Ph), 4.61 (d, 1H, J = 7.0 Hz, CH2Ph), 4.31-
4.25 (m, 2H, H-2, H-5), 4.18 (dd, 1H, J = 2.8 Hz, J = 4.5 Hz, H-6), 4.05 (dd, 
1H, J = 3.3Hz, J = 3.8Hz, H-6), 3.85-3.84 (m, 1H, H-4), 3.79 (dd, 1H, J = 1.8 
Hz, J=4.5 Hz, H-3), 2.62-2.44 (m, 2H, SCH2CH3), 1.97 (s, 3H, OAc), 1.27 (t, 
3H, J = 4.5 Hz, SCH2CH3) ppm. 13C NMR (CDCl3): δ 170.4 (COCH3), 138.7, 
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138.2, 138.1, 128.5-127.5, 83.2 (C-1), 79.4, 76.4, 74.7, 74.5 (CH2Ph), 73.7 
(CH2Ph), 72.5 (CH2Ph), 68.9, 63.4 (C-6), 23.5 (SCH2CH3), 20.8 (COCH3), 
14.7 (SCH2CH3) ppm. HR-MS: calcd for C31H36O6SH+ [M+H]+: 537.23054; 
found: 537.23155. Beta product: [α]D20 +17.1 (c 1.18, CH2Cl2). FT-IR (film) 
υmáx.: 1742 (C=O) cm-1. 1H NMR (CDCl3): δ 7.39-7.26 (m, 15H, Ph), 4.98 (d, 
1H, J = 7.3 Hz, CH2Ph), 4.89 (d, 1H, J = 6.3 Hz, CH2Ph), 4.83-4.74 (m, 3H, 
CH2Ph), 4.65 (d, 1H, J = 7.5Hz, CH2Ph), 4.41 (d, 1H, J = 6.0Hz, H-1), 4.22 
(dd, 1H, J = 2.8Hz, J = 4.3 Hz, H-6), 4.05 (dd, 1H, J = 3.8 Hz, J=3.3 Hz, H-6), 
3.87-3.82 (m, 2H, H-2, H-4), 3.58-3.53 (m, 2H, H-3, H-5), 2.80-2.64 (m, 2H, 
SCH2CH3), 1.96 (s, 3H, OAc), 1.29 (t, 3H, J = 4.5 Hz, SCH2CH3) ppm. 13C 
NMR (CDCl3): δ 170.5 (COCH3), 138.28, 138.25, 138.22, 128.5-127.6, 85.4 
(C-1), 84.1, 78.4, 75.9, 75.8 (CH2Ph), 74.3 (CH2Ph), 73.3, 73.1 (CH2Ph), 63.3 
(C-6), 24.9 (SCH2CH3), 20.8 (COCH3), 15.1 (SCH2CH3) ppm. HR-MS: calcd 
for C31H36O6SH+ [M+H]+: 537.23054; found: 537.23002. 
 
Experiment 15. Synthesis of Ethyl 2,3,4-tri-O-benzyl-1-thio-α /β-D-
galactopyranoside (20) 
  The procedure of Experiment 2 was applied to compound 19, affording the 
product 20 (0.856 g, 81%, α:β=2.6:1) as a white solid. Alpha product: f.p. 
84.0-85.1 ºC. [α]D20 +145.2 (c 1.03, CH2Cl2). FT-IR (KBr disk) υmáx.: 3422-
3508 (O-H) cm-1. 1H NMR (CDCl3): δ 7.41-7.28 (m, 15H, Ph), 5.51 (d, 1H, J = 
3.5 Hz, H-1), 4.97 (d, 1H, J = 7.3 Hz, CH2Ph), 4.87 (d, 1H, J = 7.5 Hz, 
CH2Ph), 4.72 (q, 2H, J = 7.3 Hz, J = 9.3 Hz), 4.64 (d, 1H, J = 7.3Hz), 4.30 (dd, 
1H, J = 3.3 Hz, J = 3.5 Hz), 4.13-4.10 (m, 1H), 3.88-3.87 (m, 1H), 3.73 (dd, 
1H, J = 3.3 Hz, J = 4.0 Hz), 3.53 (dd, 1H, J = 3.3 Hz, J = 3.8 Hz), 2.61-2.45 
(m, 2H, SCH2CH3), 1.27 (t, 3H, J = 4.5 Hz, SCH2CH3) ppm. 13C NMR (CDCl3): 
δ 138.6, 138.2, 138.1, 128.5-127.6, 83.4 (C-1), 79.5, 76.2, 75.2, 74.5 
(CH2Ph), 73.7 (CH2Ph), 72.8 (CH2Ph), 70.5, 62.5 (C-6), 23.5 (SCH2CH3), 14.6 
(SCH2CH3) ppm. Anal. Calcd for C29H34O5S: C, 70.42; H, 6.93; S, 6.48. 
Found: C, 69.93; H, 6.86; S, 6.18. Beta anomer: f.p. 100.3-101.4 ºC. [α]D20 
+6.6 (c 0.89, CH2Cl2). FT-IR (KBr disk) υmáx.: 3420-3510 (O-H) cm-1. 1H NMR 
(CDCl3): δ 7.41-7.28 (m, 15H, Ph), 4.97 (d, 1H, J = 7.3 Hz), 4.90 (d, 1H, J = 
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6.3 Hz), 4.81 (d, 1H, J = 6.3 Hz), 4.80-4.74 (m, 2H), 4.43 (d, 1H, J = 6.3 Hz, 
H-1), 3.87-3.76 (m, 3H), 3.58 (dd, 1H, J = 1.8 Hz, J = 4.0 Hz), 3.47 (dd, 1H, J 
= 3.3 Hz, J = 3.8 Hz), 3.42-3.39 (m, 1H), 2.82-2.67 (m, 2H, SCH2CH3), 1.30 (t, 
3H, J = 4.5 Hz, SCH2CH3) ppm. 13C NMR (CDCl3): δ 138.3, 138.2, 138.19, 
128.5-127.6, 85.4 (C-1), 84.1, 78.6, 78.5, 75.8 (CH2Ph), 74.1 (CH2Ph), 73.1 
(CH2Ph), 73.0, 62.2 (C-6), 24.9 (SCH2CH3), 15.1 (SCH2CH3) ppm. Anal. 
Calcd for C29H34O5S: C, 70.42; H, 6.93; S, 6.48. Found: C, 70.17; H, 6.97; S, 
6.32. 
	  
Experiment 16. Synthesis of Ethyl 2,3,4-tri-O-benzyl-6-O-chloroacetyl-1-
thio-α /β-D-galactopyranoside (21) 
  To a stirred solution of 20 (0.845 g, 1.70 mmol) in pyridine (5 mL) at 0ºC was 
added chloroacetic anhydride (0.320 g, 1.87 mmol). After complete 
conversion of the starting material water was added. The mixture was 
extracted with EtOAc, dried (MgSO4) and concentrated to furnish a yellow 
viscous residue. Purification by flash column chromatography on silica gel 
(20:80, EtOAc/hexane) afforded the product 21 as a viscous colourless foam 
(0.878 g, 90%). HRMS: calcd for C31H35ClO6SNa+ [M+Na]+: 593.1740; found 
593.1735. Alpha product: [α]D20 +104.00 (c 1.60, CH2Cl2). FT-IR (film) υmáx.: 
1745 (C=O) cm-1. 1H NMR (CDCl3): δ 7.40-7.28 (m, 15H, Ph), 5.47 (d, 1H, J = 
5.4 Hz, H-1), 4.96 (d, 1H, J = 11.6 Hz, CH2Ph), 4.87 (d, 1H, J = 11.8 Hz, 
CH2Ph), 4.76-4.67 (m, 3H, CH2Ph), 4.62 (d, 1H, J = 11.6Hz, CH2Ph), 4.32-
4.25 (m, 3H, H-2, H-4, H-6), 4.15-4.06 (m, 1H, H-6), 3.96-3.88 (m, 2H, AcCl), 
3.85-3.83 (m, 1H, H-5), 3.79 (dd, 1H, J = 2.8 Hz, J = 9.7 Hz, H-3), 2.62-2.35 
(m, 2H, SCH2CH3), 1.28-1.24 (m, 3H, SCH2CH3) ppm. 13C NMR (CDCl3): 
δ 166.8 (COCH2Cl), 138.5, 138.1, 138.0, 128.5-127.6, 83.1 (C-1), 79.2 (C-3), 
76.1 (C-2), 74.4 (CH2Ph), 74.3 (C-5), 73.8 (CH2Ph), 72.5 (CH2Ph), 68.5 (C-4), 
64.9 (C-6), 40.5 (COCH2Cl), 23.5 (SCH2CH3), 14.7 (SCH2CH3) ppm.  
Beta product: [α]D20 +2.03 (c 1.02, CH2Cl2). FT-IR (film) υmáx.: 1747 (C=O) 
cm-1. 1H NMR (CDCl3): δ 7.40-7.28 (m, 15H, Ph), 4.99 (d, 1H, J=11.8 Hz, 
CH2Ph), 4.89 (d, 1H, J = 10.2 Hz, CH2Ph), 4.83-4.75 (m, 3H, CH2Ph), 4.65 (d, 
1H, J = 11.8 Hz, CH2Ph), 4.42 (d, 1H, J = 9.6 Hz, H-1), 4.31 (dd, 1H, J = 6.8 
Hz, J = 11.1 Hz, H-6), 4.10 (dd, 1H, J = 5.9, Hz, J = 11.1 Hz, H-6), 3.91 (dd, 
Experimental Procedures 
	  
	  
	  
161 
2H, J = 15.0, Hz, v19.0 Hz, AcCl), 3.87-3.80 (m, 2H, H-2, H-4), 3.59-3.55 (m, 
2H, H-3, H-5), 2.81-2.65 (m, 2H, SCH2CH3), 1.30 (t, 3H, J = 7.4 Hz, 
SCH2CH3) ppm. 13C NMR (CDCl3): δ 166.8 (COCH2Cl), 138.1, 128.5-127.6, 
85.4 (C-1), 84.0 (C-3), 78.3 (C-2), 75.8 (CH2Ph), 75.5 (C-5), 74.1 (CH2Ph), 
73.3 (CH2Ph), 72.9 (C-4), 64.8 (C-6), 40.6 (COCH2Cl), 24.9 (SCH2CH3), 15.1 
(SCH2CH3) ppm. 
 
Experiment 17. Synthesis of Methyl (2S)-2-(6-O-acetyl-2,3,4-tri-O-benzyl-
α /β-D-galactopyranosyl)propanoate (32) 
  The glycosylation reaction of donor 19 with acceptor 4 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 3, Chapter 1. FT-IR (film) υmáx.: 1743 (C=O) cm-1. 1H NMR 
(CDCl3): δ 7.45-7.25 (m, Ph), 5.12 (d, J = 10.8 Hz, CH2Ph), 4.98-4.58 (m, 
CH2Ph), 4.85 (s, H-1 (α)), 4.51-4.44 (m, CHCH3 (β)), 4.45 (d, J = 7.6 Hz, H-1 
(β)), 4.21-3.95 (m, H-6 (α), H-6 (β), H-5(α), CHCH3 (α)), H-2 (α), H-6 (α), H-6 
(β), H-3 (α)), 3.93 (sl, 1H, H-4 (α)), 3.86 (dd, J = 7.6Hz, J = 9.6Hz, H-2 (β)), 
3.75 (d, J = 2.2 Hz, H-4 (β)), 3.69 (s, OMe (β)), 3.67 (s, OMe (α)), 3.58-3.44 
(m, H-3 (β), H-5 (β)), 1.96 (s, Ac (β)), 1.95 (s, Ac (α)), 1.49 (d, J = 6.9 Hz, 
CHCH3 (β)), 1.43 (d, J = 6.8 Hz, CHCH3 (α)) ppm. 13C NMR (CDCl3): δ 173.0, 
172.9, 170.5, 138.8, 138.7, 138.5, 138.3, 138.1, 128.6, 128.4, 128.37, 128.3, 
128.2, 128.1, 127.9, 127.8, 127.7, 127.6, 127.57, 127.53, 127.45, 127.43, 
102.6 (C-1 (α)), 98.0 (C-1 (β)), 81.9 (C-3 (β)), 79.1 (C-2 (β)), 78.9 (C-3 (α)), 
76.3 (C-2 (α)), 74.9, 74.57, 74.53, 74.2, 73.7, 73.4, 73.2, 72.8, 72.5, 72.1 (C-5 
(β)), 68.9 (C-5 (α)), 63.1 (C-6 (α)), 62.9 (C-6 (β)), 51.98, 51.94, 20.7, 19.1, 
17.8 ppm. 
 
Experiment 18. 4.2.9. Synthesis of Benzyl (2S)-2-(6-O-acetyl-2,3,4-tri-O-
benzyl-α /β-D- galactopyranosyl)propanoate (33) 
  The glycosylation reaction of donor 19 with acceptor 6 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 3, Chapter 1. FT-IR (film) υmáx.: 1744 (C=O) cm-1. 1H NMR 
(CDCl3): δ 7.37–7.23 (m, Ph), 5.15–5.07 (m, CO2CH2Ph), 4.97-4.89 (m, 
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CH2Ph), 4.86-4.84 (m, H-1 (α)), 4.82-4.49 (m, CH2Ph), 4.46 (d, J = 7.6 Hz, H-
1 (β)), 4.19-4.12 (m, H-5, CHCH3), 4.10-3.96 (m, H-2, H-3, H-6), 3.87 (bs, H-
4), 1.93 (s, Ac (β)), 1.92 (s, Ac (α)), 1.50 (d, J = 6.9 Hz, CHCH3 (β)), 1.44 (d, J 
= 6.8 Hz, CHCH3 (α)) ppm. 13C NMR (CDCl3): δ 172.2, 170.4, 138.7, 138.5, 
138.2, 128.2-127.4, 102.6 (C-1(β)), 98.0 (C-1 (α)), 81.9 (β), 79.1 (β), 78.9 (α), 
76.3 (α), 74.9 (β), 74.6 (α), 74.5 (α), 74.2 (β), 73.7 (β), 73.5 (α), 73.2, 72.9 (β), 
72.4 (β), 72.2 (β), 68.9, 66.6 (α), 66.5 (β), 63.0 (α), 62.9 (β), 20.8, 17.8 ppm. 
 
Experiment 19. Synthesis of Methyl 2-(6-O-acetyl-2,3,4-tri-O-benzyl-α /β-
D-galactopyranosyl)acetate (34) 
  The glycosylation reaction of donor 19 with acceptor 7 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 3, Chapter 1. FT-IR (film) υmáx.: 1743 (C=O) cm-1. 1H NMR 
(CDCl3): δ 7.43-7.26 (m, Ph), 5.08 (d, J = 10.0 Hz, CH2Ph), 5.05 (d, J = 3.6 
Hz, H-1 (α)) 4.99-4.91 (m, CH2Ph), 4.85-4.72 (m, CH2Ph), 4.67-4.60 (m, 
CH2Ph), 4.48 (d, J = 7.6 Hz, H-1 (β)), 4.39-4.26 (m, CH2CO2Me), 4.22-3.98 
(m, H-6 (α), H-6 (β), CH2CO2Me, H-2 (α), H-6 (β), H-6 (α), H-5 (α), H-3 (α)), 
3.93–3.88 (m, H-2 (β), H-4 (α)), 3.77 (bs, H-4 (β), OMe (β)), 3.75 (bs, OMe 
(α)), 3.56–3.48 (m, H-3 (β), H-5 (β)), 1.98 (s, Ac (α)), 1.97 (s, Ac (β)) ppm. 13C 
NMR (CDCl3): δ 170.5, 170.2, 138.7, 138.3, 138.1, 138.0, 128.5–128.1, 103.3 
(C-1 (β)), 97.3 (C-1 (α)), 81.8 (β), 79.0 (β), 78.6 (α), 76.0 (α), 75.0 (β), 74.7 
(α), 74.6 (α), 74.3 (β), 73.7 (α), 73.6 (β), 73.1 (α), 72.9 (β), 72.2 (β), 69.1 (α), 
65.5 (β), 63.6 (α), 63.4 (α), 63.0 (β), 51.9, 20.8 ppm. 
 
Experiment 20. Synthesis of Methyl 3-O-tert-butyldimethylsilyl-(2R)-2-O-
(6-O-acetyl-2,3,4-tri-O-benzyl-α /β-D-galactopyranosyl)-2,3-
dihydroxypropanoate (35) 
  The glycosylation reaction of donor 19 with acceptor 9 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 3, Chapter 1. 1H NMR (CDCl3): δ 7.65-7.61 (m), 7.45-7.24 
(m), 5.23 (d, J = 3.4 Hz, H-1 (α)), 4.97-4.58 (m), 4.51 (dd, J = 6.8 Hz, J = 4.8 
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Hz), 4.43 (d, J = 7.7 Hz, H-1 (β), 4.28-4.23 (m), 4.14-3.86 (m), 3.79 (s), 3.71 
(s), 1.97 (s), 1.86 (s), 1.03 (s), 1.01 (s) ppm. 13C NMR (CDCl3): δ 170.8, 
170.6, 138.5, 138.3, 138.2, 135.6, 135.5, 129.8, 129.7, 128.5-127.4, 103.9 (C-
1 (β)), 82.0 (C-1 (α)), 79.7, 79.0, 75.1, 74.3, 73.4, 73.1, 72.4, 63.6, 63.1, 51.9, 
26.6, 20.8, 19.1 ppm. 
 
Experiment 21. Synthesis of Methyl (2S)-2-(2,3,4-tri-O-benzyl-6-O-
chloroacetyl-α /β-D-galactopyranosyl)propanoate (36) 
  The glycosylation reaction of donor 21 with acceptor 4 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 3, Chapter 1. FT-IR (film) υmáx.: 1751 (C=O) cm-1. 1H NMR 
(CDCl3): δ 7.44-7.25 (m, Ph), 5.12 (d, J = 10.8 Hz, CH2Ph (β)), 4.98-4.94 (m, 
CH2Ph), 4.91-4.82 (m, CH2Ph), 4.82 (d, J = 3.9 Hz, H-1 (α)), 4.79-4.70 (m, 
CH2Ph), 4.68-4.59 (m, CH2Ph), 4.45 (d, J = 7.6 Hz, H-1 (β)), 4.27 (dd, J = 6.6 
Hz, J = 11.0 Hz, H-6 (β)), 4.20 (t, J = 6.2 Hz), 4.13-3.96 (m), 3.93-3.84 (m), 
3.74-3.69 (m), 3.70 (s, OMe (β)), 3.69 (s, OMe (α)), 3.53-3.49 (m), 1.48 (d, J = 
7.0 Hz, CHCH3 (β)), 1.42 (d, J = 6.8 Hz, CHCH3 (α)) ppm. 13C NMR (CDCl3): δ 
172.9 (CO2Me), 166.9 (COCH2Cl (α)), 166.8 (COCH2Cl (β)), 138.7, 138.6, 
138.5, 138.4, 138.1, 138.0, 128.8-127.5, 102.6 (C-1 (β)), 98.1 (C-1 (α)), 81.8, 
79.0, 78.8, 78.5, 76.3, 75.3, 74.9 (CH2Ph(β)), 74.4 (CH2Ph (α)), 74.3, 74.1 
(CH2Ph (β)), 73.8 (CH2Ph (β)), 73.6 (CH2Ph (α)), 73.54 (CH2Ph (α)), 73.52, 
72.55, 72.52, 71.8, 70.4, 68.3, 64.7 (C-6 (α)), 64.3 (C-6 (β)), 52.1 (OMe (α)), 
52.0 (OMe (β)), 40.7 (COCH2Cl (α)), 40.5 (COCH2Cl (β)), 19.0 (CHCH3 (β)), 
17.8 (CHCH3 (α)) ppm. HR-MS: calcd for C33H37ClO9Na+ [M+Na]+: 635.2018; 
found: 635.2018. 
 
Experiment 22. Synthesis of Methyl 2-(2,3,4-tri-O-benzyl-6-O-
chloroacetyl-α /β-D-galactopyranosyl)acetate (37) 
  The glycosylation reaction of donor 21 with acceptor 7 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 3, Chapter 1. FT-IR (film) υmáx.: 1755 (C=O) cm-1. 1H NMR 
Chapter 7 
	  
	  
164 
(CDCl3): δ 7.42-7.25 (m, Ph), 5.07 (d, J = 10.7 Hz, CH2Ph (β)), 5.02 (d, J = 3.3 
Hz, H-1 (α)), 4.99-4.91 (m, CH2Ph), 4.86-4.72 (m, CH2Ph), 4.66-4.60 (m, 
CH2Ph), 4.48 (d, J = 7.6 Hz, H-1 (β)), 4.39-4.18 (m), 4.11-3.97 (m), 3.95-3.87 
(m), 3.74 (s, OMe), 3.55-3.52 (m) ppm. 13C NMR (CDCl3): δ 170.2 (CO2Me 
(α)), 169.9 (CO2Me (β)), 166.85 (COCH2Cl (α)), 166.83 (COCH2Cl (β)), 138.7, 
138.6, 138.3, 138.2, 138.1, 138.0, 128.6-127.5, 103.3 (C-1 (β)), 97.5 (C-1 
(α)), 81.7, 79.0, 78.5, 75.9, 75.0 (CH2Ph (β)), 74.5 (CH2Ph (α)), 74.4, 74.2 
(CH2Ph (β)), 73.8 (CH2Ph (α)), 73.7 (CH2Ph (β)), 73.2 (CH2Ph (α)), 72.6, 71.9, 
68.8, 65.5 (CH2CO2Me (β)), 64.9 (C-6 (α)), 64.4 (C-6 (β)), 63.9 (CH2CO2Me 
(α)), 51.9 (OMe), 40.6 (COCH2Cl (α)), 40.5 (COCH2Cl (β)) ppm. HR-MS: 
calcd for C32H35ClO9Na+ [M+Na]+: 621.1862; found: 621.1852. 
 
Experiment 23. Synthesis of Methyl 3-O-tert-butyldimethylsilyl-(2R)-2-O-
(2,3,4-tri-O-benzyl-6-O-chloroacetyl-α /β-D-galactopyranosyl)-2,3-
dihydroxypropanoate (38) 
  The glycosylation reaction of donor 21 with acceptor 9 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 3, Chapter 1. FT-IR (film) υmáx.: 1743, 1749 (C=O) cm-1. 1H 
NMR (CDCl3): δ 7.66-7.61 (m, Ph), 7.45-7.25 (m, Ph), 5.22 (d, J = 3.5 Hz, H-1 
(α)), 4.96-4.81 (m, CH2Ph), 4.78-4.66 (m, CH2Ph), 4.61-4.56 (m, CH2Ph), 4.50 
(dd, J = 3.8 Hz, J = 7.0 Hz, CHCO2Me), 4.41 (d, J = 7.7 Hz, H-1 (β)), 4.26-
4.20 (m), 4.17-4.09 (m), 4.06-3.85 (m), 3.79-3.68 (m), 3.79 (s, OMe (β)), 3.72 
(s, OMe (α)), 3.49-3.44 (m), 1.03 (s, t-Bu (α)), 1.00 (s, t-Bu (β)) ppm. 13C NMR 
(CDCl3): δ 170.2 (CO2Me), 166.6 (COCH2Cl), 138.8, 138.5, 138.1, 135.6-
135.5, 133.1, 132.9, 132.8, 129.8, 128.5-127.5, 104.0 (C-1 (β)), 95.5 (C-1 
(α)), 81.8, 79.8, 78.9, 78.4, 75.9, 75.1 (CH2Ph (β)), 74.6 (CHCO2Me), 74.4 
(CH2Ph (α)), 74.3, 74.2 (CH2Ph (β)), 73.8 (CH2Ph (α)), 73.5 (CH2Ph (β)), 72.8, 
72.2 (CH2Ph (α)), 72.0, 68.3, 64.7, 64.6, 64.5, 63.6, 52.0 (OMe (α)), 51.9 
(OMe (β)), 40.6 (COCH2Cl (β)), 40.4 (COCH2Cl (α)), 26.7 (t-Bu), 19.2 
(SiC(CH3)3) ppm. HR-MS: calcd for C49H55ClO10SiNa+ [M+Na]+: 889.3145; 
found: 889.3158. 
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Experiment 24. Synthesis of Methyl 1,3-di-O-tert-butyldimethylsilyl-(2R)-
2-O-(2,3,4-tri-O-benzyl-6-O-chloroacetyl-α /β-D-galactopyranosyl)-1,2,3-
trihydroxypropyl (39) 
  The glycosylation reaction of donor 21 with acceptor 22 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 3, Chapter 1. FT-IR (film) υmáx.: 1746, 1763 (C=O) cm-1. 1H 
NMR (CDCl3): δ 7.66-7.57 (m), 7.40-7.11 (m), 5.11 (d, J = 3.4 Hz, H-1 (α)), 
4.96-4.79 (m, CH2Ph), 4.73-4.56 (m, CH2Ph), 4.45 (d, J = 7.7 Hz, H-1 (β)), 
4.08-3.72 (m), 3.69 (bs, H-4 (β)), 3.60 (dd, J = 15.0 Hz, J = 30.0 Hz, AcCl), 
3.42 (dd, J = 2.8 Hz, J = 9.7Hz, H-3 (β)), 3.34 (dd, J=6.3 Hz, J=6.7 Hz, H-5 
(β)), 1.03 (s, t-Bu), 1.02 (s, t-Bu), 1.00 (s, t-Bu), 0.98 (s, t-Bu) ppm. 13C NMR 
(CDCl3): δ 166.5 (COCH2Cl), 138.8, 138.46, 138.41, 138.2, 138.1, 135.6-
135.5, 133.7-133.0, 129.8-129.5, 128.6-127.5, 103.2 (C-1 (β)), 96.2 (C-1 (α)), 
81.9, 80.7, 79.4, 78.7, 77.2, 76.4, 74.9 (CH2Ph (β)), 74.3 (CH2Ph (α)), 74.2, 
73.7 (CH2Ph (α)), 73.6 (CH2Ph (β)), 72.9 (CH2Ph (α)), 72.8, 71.4, 67.7, 64.6, 
64.2, 63.9, 63.7, 63.2, 62.9, 40.5 (COCH2Cl (β)), 40.4 (COCH2Cl (α)), 26.9 (t-
Bu), 26.84 (t-Bu), 26.82 (t-Bu), 26.7 (t-Bu), 19.3 (SiC(CH3)3), 19.2 (SiC(CH3)3), 
19.1 (SiC(CH3)3) ppm. 
 
Experiment 25. Synthesis of Methyl 15-O-(2,3,4-tri-O-benzyl-6-O-
chloroacetyl-α /β-D-galactopyranosyl)decapentanoate (40)  
  The glycosylation reaction of donor 21 with acceptor 23 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 3, Chapter 1. FT-IR (film) υmáx.: 1736 (C=O) cm-1. 1H NMR 
(CDCl3): δ 7.41-7.26 (m, Ph), 4.98-4.89 (m, CH2Ph), 4.85-4.80 (m, CH2Ph), 
4.80 (d, J = 3.2 Hz, H-1 (α)), 4.77-4.73 (m, CH2Ph), 4.67-4.60 (m, CH2Ph), 
4.33 (d, J = 7.6 Hz, H-1 (β)), 4.29 (dd, J = 6.4 Hz, J = 11.0 Hz, H-6 (β)), 4.22 
(dd, J = 7.1 Hz, J = 11.1 Hz, H-6 (α)), 4.10 (dd, J = 6.4 Hz, J = 11.0 Hz, H-6 
(β)), 4.07-4.01 (m, H-6 (α), H-2 (α)), 3.96-3.81 (m), 3.75 (d, J = 2.1 Hz, H-4 
(β)), 3.66 (s, OMe), 3.62-3.40 (m), 2.29 (t, J = 7.5 Hz), 1.67-1.55 (m), 1.39-
1.24 (m) ppm. 13C NMR (CDCl3): δ 174.5 (CO2Me (α)), 174.3 (CO2Me (β)), 
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166.82 (COCH2Cl (α)), 166.80 (COCH2Cl (β)), 138.7, 138.6, 138.5, 138.4, 
138.1, 128.6-127.5, 103.9 (C-1(β)), 97.4 (C-1(α)), 82.1, 79.4, 78.9, 76.6, 75.2 
(CH2Ph (β)), 74.4 (CH2Ph (α)), 74.3, 74.1 (CH2Ph (β)), 73.6 (CH2Ph (α)), 
73.5(CH2Ph (β)), 73.3 (CH2Ph (α)), 72.5, 71.5, 70.1, 68.4, 67.9, 65.1 (C-6 
(α)), 64.4 (C-6 (β)), 51.4 (OMe), 40.6 (COCH2Cl), 34.1, 29.7, 29.64, 29.61, 
29.49, 29.46, 29.40, 29.2, 29.1, 26.2, 26.1, 24.9 ppm. 
 
Experiment 26. Synthesis of Methyl 3-O-tert-butyldiphenylsilyl-(2R)-2-O-
[2,3,4-tri-O-benzyl-6-O-chloroacetyl-α /β-D-galactopyranosyl-(1→6)-2,3,4-
tri-O-benzyl-1-O-α-D-glucopyranosyl]-2,3-dihydroxypropanoate (41) 
  The glycosylation reaction of donor 21 with acceptor 24 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 3, Chapter 1. FT-IR (film) υmáx.: 1751 (C=O) cm-1. 1H NMR 
(CDCl3): δ 7.70-7.66 (m, Ph), 7.43-7.08 (m, Ph), 5.23 (d, J = 3.4 Hz, H-1 Glu 
(β,α)), 5.15 (d, J = 3.5 Hz, H-1 Glu (α,α)), 4.99-4.89 (m, CH2Ph), 4.93 (d, J = 
5.7 Hz, H-1 Gal (α,α)), 4.86-4.80 (m, CH2Ph), 4.78-4.46 (m, CH2Ph), 4.26-
4.19 (m), 4.20 (d, J = 7.8 Hz, H-1 Gal (β,α)), 4.15-3.42 (m), 3.72 (s, OMe 
(α,α)), 3.57 (s, OMe (β,α)), 1.02 (s, t-Bu (α,α)), 1.01 (s, t-Bu (β,α)) ppm. 13C 
NMR (CDCl3): δ 170.3 (CO2Me), 170.2 (CO2Me), 166.8 (COCH2Cl), 166.7 
(COCH2Cl), 139.0-138.1, 135.7, 135.6, 133.1-132.9, 129.8, 129.7, 128.5-
127.2, 104.0 (C-1 Gal (β)), 97.9 (C-1 Gal (α)), 94.5 (C-1 Glu (β,α)), 94.4 (C-1 
Glu (α,α)), 82.1, 81.7, 81.6, 79.6, 79.2, 79.0, 78.3, 77.6, 77.5, 76.5, 75.7 
(CH2Ph), 75.6 (CH2Ph), 75.3 (CH2Ph), 74.7 (CH2Ph), 74.6 (CH2Ph), 74.5, 
74.47, 74.43 (CH2Ph), 74.40, 74.2 (CH2Ph), 73.5 (CH2Ph), 73.4 (CH2Ph), 
72.9, 72.5 (CH2Ph), 71.9 (CH2Ph), 71.8 (CH2Ph), 71.7, 70.8, 70.1, 68.3, 68.2, 
66.2, 65.1, 64.8, 64.4, 52.0 (OMe (α,α)), 51.8 (OMe (β,α)), 40.6 (COCH2Cl), 
40.5 (COCH2Cl), 26.7 (t-Bu), 19.2 (SiC(CH3)3) ppm. 
 
Experiment 27. Synthesis of 3-O-(2,3,4-tri-O-benzyl-6-O-chloroacetyl-
α /β-D-galactopyranosyl)-epiandrosterone (42) 
  The glycosylation reaction of donor 21 with acceptor 25 was performed 
according to the procedure described in experiment 4. The results are 
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presented in Table 3, Chapter 1. FT-IR (film) υmáx.: 1737 (C=O st) cm-1. 1H 
NMR (CDCl3): δ 7.41-7.27 (m, Ph), 4.98-4.92 (m, CH2Ph), 4.89 (d, J = 3.7 Hz, 
H-1 (α)), 4.89-4.72 (m, CH2Ph), 4.68-4.60 (m, CH2Ph), 4.45 (d, J = 7.7 Hz, H-
1 (β)), 4.29 (dd, J = 6.6 Hz, J = 11.0 Hz, H-6 (β)), 4.23-4.18 (m, H-6 (α)), 4.11-
4.00 (m), 3.96-3.95 (m), 3.92 (d, J = 5.3 Hz, AcCl (α)), 3.88 (d, J = 5.1 Hz, 
AcCl (β)), 3.86-3.80 (m, H-2 (β), H-4 (α)), 3.74 (d, J = 2.3 Hz, H-4 (β)), 3.65-
3.57 (m), 3.53-3.47 (m), 2.43 (dd, J = 8.7 Hz, J = 19.1 Hz), 2.13-2.01 (m), 
1.95-1.88 (m), 1.84-1.19 (m), 1.14-1.03 (m), 1.01-0.90 (m), 0.84 (d, J = 9.7 
Hz), 0.67 (td, J = 3.4 Hz, J = 11.4 Hz) ppm. 13C NMR (CDCl3): δ 165.8 
(COCH2Cl), 137.7, 137.5, 137.1, 127.5-126.4, 94.5 (C-1 (α)), 78.0, 75.4, 75.3, 
72.6 (CH2Ph (α)), 72.2 (CH2Ph (α)), 66.9, 64.3 (C-6 (α)), 53.4, 50.3, 46.7, 
44.2, 39.5 (COCH2Cl (α), 35.8, 34.8, 34.7, 34.0, 30.5, 29.8, 27.4, 26.3, 20.7, 
19.4, 12.7, 11.3 ppm.  
 
Experiment 28. Synthesis of 1-O-Adamantanyl-2,3,4-tri-O-benzyl-6-O-
chloroacetyl-α /β-D-galactopyranoside (43) 
  The glycosylation reaction of donor 21 with acceptor 26 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 3, Chapter 1. FT-IR (film) υmáx.: 1741, 1743 (C=O) cm-1. 1H 
NMR (CDCl3): δ 7.41-7.25 (m, Ph), 5.31 (d, J = 3.4 Hz, H-1 (α)), 4.99-4.94 (m, 
CH2Ph), 4.88 (d, J = 11.6 Hz, CH2Ph (α)), 4.82 (d, J = 11.7 Hz, CH2Ph (β)), 
4.76-4.70 (m, CH2Ph), 4.67-4.59 (m, CH2Ph), 4.60 (d, J = 7.6 Hz, H-1 (β)), 
4.28 (dd, J = 7.1 Hz, J = 11.0 Hz, H-6 (β)), 4.28 (dd, J = 7.1 Hz, J = 10.5 Hz, 
H-6 (α)), 4.15 (t, J = 5.3 Hz ou 6.96, H-5 (α)), 4.07-3.95 (m, H-6 (β), H-6 (α), 
H-2 (α), H-3 (α)), 3.92-3.87 (m, AcCl (α), AcCl (β), H-4 (α)), 3.81 (t, J = 9.6 ou 
7.9 Hz, H-2 (β)), 3.72 (d, J = 2.4 Hz, H-4 (β)), 3.53-3.49 (m, H-5 (β), H-3 (α)), 
2.12 (bs), 1.91-1.76 (m), 1.65-1.57 (m) ppm. 13C NMR (CDCl3): δ 165.8 
(COCH2Cl), 137.8, 137.7, 137.5, 137.4, 137.3, 137.1, 127.7-127.2, 126.9-
126.4, 95.5 (C-1 (β)), 89.5 (C-1 (α)), 81.5 (C-3 (β)), 78.4 (C-2 (β)), 78.0 (C-3 
(α)), 75.4 (C-2 (α)), 74.2 (CH2Ph (β)), 74.1, 73.5 (C-4 (α)), 73.4, 73.3 (CH2Ph 
(α)), 73.0 (CH2Ph (β)), 72.6 (CH2Ph (β)), 72.3 (CH2Ph (α)), 72.0 (CH2Ph (α)), 
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71.6 (C-4 (β)), 70.3 (C-5 (β)), 66.5 (C-5 (α)), 64.2 (C-6 (α)), 63.7 (C-6 (β)), 
41.6, 41.4, 39.6, 39.5, 35.2, 35.2 (COCH2Cl (β)), 29.6 (CH(CH2)3) ppm. 
	  
Experiment 29. Synthesis of Benzyl (2S)-2-(2,3,4-tri-O-benzyl-6-O-
chloroacetyl-α-D-galactopyranosyl)-2-phenylacetate (44) 
  The glycosylation reaction of donor 21 with acceptor 27 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 3, Chapter 1. [α]D20 + 72.9 (c 0.82, CH2Cl2). FT-IR (film) 
υmáx.: 1748 (C=O) cm-1. 1H NMR (CDCl3): δ  7.52-7.49 (m, 2H, Ph), 7.43-7.18 
(m, 23H, Ph), 5.15 (s, 1H, CHCO2Bn), 5.12 (dd, 1H, J = 6.5 Hz, J = 16.5 Hz, 
CO2CH2Ph), 4.96 (d, J = 11.6 Hz, CH2Ph), 4.92 (d, J = 11.6 Hz, CH2Ph), 4.87 
(d, J = 3.6 Hz, H-1(α)), 4.78 (d, J = 11.6 Hz, CH2Ph), 4.66 (d, J = 11.7 Hz, 
CH2Ph), 4.60 (d, J = 11.6 Hz, CH2Ph), 4.48 (d, J = 11.7 Hz, CH2Ph), 4.18-
4.10 (m, 3H, H-3, H-5, H-6), 4.05-3.99 (m, 2H, H-2, H-6), 3.91-3.82 (m, 3H, H-
4, AcCl) ppm. 13C NMR (CDCl3): δ 169.9 (CO2Bn), 166.8 (COCH2Cl), 138.6, 
138.2, 138.1, 135.5, 135.4, 128.8-128.2, 127.9-127.5, 96.4 (C-1(α)), 78.7 (C-
3), 77.4 (CHCO2Bn), 76.2 (C-2), 74.4 (CH2Ph), 74.3 (C-4), 73.6 (CH2Ph), 73.1 
(CH2Ph), 68.9 (C-5), 66.8 (CO2CH2Ph), 64.8 (C-6), 40.6 (COCH2Cl) ppm. HR-
MS: calcd for C44H43ClO9Na+ [M+Na]+: 773.2493; found: 773.2485. 
 
Experiment 30. Synthesis of 1-ω-Methoxy-PEG550yl-2,3,4-tri-O-benzyl-6-
O-chloroacetyl-α /β-D-galactopyranoside  (45) 
  The glycosylation reaction of donor 21 with acceptor 28 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 3, Chapter 1. FT-IR (film) υmáx.: 1715, 1757 (C=O) cm-1. 1H 
NMR (CDCl3): δ 7.41-7.26 (m, Ph), 4.98-4.94 (m, CH2Ph), 4.91-4.88 (m, 
CH2Ph), 4.90 (d, J = 3.5 Hz, H-1 (α)), 4.84–4.60 (m, CH2Ph), 4.40 (d, J = 7.6 
Hz, H-1 (β)), 4.28 (dd, J = 6.6 Hz, J = 11.0 Hz), 4.21 (dd, J = 7.0 Hz, J = 11.0 
Hz), 4.12-3.82 (m), 3.77-3.50 (m), 3.37 (s, OMe) ppm. 13C NMR (CDCl3): δ 
166.88 (COCH2Cl), 166.81 (COCH2Cl), 138.7, 138.5, 138.3, 138.1, 138.0, 
128.6-128.1, 127.9-127.5, 104.0 (C-1 (β)), 97.6 (C-1 (α)), 81.9, 79.2, 78.8, 
76.4, 75.0, 74.4, 74.3, 73.6, 73.5, 73.2, 72.6, 71.9, 71.6, 70.5, 70.4, 70.3, 
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70.2, 68.9, 68.0, 66.9, 64.9, 64.4, 59.0 (OMe), 40.7 (COCH2Cl), 40.6 
(COCH2Cl) ppm. HR-MS: calcd for C54H81ClO19Na+ [M+Na]+: 1091.4958; 
found: 1091.4934. 
 
Experiment 31. Synthesis of O-1-L-Menthyl-2,3,4-tri-O-benzyl-6-O-
chloroacetyl-α /β-D-galactopyranoside (46) 
  The glycosylation reaction of donor 21 with acceptor 29 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 3, Chapter 1. FT-IR (film) υmáx.: 1762 (C=O) cm-1. 1H NMR 
(CDCl3): δ 7.40-7.27 (m, Ph), 5.01 (d, J = 3.5 Hz, H-1 (α)), 4.97 (d, J = 11.8 
Hz, CH2Ph (β)), 4.94 (d, J = 10.8 Hz, CH2Ph (α)), 4.88-4.64 (m, CH2Ph), 4.61 
(d, J = 11.6 Hz, CH2Ph (α)), 4.37 (d, J = 7.7 Hz, H-1 (β)), 4.27-4.22 (m, H-6 
(α), H-6 (β)), 4.10-4.01 (m), 3.98-3.91 (m), 3.87 (dd, J = 14.8 Hz, J = 18.4 Hz, 
AcCl), 3.77 (dd, J = 7.8 Hz, J = 11.0 Hz, H-2 (β)), 3.72 (d, J = 2.3 Hz, H-4 (β)), 
3.53-3.48 (m), 3.38 (td, J = 4.2 Hz, J = 10.6 Hz, CHO menthol (β)), 3.32 (td, J 
= 4.3 Hz, J = 10.6 Hz, CHO menthol (α)), 2.43-2.32 (m, CH(CH3)2 menthol), 
2.12-2.09 (m, CHCH2CH menthol (β)), 2.05-2.02 (m, CHCH2CH menthol (α)), 
1.67-1.56 (m, CH2CH2 menthol), 1.41-1.21 (m, CHCH3, CHCH(CH3)2 menthol), 
1.03-1.75 (m), 0.83 (d, J = 7.1 Hz), 0.72 (d, J = 6.8 Hz), 0.68 (d, J = 6.9 Hz) 
ppm. 13C NMR (CDCl3): δ 166.9 (COCH2Cl), 166.8 (COCH2Cl), 138.7, 138.68, 
138.61, 138.5, 138.25, 138.23, 128.6-128.2, 127.8-127.4, 101.9 (C-1 (β)), 
99.3 (C-1 (α)), 82.5, 80.6, 79.3, 78.96, 78.92, 76.8, 75.2, 74.5, 74.4, 74.1, 
73.7, 73.6, 73.1, 73.0, 71.5, 68.2, 65.4, 64.8, 48.8 (CHCH(CH3)2 menthol (α)), 
47.9 (CHCH(CH3)2 menthol (β)), 42.9 (CHCH2CH menthol (α)), 41.2 
(CHCH2CH menthol (β)), 40.63 (COCH2Cl (α)), 40.62 (COCH2Cl (β)), 34.4, 
34.2, 31.7 (CHCH3 menthol (α)), 31.5 (CHCH3 menthol (β)), 24.8 (CH(CH3)2 
menthol (β)), 24.5 (CH(CH3)2 menthol (α)), 23.0, 22.9, 22.4, 22.2, 21.1, 16.0, 
15.5 ppm. 
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Experiment 32. Synthesis of O-1-Cyclohexyl-2,3,4-tri-O-benzyl-6-O-
chloroacetyl-α /β-D-galactopyranoside (47) 
  The glycosylation reaction of donor 21 with acceptor 30 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 3, Chapter 1. FT-IR (film) υmáx.: 1759, 1744 (C=O) cm-1. 1H 
NMR (CDCl3): δ 7.41-7.21 (m, Ph), 4.98 (s, H-1 (α)), 4.98-4.73 (m, CH2Ph), 
4.68-4.60 (m, CH2Ph), 4.44 (d, J = 7.6 Hz, H-1 (β)), 4.32-4.27 (m, H-6 (β)), 
4.23-4.19 (m, H-6 (β)), 4.09-4.01 (m), 3.96-3.80 (m), 3.73 (s, H-4 (β)), 3.70-
3.62 (m), 3.52-3.50 (m), 1.95-1.89 (m), 1.82-1.73 (m), 1.54-1.12 (m) ppm. 13C 
NMR (CDCl3): δ 166.8 (COCH2Cl), 166.7 (COCH2Cl), 138.8, 138.7, 138.6, 
138.4, 138.2, 138.1, 128.7-128.2, 127.9-127.5, 102.2 (C-1 (β)), 95.6 (C-1 (α)), 
82.3 (C-3 (β)), 79.4 (C-2 (β)), 79.0 (C-3 (α)), 77.8, 76.5 (C-2 (α)), 75.8, 75.2 
(CH2Ph), 74.4 (C-4 (α)), 74.1 (CH2Ph), 73.6 (CH2Ph), 73.1 (CH2Ph), 72.5 (C-4 
(β)), 71.5 (C-5 (β)), 67.9 (C-5 (α)), 65.3 (C-6 (α)), 64.5 (C-6 (β)), 40.6 
(COCH2Cl), 33.6, 33.3, 31.9, 31.6, 25.6, 25.5, 24.5, 24.2, 24.0, 23.9 ppm. 
 
Experiment 33. Synthesis of 3-O-(2,3,4-tri-O-benzyl-6-O-chloroacetyl-
α /β-D-galactopyranosyl)-N-Boc-L-ser-methyl ester (48) 
  The glycosylation reaction of donor 21 with acceptor 31 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 3, Chapter 1. FT-IR (film) υmáx.: 1714, 1747 (C=O) cm-1. 1H 
NMR (CDCl3): δ 7.40-7.25 (m, Ph), 5.73 (d, J = 8.6 Hz, NHBoc (α)), 5.46 (d, J 
= 7.8 Hz, NHBoc (β)), 4.96 (d, J = 11.5 Hz, CH2Ph), 4.87-4.83 (m, CH2Ph), 
4.80-4.72 (m, CH2Ph), 4.76 (s, H-1 (α)), 4.65-4.59 (m, CH2Ph), 4.45-4.43 (m, 
CHNHBoc), 4.32 (d, J = 7.6 Hz, H-1 (β)), 4.29-4.19 (m), 4.15-3.96 (m), 3.92-
3.73 (m), 3.74 (s, OMe (β)), 3.66 (s, OMe (α)), 3.53-3.50 (m), 1.43 (s, t-Bu 
(α)), 1.42 (s, t-Bu (β)) ppm. 13C NMR (CDCl3): δ 170.8 (CO2Me (α)), 170.7 
(CO2Me (β)), 167.0 (COCH2Cl (α)), 166.8 (COCH2Cl (β)), 155.5 (NHCO2t-
But), 138.4, 138.37, 138.30, 138.1, 137.9, 128.6-128.2, 127.9-127.5, 104.3 
(C-1 (β)), 99.7 (C-1 (α)), 81.9, 78.9, 78.5, 76.3, 75.4, 74.5, 74.3, 74.2, 73.5, 
73.4, 72.5, 71.8, 71.1, 69.0, 65.0 (C-6 (α)), 64.3 (C-6 (β)), 54.2 (CHNHBoc 
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(α)), 53.9 (CHNHBoc (β)), 52.6 (OMe (β)), 52.4 (OMe (α)), 40.7 (COCH2Cl 
(α)), 40.6 (COCH2Cl (β)), 28.3 (t-Bu) ppm. 
 
Experiment 34. Synthesis of Ethyl 6-O-trityl-1-thio-β-D-glucopyranoside 
(49) 
  To a suspension of D-galactose (2.0 g, 11.1 mmol) in pyridine (10 mL) at 0ºC 
was added acetic anhydride (10.6 mL, 0.11 mol) and a catalytic amount of 
DMAP. The reaction mixture was stirred at r.t. overnight, then poured into 
saturated aqueous NaHCO3 solution and extracted with CH2Cl2 (3x20 mL). 
The combined organic phases were dried (MgSO4) and concentrated under 
vacuum to afford the pentaacetate (4.29 g, 99%) as a very viscous gum.  
  To a stirred solution of galactose pentaacetate (2.5 g, 6.39 mmol) in 
ethanethiol (12.5 mL, 0.166 mol) was added zinc chloride (1.22 g, 8.95 mmol) 
at 0ºC. The reaction mixture was kept at 0ºC overnight, and then diluted with 
CH2Cl2 (10 mL) and saturated aqueous NaHCO3 solution was added. After 
extraction with CH2Cl2 (2X40 mL) the combined organic extracts were dried 
(MgSO4), filtered and concentrated in vacuum. The residue was purified by 
flash column chromatography (30:70, EtOAc/Hex) to give the β-
thiogalactoside (1.2 g, 48%) as a viscous colourless foam, and the initial 
pentaacetate (1.6 g, 64%). 
  A solution of NaOMe 1N (1.94 mL, 1.94 mmol) in MeOH was added to a 
stirred solution of the β-thiogalactoside (1.13 g, 2.89 mmol) in MeOH (8.7 mL) 
at 0ºC. After 1 hour the reaction mixture was neutralized with Dowex-H+ resin. 
Filtration and evaporation of solvents afforded the product as viscous 
colourless foam (0.65 g, 100%). 
  The tetrol (0.2 g, 0.89 mol) and trityl chloride (0.31 g, 1.11 mmol) were 
dissolved in pyridine (3 mL) and stirred under argon. After 24 hours DMAP 
(13.0 mg, 0.11 mmol) and trityl chloride (0.25 g, 0.89 mmol) were added and 
the mixture stirred for a further 12 hours. The reaction mixture was 
concentrated in vacuum and the residue dissolved in dichloromethane (5 mL), 
washed with a saturated aqueous NH4Cl solution (2x3 mL) and a saturated 
aqueous NaHCO3 solution (2x3 mL). The organic layer was then dried 
(MgSO4) and concentrated under vacuum to afford the triol 49 (0.34 g, 81%). 
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as a viscous colourless foam. 1H NMR (DMSO): δ 7.44-7.42 (m, 6H, Ph), 
7.34-7.30 (m, 6H, Ph), 7.26-7.23 (m, 3H, Ph), 4.99-4.98 (m, 1H), 4.87-4.86 
(m, 1H), 4.47-4.46 (m, 1H), 4.34-4.32 (m, 1H), 3.65-3.3.63 (m, 1H), 3.28-3.24 
(m, 1H, H-6), 3.01-3.00 (m, 1H, H’-6), 2.78-2.71 (m, 1H, SCH2CH3), 2.67-2.60 
(m, 1H, SCH2CH3), 1.26 (t, 3H, J = 7.6 Hz, SCH2CH3).   13C NMR (DMSO): δ 
144.4, 128.7, 128.3, 127.4, 86.2 (CPh3), 85.5 (C-1), 78.0, 75.0, 70.1, 69.6, 
64.3 (C-6), 23.5 (SCH2CH3), 15.7 (SCH2CH3) ppm.  
 
Experiment 35. Synthesis of Ethyl 2,3,4-tetra-O-tert-butyldimethylsilyl-6-
O-trityl-1-thio-β-D-galactopyranoside (50) 
  Thiogalactoside 49 (0.16 g, 0.35 mmol) and a catalytic amount of DMAP 
were dissolved in pyridine (4 mL), and the solution was cooled at 0ºC. Then 
tert-butyldimethyl silyl triflate (0.49 mL, 2.14 mmol) was added, and the 
solution stirred for 30 minutes at 0ºC and then for 24 hours at 60ºC. MeOH 
(1.5 mL) was added, the reaction mixture was diluted with EtOAc (4 mL). After 
washing the reaction mixture with an aqueous HCl 10% solution, the aqueous 
phase was extracted with EtOAc. The combined organic extracts were dried 
(MgSO4), filtered and concentrated under vacuum. The crude product was 
purified by preparative TLC (10:90, EtOAc/Hex) to give the fully protected 
compound 50 (0.24 g, 83%) as a very viscous gum. 1H NMR (CDCl3, 400 
MHz, 243K): δ  7.76-7.67 (m, 6H, Ph), 7.59-7.50 (m, 9H, Ph), 4.53 (d, 1H J = 
8.8 Hz, H-1), 4.41-4.36 (m, 1H), 4.13 (d, 1H, J = 8.8 Hz), 3.83 (d, J = 8.9 Hz, 
1H), 3.74-3.71 (m, 2H), 3.34-3.29 (m, 1H, H-6), 3.03-2.96 (m, 1H, SCH2CH3), 
2.89-2.82 (m, 1H, SCH2CH3), 1.52 (m, 3H, SCH2CH3), 1.26 (s, 9H, t-Bu), 1.18 
(s, 9H, t-Bu), 0.98 (s, 9H, t-Bu), 0.44 (s, 6H, SiMe2), 0.41 (s, 6H, SiMe2), 0.34 
(s, 6H, SiMe2) ppm. 13C NMR (CDCl3, 100 MHz, 243K): δ 143.8, 128.7, 128.0, 
127.2, 86.63 (CPh3), 86.52 (C-1), 77.93, 77.79, 72.3, 70.4, 62.3 (C-6), 27.1 
(C(CH3)3), 26.7 (C(CH3)3), 26.0 (C(CH3)3), 24.0 (SCH2CH3), 19.7 (C-Si), 18.6 
(C-Si), 18.4 (C-Si), 14.8 (SCH2CH3), -1.5 (Si-CH3), -3.3 (Si-CH3), -3.7 (Si-
CH3), -4.0 (Si-CH3), -4.2 (Si-CH3), -4.6 (Si-CH3) ppm. 
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Experiment 36. Synthesis of Methyl (2S)-2-(2,3,4-tetra-O-tert-
butyldimethylsilyl-6-O-trityl-α-D-galactopyranosyl)propanoate (51) 
  A suspension of thioglycoside donor 50 (68.0 mg, 0.084 mmol), methyl (S)-
lactate (8 µL, 0.084 mmol) and 4Å MS in CH2Cl2 (1 mL) was stirred for 1 hour 
at room temperature then cooled to -78°C. N-Iodosuccinimide (20.8 mg, 0.092 
mmol) and TfOH (0.37 µL, 4.20 µmol) were added at -78°C. After 15 minutes 
the reaction was completed (TLC) and the temperature was allowed to rise. 
The reaction mixture was diluted with CH2Cl2 (1 mL), and 10% Na2S2O3 
aqueous solution (1 mL) and saturated aqueous NaHCO3 solution (1 mL) 
were added. The mixture was extracted with CH2Cl2 (3x2 mL) and the 
combined organic phases were dried (MgSO4), filtered and the solvent was 
removed under vacuum. The crude product was purified by preparative TLC 
(10:90, EtOAc/Hex) to give the product 51 (34.0 mg, 48%) as a viscous 
residue. 1H NMR (CDCl3): δ 7.71-7.68 (m, 6H, Ph), 7.57-7.46 (m, 9H, Ph), 
5.07 (d, 1H, J = 2.6 Hz, H-1), 4.55-4.50 (m, 2H), 4.42-4.29 (m, 3H), 3.86 (s, 
3H, CO2Me), 3.63-3.60 (m, 1H), 3.35-3.31 (m, 1H), 1.69 (d, J = 6.8 Hz, 3H, 
CHCH3), 1.18 (s, 18H, t-Bu), 0.96 (s, 9H, t-Bu), 0.36-0.27 (m, 18H, SiMe2). 
 
Experiment 37. Synthesis of Methyl 3-O-tert-butyldimethylsilyl-(2R)-2-O-
(2,3,4-tetra-O-tert-butyldimethylsilyl-6-O-trityl-α-D-galactopyranosyl)-2,3-
dihydroxypropanoate (52) 
  The glycosylation reaction of donor 50 (46.0 mg, 0.057 mmol) with acceptor 
9 (20.0 mg, 0.057 mmol) was performed according to the procedure described 
in experiment 36. The results are presented in Table 3, Chapter 1. Product 52 
was obtained with 22% yield as a viscous residue. 1H NMR (CDCl3): δ 7.72-
7.66 (m, 4H, Ph), 7.45-7.33 (m, 12H, Ph), 7.25-7.15 (m, 9H, Ph), 4.96 (bs, 1H, 
H-1), 4.60-4.58 (m, 1H, CHCH2OTBDPS), 4.07-3.84 (m, 6H), 3.68 (s, 3H, 
CO2Me), 3.56-3.49 (m, 1H), 3.09-3.06 (m, 1H), 1.01 (s, 9H, t-Bu), 0.92 (s, 9H, 
t-Bu), 0.79 (s, 9H, t-Bu), 0.73 (s, 9H, t-Bu), 0.12 (s, 3H, SiMe2), 0.09 (s, 3H, 
SiMe2), 0.03-0.01 (m, 9H, SiMe2), -0.16 (s, 3H, SiMe2). 
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Experiment 38. Synthesis of Phenyl 1-thio-β-D-galactopyranoside (53) 
  The synthesis of compound 53 was carried out according to the procedure 
described in the literature3 with 98% yield. 
 
Experiment 39. Synthesis of Phenyl 4,6-O-benzylidene-1-thio-β-D-
galactopyranoside (54)  
  To a stirred solution of 53 (0.834 g, 3.0 mmol) in THF (5 mL) at r.t. was 
added benzaldehyde dimethylacetal (0.920 mL, 6.12 mmol) and a catalytic 
amount of camphorsulfonic acid. The reaction mixture was refluxed and after 
3 hours it was quenched with saturated aqueous NaHCO3. The mixture was 
extracted with EtOAc, dried (MgSO4), filtred and concentrated in vacuum. 
Purification by flash chromatography on silica gel (70:30, EtOAc/Hex) afforded 
the product 54 as a viscous colorless foam (0.878 g, 90%). Characterisation 
data of compound 54 identical to the literature4. 
 
Experiment 40. Synthesis of Phenyl 2,3-di-O-benzyl-4,6-O-benzylidene-1-
thio-β-D-galactopyranoside (55) 
  The synthesis of compound 55 was carried out according to the procedure 
described in the literature5 with 86% yield. 
 
Experiment 41. Synthesis of Phenyl 2,3-di-O-benzyl-1-thio-β-D-
galactopyranoside (56) 
  To a stirred solution of 55 (1.10 g, 2.03 mmol) in dry CH2Cl2 (3 mL) was 
added MeOH (6 mL) and a catalytic amount of p-toluenesulfonic acid at r.t. 
After 12h the reaction mixture was quenched with saturated aqueous 
NaHCO3, extracted with EtOAc, dried (MgSO4) and concentrated in vacuum. 
Purification by flash chromatography on silica gel (50:50, EtOAc/Hex) afforded 
the product 56 as a viscous colourless foam (0.808 g, 88%), and recovered 
55 (0.121, 11%). 
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Experiment 42. Synthesis of Phenyl 4,6-di-O-acetyl-2,3-di-O-benzyl-1-
thio-β-D-galactopyranoside (57) 
  To a stirred solution of 56 (0.810 g, 1.78 mmol) in pyridine (5 mL) at 0ºC was 
added acetic anhydride (0.507 mL, 5.36 mmol) and a catalytic amount of 
DMAP. After complete conversion of the starting material water was added. 
The mixture was extracted with EtOAc, dried (MgSO4) and concentrated to 
furnish a viscous residue. Purification by flash column chromatography on 
silica gel (70:30, EtOAc/Hex) afforded the product 57 as a viscous colourless 
foam (0.960 g, 100%). [α]20D: +29.5 (c 0.50, CH2Cl2). FT-IR (film) υmáx.: 1741 
(C=O st) cm-1. 1H NMR (CDCl3): δ 7.59-7.56 (m, 2H, Ph), 7.41-7.26 (m, 13H, 
Ph), 5.54 (d, 1H, J = 1.5 Hz, H-4), 4.79-4.72 (m, 3H, CH2Ph), 4.67-4.65 (m, 
1H, H-1), 4.50 (d, 1H, J = 11.0 Hz, CH2Ph), 4.17 (d, 2H, J = 6.4 Hz, H-6, H-6), 
3.80 (dd, 1H, J = 6.0Hz, J = 7.0Hz, H-5), 3.69-3.63 (m, 2H, H-2, H-3), 2.14 (s, 
3H, Ac), 2.06 (s, 3H, Ac) ppm. 13C NMR (CDCl3): δ 170.5 (COCH3), 170.3 
(COCH3), 138.1, 137.4, 133.4, 132.2, 128.7-127.6, 87.7 (C-1), 80.9 (C-2), 
75.8 (CH2Ph), 74.4 (C-5), 72.0 (CH2Ph), 66.5 (C-4), 62.3 (C-6), 20.8 
(COCH3), 20.7 (COCH3) ppm. HR-MS: calcd for C30H32O7SNa+ [M+Na]+: 
559.1766; found: 559.1766. 
 
Experiment 43. Synthesis of Phenyl 2,3-di-O-benzyl-4,6-di-O-
chloroacetyl-1-thio-β-D-galactopyranoside (58) 
  To a stirred solution of 56 (0.530 g, 1.17 mmol) in pyridine (3 mL) at 0ºC was 
added chloroacetic anhydride (0.440 g, 2.57 mmol). After complete 
conversion of the starting material water was added. The mixture was 
extracted with EtOAc, dried (MgSO4) and concentrated to furnish a yellow 
viscous residue. Purification by flash column chromatography on silica gel 
(80:20 EtOAc/hexane) afforded the product 58 as a viscous colourless foam 
(0.488 g, 69%). [α]20D: +23.6 (c 0.59, CH2Cl2). FT-IR (film) υ máx.: 1747, 1762 
(C=O) cm-1. 1H NMR (CDCl3): δ 7.57-7.54 (m, 2H, Ph), 7.40-7.28 (m, 13H, 
Ph), 5.56 (d, 1H, J = 2.9 Hz, H-4), 4.79-4.71 (m, 3H, CH2Ph), 4.66 (d, 1H, J = 
9.3 Hz, H-1), 4.52 (d, 1H, J = 10.9 Hz, CH2Ph), 4.36-4.24 (m, 2H, H-6, H-6), 
4.18-4.09 (m, 2H, AcCl), 4.05 (s, 2H, AcCl), 3.87 (dd, 1H, J = 6.7 Hz, J = 6.4 
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Hz, H-5), 3.70-3.61 (m, 2H, H-2, H-3) ppm. 13C NMR (CDCl3): δ 167.0 
(COCH2Cl), 166.9 (COCH2Cl), 137.9, 137.0, 132.9, 132.5, 128.9, 128.5-127.9 
(m), 87.7 (C-1), 80.6 (C-3), 76.5 (C-2), 75.9 (CH2Ph), 73.9 (C-5), 72.5 
(CH2Ph), 68.7 (C-4), 63.5 (C-6), 40.7 (COCH2Cl), 40.5 (COCH2Cl) ppm. HR-
MS: calcd for C30H30Cl2O7SNa+ [M+Na]+: 627.0987; found: 627.0968. 
 
Experiment 44. Synthesis of Methyl (2S)-2-(4,6-di-O-acetyl-2,3-di-O-
benzyl-α /β-D-galactopyranosyl)propanoate (59) 
  The glycosylation reaction of donor 57 with acceptor 4 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 4, Chapter 1. FT-IR (film) υmáx.: 1736 (C=O) cm-1. 1H NMR 
(CDCl3): δ 7.35-7.26 (m, Ph), 5.60 (d, J = 2.9 Hz, H-4 (α)), 5.47 (d, J = 3.2 Hz, 
H-4 (β)), 5.06 (d, J = 10.7 Hz, CH2Ph (β)), 4.85 (d, J = 3.9 Hz, H-1 (α)), 4.84 
(d, J = 12.0 Hz, CH2Ph (α)), 4.75 (d, J = 10.8 Hz, CH2Ph (α)), 4.72-4.65 (m), 
4.60 (d, J = 12.0 Hz, CH2Ph (α)), 4.56 (d, J = 10.8 Hz, CH2Ph (α)), 4.51-4.47 
(m), 4.49 (d, J = 7.5 Hz, H-1 (β)), 4.42 (t, J = 6.5  Hz, H-5 (α)), 4.22 (t, J = 7.0  
Hz, H-5 (β)), 4.18-4.07 (m), 4.03 (dd, J = 3.3 Hz, J = 10.1 Hz, H-3 (α)), 3.94 
(dd, J = 6.7 Hz, J = 11.2 Hz, H-6 (α)), 3.78 (dd, J = 3.8 Hz, J = 10.1 Hz, H-2 
(α)), 3.72 (s, CO2Me (α)), 3.70 (s, CO2Me (β)), 3.63-3.53 (m), 2.14 (s, Ac (β)), 
2.10 (s, Ac (α)), 2.07 (s, Ac (β)), 2.05 (s, Ac (α)), 1.45 (d, J = 6.8 Hz, CHCH3 
(β)), 1.51 (d, J = 6.8 Hz, CHCH3 (α)) ppm. 13C NMR (CDCl3): δ 172.8, 170.5, 
170.4, 170.3, 138.5, 138.0, 128.3-127.5, 102.5 (C-1 (β)), 98.5 (C-1 (α)), 78.8 
(β), 78.4 (β), 75.9 (C-3 (α)), 75.6 (β), 75.3 (C-2 (α)), 75.1 (CH2Ph (β)), 74.3 
(β), 74.0 (CHCH3 (α)), 73.5 (CH2Ph (α)), 73.0 (β), 72.4 (CH2Ph (β)), 72.2 
(CH2Ph (α)), 70.8 (β), 67.7 (C-4 (α)), 67.2 (C-5 (α)), 66.5 (β), 62.1 (C-6 (β)), 
61.9 (C-6 (β)), 52.1 (CO2Me), 20.9 (COCH3 (β)), 20.89 (COCH3 (α)), 20.83 
(COCH3 (β)), 20.7 (COCH3 (α)), 19.0 (CHCH3 (β)), 18.0 (CHCH3 (α)) ppm. HR-
MS: calcd for C28H34O10Na+ [M+Na]+: 553.2044; found: 553.2035. 
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Experiment 45. Synthesis of Methyl 2-(4,6-di-O-acetyl-2,3-di-O-benzyl-
α /β-D-galactopyranosyl)acetate (60) 
  The glycosylation reaction of donor 57 with acceptor 7 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 4, Chapter 1. FT-IR (film) υmáx.: 1742 (C=O) cm-1. 1H NMR 
(CDCl3): δ 7.40-7.26 (m, Ph), 5.51 (d, J = 2.4 Hz, H-4 (α)), 5.48 (d, J = 2.6 Hz, 
H-4 (β)), 5.04 (d, J = 3.7 Hz, H-1 (α)), 4.81 (d, J = 11.8 Hz, CH2Ph (α)), 4.76 
(d, J = 11.8 Hz, CH2Ph (α)), 4.74 (d, J = 11.1 Hz, CH2Ph (α)), 4.58 (d, J = 
11.1 Hz, CH2Ph (α)), 4.53 (d, J = 11.3 Hz, CH2Ph (β)), 4.50 (d, J = 7.6 Hz, H-1 
(β)), 4.41 (d, J = 16.0 Hz, CH2CO2Me (β)), 4.30 (d, J = 16.0 Hz, CH2CO2Me 
(β)), 4.29 (d, J = 16.4 Hz, CH2CO2Me (α)), 4.27-4.23 (m), 4.14 (d, J = 16.4 Hz, 
CH2CO2Me (α)), 4.15-4.00 (m), 3.82 (dd, J = 3.6 Hz, J = 10.0 Hz, H-2 (α)), 
3.76 (s, OMe), 3.66 (dd, J = 7.6 Hz, J = 9.6 Hz, H-2 (β)), 3.57 (dd, J = 3.5 Hz, 
J = 9.6 Hz, H-3 (β)), 2.14 (s, Ac (β)), 2.11 (s, Ac (α)), 2.07 (s, Ac (β)), 2.06 (s, 
Ac (α)) ppm. 13C NMR (CDCl3): δ 170.5, 170.4, 170.3, 170.0, 138.5, 138.3, 
138.0, 128.3-127.6, 103.3 (C-1 (β)), 97.6 (C-1 (α)), 78.7 (C-3 (β)), 78.4 (C-2 
(β)), 75.5 (C-3 (α)), 75.2 r (β)), 75.0 (C-2 (α)), 73.3 (CH2Ph (α)), 72.4 (CH2Ph 
(α)), 72.3 (CH2Ph (β)), 70.9 (C-4 (β)), 67.8 (C-4 (α)), 67.3 (C-5 (α)), 66.4 (C-5 
(β)), 66.0 (CH2CO2Me (β)), 64.1 (CH2CO2Me (α)), 62.3 (C-6 (α)), 61.9 (C-6 
(β)), 51.9 (CO2Me), 20.8 (COCH3), 20.7 (COCH3) ppm. 
 
Experiment 46. Synthesis of Methyl 3-O-tert-butyldiphenylsilyl-(2R)-2-O-
(4,6-di-O-acetyl-2,3-di-O-benzyl-α-D-galactopyranosyl)-2,3-
dihydroxypropanoate (61) 
  The glycosylation reaction of donor 57 with acceptor 9 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 4, Chapter 1. [α]D20 +95.88 (c 1.12, CH2Cl2). FT-IR (film) 
υmáx.: 1745 (C=O) cm-1. 1H NMR (CDCl3): δ 7.68-7.65 (m, 4H, Ph), 7.43-7.26 
(m, 16H, Ph), 5.44 (d, 1H, J = 2.3 Hz, H-4), 5.23 (d, 1H, J = 3.6 Hz, H-1 (α)), 
4.85 (d, 1H, J = 11.7 Hz, CH2Ph), 4.75 (d, 1H, J = 11.7 Hz, CH2Ph), 4.69 (d, 
1H, J = 11.2 Hz, CH2Ph), 4.54 (d, 1H, J = 11.2 Hz, CH2Ph), 4.51 (dd, 1H, J = 
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3.9 Hz, J = 7.2 Hz, CHCO2Me), 4.27 (t, 1H, J = 6.5 Hz, H-5), 4.06-3.96 (m, 
5H, H-3, H-6, H-6, CH2OTBDPS), 3.85 (dd, 1H, J = 3.6 Hz, J = 10.0 Hz, H-2), 
3.73 (s, 3H, CO2Me), 2.09 (s, 3H, Ac), 1.97 (s, 3H, Ac), 1.02 (s, 9H, t-Bu) 
ppm. 13C NMR (CDCl3): δ 170.4, 170.3, 170.0, 138.6, 138.2, 135.6, 135.5, 
132.9, 132.8, 129.9, 128.3-127.5, 95.6 (C-1 (α)), 75.4 (C-3), 75.0, 74.9, 72.4 
(CH2Ph), 67.8 (C-4), 66.9 (C-5), 64.6 (CH2OTBDPS), 62.3 (C-6), 52.1 
(CO2Me), 26.7 (t-Bu), 20.9 (COCH3), 20.7 (COCH3), 19.2 (SiC(CH3)3) ppm. 
HR-MS: calcd for C44H52O11SiNa+ [M+Na]+: 807.3171; found: 807.3165. 
 
Experiment 47. Synthesis of 1,3-di-O-tert-butyldiphenylsilyl-(2R)-2-O-
(4,6-di-O-acetyl-2,3-di-O-benzyl-α-D-galactopyranosyl)-1,2,3-
trihydroxypropyl (62) 
  The glycosylation reaction of donor 57 with acceptor 22 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 4, Chapter 1. [α]D20 +62.45 (c 2.63, CH2Cl2). FT-IR (film) 
υmáx.: 1744 (C=O) cm-1. 1H NMR (CDCl3): δ 7.67-7.61 (m, 8H, Ph), 7.41-7.14 
(m, 22H, Ph), 5.43 (d, 1H, J = 2.9 Hz, H-4), 5.10 (d, 1H, J = 3.5 Hz, H-1 (α)), 
4.68 (d, 1H, J = 10.9 Hz, CH2Ph), 4.67 (d, 1H, J = 11.9 Hz, CH2Ph), 4.55 (d, 
1H, J = 11.9 Hz, CH2Ph), 4.49 (d, 1H, J = 11.0 Hz, CH2Ph), 4.23 (t, 1H, J = 
6.7 Hz, H-5), 3.99-3.75 (m, 8H), 3.72 (dd, 1H, J = 3.6 Hz, J = 10.0 Hz, H-2), 
2.08 (s, 3H, Ac), 1.91 (s, 3H, Ac), 1.00 (s, 18H, t-Bu) ppm. 13C NMR (CDCl3): 
δ 170.4 (COCH3), 170.3 (COCH3), 138.4, 138.1, 135.6, 135.4, 133.4, 133.3, 
133.2, 133.1, 129.7, 128.3-127.5, 96.2 (C-1 (α)), 77.3, 75.7 (C-3), 75.4 (C-2), 
73.0 (CH2Ph), 72.3 (CH2Ph), 67.8 (C-4), 66.4 (C-5), 64.0 (CH2OTBDPS), 62.8 
(CH2OTBDPS), 62.1 (C-6), 26.84 (t-Bu), 26.82 (t-Bu), 20.9 (COCH3), 20.6 
(COCH3), 19.2 (SiC(CH3)3), 19.1 (SiC(CH3)3) ppm. HR-MS: calcd for 
C59H70O10Si2Na+ [M+Na]+: 1017.4400; found: 1017.4394. 
 
Experiment 48. Synthesis of Methyl 15-O-(4,6-di-O-acetyl-2,3-di-O-
benzyl-α /β-D-galactopyranosyl)decapentanoate (63) 
  The glycosylation reaction of donor 57 with acceptor 23 was performed 
according to the procedure described in experiment 4. The results are 
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presented in Table 4, Chapter 1.  FT-IR (film) υmáx.: 1740 (C=O) cm-1. 1H NMR 
(CDCl3): δ 7.33-7.25 (m, Ph), 5.55 (d, J = 3.1 Hz, H-4 (α)), 5.49 (d, J = 2.3 Hz, 
H-4 (β)), 4.88 (d, J = 10.8 Hz, CH2Ph), 4.82 (d, J = 11.2 Hz, CH2Ph), 4.81 (d, 
J = 4.4 Hz, H-1 (α)), 4.76-4.70 (m, CH2Ph), 4.62 (d, J = 12.0 Hz, CH2Ph), 4.56 
(d, J = 11.1 Hz, CH2Ph), 4.53 (d, J = 11.4 Hz, CH2Ph), 4.38 (d, J = 6.9 Hz, H-
1 (β)), 4.16-4.09 (m), 4.07-4.04 (m), 3.99-3.91 (m), 3.78-3.73 (m), 3.66 (s, 
CO2Me), 3.65-3.42 (m), 2.29 (t, J = 7.5 Hz), 2.14 (s, Ac), 2.11 (s, Ac), 2.07 (s, 
Ac), 2.05 (s, Ac), 1.70-1.54 (m), 1.41-1.25 (m) ppm. 13C NMR (CDCl3): δ 174.3 
(CO2Me), 170.57 (COCH3), 170.53 (COCH3), 170.48 (COCH3), 170.40 
(COCH3), 138.6, 138.5, 138.1, 137.7, 128.3-127.6, 103.8 (C-1 (β)), 97.6 (C-1 
(α)), 79.0, 78.8, 76.0, 75.6, 75.3 (CH2Ph), 73.4 (CH2Ph), 72.3 (CH2Ph), 72.2 
(CH2Ph), 70.6, 70.5, 68.6, 67.9, 66.6, 66.5, 62.6 (C-6), 62.0 (C-6), 51.4, 34.1, 
29.7-29.1, 26.2, 26.1, 24.9, 20.93 (COCH3), 20.90 (COCH3), 20.7 (COCH3) 
ppm. 
 
Experiment 49. Synthesis of Methyl 3-O-tert-butyldiphenylsilyl-(2R)-2-O-
[4,6-di-O-acetyl-2,3-di-O-benzyl-α-D-galactopyranosyl-(1→6)-2,3,4-tri-O-
benzyl-1-O-α-D-glucopyranosyl]-2,3-dihydroxypropanoate (64) 
  The glycosylation reaction of donor 57 with acceptor 24 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 4, Chapter 1.  [α]D20 +112.06 (c 0.88, CH2Cl2). FT-IR (film) 
υmáx.:1744 (C=O) cm-1. 1H NMR (CDCl3): δ 7.70-7.67 (m, 4H, Ph), 7.39-7.17 
(m, 31H, Ph), 5.46 (d, 1H, J = 3.0 Hz, H-4 Gal), 5.14 (d, 1H, J = 3.5 Hz, H-1 
Glu (α)), 4.98 (d, 1H, J = 10.8 Hz, CH2Ph), 4.97 (d, 1H, J = 1.8 Hz, H-1 Gal 
(α), 4.87 (d, 1H, J = 11.5 Hz, CH2Ph), 4.83 (d, 1H, J = 11.6 Hz, CH2Ph), 4.74 
(d, 1H, J = 10.7 Hz, CH2Ph), 4.70 (d, 1H, J = 11.3 Hz, CH2Ph), 4.69 (d, 1H, J 
= 12.1 Hz, CH2Ph), 4.60 (d, 1H, J = 12.1 Hz, CH2Ph), 4.59 (d, 1H, J = 11.6 
Hz, CH2Ph), 4.53 (d, 1H, J = 11.5 Hz, CH2Ph), 4.52 (d, 1H, J = 11.3 Hz, 
CH2Ph), 4.48 (dd, 1H, J = 4.0 Hz, J = 5.9 Hz, CHCO2Me), 4.09-3.86 (m, 8H), 
3.77-3.60 (m, 4H), 3.75 (s, 3H, CO2Me), 3.48 (dd, 1H, J = 3.6 Hz, J = 9.5 Hz, 
H-2 Glu), 2.09 (s, 3H, Ac), 1.94 (s, 3H, Ac), 1.02 (s, 9H, t-Bu) ppm. 13C NMR 
(CDCl3): δ 170.5, 170.4, 170.2, 138.9, 138.7, 138.6, 138.3, 138.0, 135.7, 
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135.6, 133.1, 132.8, 129.7, 128.3-127.3, 98.0 (C-1 Gal (α)), 94.5 (C-1 Glu 
(α)), 81.7 (C-3 Glu), 79.5 (C-2 Glu), 75.7 (CH2Ph), 75.5, 75.3, 74.7 (CH2Ph), 
74.5, 72.7 (CH2Ph), 72.0 (CH2Ph), 71.9 (CH2Ph), 70.8, 67.9, 66.7 (C-4 Gal), 
66.1 (C-6 Gal), 64.7, 62.5 (C-6 Glu), 52.0 (CO2Me), 26.7 (t-Bu), 20.9 
(COCH3), 20.7 (COCH3), 19.2 (SiC(CH3)3) ppm. HR-MS: calcd for 
C71H80O16SiNa+ [M+Na]+: 1239.5008; found: 1239.5109. 
 
Experiment 50. Synthesis of 3-O-(4,6-di-O-acetyl-2,3-di-O-benzyl-α /β-D-
galactopyranosyl)-epiandrosterone (65) 
  The glycosylation reaction of donor 57 with acceptor 25 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 4, Chapter 1.  FT-IR (film) υmáx.: 1741 (C=O) cm-1. 1H NMR 
(CDCl3): δ 7.36-7.27 (m, Ph), 5.55 (d, J = 3.0 Hz, H-4 (α)), 5.47 (d, J = 2.8 Hz, 
H-4 (β)), 4.97 (d, J = 3.6 Hz, H-1 (α)), 4.88 (d, J = 10.9 Hz, CH2Ph (β)), 4.80 
(d, J = 12.0 Hz, CH2Ph (α)), 4.75-4.71 (m, CH2Ph), 4.62 (d, J = 12.0 Hz, 
CH2Ph (α)), 4.55 (d, J = 11.3 Hz, CH2Ph), 4.50 (d, J =  Hz, CH2Ph), 4.48 (d, J 
= 7.2 Hz, H-1 (β)), 4.23 (t, J = 6.4 Hz, H-5 (α)), 4.19-4.10 (m, H-6 (α), H-6 (β), 
H-6 (β)), 4.03 (dd, J = 7.3 Hz, J = 11.1 Hz, H-6 (α)), 3.95 (dd, J = 3.3 Hz, J = 
10.0 Hz, H-3 (α)), 3.77-3.73 (m, H-2 (α), H-5 (β)), 3.64-3.48 (m), 2.43 (dd, J = 
8.9 Hz, J = 19.2 Hz), 2.13 (s, Ac (β)), 2.10 (s, Ac (α)), 2.06 (s, Ac (β)), 2.05 (s, 
Ac (α)), 2.11-2.01 (m), 1.95-1.43 (m), 1.40-1.20 (m), 1.15-1.07 (m), 1.01-0.91 
(m), 0.68 (td, J = 3.3 Hz, J = 11.5 Hz) ppm. 13C NMR (CDCl3): δ 170.5 
(COCH3), 170.4 (COCH3), 138.6, 138.5, 138.1, 137.8, 128.3-127.6, 102.3 (C-
1 (β)), 96.2 (C-1 (α)), 79.7 (C-2 (β)), 79.2 (C-3 (β)), 78.9, 76.1 (C-3 (α)), 75.5 
(C-2 (α)), 75.4 (CH2Ph (β)), 73.3 (CH2Ph (α)), 72.3 (CH2Ph (α)), 72.2 (CH2Ph 
(β)), 70.5 (C-5 (β)), 67.9 (C-4 (α)), 66.6 (C-5 (α)), 66.5 (C-4 (β)), 62.7 (C-6 
(α)), 62.0 (C-6 (β)), 54.4, 51.4, 47.8, 45.2, 44.8, 36.9, 35.85, 35.8, 35.0, 34.7, 
31.5, 30.9, 29.5, 28.5, 28.4, 27.5, 21.7, 20.9 (COCH3), 20.7 (COCH3), 20.5 
(COCH3), 13.8, 12.3, 12.2 ppm. 
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Experiment 51. Synthesis of 1-O-Adamantanyl-4,6-di-O-acetyl-2,3-di-O-
benzyl-α /β-D-galactopyranoside (66) 
  The glycosylation reaction of donor 57 with acceptor 26 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 4, Chapter 1. Alpha product: [α]D20 +108.3 (c 0.94, 
CH2Cl2). FT-IR (film) υmáx.: 1745 (C=O) cm-1. 1H NMR (CDCl3): δ 7.36-7.25 (m, 
10H, Ph), 5.56 (d, 1H, J = 2.9 Hz, H-4), 5.32 (d, 1H, J = 3.8 Hz, H-1 (α)), 4.76 
(d, 1H, J = 11.8 Hz, CH2Ph), 4.73 (d, 1H, J = 10.6Hz, CH2Ph), 4.64 (d, 1H, J = 
11.9 Hz, CH2Ph), 4.55 (d, 1H, J = 10.7 Hz, CH2Ph), 4.35 (t, 1H, J = 6.6 Hz, H-
5), 4.12-4.03 (m, 2H, H-6, H-6), 3.99 (dd, 1H, J = 3.4 Hz, J = 10.0 Hz, H-3), 
3.75 (dd, 1H, J = 3.8 Hz, J = 10.0 Hz, H-2), 2.15 (bs, 3H, CH(CH2)3), 2.10 (s, 
Ac), 2.04 (s, Ac), 1.93-1.78 (m), 1.69-1.59 (m) ppm. 13C NMR (CDCl3): δ 
170.69 (COCH3), 170.62 (COCH3), 138.7, 138.4, 128.4-127.6, 90.8 (C-1 (α)), 
76.2 (C-3), 75.7 (C-2), 74.8 (OC(CH2)3), 73.3 (CH2Ph), 72.3 (CH2Ph), 68.2 (C-
4), 66.3 (C-5), 62.7 (C-6), 42.6, 36.3, 30.8 (CH(CH2)3), 21.0 (COCH3), 20.8 
(COCH3) ppm. Beta product: [α]D20 +41.7 (c 0.17, CH2Cl2). FT-IR (film) υmáx.: 
1744 (C=O) cm-1. 1H NMR (CDCl3): δ 7.36-7.25 (m, 10H, Ph), 5.46 (d, 1H, J = 
2.4 Hz, H-4 (β)), 4.92 (d, 1H, J = 10.9 Hz, CH2Ph), 4.67-4.56 (m, 3H, CH2Ph, 
H-1 (β)), 4.44 (d, 1H, J = 10.9 Hz,CH2Ph), 4.14-4.03 (m, 2H, H-6), 3.72-3.67 
(m, 1H, H-5), 3.55-3.48 (m, 2H, H-2, H-3), 2.15 (bs), 2.13 (s), 2.10 (s), 2.04 
(s), 1.93-1.78 (m), 1.69-1.59 (m) ppm. 13C NMR (CDCl3): δ 170.76 (COCH3), 
170.72 (COCH3), 138.8, 138.0, 128.4-127.6, 96.5 (C-1 (β)), 79.6 (C-3), 78.9 
(C-2), 75.6 (OC(CH2)3), 75.5 (CH2Ph), 72.5 (CH2Ph), 70.6 (C-5), 66.8 (C-4) 
62.3 (C-6), 42.7, 42.5, 36.4, 30.8 (CH(CH2)3), 21.1 (COCH3), 20.9 (COCH3) 
ppm. 
 
Experiment 52. Synthesis of Benzyl (2S)-2-(4,6-di-O-acetyl-2,3-di-O-
benzyl-α-D-galactopyranosyl)-2-phenylacetate (67) 
  The glycosylation reaction of donor 57 with acceptor 27 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 4, Chapter 1.  [α]D20 +101.8 (c 1.57, CH2Cl2). FT-IR (film) 
υmáx.: 1743 (C=O) cm-1. 1H NMR (CDCl3): δ 7.44-7.15 (m, 20H, Ph), 5.57 (d, 
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1H, J = 3.0 Hz, H-4), 5.19-5.09 (m, 3H, CHPh, CO2CH2Ph), 4.88 (d, 1H, J = 
3.6 Hz, H-1 (α)), 4.75 (d, 1H, J = 10.8 Hz, CH2Ph), 4.69 (d, 1H, J = 11.8 Hz, 
CH2Ph), 4.58 (d, 1H, J = 10.8 Hz, CH2Ph), 4.45 (d, 1H, J = 11.8 Hz, CH2Ph), 
4.37 (t, 1H, J = 6.4 Hz, H-5), 4.13 (dd, 1H, J = 3.2 Hz, J = 10.0 Hz, H-3), 4.08 
(dd, 1H, J = 6.0 Hz, J = 11.2 Hz, H-6), 3.96 (dd, 1H, J = 6.9 Hz, J = 11.1 Hz, 
H-6), 3.77 (dd, 1H, J = 3.6 Hz, J = 9.9 Hz, H-2), 2.09 (s, 3H, Ac), 2.03 (s, 3H, 
Ac) ppm. 13C NMR (CDCl3): δ 170.5 (COCH3), 170.3 (COCH3), 169.7 
(CO2Bn), 138.3, 138.0, 135.39, 135.34, 128.8-128.0, 127.9-127.3, 96.7 (C-1 
(α)), 77.8 (CHPh), 75.9 (C-3), 75.3 (C-2), 73.3 (CH2Ph), 72.2 (CH2Ph), 67.7 
(C-4), 67.4 (C-5), 66.9 (CO2CH2Ph), 62.2 (C-6), 20.8 (COCH3), 20.7 (COCH3) 
ppm. HR-MS: calcd for C39H40O10Na+ [M+Na]+: 691.2514; found: 691.2504. 
 
Experiment 53. Synthesis of 1-ω-Methoxy-PEG550yl-4,6-di-O-acetyl-2,3-di-
O-benzyl-α /β-D-galactopyranosy (68) 
  The glycosylation reaction of donor 57 with acceptor 28 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 4, Chapter 1. FT-IR (film) υmáx.: 1716, 1742 (C=O) cm-1. 1H 
NMR (CDCl3): δ 7.37-7.26 (m, Ph), 5.55 (d, J = 2.6 Hz, H-4 (α)), 5.48 (d, J = 
2.4 Hz, H-4 (β)), 4.91 (d, J = 3.6 Hz, H-1 (α)), 4.90 (d, J = 10.8 Hz, CH2Ph), 
4.80 (d, J = 12.0 Hz, CH2Ph), 4.74 (d, J = 11.1 Hz, CH2Ph), 4.71 (d, J = 12.3 
Hz, CH2Ph), 4.64 (d, J = 12.0 Hz, CH2Ph), 4.56 (d, J = 11.0 Hz, CH2Ph), 4.52 
(d, J = 11.4 Hz, CH2Ph), 4.44 (d, J = 7.2 Hz, H-1 (β)), 4.21-4.18 (m), 4.15-4.10 
(m), 4.06-4.01 (m), 3.98 (dd, J = 3.4 Hz, J = 9.9 Hz, H-3 (α)), 3.81-3.53 (m), 
3.37 (s, CO2Me), 2.13 (s, Ac), 2.11 (s, Ac), 2.07 (s, Ac), 2.06 (s, Ac) ppm. HR-
MS: calcd for C49H79O20 [M+H]+: 987.5159; found: 987.5157. 
 
Experiment 54. Synthesis of O-1-L-Menthyl-4,6-di-O-acetyl-2,3-di-O-
benzyl-1-O-Menthyl−α /β-D-galactopyranoside (69) 
  The glycosylation reaction of donor 57 with acceptor 29 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 4, Chapter 1.  FT-IR (film) υmáx.: 1746 (C=O) cm-1. 1H NMR 
(CDCl3): δ 7.36-7.25 (m, Ph), 5.56 (d, J = 2.6 Hz, H-4 (α)), 5.46 (s, H-4 (β)), 
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5.02 (d, J = 3.5 Hz, H-1 (α)), 4.87 (d, J = 10.7 Hz, CH2Ph (β)), 4.80 (d, J = 
11.6 Hz, CH2Ph (α)), 4.73 (d, J = 11.0 Hz, CH2Ph (α)), 4.68 (d, J = 10.7 Hz, 
CH2Ph (β)), 4.62 (d, J = 11.6 Hz, CH2Ph (α)), 4.56-4.50 (m, CH2Ph), 4.42 (d, J 
= 6.2 Hz, H-1 (β)), 4.29 (t, J = 6.2 Hz, H-5 (α)), 4.14-4.04 (m, H-6 (α), H-6 (α), 
H-6 (β), H-6 (β)), 3.99 (dd, J = 3.0 Hz, J = 10.0 Hz, H-3 (α)), 3.77 (dd, J = 3.5 
Hz, J = 10.0 Hz, H-2 (α)), 3.72 (t, J = 6.6 Hz, H-5 (β)), 3.57-3.50 (m, H-2 (β), 
H-3 (β)), 3.41 (td, J = 4.1 Hz, J = 10.6 Hz, CH-O menthol (β)), 3.34 (td, J = 4.2 
Hz, J = 10.6 Hz, CH-O menthol (α)), 2.44-2.31 (m, CH(CH3)2), 2.14-2.05 (m, 
CHCH2CH), 2.14 (s, Ac (β)), 2.11 (s, Ac (α)), 2.07 (s, Ac (α)), 2.05 (s, Ac (β)), 
1.67-1.60 (m, CH2CH2), 1.42-1.25 (m, CHCH3, CHCH(CH3)2), 1.08-0.80 (m), 
0.75 (d, J = 6.7 Hz), 0.68 (d, J = 6.8 Hz) ppm. 13C NMR (CDCl3): δ 170.6 
(COCH3), 170.59 (COCH3), 170.58 (COCH3), 170.4 (COCH3), 138.66, 138.62, 
138.1, 137.9, 128.3-128.0, 127.9-127.4, 101.7 (C-1 (β)), 99.5 (C-1 (α)), 81.2 
(CH-O menthol (α)), 79.5 (CH-O menthol (β)), 79.3, 78.7, 76.1 (C-3 (α)), 76.0 
(C-2 (α)), 75.3 (CH2Ph (β)), 73.8 (CH2Ph (α)), 72.3 (CH2Ph (β)), 71.8 (CH2Ph 
(α)), 70.4 (C-5 (β)), 68.0 (C-4 (α)), 66.8 (C-5 (α)), 66.7 (C-4 (β)), 63.0 (C-6 
(α)), 62.3 (C-6 (β)), 48.7 (CHCH(CH3)2 (α)), 47.9 (CHCH(CH3)2 (β)), 42.9 
(CHCH2CH (α)), 41.3 (CHCH2CH (β)), 34.3, 34.2, 31.7 (CHCH3 (α)), 31.5 
(CHCH3 (β)), 25.0 (CH(CH3)2 (β)), 24.4 (CH(CH3)2 (α)), 23.0, 22.9, 22.4, 22.2, 
21.0, 20.98 (COCH3), 20.92 (COCH3), 20.8 (COCH3), 20.7 (COCH3), 16.0, 
15.5 ppm. 
 
Experiment 55. Synthesis of 1-O-Cyclohexyl-4,6-di-O-acetyl-2,3-di-O-
benzyl- -α /β-D-galactopyranoside (70) 
  The glycosylation reaction of donor 57 with acceptor 30 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 4, Chapter 1.  FT-IR (film) υmáx.: 1744 (C=O) cm-1. 1H NMR 
(CDCl3): δ 7.36-7.25 (m, Ph), 5.56 (d, J = 2.8 Hz, H-4 (α)), 5.48 (d, J = 2.3 Hz, 
H-4 (β)), 4.99 (d, J = 3.6 Hz, H-1 (α)), 4.91 (d, J = 10.8 Hz, CH2Ph), 4.79 (d, J 
= 12.0 Hz, CH2Ph), 4.75-4.69 (m, CH2Ph), 4.62 (d, J = 12.0 Hz, CH2Ph), 4.57-
4.49 (m, CH2Ph), 4.48 (d, J=7.2 Hz, H-1 (β)), 4.23 (t, J = 6.2 Hz, H-5 (α)), 
4.20-4.09 (m, H-6 (α), H-6 (β), H-6 (β)), 4.03 (dd, J = 7.4 Hz, J = 11.2 Hz, H-6 
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(α)), 3.97 (dd, J = 3.3 Hz, J = 10.0 Hz, H-3 (α)), 3.78-3.73 (m, H-2 (α), H-5 
(α)), 3.70-3.63 (m), 3.61-3.49 (m), 2.13 (s, Ac), 2.10 (s, Ac), 2.06 (s, Ac), 2.05 
(s, Ac), 1.99-1.84 (m), 1.77-1.75 (m), 1.62-1.17 (m) ppm. 13C NMR (CDCl3): δ 
170.58 (COCH3), 170.56 (COCH3), 170.4 (COCH3), 138.6, 138.1, 137.8, 
128.3-127.5, 102.1 (C-1 (β)), 95.9 (C-1 (α)), 79.4, 78.5 (CH-O cyclohexanol), 
76.3 (CH-O cyclohexanol), 76.1 (C-3 (α)), 75.6 (C-2 (α)), 75.3 (CH2Ph), 73.2 
(CH2Ph), 72.2 (CH2Ph), 70.5 (C-5 (β)), 68.0 (C-4 (α)), 66.6 (C-4 (β)), C-5 (α)), 
62.6 (C-6 (α)), 62.0 (C-6 (β)), 33.7, 33.3, 32.0, 31.6, 25.58, 25.55, 24.5, 24.2, 
24.1, 24.0, 20.97 (COCH3), 20.92 (COCH3), 20.77 (COCH3), 20.75 (COCH3) 
ppm. 
 
Experiment 56. Synthesis of 3-O-(4,6-Di-O-acetyl-2,3-di-O-benzyl-α /β-D-
galactopyranosyl)-N-Boc-L-ser-methyl ester (71) 
  The glycosylation reaction of donor 57 with acceptor 31 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 4, Chapter 1.  Alpha product: [α]D20 +99.0 (c 1.25, 
CH2Cl2). FT-IR (film) υmáx.: 1715, 1745 (C=O) cm-1. 1H NMR (CDCl3): δ 7.32-
7.26 (m, 10H, Ph), 5.62 (d, 1H, J = 8.2 Hz, NHBoc), 5.55 (s, 1H, H-4), 4.80 (s, 
1H, H-1 (α)), 4.77 (d, 1H, J = 12.0 Hz, CH2Ph), 4.73 (d, 1H, J = 11.1 Hz, 
CH2Ph), 4.58 (d, 1H, J = 11.9 Hz, CH2Ph), 4.53 (d, 1H, J = 11.0 Hz, CH2Ph), 
4.47-4.45 (m, 1H, CH serine), 4.17-4.02 (m, 4H, H-5, H-6, H-6, CH2 serine), 
3.90-3.83 (m, 2H, H-3, CH2 serine), 3.77-3.74 (m, 1H, H-2), 3.66 (s, 3H, 
CO2Me), 2.10 (s, 3H, Ac), 2.04 (s, 3H, Ac), 1.45 (s, 3H, t-Bu) ppm. 13C NMR 
(CDCl3): δ 170.7, 170.5, 170.2, 155.4, 138.4, 137.9, 128.36, 128.34, 127.9, 
127.7, 127.6, 99.2 (C-1 (α)), 75.6 (C-3), 75.4 (C-2), 73.4 (CH2Ph), 72.1 
(CH2Ph), 70.2 (CH2 serine), 67.5 (C-4), 67.3 (C-5), 62.3 (C-6), 54.1 (CH 
serine), 52.5 (CO2CH3), 28.3 (t-Bu), 20.8 (COCH3), 20.7 (COCH3) ppm. Beta 
product: [α]D20 +38.8 (c 0.57, CH2Cl2). FT-IR (film) υmáx.: 1715, 1744 (C=O) 
cm-1. 1H NMR (CDCl3): δ 7.39-7.28 (m, 10H, Ph), 5.48 (s, 2H, NHBoc, H-4), 
4.80 (d, 1H, J = 10.7 Hz, CH2Ph), 4.75-4.69 (m, 2H, CH2Ph), 4.50 (d, 1H, J = 
11.3 Hz, CH2Ph), 4.49-4.46 (m, 1H, CH serine), 4.36 (d, 1H, J = 7.1 Hz, H-1 
(β)), 4.35-4.31 (m, 1H, CH2 serine), 4.13 (d, 2H, J = 6.5 Hz, H-6, H-6), 3.83 
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(dd, 1H, J = 3.4 Hz, J = 10.4 Hz, CH2 serine), 3.75 (s, 3H, CO2Me), 3.75-3.72 
(m, 1H, H-5), 3.58-3.52 (m, 2H, H-2, H-3), 2.14 (s, 3H, Ac), 2.08 (s, 3H, Ac), 
1.42 (s, 3H, t-Bu) ppm. 13C NMR (CDCl3): δ 170.7, 170.5, 170.3, 155.4, 138.2, 
137.5, 128.3, 128.1, 128.0, 127.8, 127.7, 104.1 (C-1 (β)), 79.0, 78.3, 75.4 
(CH2Ph), 72.1 (CH2Ph), 70.8 (C-5), 70.3 (CH2 serine), 66.3 (C-4), 61.9 (C-6), 
54.0 (CH serine), 52.6 (CO2CH3), 28.3 (t-Bu), 20.8 (COCH3), 20.7 (COCH3) 
ppm. 
 
Experiment 57. Synthesis of Methyl (2S)-2-(2,3-di-O-benzyl-4,6-di-O-
chloroacetyl-α-D-galactopyranosyl)propanoate (72) 
  The glycosylation reaction of donor 58 with acceptor 4 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 4, Chapter 1.  [α]D20 +79.1 (c 0.63, CH2Cl2). FT-IR (film) 
υmáx.: 1747 (C=O) cm-1. 1H NMR (CDCl3): δ 7.33-7.27 (m, 10H, Ph), 5.63 (d, 
1H, J = 2.9 Hz, H-4), 4.83 (d, 1H, J = 3.8 Hz, H-1 (α)), 4.82 (d, 1H, J = 12.0 
Hz, CH2Ph), 4.73 (d, 1H, J = 10.8 Hz, CH2Ph), 4.59 (d, 1H, J = 12.0 Hz, 
CH2Ph), 4.58 (d, 1H, J = 10.8 Hz, CH2Ph), 4.53 (t, 1H, J = 6.5 Hz, H-5), 4.21 
(dd, 1H, J = 6.2 Hz, J = 11.2 Hz, H-6), 4.11-4.03 (m, 7H), 3.75 (dd, 1H, J = 3.8 
Hz, J = 10.1 Hz, H-2), 3.72 (s, 3H, CO2Me), 1.45 (d, 3H, J = 6.8 Hz, CHCH3) 
ppm. 13C NMR (CDCl3): δ 172.8 (CO2Me), 166.9 (COCH2Cl), 138.3, 137.7, 
128.4-127.7, 98.5 (C-1 (α)), 75.6 (C-2), 75.1 (C-3), 74.3 (CHCH3), 73.6 
(CH2Ph), 72.6 (CH2Ph), 69.9 (C-4), 66.7 (C-5), 63.4 (C-6), 52.1 (CO2CH3), 
40.7 (COCH2Cl), 40.6 (COCH2Cl), 18.0 (CHCH3) ppm. HR-MS: calcd for 
C28H32O10Cl2Na+ [M++Na]+: 621.1265; found: 621.1257. 
 
Experiment 58. Methyl 2-(2,3-di-O-benzyl-4,6-di-O-chloroacetyl-α /β-D-
galactopyranosyl)acetate (73) 
  The glycosylation reaction of donor 58 with acceptor 7 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 4, Chapter 1.  FT-IR (film) υmáx.: 1751 (C=O) cm-1. 1H NMR 
(CDCl3): δ 7.39-7.27 (m, Ph), 5.59 (d, J = 2.4 Hz, H-4 (α)), 5.50 (d, J = 2.2 Hz, 
H-4 (β)), 5.00 (d, J = 3.6 Hz, H-1 (α)), 4.80 (d, J = 11.9 Hz, CH2Ph (α)), 4.74 
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(d, J = 11.8 Hz, CH2Ph (α)), 4.73 (d, J = 11.0 Hz, CH2Ph (α)), 4.60 (d, J = 
11.0 Hz, CH2Ph (α)), 4.55 (d, J = 11.2 Hz, CH2Ph (β)), 4.52 (d, J = 7.1 Hz, H-1 
(β)), 4.40-4.14 (m), 4.11-4.03 (m), 3.79 (dd, J = 3.6 Hz, J = 10.0 Hz, H-2 (α)), 
3.76 (s, CO2Me), 3.66-3.55 (m) ppm. 13C NMR (CDCl3): δ 169.9 (CO2Me (α)), 
169.5 (CO2Me (β)), 167.0 (COCH2Cl (β)), 166.9 (COCH2Cl (α)), 166.8 
(COCH2Cl (α)), 138.0, 137.6, 128.4-127.6, 103.2 (C-1 (β)), 97.9 (C-1 (α)), 
78.3 (C-3 (β)), 78.1 (C-2 (β)), 75.2 (C-3 (α)), 74.8 (C-2 (α)), 73.4 (CH2Ph), 
72.7 (CH2Ph), 70.3 (β), 70.0 (C-4 (α)), 68.5 (β), 66.8 (C-5 (α)), 66.0 
(CH2CO2Me (β)), 64.5 (CH2CO2Me (α)), 63.5 (C-6 (α)), 63.1 (C-6 (β)), 52.0 
(CO2CH3), 40.7 (COCH2Cl), 40.5 (COCH2Cl) ppm. 
 
Experiment 59. Methyl 3-O-tert-butyldiphenylsilyl-(2R)-2-O-(4,6-di-O-
chloroacetyl-2,3-di-O-benzyl-α-D-galactopyranosyl)-2,3-
dihydroxypropanoate (74) 
  The glycosylation reaction of donor 58 with acceptor 9 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 4, Chapter 1. [α]D20 +69.4 (c 2.02, CH2Cl2). FT-IR (film) 
υmáx.: 1750 (C=O) cm-1. 1H NMR (CDCl3): δ 7.67-7.64 (m, 4H, Ph), 7.42-7.26 
(m, 16H, Ph), 5.40 (d, 1H, J = 2.8 Hz, H-4), 5.23 (d, 1H, J = 3.5 Hz, H-1 (α)), 
4.85 (d, 1H, J = 11.7 Hz, CH2Ph), 4.74 (d, 1H, J = 11.7 Hz, CH2Ph), 4.66 (d, 
1H, J = 11.2 Hz, CH2Ph), 4.55 (d, 1H, J = 11.2 Hz, CH2Ph), 4.51 (dd, 1H, J = 
3.8 Hz, J = 7.2 Hz, CHCO2Me), 4.32 (t, 1H, J = 6.5 Hz, H-5), 4.15-4.00 (m, 
7H), 3.91 (s, 2H, AcCl), 3.81 (dd, 1H, J = 3.5 Hz, J = 9.9 Hz, H-2), 3.73 (s, 3H, 
CO2Me), 1.03 (s, 9H, t-Bu) ppm. 13C NMR (CDCl3): δ 169.8 (CO2Me), 166.9 
(COCH2Cl), 166.6 (COCH2Cl), 138.3, 137.8, 135.5, 135.4, 132.9, 132.8, 
129.9, 128.3, 128.2, 127.9-127.6, 95.5 (C-1), 75.1 (C-3), 75.0 (CHCO2Me), 
74.7 (C-2), 72.8 (CH2Ph), 72.4 (CH2Ph), 70.0 (C-4), 66.3 (C-5), 64.5 
(CH2OTBDPS), 63.3 (C-6), 52.1 (CO2CH3), 40.7 (COCH2Cl), 40.4 (COCH2Cl), 
26.7 (t-Bu), 19.2 (SiC(CH3)3) ppm. HR-MS: calcd for C44H50O11Cl2SiNa+ 
[M+Na]+: 875.2392; found: 875.2369. 
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Experiment 60. 1,3-di-O-tert-butyldiphenylsilyl-(2R)-2-O-(4,6-di-O-acetyl-
2,3-di-O-benzyl-α-D-galactopyranosyl)-1,2,3-trihydroxypropyl (75) 
  The glycosylation reaction of donor 58 with acceptor 22 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 4, Chapter 1. [α]D20 +66.9 (c 12.15, CH2Cl2). FT-IR (film) 
υmáx.: 1747, 1766 (C=O) cm-1. 1H NMR (CDCl3): δ 7.63-7.61 (m, 8H, Ph), 7.43-
7.27 (m, 18H, Ph), 7.18-7.14 (m, 4H, Ph), 5.39 (d, 1H, J = 2.9 Hz, H-4), 5.06 
(d, 1H, J = 3.5 Hz, H-1 (α)), 4.64 (d, 2H, J = 11.4 Hz, CH2Ph), 4.54 (d, 1H, J = 
11.9 Hz, CH2Ph), 4.50 (d, 1H, J = 10.9 Hz, CH2Ph), 4.26 (t, 1H, J = 6.6 Hz, H-
5), 4.14-3.91 (m, 6H), 3.88-3.72 (m, 6H), 3.67 (dd, 1H, J = 3.4 Hz, J = 10.0 
Hz, H-2), 1.01 (s, 18H, t-Bu) ppm. 13C NMR (CDCl3): δ 167.0 (COCH2Cl), 
166.6 (COCH2Cl), 138.1, 137.8, 135.6-135.5, 133.3, 133.2, 133.0, 129.83, 
129.80, 128.3, 128.2, 128.0, 127.8-127.6, 96.2 (C-1 (α)), 77.6 
(OCH(CH2OTBDPS)2), 75.4 (C-3), 75.1 (C-2), 73.1 (CH2Ph), 72.6 (CH2Ph), 
70.0 (C-4), 65.8 (C-5), 64.1 (OCH(CH2OTBDPS)2), 63.2 (C-6), 62.8 
(OCH(CH2OTBDPS)2), 40.7 (COCH2Cl), 40.4 (COCH2Cl), 26.9 (t-Bu), 26.8 (t-
Bu), 19.3 (SiC(CH3)3), 19.1 (SiC(CH3)3) ppm. HR-MS: calcd for 
C59H68O10Cl2Si2Na+ [M+Na]+: 1085.3620; found: 1085.3622. 
 
Experiment 61. Synthesis of Methyl 15-O-(2,3-di-O-benzyl-4,6-di-O-
chloroacetyl-α /β-D-galactopyranosyl)decapentanoate (76) 
  The glycosylation reaction of donor 58 with acceptor 23 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 4, Chapter 1. FT-IR (film) υ máx.: 1736, 1764 (C=O) cm-1. 1H 
NMR (CDCl3): δ 7.35-7.27 (m, Ph), 5.57 (d, J = 3.3 Hz, H-4 (α)), 5.51 (d, J = 
2.1 Hz, H-4 (β)), 4.87 (d, J = 10.8 Hz, CH2Ph), 4.807 (d, J = 3.6 Hz, H-1 (α)), 
4.805 (d, J = 12.0 Hz, CH2Ph), 4.73 (d, J = 11.0 Hz, CH2Ph), 4.72 (d, J = 10.9 
Hz, CH2Ph), 4.70 (d, J = 10.4 Hz, CH2Ph), 4.61 (d, J = 12.2 Hz, CH2Ph), 4.58 
(d, J = 11.0 Hz, CH2Ph), 4.54 (d, J = 11.2 Hz, CH2Ph), 4.39 (d, J = 7.1 Hz, H-
1 (β)), 4.32 (dd, J = 6.8 Hz, J = 11.2 Hz, H-6 (β)), 4.25 (dd, J = 6.8 Hz, J = 
11.2 Hz, H-6 (β)), 4.21-4.19 (m, H-6 (α),H-6 (α), H-5 (α)), 4.15 (d, J = 2.2 Hz, 
AcCl (β)), 4.10 (d, J = 2.8 Hz, AcCl (α)), 4.08 (s, AcCl (β)), 4.06 (s, AcCl (α)), 
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4.00 (dd, J = 3.4 Hz, J = 10.0 Hz, H-3 (α)), 3.95-3.90 (m), 3.83 (t, J = 7.0 Hz, 
H-5 (β)), 3.73 (dd, J = 3.6 Hz, J = 10.0 Hz, H-2 (α)), 3.66 (s, CO2Me), 3.63-
3.43 (m), 2.29 (t, J = 7.5 Hz), 1.67-1.57 (m), 1.42-1.24 (m) ppm. 13C NMR 
(CDCl3): δ 174.3 (CO2Me), 167.1 (COCH2Cl), 167.0 (COCH2Cl), 166.9 
(COCH2Cl), 166.8 (COCH2Cl), 138.3, 137.7, 137.4, 128.4-127.7, 103.7 (C-1 
(β)), 97.6 (C-1 (α)), 78.6, 78.5, 75.7 (C-3 (α)), 75.4 (CH2Ph (β)), 75.3 (C-2 
(α)), 73.4 (CH2Ph (α)), 72.7 (CH2Ph (α)), 72.6 (CH2Ph (β)), 70.6 (β), 70.0 (C-4 
(α)), 68.7, 68.6 (C-4 (β), C-5 (β)), 66.0 (C-5 (α)), 63.7 (C-6 (α)), 63.1 (C-6 (β)), 
51.4 (CO2CH3), 40.8 (COCH2Cl), 40.7 (COCH2Cl), 40.6 (COCH2Cl), 40.5 
(COCH2Cl), 34.1, 29.6-29.1, 26.2, 26.1, 24.9 ppm. HR-MS: calcd for 
C40H56Cl2O10Na+ [M+Na]+: 789.3143; found: 789.3119. 
 
Experiment 62. Methyl 3-O-tert-butyldiphenylsilyl-(2R)-2-O-[2,3-di-O-
benzyl-4,6-di-O-chloroacetyl-α-D-galactopyranosyl-(1→6)-2,3,4-tri-O-
benzyl-1-O-α-D-glucopyranosyl]-2,3-dihydroxypropanoate (77) 
  The glycosylation reaction of donor 58 with acceptor 24 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 4, Chapter 1. [α]D20 +98.5 (c 0.76, CH2Cl2). FT-IR (film) 
υmáx.: 1751 (C=O) cm-1. 1H NMR (CDCl3): δ 7.69-7.68 (m, 4H, Ph), 7.40-7.17 
(m, 31H, Ph), 5.48 (d, 1H, J = 2.9 Hz, H-4 Gal), 5.15 (d, 1H, J = 3.3 Hz, H-1 
(α) Glu), 4.98 (d, 1H, J = 10.6 Hz, CH2Ph), 4.92 (d, 1H, J = 3.2 Hz, H-1 (α) 
Gal), 4.88 (d, 1H, J = 11.6 Hz, CH2Ph), 4.84 (d, 1H, J = 11.5 Hz, CH2Ph), 4.73 
(d, 1H, J = 10.6 Hz, CH2Ph), 4.67 (d, 2H, J = 11.8 Hz, CH2Ph), 4.60 (d, 1H, J 
= 11.4 Hz, CH2Ph), 4.58 (d, 1H, J = 12.0 Hz, CH2Ph), 4.53 (d, 1H, J = 11.2 
Hz, CH2Ph), 4.52 (d, 1H, J = 11.6 Hz, CH2Ph), 4.47 (t, 1H, J = 4.64 ou 5.08 
Hz, CHCO2Me), 4.19-3.88 (m, 13H), 3.76 (s, 3H, CO2Me), 3.74-3.58 (m, 4H), 
3.51 (dd, 1H, J = 3.4 Hz, J = 9.4 Hz, H-2), 1.03 (s, 9H, t-Bu) ppm. 13C NMR 
(CDCl3): δ 170.2 (CO2Me), 167.0 (COCH2Cl), 166.7 (COCH2Cl), 138.8, 138.6, 
138.4, 138.2, 137.7, 135.6, 135.5, 133.0, 132.8, 129.7, 128.3-127.3, 97.8 (C-1 
(α) Gal), 94.4 (C-1 (α) Glu), 81.7 (C-3 Glu), 79.5 (C-2 Glu), 77.4 (C-4 Glu), 
75.7 (CH2Ph), 75.3 (C-2 Gal), 75.0, 74.7 (CH2Ph), 74.5 (CHCO2Me), 72.8 
(CH2Ph), 72.4 (CH2Ph), 71.9 (CH2Ph), 70.8, 70.1, 66.3 (C-6 Glu), 66.2, 64.7 
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(CH2OTBDPS), 63.7 (C-6 Gal), 52.0 (CO2CH3), 40.7 (COCH2Cl), 40.5 
(COCH2Cl), 26.7 (t-Bu), 19.2 (SiC(CH3)3) ppm. HR-MS: calcd for 
C71H78O16Cl2SiNa+ [M+ + Na]: 1307.4328; found: 1307.4334. 
 
Experiment 63. Synthesis of 3-O-(2,3-Di-O-benzyl-4,6-di-O-chloroacetyl-
α /β-D-galactopyranosyl)-epiandrosterone (78) 
  The glycosylation reaction of donor 58 with acceptor 25 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 4, Chapter 1. FT-IR (film) υmáx.: 1737, 1764 (C=O) cm-1. 1H 
NMR (CDCl3): δ 7.35-7.27 (m, Ph), 5.58 (d, J = 2.7 Hz, H-4 (α)), 5.50 (d, J = 
1.9 Hz, H-4 (β)), 4.97 (d, J = 3.7 Hz, H-1 (α)), 4.88 (d, J = 10.9 Hz, CH2Ph 
(β)), 4.79 (d, J = 12.0 Hz, CH2Ph (α)), 4.73-4.69 (m, CH2Ph), 4.63-4.56 (m, 
CH2Ph), 4.54 (d, J = 11.3 Hz, CH2Ph (β)), 4.50 (d, J = 7.4 Hz, H-1 (β)), 4.34-
4.30 (m), 4.25-4.20 (m), 4.15-4.04 (m), 3.99 (dd, J = 10.0 Hz, J = 3.4 Hz, H-3 
(α)), 3.83 (t, J = 7.0 Hz, H-5 (β)), 3.73 (dd, J = 10.0 Hz, J = 3.7 Hz, H-2 (α)), 
3.57-3.48 (m), 2.44 (dd, J = 19.2 Hz, J = 8.5 Hz), 2.11-2.01 (m), 1.96-1.63 
(m), 1.59-1.43 (m), 1.39-1.20 (m), 1.15.1.07 (m), 1.02-0.91 (m), 0.68 (td, J = 
0.63 Hz, J = 11.4 Hz) ppm. 13C NMR (CDCl3): δ 167.2 (COCH2Cl (β)), 167.0 
(COCH2Cl), 166.9 (COCH2Cl), 138.4, 138.3, 137.8, 128.4-127.7, 102.2 (C-1 
(β)), 95.8 (C-1 (α)), 79.7, 78.8, 77.1, 75.7 (C-3 (α)), 75.4 (CH2Ph (β)), 75.2 (C-
2 (α)), 73.4 (CH2Ph), 72.6 (CH2Ph), 70.1 (C-4 (α)), 70.0 (C-5 (β)), 68.7 (C-4 
(β)), 66.0 (C-5 (α)), 63.9 (C-6 (α)), 63.2 (C-6 (β)), 54.4, 51.4, 47.8, 45.2, 44.7, 
40.8 (COCH2Cl (β)), 40.7 (COCH2Cl), 40.5 (COCH2Cl), 36.8, 35.8, 35.7, 35.0, 
31.5, 30.8, 29.5, 28.4, 27.4, 21.7, 20.5, 14.2, 13.8, 12.9, 12.3 ppm. HR-MS: 
calcd for C43H54Cl2O9Na+ [M+Na]+: 807.3043; found: 807.3018. 
 
Experiment 64. Synthesis of 1-O-Adamantanyl-2,3-di-O-benzyl-4,6-di-O-
chloroacetyl-α /β-D-galactopyranoside (79)  
  The glycosylation reaction of donor 58 with acceptor 26 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 4, Chapter 1. HR-MS: calcd for C34H40Cl2O8Na+ [M+Na]+: 
669.1998; found: 669.1986. Alpha product: [α]D20 +89.8 (c 0.85, CH2Cl2). 
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FT-IR (film) υmáx.: 1743, 1763 (C=O) cm-1. 1H NMR (CDCl3): δ 7.29-7.19 (m, 
10H, Ph), 5.52 (d, 1H, J = 2.4 Hz, H-4), 5.23 (d, 1H, J = 3.7 Hz, H-1 (α)), 4.68-
4.62 (m, 2H, CH2Ph), 4.63 (d, 1H, J = 11.9 Hz, CH2Ph), 4.57 (d, 1H, J = 10.6 
Hz, CH2Ph), 4.35 (t, 1H, J = 6.5 Hz, H-5), 4.17-4.07 (m, 2H, H-6, H-6), 4.02 
(d, 2H, J = 3.1 Hz, AcCl), 3.98 (s, 2H, AcCl), 3.95 (dd, 1H, J = 3.4 Hz, J=10.0 
Hz, H-3), 3.65 (dd, 1H, J = 3.7 Hz, J = 10.0 Hz, H-2), 2.13 (bs, 3H, CH(CH2)3), 
1.79-1.76 (m, 3H), 1.72-1.69 (m, 3H), 1.60-1.51 (m, 6H) ppm. 13C NMR 
(CDCl3): δ 167.2 (COCH2Cl), 167.0 (COCH2Cl), 138.5, 138.0, 128.4-127.8, 
90.6 (C-1 (α)), 75.3 (C-3), 75.4 (C-2), 75.1, 73.3 (CH2Ph), 72.6 (CH2Ph), 70.4 
(C-4), 65.8 (C-5), 64.0 (C-6), 42.5, 40.9 (COCH2Cl), 40.7 (COCH2Cl), 36.3, 
30.7 (CH(CH2)3) ppm. Beta product: [α]D20 +38.0 (c 0.35, CH2Cl2). FT-IR 
(film) υmáx.: 1747, 1762 (C=O) cm-1. 1H NMR (CDCl3): δ 7.35-7.28 (m, 10H, 
Ph), 5.49 (d, 1H, J = 2.4 Hz, H-4), 4.91 (d, 1H, J = 10.9 Hz, CH2Ph), 4.72-4.66 
(m, 2H, CH2Ph), 4.53 (d, 1H, J = 11.2 Hz, CH2Ph), 4.30 (dd, 1H, J = 7.4 Hz, J 
= 11.2 Hz, H-6), 4.22 (dd, 1H, J = 5.9 Hz, J = 11.2 Hz, H-6), 4.14 (d, 2H, J = 
2.3 Hz, AcCl), 4.05 (s, 2H, AcCl), 3.83 (t, 1H, J = 6.5 Hz, H-5), 3.60-3.53 (m, 
2H, H-2, H-3), 2.16 (bs, 3H, CH(CH2)3), 1.91-1.88 (m, 3H), 1.79-1.77 (m, 3H), 
1.67-1.58 (m, 6H) ppm. 13C NMR (CDCl3): δ 167.4 (COCH2Cl), 167.0 
(COCH2Cl), 138.5, 137.6, 128.6-127.7, 96.4 (C-1 (β)), 79.2, 78.6, 75.8, 75.5 
(CH2Ph), 72.8 (CH2Ph), 70.0 (C-5), 69.0 (C-4), 63.6 (C-6), 42.7, 40.9 
(COCH2Cl), 40.6 (COCH2Cl), 36.3, 30.8 (CH(CH2)3) ppm. 
 
Experiment 65. Synthesis of Benzyl (2S)-2-O-(4,6-di-O-chloroacetyl-2,3-
di-O-benzyl-α-D-galactopyranosyl)-2-phenylacetate (80) 
  The glycosylation reaction of donor 58 with acceptor 27 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 4, Chapter 1. [α]D20 +80.5 (c 2.10, CH2Cl2). FT-IR (film) 
υmáx.: 1747 (C=O) cm-1. 1H NMR (CDCl3): δ 7.49-7.13 (m, 20H, Ph), 5.58 (d, 
1H, J = 3.0 Hz, H-4), 5.18-5.11 (m, 3H, CHPh, CO2CH2Ph), 4.87 (d, 1H, J = 
3.6 Hz, H-1 (α)), 4.73 (d, 1H, J = 10.8 Hz, CH2Ph), 4.66 (d, 1H, J = 11.8 Hz, 
CH2Ph), 4.63 (d, 1H, J = 10.8 Hz, CH2Ph), 4.45-4.42 (m, 2H, H-5, CH2Ph), 
4.18-4.04 (m, 3H, H-3, H-6, H-6), 4.08 (s, 2H, AcCl), 4.02 (s, 2H, AcCl), 3.73 
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(dd, 1H, J = 3.6 Hz, J = 10.0 Hz, H-2) ppm. 13C NMR (CDCl3): δ 169.7 
(CO2Me), 166.9 (COCH2Cl), 166.8 (COCH2Cl), 138.1, 137.7, 135.3, 135.1, 
128.9-128.0, 127.9-127.4, 96.7 (C-1 (α)), 78.0 (CHPh), 75.5 (C-3), 75.1 (C-2), 
73.3 (CH2Ph), 72.6 (CH2Ph), 69.9 (C-4), 67.0 (CO2CH2Ph), 66.9 (C-5), 63.4 
(C-6), 40.7 (COCH2Cl), 40.5 (COCH2Cl) ppm. HR-MS: calcd for 
C39H40Cl2O10Na+ [M+Na]+: 759.1734; found: 759.1726. 
 
Experiment 66. Synthesis of 1-ω-Methoxy-PEG550yl-4,6-di-O-
chloroacetyl-2,3-di-O-benzyl-α /β-D-galactopyranoside (81) 
  The glycosylation reaction of donor 58 with acceptor 28 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 4, Chapter 1. FT-IR (film) υmáx.: 1716, 1760 (C=O) cm-1. 1H 
NMR (CDCl3): δ 7.46-7.25 (m, Ph), 5.58 (d, J = 2.7 Hz, H-4 (α)), 5.50 (bs, H-4 
(β)), 4.90 (d, J = 10.5 Hz, CH2Ph), 4.89 (d, J = 3.6 Hz, H-1 (α)), 4.83-4.53 (m, 
CH2Ph), 4.47 (d, J = 6.7 Hz, H-1 (β)), 4.32–4.19 (m), 4.16–4.06 (m), 4.04–
3.97 (m), 3.90–3.53 (m), 3.37 (s, OMe) ppm. 13C NMR (CDCl3): δ 167.1 
(COCH2Cl), 167.0 (COCH2Cl), 166.9 (COCH2Cl), 138.4, 138.2, 137.7, 137.3, 
128.4-128.0, 127.9-127.6, 103.8 (C-1 (β)), 97.7 (C-1 (α)), 78.5, 78.4, 75.5 (C-
3 (α)), 75.1, 73.4, 72.6, 72.5, 71.9, 71.8, 70.4, 70.3, 70.1, 70.0 (C-4 (α)), 69.3, 
68.6 (C-4 (β)), 67.3, 66.0 (C-5 (α)), 63.5 (C-6 (α), 63.1 (C-6 (β), 59.0 (OMe), 
40.77 (COCH2Cl), 40.75 (COCH2Cl), 40.6 (COCH2Cl), 40.5 (COCH2Cl) ppm. 
 
Experiment 67. Sinthesis of O-1-L-Menthyl-4,6-di-O-chloroacetyl-2,3-di-
O-benzyl-α /β-D-galactopyranoside (82) 
  The glycosylation reaction of donor 58 with acceptor 29 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 4, Chapter 1. HR-MS: calcd for C34H44Cl2O8Na+ [M+Na]+: 
673.2305; found: 673.2294. Alpha product: [α]D20 +52.8 (c 2.48, CH2Cl2). 
FT-IR (film) υmáx.: 1748, 1765 (C=O) cm-1. 1H NMR (CDCl3): δ 7.32-7.26 (m, 
10H, Ph), 5.58 (s, 1H, H-4), 5.00 (d, 1H, J = 3.0 Hz, H-1 (α)), 4.77 (d, 1H, J = 
11.6 Hz, CH2Ph), 4.71 (d, 1H, J = 10.9 Hz, CH2Ph), 4.62 (d, 1H, J = 11.6 Hz, 
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CH2Ph), 4.57 (d, 1H, J = 10.9 Hz, CH2Ph), 4.36 (t, 1H, J = 6.4 Hz, H-5), 4.25-
4.15 (m, 2H, H-6, H-6), 4.11 (s, 2H, AcCl), 4.07 (s, 2H, AcCl), 4.02 (dd, 1H, J 
= 2.0 Hz, J = 10.0, H-3), 3.73 (dd, 1H, J = 2.9 Hz, J = 10.0 Hz, H-2), 3.34 (td, 
1H, J = 4.0 Hz, J = 10.5 Hz, CH-O menthol), 2.41-2.35 (m, 1H, CHCH(CH3)2), 
2.06-2.03 (m, 1H, CHCH2CH), 1.64-1.57 (m, 3H, CHCH2CH2CH), 1.43-1.35 
(m, 1H, CHCH3), 1.30-1.25 (m, 1H, CHCH(CH3)2), 1.07-0.77 (m, 2H, 
CHCH2CH, CHCH2CH2CH), 0.91 (d, 3H, J = 6.5 Hz, CHCH3), 0.83 (d, 3H, J = 
6.6 Hz, CH(CH3)2), 0.69 (d, 3H, J = 6.7 Hz, CH(CH3)2) ppm. 13C NMR (CDCl3): 
δ 167.0 (COCH2Cl), 166.9 (COCH2Cl), 138.3, 137.7, 128.3, 128.2, 128.0, 
127.7, 127.6, 127.5, 99.4 (C-1 (α)), 81.3 (CH-O menthol), 75.78, 75.75, 73.8 
(CH2Ph), 72.2 (CH2Ph), 70.1 (C-4), 66.2 (C-5), 63.9 (C-6), 48.7 
(CHCH(CH3)2), 42.8 (CHCH2CH), 40.7 (COCH2Cl), 40.5 (COCH2Cl), 34.2 
(CHCH2CH2CH), 31.7 (CHCH3), 24.5 (CHCH(CH3)2), 22.9 (CHCH2CH2CH), 
22.4 (CHCH3), 21.0 (CH(CH3)2), 16.0 (CH(CH3)2) ppm. Beta product: [α]D20 -
0.75 (c 0.53, CH2Cl2). FT-IR (film) υmáx.: 1763 (C=O) cm-1. 1H NMR (CDCl3): 
δ 7.36-7.27 (m, 10H, Ph), 5.49 (d, 1H, J = 3.2 Hz, H-4), 4.87 (d, 1H, J = 10.8 
Hz, CH2Ph), 4.71 (d, 1H, J = 11.2 Hz, CH2Ph), 4.67 (d, 1H, J = 10.8 Hz, 
CH2Ph), 4.54 (d, 1H, J = 11.2 Hz, CH2Ph), 4.44 (d, 1H, J = 7.6 Hz, H-1 (β)), 
4.28-4.12 (m, 4H, AcCl, H-6, H-6), 4.05 (s, 2H, AcCl), 3.80 (t, 1H, J = 6.4 Hz, 
H-5), 3.57 (dd, 1H, J = 3.4 Hz, J = 9.6 Hz, H-3), 3.50 (dd, 1H, J = 7.6 Hz, J = 
9.5 Hz, H-2), 3.42 (td, 1H, J = 4.2 Hz, J = 10.7 Hz, CH-O menthol), 2.34-2.26 
(m, 1H, CHCH(CH3)2), 2.11-2.08 (m, 1H, CHCH2CH), 1.67-1.64 (m, 2H, 
CHCH2CH2CH), 1.39-1.24 (m, 2H, CHCH3, CHCH(CH3)2), 1.02-0.80 (m, 9H), 
0.74 (d, 3H, J = 6.8 Hz, CH(CH3)2) ppm. 13C NMR (CDCl3): δ 167.2 
(COCH2Cl), 166.9 (COCH2Cl), 138.4, 137.5, 128.4, 128.2, 128.17, 128.14, 
127.8, 127.6, 101.4 (C-1 (β)), 79.1 (CH-O menthol), 79.0 (C-3), 78.5 (C-2), 
75.3 (CH2Ph), 72.7 (CH2Ph), 69.2 (C-5), 68.9 (C-4), 63.4 (C-6), 47.9 
(CHCH(CH3)2), 41.1 (CHCH2CH), 40.8 (COCH2Cl), 40.5 (COCH2Cl), 34.3 
(CHCH2CH2CH), 31.5 (CHCH3), 25.1 (CHCH(CH3)2), 23.0 (CHCH2CH2CH), 
22.1 (CHCH3), 21.0 (CH(CH3)2), 15.6 (CH(CH3)2) ppm.  
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Experiment 68. Synthesis of O-1-Cyclohexyl-4,6-di-O-chloroacetyl-2,3-di-
O-benzyl-α /β-D-galactopyranoside (83) 
  The glycosylation reaction of donor 58 with acceptor 30 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 4, Chapter 1. HR-MS: calcd for C30H36Cl2O8Na+ [M+Na]+: 
617.1679; found: 617.1675. Alpha product: [α]D20 +94.0 (c 1.06, CH2Cl2). 
FT-IR (film) υmáx.: 1744, 1762 (C=O) cm-1. 1H NMR (CDCl3): δ 7.32-7.28 (m, 
10H, Ph), 5.58 (d, 1H, J = 2.9 Hz, H-4), 4.98 (d, 1H, J = 3.6 Hz, H-1 (α)), 4.77 
(d, 1H, J = 11.9 Hz, CH2Ph), 4.71 (d, 1H, J = 10.7 Hz, CH2Ph), 4.63-4.57 (m, 
2H, CH2Ph), 4.31 (t, 1H, J = 6.4 Hz, H-5), 4.24-4.17 (m, 2H, H-6, H-6), 4.14–
4.06 (m, 4H, AcCl), 4.00 (dd, 1H, J = 3.3 Hz, J = 10.0 Hz, H-3), 3.73 (dd, 1H, 
J = 3.3 Hz, J = 10.0 Hz, H-2), 3.56-3.49 (m, 1H, CH-O cyclohexanol), 1.92-
1.74 (m, 4H), 1.58-1.53 (2H, m), 1.47-1.14 (m, 4H) ppm. 13C NMR (CDCl3): δ 
167.0 (COCH2Cl), 166.9 (COCH2Cl), 138.3, 137.8, 128.3, 128.0, 127.8, 127.7, 
95.8 (C-1 (α)), 76.4 (CH-O cyclohexanol), 75.7 (C-3), 75.3 (C-2), 73.3 
(CH2Ph), 72.6 (CH2Ph), 70.1 (C-4), 66.0 (C-5), 63.8 (C-6), 40.7 (COCH2Cl), 
40.5 (COCH2Cl), 33.3, 31.5, 25.5, 24.4, 24.1 ppm. Beta product: [α]D20 +22.7 
(c 0.65, CH2Cl2). FT-IR (film) υmáx.: 1748, 1760 (C=O) cm-1. 1H NMR (CDCl3): 
δ 7.35-7.27 (m, 10H, Ph), 5.50 (d, 1H, J = 1.8 Hz, H-4), 4.90 (d, 1H, J = 10.8 
Hz, CH2Ph), 4.70 (t, 2H, J = 11.4 Hz, CH2Ph), 4.54 (d, 1H, J = 11.2 Hz, 
CH2Ph), 4.49 (d, 1H, J = 7.4 Hz, H-1 (β)), 4.32 (dd, 1H, J = 6.9 Hz, J = 11.2 
Hz, H-6), 4.23 (dd, 1H, J = 6.5 Hz, J = 11.2 Hz, H-6), 4.15 (dd, 2H, J = 15.1 
Hz, J = 18.1 Hz, AcCl), 4.07 (s, 2H, AcCl), 3.82 (t, 1H, J = 6.7 Hz, H-5), 3.70-
3.63 (m, 1H, CH-O cyclohexanol), 3.60-3.53 (m, 2H, H-2, H-3), 1.98-1.91 (m, 
2H), 1.79-1.74 (m, 2H), 1.57-1.50 (m, 2H), 1.47-1.37 (m, 2H), 1.34-1.17 (m, 
2H) ppm. 13C NMR (CDCl3): δ 167.2 (COCH2Cl), 166.9 (COCH2Cl), 138.3, 
137.4, 128.4, 128.3, 128.15, 128.11, 127.8, 127.7, 102.1 (C-1 (β)), 78.8, 78.6 
(CH-O cyclohexanol), 78.5, 75.3 (CH2Ph), 72.6 (CH2Ph), 70.0 (C-5), 68.7 (C-
4), 63.2 (C-6), 40.8 (COCH2Cl), 40.5 (COCH2Cl), 33.6, 31.9, 25.5, 24.0, 23.9 
ppm. 
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Experiment 69. Synthesis of 3-O-(4,6-Di-O-chloroacetyl-2,3-di-O-benzyl-
α /β-D-galactopyranosyl)-N-Boc-L-ser-methyl ester (84) 
  The glycosylation reaction of donor 58 with acceptor 31 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 4, Chapter 1. FT-IR (film) υmáx.: 1714, 1715, 1747 (C=O) 
cm-1. 1H NMR (CDCl3): δ 7.37-7.27 (m, Ph), 5.58 (d, 2H, J = 8.2 Hz, NHBoc, 
H-4 (α)), 5.49 (d, J = 2.7 Hz, H-4 (β)), 5.44 (d, J = 7.9 Hz, NHBoc (β)), 4.80 (d, 
J = 10.7 Hz, CH2Ph (β)), 4.79 (s, H-1 (α)), 4.77-67 (m), 4.59-4.51 (m), 4.48-
4.45 (m, CH serine), 4.37 (d, J = 7.6 Hz, H-1 (β)), 4.31-4.16 (m), 4.15-4.06 
(m), 3.92 (dd, J = 3.3 Hz, J = 10.0 Hz, H-3 (α)), 3.86-3.80 (m), 3.78-3.71 (m, 
H-2 (α)), 3.76 (s, CO2Me (β)), 3.67 (s, CO2Me (α)), 3.59 (dd, J = 3.0 Hz, J = 
9.6 Hz, H-3 (β)), 3.53 (dd, J = 9.3 Hz, J = 17.0 Hz, H-2 (β)), 1.45 (s, t-Bu (α)), 
1.42 (s, t-Bu (β)) ppm. 13C NMR (CDCl3): δ 170.7 (CO2Me), 167.0 (COCH2Cl), 
166.99 (COCH2Cl), 166.94 (COCH2Cl), 138.1, 137.5, 137.1, 128.4-127.7, 
104.0 (C-1 (β)), 99.3 (C-1 (α)), 78.6 (β), 78.0 (β), 75.5 (β), 75.3 (C-3 (α)), 75.1 
(C-2 (α)), 73.5 (α), 72.59 (β), 72.52 (α), 70.6 (CH2 serine (α)), 70.4 (CH2 
serine (β)), 70.2 (C-5 (β)), 69.7 (C-4 (α)), 68.4 (C-4 (b)), 66.8 (C-5 (a)), 63.5 
(C-6 (a)), 63.0 (C-6 (b)), 54.1 (CH serine (α)), 54.0 (CH serine (β)),52.6 (OMe 
(β)), 52.5 (OMe (α)), 40.7 (COCH2Cl (β)), 40.67 (COCH2Cl (α)), 40.61 
(COCH2Cl (α)), 40.5 (COCH2Cl (β)), 28.3 (t-Bu) ppm. HR-MS: calcd for 
C33H41Cl2O12NNa+ [M+Na]+: 736.1904; found: 736.1889. 
 
Experiment 70. Synthesis of Phenyl 3,4,6-tri-O-acetyl-2-azido-2-deoxy-1-
thio-α /β-D-glucopyranoside (85) 
  To a solution of 1,3,4,6-tetra-O-acetyl-2-azido-2-deoxy-α/β-D-
glucopyranose6 (6.42 g, 17.2 mmol) and thiophenol (3.55 mL, 34.4 mmol) in 
CH2Cl2 (60 mL) at 0ºC was added and BF3.OEt2 (9.81 mL, 77.4 mmol). The 
reaction mixture was stirred at r.t. for 48 hours, then diluted with CH2Cl2 and 
washed with NaHCO3. The aqueous phase was extracted with CH2Cl2 and the 
combined organic phases were dried with MgSO4, filtered and concentrated 
under vacuum. The crude was purified by flash column chromatography on 
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silica gel (30:70, EtOAc/hexane) to afford 85 (5.40 g, 74%, α/β=2.5:1) as a 
colourless viscous foam, and to recover the initial tetraacetate (1.30 g, 20%). 
FT-IR (film) υmáx.: 1740 (C=O), 2107 (N3) cm-1. 1H NMR (CDCl3): δ 7.60-7.58 
(m, Ph), 7.51-7.48 (m, Ph), 7.38-7.28 (m, Ph), 5.64 (d, J = 5.6 Hz, H-1 (α)), 
5.34 (t, J = 10.0, H-3 (α)), 5.10-5.02 (m, H-3 (β), H-4 (α)), 4.92 (t, J = 10.0 Hz, 
H-4 (β)), 4.62-4.57 (m, H-5 (α)), 4.49 (d, J = 10.0, H-1 (β)), 4.29 (dd, J = 5.2 
Hz, J = 12.4 Hz, H-6 (α)), 4.23-4.18 (m, H-6 (β)), 4.16-4.01 (m, H-2 (α), H’-6 
(α)), 3.71-3.67 (m, H-5 (β)), 3.41 (t, J = 10.0, H-2 (β)), 2.105 (Ac (α)), 2.06 (Ac 
(β)), 2.05 (Ac (α)), 2.04 (Ac (β)), 2.03 (Ac (α)), 2.00 (Ac (β)) ppm. 13C NMR 
(CDCl3): δ 170.4, 169.7, 134.1, 132.24, 132.21, 130.1, 129.2, 129.1, 128.0, 
86.5 (C-1 (α)), 85.3 (C-1 (β)), 75.7 (β), 74.4 (β), 72.0 (α), 68.7 (α), 68.5 (α), 
68.0 (β), 62.6 (β), 62.0 (C-6 (β), 61.9 (C-6(α)), 61.6 (α), 20.7 (Ac (β), 20.66 
(Ac (α)), 20.64 (Ac (β)), 20.61 (Ac (α)), 20.5 (Ac (β)) ppm. 
 
Experiment 71. Synthesis of p-Tolyl 3,4,6-tri-O-acetyl-2-azido-2-deoxy-1-
thio-α /β-D-glucopyranoside (86) 
  To a solution of 1,3,4,6-tetra-O-acetyl-2-azido-2-deoxy-α/β-D-
glucopyranose6 (3.87 g, 10.4 mmol) and p-toluenethiol (2.57 g, 20.7 mmol) in 
CH2Cl2 (60 mL) at 0ºC was added and BF3.OEt2 (6.57 mL, 51.8 mmol). The 
reaction mixture was stirred at r.t. for 60 hours, then diluted with CH2Cl2 and 
washed with NaHCO3. The aqueous phase was extracted with CH2Cl2 and the 
combined organic phases were dried with MgSO4, filtered and concentrated 
under vacuum. The crude was purified by flash column chromatography on 
silica gel (30:70, EtOAc/hexane) to afford 85 (2.26 g, 50%, α/β=1.8:1) as a 
colourless viscous foam, and to recover the initial tetraacetate (1.69 g, 44%). 
FT-IR (film) υmáx.: 1747 (C=O), 2109 (N3) cm-1. 1H NMR (CDCl3): δ 7.48 (d, J = 
8.0 Hz, Ph), 7.38 (d, J = 7.6 Hz, Ph), 7.14 (t, J = 10.8 Hz, Ph), 5.56 (d, J = 5.6 
Hz, H-1 (α)), 5.33 (t, J = 9.6 Hz, H-3 (α)), 5.9-5.01 (m, H-3 (β), H-4 (α)), 4.90 
(t, J = 10.0 Hz, H-4 (β)), 4.63-4.59 (m, H-5 (α)), 4.42 (d, J = 10.0 Hz, H-1 (β)), 
4.29 (dd, J = 5.2 Hz, J = 12.4 Hz, H-6 (α)), 4.22 (dd, J = 4.4 Hz, J = 12.0 Hz, 
H-6 (β)), 4.16 (dd, J = 2.0 Hz, J = 12.4 Hz, H’-6 (β)), 4.08-4.01 (m, H-2 (α), H’-
6 (α)), 3.69-3.65 (m, H-5 (β)), 3.36 (t, J = 10.0 Hz, H-2 (β)), 2.37 (Me (β)), 2.33 
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(Me (α)), 2.09 (Ac (β)), 2.05 (Ac (α)), 2.04 (Ac (α)), 2.00 (Ac (β)) ppm. 13C 
NMR (CDCl3): δ 170.5, 170.4, 169.8, 169.7, 169.6, 139.3, 138.4, 134.6, 132.8, 
130.0, 129.8, 128.5, 126.1, 86.8 (C-1 (α)), 85.7 (C-1 (β)), 75,7 (C-5 (β)), 74.4 
(C-3 (β)), 72.0 (C-3 (α)), 68.7 (C-4 (α)), 68.3 (C-5 (α)), 68.0 (C-4 (β)), 62.4 (C-
2 (β)), 62.0 (C-6 (β)), 61.9 (C-6 (α)), 61.6 (C-2 (α)), 21.2 (Me), 21.1 (Me), 20.7 
(Ac), 20.66 (Ac), 20.61 (Ac), 20.5 (Ac). 
 
Experiment 72. Synthesis of Phenyl 2-azido-6-O-tert-butyldiphenylsilyl-2-
deoxy-1-thio-α /β-D-glucopyranoside (87) 
  A solution of NaOMe 1N (6.73 mL, 6.73 mmol) in MeOH was added to a 
stirred solution of 85 (4.75 g, 11.21 mmol) in MeOH (20 mL) at 0 ºC. After 3 
hours the starting material had been consumed. The reaction mixture was 
diluted with MeOH and Dowex-H+ resin was added until neutral pH. Filtration 
and evaporation of the solvents afforded the triol (3.23 g, 97%) as a viscous 
gum. To a solution of triol (2.46 g, 8.27 mmol) in pyridine (20 mL) at rt was 
added TBDPSCl (2.36 mL, 9.10 mmol), followed by a catalytic amount of 
DMAP. The mixture was stired overnight, then quenched with H2O (20 mL), 
extracted with CH2Cl2 (3x20 mL) and the combined organic phases were dried 
(MgSO4) and concentrated. Purification by flash column chromatography 
(30:70 AcOEt/hexane) afforded the product 87 (4.12 g, 93%, α/β=1.8:1) as a 
white solid. Alpha product: FT-IR (film) υmáx.: 2108 (N3), 3406 (OH) cm-1. 1H 
NMR (CDCl3): δ 7.76-7.72 (m, 4H, Ph), 7.50-7.39 (m, 8H, Ph), 7.28-7.24 (m, 
3H, Ph), 5.55 (d, 1H, J = 4.9 Hz, H-1), 4.29-4.24 (m, 1H, H-5), 3.96-3.81 (m, 
4H, H-2, H-6, H’-6, H-3), 3.73 (t, 1H, J = 8.9 Hz, H-4), 2.67 (bs, 2H, OH), 1.00 
(s, 9H, t-Bu) ppm. 13C NMR (CDCl3): δ 135.6, 135.5, 133.5, 132.7, 132.6, 
132.1, 129.99, 129.94, 129.0, 127.88, 127.81, 127.6, 87.2 (C-1), 73.4, 72.9, 
71.1, 64.5 (C-6), 63.4, 26.8 (C(CH3)3), 19.2 (C-Si) ppm. Beta product: FT-IR 
(film) υmáx.: 2111 (N3), 3387 (OH) cm-1. 1H NMR (CDCl3): δ 7.72-7.68 (m, 4H, 
Ph), 7.46-7.35 (m, 8H, Ph), 7.29-7.23 (m, 3H, Ph), 4.45 (d, 1H, J = 10.0 Hz, 
H-1), 3.98-3.91 (m, 2H, H-6), 3.62 (t, 1H, J = 9.1 Hz, H-4), 3.51 (t, 1H, J = 9.1 
Hz, H-3), 3.40-3.35 (m, 1H, H-5), 3.27 (t, 1H, J = 9.4 Hz, H-2), 2.87 (bs, 2H, 
OH), 1.06 (s, 9H, t-Bu) ppm. 13C NMR (CDCl3): δ 135.6, 135.5, 133.2, 132.8, 
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132.6, 131.4, 129.95, 129.92, 128.9, 128.2, 127.86, 127.84, 86.2 (C-1), 78.7, 
77.1, 71.3, 64.5, 64.2 (C-6), 26.8 (C(CH3)3), 19.2 (C-Si) ppm. 
 
Experiment 73. Synthesis of p-Tolyl 2-azido-6-O-tert-butyldiphenylsilyl-2-
deoxy-1-thio-α /β-D-glucopyranoside (88) 
  The procedure of experiment 72 was applied to compound 86 affording 
compound 88 as a colourless viscous gum in 98% yield (α/β=1.8:1) over the 
two steps. FT-IR (film) υmáx.: 2108 (N3), 3385 (OH) cm-1. 1H NMR (CDCl3): 
δ 7.74-7.65 (m, Ph), 7.47-7.26 (m, Ph), 7.07-7.01 (m, Ph), 5.44 (d, J = 5.1 Hz, 
H-1 (α)), 4.39 (d, J = 10.0 Hz, H-1 (β)), 4.25 (dt, J = 4.7 Hz, J = 9.4 Hz, H-5 
(α)), 3.95-3.83 (m, H-3 (α), H-6 (α), H-6 (β)), 3.78 (dd, J = 5.2 Hz, J = 10.3 Hz, 
H-2 (α)), 3.68 (t, J = 9.0 Hz, H-4 (α)), 3.61 (t, J = 9.1 Hz, H-4 (β)), 3.50 (t, J = 
9.1 Hz, H-3 (β)), 3.37 (dt, J = 4.5 Hz, J = 9.1 Hz, H-5 (β)), 3.24 (t, J = 9.6 Hz, 
H-2 (β)), 2.84 (bs, OH), 3.32 (s, Me (β)), 2.29 (s, Me (α)), 1.07 (s, t-Bu (β)), 
1.06 (s, t-Bu (β)) ppm. 13C NMR (CDCl3): δ 138.5, 137.9, 136.7, 135.6-135.5, 
133.8, 132.9-132.6, 129.9-129.7, 127.8-127.7, 87.6 (C-1 (α)), 86.1 (C-1 (β)), 
78.7 (β), 77.3 (β), 73.4 (α), 72.8 (α), 71.3 (α), 71.2 (β), 64.4 (C-6 (α)), 63.3 (β), 
64.1 (C-6 (β)), 63.5 (α), 26.88 (C(CH3)3 (α)), 26.82 (C(CH3)3 (β)), 21.17 (Me 
(β)), 21.12 (Me (α)), 19.23 (C-Si) ppm. 
 
Experiment 74. Synthesis of Phenyl 6-O-acetyl-2-azido-3,4,di-O-benzyl-2-
deoxy-1-thio-α /β-D-glucopyranoside (89) 
  To a stirred solution of 87 (3.91 g, 7.30 mmol) and benzyl bromide (1.97 mL, 
22.6 mmol) in DMF (15 mL) at 0ºC was added portion-wise sodium hydride 
(0.45 g, 18.6 mmol). After 2 hours, MeOH was added at 0ºC and the reaction 
mixture was quenched with a saturated aqueous solution and extracted with 
Et2O. The combined organic phases were dried with MgSO4, filtered and 
evaporated in vacuum. Purification by flash column chromatography (10:90 
AcOEt/hexane) afforded the dibenzylated product (4.45 g, 85%) as a whyte 
solid, and the tribenzylated product 92 (0.31 g, 7%) as a viscous gum. 
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  Compound 92: FT-IR (film) υmáx.: 2105 (N3) cm-1. 1H NMR (CDCl3): δ 7.61-
7.59 (m), 7.52-7.48 (m), 7.41-7.16 (m), 5.61 (d, J = 5.4 Hz, H-1 (α)), 4.93-4.77 
(m), 4.63-4.52 (m), 4.44 (d, J = 12.0 Hz), 4.41 (d, J = 10.0 Hz, H-1 (β)), 4.38-
4.35 (m), 3.95 (dd, J = 10.0, 5.4 Hz), 3.85-3.72 (m), 3.65-3.58 (m), 3.53-3.47 
(m), 3.37-3.32 (m) ppm. 13C NMR (CDCl3): δ 137.8, 137.7, 137.6, 133.6, 
133.4, 132.0, 129.0, 128.9, 128.5-127.5, 87.2 (C-1 (α)), 85.9 (C-1 (β)), 85.0 
(β), 81.8 (α), 79.3 (β), 78.2 (α), 77.5 (β), 75.8 (β), 75.1 (α), 75.0 (β), 73.45 (α), 
73.43 (β), 71.8 (α), 68.7 (C-6 (β)), 68.2 (C-6 (α)), 65.0 (β), 64.1 (α). 
  To a solution of the dibenzylated product (2.42 g, 3.38 mmol) in THF (10 mL) 
at r.t. was added TBAF (1.15 g, 4.39 mmol). The reaction mixture was stirred 
for 3 hours and then water was added. The mixture was extracted with AcOEt 
(3x20 mL), dried (MgSO4) and concentrated to furnish a yellow viscous 
residue. Purification by flash column chromatography (30:70, AcOEt/hexane) 
afforded the alcohol (1.43 g, 88%) as a viscous gum. 
  To a stirred solution of the alcohol (1.396 g, 2.92 mmol) in pyridine (5 mL) at 
0ºC was added acetic anhydride (0.55 mL, 5.85 mmol) and a catalytic amount 
of DMAP. After complete conversion of the starting material water was added. 
The mixture was extracted with EtOAc, dried (MgSO4) and concentrated to 
furnish a viscous residue. Filtration through celite with a mixture of 
EtOAc/hexane (10/90) afforded the product 89 as a viscous colourless gum 
(1.38 g, 91%, α/β=1.4:1). 1H NMR (CDCl3): δ 7.64-7.57 (m), 7.57-7.50 (m), 
7.47-7.28 (m), 5.62 (d, J = 5.3 Hz, H-1 (α)), 5.00-4.86 (m), 4.62 (t, J = 10.9 
Hz), 4.50-4.42 (m), 4.45 (d, J = 10.1 Hz, H-1 (β)), 4.33-4.27 (m), 4.25-4.19 
(m), 3.98 (dd, J = 10.3 Hz, J = 5.3 Hz), 3.89 (dd, J = 10.2 Hz, J = 8.7 Hz), 
3.63-3.47 (m), 3.37 (t, J = 9.7 Hz), 2.08 (s), 2.02 (s). 13C NMR (CDCl3): 
δ 170.56, 170.54, 137.46, 137.40, 137.35, 133.8, 133.0, 132.3, 131.0, 129.12, 
128.94, 128.58, 128.52, 128.22, 128.18, 128.15, 128.13, 128.09, 128.01, 
127.98, 127.87, 86.9 (C-1 (α)), 85.9 (C-1 (β)), 85.1, 81.8, 78.0, 77.34, 77.24, 
77.12, 77.02, 75.97, 75.86, 75.19, 75.13, 70.1, 65.1, 64.1, 62.87, 62.79, 
20.83, 20.78 ppm. 
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Experiment 75. Synthesis of Phenyl 2-azido-3,4,di-O-benzyl-6-O-
chloroacetyl-2-deoxy-1-thio-α /β-D-glucopyranoside (90) 
  The procedure of experiment 74 was applied to compound 87 using 
chloroacetic anhydride and affording compound 90 as a colourless viscous 
gum in 66% (α/β=1.6:1) yield over the three steps.  Characterisation data of 
compound 90 identical to the literature7. 
 
Experiment 76. Synthesis of p-Tolyl 2-azido-3,4,di-O-benzyl-6-O-
chloroacetyl-2-deoxy-1-thio-α /β-D-glucopyranoside (91) 
  The procedure of experiment 74 was applied to compound 88 using 
chloroacetic anhydride and affording compound 91 as a colourless viscous 
gum in 82% yield (α/β=1:1) over the three steps. FT-IR (film) υmáx.: 1739, 1765 
(C=O), 2107 (N3) cm-1. 1H NMR (CDCl3): δ  7.45 (d, J = 8.1 Hz, Ph), 7.41-7.24 
(m, Ph), 7.13-7.11 (m, Ph), 5.50 (d, J = 5.1 Hz, H-1 (α)), 4.95 (d, J = 10.5 Hz, 
CH2Ph (α)), 4.91-4.81 (m), 4.61-4.55 (m), 4.50-4.43 (m), 4.35-4.30 (m), 4.33 
(d, J = 10.1 Hz, H-1 (β)), 4.24 (dd, J = 11.9 Hz, J = 4.6 Hz), 3.98 (s), 3.94-3.83 
(m), 3.57-3.41 (m), 3.28 (t, J = 9.6 Hz, H-2 (β)), 2.35 (s, PhCH3), 2.33 (s, 
PhCH3) ppm. 13C NMR (CDCl3): δ 166.85, 166.80, 139.1, 138.2, 137.42, 
137.32, 134.5, 132.7, 129.97, 129.79, 129.0, 128.62, 128.60, 128.30, 128.22, 
128.21, 128.19, 128.13, 128.11, 128.07, 126.6, 87.1 (C-1 (α)), 85.9 (C-1 (β)), 
85.2, 81.8, 77.7, 77.4, 77.1, 76.76, 76.74, 76.72, 76.02, 75.88, 75.11, 75.04, 
69.8, 64.9, 64.35, 64.22, 64.05, 40.64, 40.57, 21.22, 21.15 ppm. 
 
Experiment 77. Synthesis of Methyl (2S)-2-(2-azido-3,4,6-tri-O-benzyl-2-
deoxy-α /β-D- glucopyranosyl)propanoate (93) 
  The glycosylation reaction of donor 92 with acceptor 4 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 5, Chapter 1. FT-IR (film) υmáx.: 1752 (C=O), 2108 (N3) cm-
1. 1H NMR (CDCl3): δ 7.34-7.24 (m, Ph), 7.17-7.14 (m, Ph), 4.98 (d, J = 3.6 
Hz, H-1 (α)), 4.90 (d, J = 10.6 Hz, CH2Ph), 4.87 (s), 4.81-4.76 (m, CH2Ph), 
4.59 (d, J = 12.0 Hz, CH2Ph), 4.54-4.42 (m), 4.43 (d, J = 7.3 Hz, H-1 (β)), 4.10 
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(dt, J = 2.4 Hz, J = 10.1 Hz), 4.07-4.02 (m), 3.78-3.72 (m), 3.67 (s, CO2Me), 
3.60 (t, J = 9.1 Hz, H-3 (β)), 3.52 (dd, J = 1.9 Hz, J =10.8 Hz), 3.43 (t, J = 7.9 
Hz, H-2 (β)), 3.34 (dd, J = 3.6 Hz, J = 10.3 Hz, H-2 (α)), 1.50 (d, J = 6.9 Hz, 
CHCH3 (β)), 1.46 (d, J = 6.7 Hz, CHCH3 (β)) ppm. 13C NMR (CDCl3): δ 172.6, 
138.0-137.8, 128.5-128.3, 128.0-127.6, 100.6 (C-1 (β)), 98.8 (C-1 (α)), 83.0 
(β), 79.9 (α), 78.1 (α), 77.5 (β), 75.5 (β), 75.3 (α), 75.0 (β), 74.9 (α), 74.6 (α), 
73.4, 72.2 (β), 71.3 (α), 68.5 (β), 68.0 (α), 66.0 (β), 63.1 (α), 52.1 (CO2Me 
(β)), 52.0 (CO2Me (α)), 18.8 (CHCH3 (β)), 18.1 (CHCH3 (α)) ppm.  
 
Experiment 78. Synthesis of Methyl (2S)-2-(6-O-acetyl-2-azido-3,4,di-O-
benzyl-2-deoxy-α /β-D- glucopyranosyl)propanoate (94) 
    The glycosylation reaction of donor 89 with acceptor 4 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 5, Chapter 1. FT-IR (film) υmáx.: 1741 (C=O), 2107 (N3) cm-
1. 1H NMR (CDCl3): δ 7.39-7.23 (m), 4.95 (d, J = 3.7 Hz, H-1 (α)), 4.93-4.83 
(m), 4.78 (d, J = 10.7 Hz, CH2Ph (β)), 4.59-4.54 (m), 4.48-4.43 (m), 4.44 (d, J 
= 7.8 Hz, H-1 (β)), 4.33-4.14 (m), 4.07 (dd, J = 8.8 Hz, J = 10.3 Hz, H-3 (α)), 
3.73 (s, CO2Me (α)), 3.78 (s, CO2Me (β)), 3.57 (dd, J = 8.9 Hz, J = 9.8 Hz, H-4 
(α)), 3.45-3.41 (m), 3.32 (dd, J = 3.7 Hz, J = 10.3 Hz, H-2 (α)), 2.03 (Ac (β)), 
2.02 (Ac (α)), 1.48 (d, J = 6.9 Hz, CHCH3 (β)), 1.47 (d, J = 6.8 Hz, CHCH3 (α)) 
ppm. 13C NMR (CDCl3): δ 172.4, 170.6, 137.8 (β), 137.7 (α), 137.6 (α), 137.4 
(β), 128.54, 128.51, 128.0, 127.9, 100.6 (C-1 (β)), 98.7 (C-1 (α)), 82.9 (β), 
79.8 (α), 77.8 (α), 77.1 (β), 75.6 (CH2Ph (β)), 75.4 (CH2Ph (α)), 75.09 (CH2Ph 
(β)), 75.02 (CH2Ph (α)), 74.9 (α), 73.0 (β), 72.4 (β), 69.7 (a), 66.0 (β), 63.1 (α), 
62.7 (C-6 (β)), 62.5 (C-6 (α)), 52.1 (CO2Me), 20.8 (Ac), 18.7 (CHCH3 (β)), 
18.2 (CHCH3 (α)) ppm. 
 
Experiment 79. Synthesis of Methyl (2S)-2-(2-azido-3,4,di-O-benzyl-6-O-
chloroacetyl-2-deoxy-α /β-D- glucopyranosyl)propanoate (95) 
  The glycosylation reactions of donor 90 and 91 with acceptor 4 were 
performed according to the procedure described in experiment 4. The results 
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are presented in Table 5, Chapter 1. FT-IR (film) υmáx.: 1742 (C=O), 2106 (N3) 
cm-1. 1H NMR (CDCl3): δ 7.41-7.23 (m, Ph), 4.96-4.84 (m), 4.93 (d, J = 3.4 Hz, 
H-1 (α)), 4.79 (d, J = 10.7 Hz, CH2Ph (β)), 4.62-4.56 (m), 4.46-4.39 (m), 4.45 
(d, J = 7.9 Hz, H-1 (β)), 4.34-4.21 (m), 4.07 (dd, J = 8.8 Hz, J = 10.3 Hz), 
4.03-3.93 (m), 3.78 (s, CO2Me (β)), 3.73 (s, CO2Me (α)), 3.56 (dd, J = 8.9 Hz, 
J = 9.9 Hz), 3.48-3.41 (m), 3.31 (dd, J = 3.7 Hz, J = 10.3 Hz), 1.47 (d, J = 6.8 
Hz, CHCH3) ppm. 13C NMR (CDCl3): δ  172.4, 166.8, 137.6, 137.5, 128.5, 
128.1-128.0, 100.5 (C-1 (β)), 98.7 (C-1 (α)), 82.9 (β), 80.0 (α), 77.3 (α), 76.6 
(β), 75.6 (β), 75.5 (α), 75.0 (α), 74.9, 72.8 (β), 72.4 (β), 69.5 (α), 65.9 (β), 64.1 
(C-6 (β)), 64.0 (C-6 (α)), 63.1 (α), 52.1 (CO2Me), 40.67 (COCH2Cl (α)), 40.65 
(COCH2Cl (β)), 18.7 (CHCH3 (β)), 18.2 (CHCH3 (β)) ppm. 
 
Experiment 80. Synthesis of Methyl 2-(2-azido-3,4,di-O-benzyl-6-O-
chloroacetyl-2-deoxy-α /β-D-glucopyranosyl)acetate (96) 
  The glycosylation reaction of donor 91 with acceptor 7 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 6, Chapter 1. FT-IR (film) υmáx.: 1759 (C=O), 2110 (N3) cm-
1. 1H NMR (CDCl3): δ 7.40-7.26 (m, Ph), 5.02 (d, J = 3.5 Hz, H-1 (α)), 4.96-
4.84 (m), 4.81 (d, J = 10.6 Hz, CH2Ph (β)), 4.60 (d, J = 11.1 Hz, CH2Ph (a)), 
4.55 (d, J = 12.0 Hz, CH2Ph (β)), 4.45 (d, J = 6.5 Hz, H-1 (β)), 4.38 (dd, J = 
3.6 Hz, J = 10.2 Hz, H-6 (α)), 4.31-4.25 (m), 4.18 (d, J = 16.6 Hz), 4.07-3.94 
(m), 3.78 (s, CO2Me (β)), 3.77 (s, CO2Me (α)), 3.55 (dd, J = 8.8 Hz, J = 10.0 
Hz, H-4 (α)), 3.44 (dd, J = 3.6 Hz, J = 10.2 Hz, H-2 (α)) ppm. 13C NMR 
(CDCl3): δ 169.5, 166.8, 137.5, 137.3, 128.58, 128.55, 128.16, 128.13, 128.0, 
101.2 (C-1 (β)), 97.8 (C-1 (α)), 80.2 (α), 77.2 (α), 75.6 (CH2Ph (α)), 75.0 
(CH2Ph (α)), 72.8 (β), 69.6 (α), 65.9 (β), 64.3 (α), 64.0 (α), 63.3 (C-2 (α)), 
52.1 (CO2CH3 (α)), 40.6 (COCH2Cl (α)) ppm. 
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Experiment 81. Synthesis of Methyl (2R)-tert-butyldimethylsilyl-3-(2-
azido-3,4,di-O-benzyl-6-O-chloroacetyl-2-deoxy-α /β-D- glucopyranosyl)-
2,3-dihydroxyropanoate (97) 
  The glycosylation reaction of donor 91 with acceptor 9 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 6, Chapter 1. FT-IR (film) υmáx.: 1743 (C=O), 2107 (N3) cm-
1. 1H NMR (CDCl3): δ  7.69-7.26 (m, Ph), 7.69-7.61 (m, Ph), 7.45-7.28 (m, Ph), 
7.22-7.19 (m, Ph), 5.10 (d, J = 3.5 Hz, H-1 (α)), 4.93 (d, J = 10.4 Hz, CH2Ph 
(α)), 4.86 (d, J = 11.3 Hz, CH2Ph (α)), 4.83 (d, J = 10.4 Hz, CH2Ph (α)), 4.57 
(d, J = 11.3 Hz, CH2Ph (α)), 4.46 (dd, J = 3.8 Hz, J = 6.6 Hz, 
CHCH2OTBDPS), 4.40 (d, J = 8.1 Hz, H-1 (β)), 4.28-4.23 (m), 4.14.4.15 (m), 
4.02-3.90 (m), 3.75 (s, CO2Me (α)), 3.56-3.51 (m), 3.38 (dd, J = 3.5 Hz, J = 
10.3 Hz, H-2 (α)), 1.04 (s, t-Bu) ppm. 13C NMR (CDCl3): δ 169.6, 166.8, 
137.65, 137.63, 135.6-135.5, 132.8, 132.7, 129.9, 129.8, 128.6, 128.5, 128.4, 
128.1, 128.0, 127.88, 127.85, 127.78, 127.75, 102.2 (C-1 (β)), 96.3 (C-1 (α)), 
83.1 (β), 80.08 (α), 80.02 (β), 75.63 (α), 75.60 (CH2Ph (α)), 75.5 (CH2Ph (β)), 
75.0 (CH2Ph (β)), 74.8 (CH2Ph (α)), 72.9 (β), 71.9 (α), 69.2, 65.86 (β), 65.81, 
64.4 (α), 64.0 (α), 63.9 (β), 63.07 (α), 63.04 (β), 52.3 (CO2CH3 (α)), 52.1 
(CO2CH3 (β)), 40.6 (COCH2Cl (β)), 40.5 (COCH2Cl (α)), 26.7 (t-Bu (α)), 26.6 
(t-Bu (β)), 19.2 (C-Si (β)), 19.1 (C-Si (α)). 
 
Experiment 82. Synthesis of Methyl 3-O-tert-butyldiphenylsilyl-(2R)-2-O-
[2-azido-3,4,di-O-benzyl-6-O-chloroacetyl-2-deoxy-α /β-D-
glucopyranosyl-(1→6)-2,3,4-tri-O-benzyl-1-O-α-D-glucopyranosyl]-2,3-
dihydroxypropanoate (98) 
  The glycosylation reaction of donor 91 with acceptor 24 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 6, Chapter 1. FT-IR (film) υmáx.: 1752 (C=O), 2108 (N3) cm-
1. 1H NMR (CDCl3): δ 7.71-7.69 (m, Ph), 7.46-7.19 (m, Ph), 5.23 (d, J = 3.5 
Hz, H-1 (α)), 5.02-4.81 (m), 4.79-4.68 (m), 4.63 (d, J = 11.2 Hz, CH2Ph (β)), 
4.58-4.52 (m), 4.39 (dd, J = 1.8 Hz, J = 12.0 Hz, β), 4.22 (dd, J=1.8 Hz, 
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J=11.9 Hz, α), 4.13-3.83 (m), 3.73-3.46 (m), 3.72 (s, CO2Me (β)), 3.70 (s, 
CO2Me (α)), 3.41 (dd, J = 2.5 Hz, J = 5.8 Hz), 3.28 (dd, J = 3.4 Hz, J = 10.2 
Hz), 1.04 (s, t-Bu (α)), 1.03 (t-Bu (β)) ppm. 
 
Experiment 83. Synthesis of 1-O-Adamantanyl-2-azido-3,4,di-O-benzyl-6-
O-chloroacetyl-2-deoxy-α /β-D-glucopyranoside (99) 
  The glycosylation reaction of donor 91 with acceptor 26 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 6, Chapter 1. FT-IR (film) υmáx.: 1763, 1743 (C=O), 2104 
(N3) cm-1. 1H NMR (CDCl3): δ 7.41-7.23 (m, Ph), 5.29 (d, J = 3.7 Hz, H-1 (α)), 
4.93-4.84 (m), 4.77 (d, J = 10.8 Hz, CH2Ph (β)), 4.59 (d, J = 6.4 Hz, H-1 (β)), 
4.58 (d, J = 10.8 Hz, CH2Ph (α)), 4.57 (d, J = 11.0 Hz, CH2Ph (β)), 4.38-4.29 
(m), 4.20 (dd, J = 5.3 Hz, J=11.6 Hz, β), 4.13 (ddd, J=2.4 Hz, J=4.3Hz, J=10.0 
Hz, α), 4.11-3.92 (m), 3.51 (dd, J = 8.8 Hz, J = 9.9 Hz, H-4 (α)), 3.17 (dd, J = 
3.6 Hz, J = 10.3 Hz, H-2 (α)), 2.16 (bs), 1.88-1.76 (m), 1.67-1.57 (m) ppm. 13C 
NMR (CDCl3): δ 166.9, 137.8 (β), 137.5 (α), 128.6-128.5, 128.13, 128.10, 
128.0, 127.9, 95.1 (C-1 (β)), 95.0 (C-1 (α)), 83.3 (β), 79.9 (α), 77.9 (α), 77.1 
(β), 75.7, 75.5 (CH2Ph (β)), 75.2 (CH2Ph (α)), 75.1 (CH2Ph (α)), 74.9 (CH2Ph 
(β)), 72.4 (β), 68.4 (α), 66.4 (β), 64.7 (C-6 (β)), 64.6 (C-6 (α)), 63.1 (α), 42.36 
(COCH2Cl (β)), 42.30 (COCH2Cl (α)), 40.6, 46.1, 30.68 (β), 30.62 (α). 
 
Experiment 84. Synthesis of 3-O-(2-azido-3,4,di-O-benzyl-6-O-
chloroacetyl-2-deoxy-α /β-D-glucopyranosyl)-epiandrosterone (100) 
  The glycosylation reaction of donor 91 with acceptor 25 was performed 
according to the procedure described in experiment 4. The results are 
presented in Table 6, Chapter 1.  FT-IR (film) υmáx.: 1742, 1762 (C=O), 2107 
(N3) cm-1. 1H NMR (CDCl3): δ 7.46-7.43 (m, Ph), 7.41-7.24 (m, Ph), 7.13 (d, J 
= 7.9 Hz, Ph), 5.30 (d, J = 3.6 Hz, H-1 (α)), 4.94-4.82 (m), 4.78 (d, J = 10.8 
Hz, CH2Ph (β)), 4.61-4.55 (m), 4.48 (dd, J = 11.9, J = 1.9 Hz), 4.39-4.29 (m), 
4.24 (dd, J = 11.9, J = 4.6 Hz), 4.22-4.18 (m), 4.14 (ddd, J = 10.1 Hz, J = 4.5 
Hz, J = 2.5 Hz), 4.08 (dd, J = 10.3 Hz, J = 8.7 Hz, H-3 (α)), 4.03-3.89 (m), 
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3.54-3.39 (m), 3.28 (dd, J = 10.0, J = 9.3 Hz, H-5 (α)), 3.17 (dd, J = 10.3, J = 
3.6 Hz, H-2 (α)), 2.35 (s), 2.19-2.13 (m), 1.92-1.75 (m), 1.67-1.57 (m) ppm. 
13C NMR (CDCl3): δ 166.99, 166.79, 139.1, 137.9, 137.51, 137.48, 137.32, 
137.31, 134.5, 129.8, 128.66, 128.60, 128.56, 128.52, 128.51, 128.29, 
128.19, 128.18, 128.14, 128.10, 128.06, 128.02, 127.94, 126.6, 95.1 (C-1 
(β)), 91.1 (C-1 (α)), 85.9 (α), 85.1 (α), 83.3 (β), 80.0 (α), 78.0 (α), 77.1 (β), 
76.75, 76.71, 76.2, 76.0, 75.8, 75.5, 75.25, 75.12, 75.04, 74.95, 72.4 (β), 68.5 
(α), 66.4 (β), 64.85 (α), 64.74 (β), 64.67, 64.2, 63.1 (α), 42.36, 42.31, 40.6, 
36.16, 36.11, 30.68, 30.62, 21.2 
 
Experiment 85. Synthesis of Phenyl 3-O-benzyl-4,6-O-benzylidene-1-thio-
β-D-glucopyranose (102) 
  The synthesis of compound 102 was carried out according to the procedure 
described in the literature8. 
 
Experiment 86. Synthesis of 2,3,4,6-Tetra-O-acetyl-α-D-mannopyranosyl 
trichloroacetimidate (103) 
  The synthesis of compound 103 was carried out according to the procedure 
described in the literature9. 
 
Experiment 87. Synthesis of Phenyl 2,3,4,6-tetra-O-acetyl-α-D-
mannopyranosyl-(1→2)-3-O-benzyl-4,6-O-benzylidene-1-thio-β-D-
glucopyranose (104) 
  Acceptor 102 (0.140 g, 0.31 mmol) was added to a solution of 
trichloroacetamidate 103 (0.344 g, 0.46 mmol) in dry CH2Cl2 (3 mL). The 
solution was cooled to -20°C and TMSOTf (56.5 µL, 0.31 mmol) was slowly 
added. When the reaction was completed, a saturated aqueous solution of 
NaHCO3 (2 mL) was added, followed by extractions with CH2Cl2. The 
combined organic phases were dried (MgSO4) and concentrated. The residue 
was purified by flash column chromatography on silica gel (50:50, 
EtOAc/hexane) to afford 104 as a white foam (0.180 g, 74%). FTIR (film) υ 
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máx: 1749 (C=O) cm–1. 1H NMR (CDCl3): δ 7.55-7.52 (m, 2H, Ph), 7.45-7.42 
(m, 2H, Ph), 7.38-7.28 (m, 11H, Ph), 5.58 (s, 1H, CHPh), 5.56 (d, J = 3.1 Hz, 
1H, H-1 Man), 5.40 (dd, J = 3.1 Hz, J = 1.8 Hz, 1H), 5.35-5.26 (m, 2H), 5.06 
(d, J = 10.9 Hz, 1H, CH2Ph), 4.69 (d, J = 9.3 Hz, 1H, H-1 Glu), 4.66 (d, J = 
10.9 Hz, 1H, CH2Ph), 4.39 (dd, J = 10.5 Hz, J = 5.0 Hz, 1H), 4.28 (dt, J = 9.4 
Hz, J = 2.5 Hz, 1H), 3.83-3.71 (m, 5H), 3.60 (dd, J = 12.6 Hz, J = 2.2 Hz, 1H), 
3.53-3.48 (m, 1H), 2.17 (s, 3H, Ac), 2.01 (s, 3H, Ac), 2.01 (s, 3H, Ac), 2.00 (s, 
3H, Ac) ppm. 13C NMR (CDCl3): δ 170.6, 169.99, 169.85, 169.4, 137.7, 137.0, 
132.64, 132.58, 129.17, 129.06, 128.40, 128.32, 128.28, 128.24, 128.0, 
126.0, 101.3 (C-1 (α) Man), 97.9 (C-1 (β) Glu), 89.1, 81.9, 80.8, 77.4, 77.1, 
76.8, 76.6, 75.1 (CH2Ph), 70.1, 69.31, 69.15, 68.76, 68.58, 65.6, 61.4, 20.9 
(COCH3), 20.7 (COCH3) ppm. 
 
Experiment 88. Synthesis of Methyl 3-O-tert-butyldiphenylsilyl-(2R)-2-O-
[2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-3-O-benzyl-4,6-O-
benzylidene-α-D-glucopyranosyl]-2,3-di-hydroxypropanoate (105) 
  A suspension of thioglycoside 104 (0.370 g, 0.47 mmol), glycerate 9 (0.204 
g, 0.57 mmol) and 4 Å molecular sieves in CH2Cl2 (3 mL) was stirred at r.t. for 
1 hour. The solution was cooled to 0°C and N-iodosuccinimide (0.135 g, 0.60 
mmol) and TMSOTf (42 µL, 0.24 mmol) were added. After all of the starting 
material had been consumed, a 10% aqueous solution of Na2S2O3 (2 mL) and 
a saturated aqueous solution of NaHCO3 (1 mL) were added to the mixture. 
After extraction with CH2Cl2, the combined organic phases were dried 
(MgSO4), filtered and the solvent was removed in vacuum. The crude product 
was purified by flash column chromatography (30:70, EtOAc/hexane) to afford 
the glycoside 105 as a colourless viscous foam (0.190 g, 40%), and the 
product of the deprotection of the benzylidene acetal 106 (0.100 g, 23%). 
[α]20D = +51.9 (c = 2.67, CH2Cl2). FTIR (film) υ máx: 1752 (C=O) cm–1. 1H NMR 
(CDCl3): δ 7.72-7.70 (m, 4H, Ph), 7.45-7.25 (m, 16H, Ph), 5.56 (s, 1H, CHPh), 
5.49-5.43 (m, 2H), 5.46 (s, 1H, H-1 Man), 5.31-5.20 (m, 2H), 5.26 (bs, 1H, H-1 
Glu), 4.92 (d, J = 11.0 Hz, 1H, CH2Ph), 4.79 (d, J = 10.9 Hz, 1H, CH2Ph), 4.44 
(dd, J = 6.4, 3.4 Hz, 1H, CHCH2OTBDPS), 4.28-4.24 (m, 1H), 4.21-3.92 (m, 
8H), 3.89 (dd, J = 9.5, 3.7 Hz, 1H), 3.72-3.63 (m, 2H), 3.66 (s, 3H, CO2Me), 
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2.16 (s, 3H, Ac), 2.07 (s, 3H, Ac), 1.99 (s, 3H, Ac), 1.98 (s, 3H, Ac), 1.05 (s, 
9H, t-Bu) ppm. 13C NMR (CDCl3): δ 170.6, 169.86, 169.66, 169.63, 169.48, 
138.2, 137.3, 135.64, 135.61, 135.54, 135.51, 133.05, 132.86, 129.88, 
129.81, 128.9, 128.6, 128.31, 128.26, 128.12, 127.90, 127.81, 127.78, 
127.66, 126.1, 101.5 101.3 (C-1 (α) Man), 94.8 (C-1 (β) Glu), 94.3, 82.3, 76.5, 
75.5 (CH2Ph), 75.1, 73.5, 69.36, 69.20, 68.8, 68.4, 65.9, 64.5, 62.7, 61.9, 52.0 
(CO2CH3), 26.7 (C(CH3)3) 20.87 (COCH3), 20.76 (COCH3), 20.73 (COCH3), 
20.68 (COCH3), 19.1 (C-Si) ppm. 
 
Experiment 89. Synthesis of Methyl 3-O-tert-butyldiphenylsilyl-(2R)-2-O-
[2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-3-O-benzyl-α-D-
glucopyranosyl]-2,3-di-hydroxypropanoate (106) 
  To a solution of glycoside 105 (0.190 g, 0.185 mmol) in CH2Cl2 (2 mL) was 
added a catalytic amount of p-toluenesulfonic acid. The reaction mixture was 
stirred until all of the starting material was consumed as confirmed by TLC. 
After adition of saturated aqueous solution of NaHCO3 (1 mL) and extraction 
with CH2Cl2, the combined organic phases were dried (MgSO4), filtered and 
the solvent was removed in vacuum. The crude product was purified by 
preparative TLC (50:50, EtOAc/hexane) to afford 106 as a colourless viscous 
foam (0.158 g, 91%). [α]20D = +69.3 (c = 1.21, CH2Cl2). FTIR (film) υ máx: 3483 
(OH), 1751 (C=O) cm–1. 1H NMR (CDCl3): δ 7.71-7.68 (m, 4H, Ph), 7.45-7.26 
(m, 11H, Ph), 5.48-5.45 (m, 2H, H-2 Man, H-3 Man), 5.31-5.27 (m, 1H, H-4 
Man), 5.31 (s, 1H, H-1 Man), 5.21 (d, J = 3.3 Hz, 1H, H-1 Glu), 5.02 (d, J = 
11.6 Hz, 1H, CH2Ph), 4.77 (d, J = 11.6 Hz, 1H, CH2Ph), 4.44 (dd, J = 6.5 Hz, 
J = 3.4 Hz, 1H, CHCH2OTBDPS), 4.18-4.11 (m, 2H, H-5 Man, H-6 Man), 
4.09-4.02 (m, 2H, H’-6 Man, CHCH2OTBDPS), 3.95 (dd, J = 10.8 Hz, J = 3.4 
Hz, 1H, CHCH2OTBDPS), 3.90-3.75 (m, 3H, H-2 Glu, H-3 Glu, H-5 Glu), 3.70-
3.68 (m, 2H, H-6 Glu, H’-6 Glu), 3.66 (s, 3H, CO2Me), 3.59 (dd, J = 9.6 Hz, J 
= 8.8 Hz, 1H, H-2 Glu), 2.17 (s, 3H, Ac), 2.08 (s, 3H, Ac), 1.99 (s, 3H, Ac), 
1.96 (s, 3H, Ac), 1.06 (s, 9H, t-Bu) ppm. 13C NMR (CDCl3): δ 170.6, 169.93, 
169.74, 169.69, 169.54, 138.3, 135.60, 135.51, 133.1, 132.9, 129.87, 129.85, 
128.6, 127.89, 127.85, 127.82, 127.79, 94.5 (C-1 Man), 93.6 (C-1 Glu), 80.0, 
75.6 (CH2Ph), 75.0 (CHCH2OTBDPS), 73.7, 71.3, 70.3, 69.23, 69.21, 68.7, 
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65.8, 64.5 (CHCH2OTBDPS), 62.17 (C-6 Man), 62.01 (C-6 Glu), 52.0 
(CO2CH3), 26.7 (C(CH3)3), 20.86 (COCH3), 20.76 (COCH3), 20.66 (COCH3), 
19.2 (C-Si) ppm. 
 
Experiment 90. Synthesis of Methyl (2R)-2-O-[2,3,4,6-tetra-O-acetyl-α-D-
mannopyranosyl-(1→2)-3-O-benzyl-α-D-glucopyranosyl]-2,3-di-
hydroxypropanoate (107) 
  TBAF (1M in THF; 0.14 mL, 0.14 mmol) was added to a solution of 106 
(0.110 g, 0.117 mmol) in THF (2 mL) at r.t. The reaction mixture was stirred 
for 4 hours and then water was added. The mixture was extracted with EtOAc, 
dried (MgSO4) and concentrated to give a yellow viscous residue. Purification 
by preparative TLC (80:20, EtOAc/hexane) afforded product 107 as a viscous 
colourless foam (0.050 g, 73%). [α]20D = +84.1 (c = 1.00, CH2Cl2). FTIR (film) 
υ máx: 3441 (O–H), 1747 (C=O) cm–1. 1H NMR (CDCl3): δ 7.42-7.26 (m, 5H, 
Ph), 5.43 (dd, J = 3.2 Hz, J = 1.7 Hz, 1H, H-2 Man), 5.36-5.25 (m, 2H, H-3 
Man, H-4 Man), 5.23 (d, J = 1.4 Hz, 1H, H-1 Man), 5.20 (d, J = 3.4 Hz, 1H, H-
1 Glu), 4.94 (d, J = 11.4 Hz, 1H, CH2Ph), 4.86 (d, J = 11.5 Hz, 1H, CH2Ph), 
4.39 (dd, J = 6.1 Hz, J = 3.2 Hz, 1H, CHCH2OH), 4.15-3.74 (m, 10H), 3.70 (s, 
3H, CO2Me), 3.58 (t, J = 3.5 Hz, 1H), 3.10 (bs, 3H), 2.16 (s, 3H, Ac), 2.06 (s, 
3H, Ac), 1.98 (s, 3H, Ac), 1.95 (s, 3H, Ac) ppm. 13C NMR (CDCl3): δ 170.7, 
170.2, 169.91, 169.77, 169.60, 138.3, 128.55, 128.49, 127.81, 127.72, 94.6 
(C-1 Man), 93.9 (C-1 Glu), 79.7, 75.6 (CH2Ph), 75.3 (CHCH2OH), 73.8, 71.9, 
71.0, 69.4, 69.1, 68.7, 65.5, 63.1, 62.3 (C-6 Man), 62.0 (C-6 Glu), 52.2 
(CO2CH3), 20.84 (COCH3), 20.73 (COCH3), 20.70 (COCH3), 20.64 (COCH3) 
ppm. 
 
Experiment 91. Synthesis of Methyl (2R)-2-O-[α-D-mannopyranosyl-
(1→2)-3-O-benzyl-α-D-glucopyranosyl]-2,3-di-hydroxypropanoate (108) 
  A 1N solution of NaOMe (57 µL, 0.057 mmol) in MeOH was added to a 
stirred solution of 107 (0.058 g, 0.082 mmol) in MeOH (1 mL) at 0 °C. After 
complete conversion of the starting material, previously activated Dowex-H+ 
resin was added until neutral pH. After filtration with MeOH and water, the 
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solvent was removed in vacuum to yield 108 as a viscous colourless foam 
(0.026 g, quantitative). 1H NMR (D2O): δ 7.50-7.40 (m, 5H), 5.33 (d, J = 2.7 
Hz, 1H, H-1 Glu), 5.16 (d, J = 1.5 Hz, 1H, H-1 Man), 4.85 (s, 2H, CH2Ph) 4.57 
(t, J = 4.0 Hz, 1H, CHCH2OH), 4.09 (dd, J = 3.3 Hz, J = 1.7 Hz, 1H, H-2 Man), 
4.00-3.94 (m, 2H, CHCH2OH), 3.89-3.61 (m, 10H), 3.81 (s, 3H, CO2Me), 3.56 
(t, J = 9.2 Hz, 1H) ppm. 13C NMR (D2O): δ 172.0 (CO2Me), 137.1, 129.0, 
128.7, 128.5, 97.0 (C-1 Man), 94.0 (C-1 Glu), 79.5, 75.9 (CH2Ph), 75.2 
(CHCH2OH), 73.4, 72.7, 72.3, 70.5, 69.8, 69.4, 66.2, 62.4 (CHCH2OH), 60.4, 
60.2, 52.7 (CO2CH3) ppm. 
 
Experiment 92. Synthesis of Methyl (2R)-2-O-[α-D-mannopyranosyl-
(1→2)-1-O-α-D-glucopyranosyl]-2,3-dihydroxypropanoate (109) 
  From compound 108: Benzyl ether 108 (0.036 g, 0.067 mmol) in EtOH (1 
mL) was hydrogenated at 50 psi in the presence of Pd/C 10% (0.25 equiv). 
After 3 hours, the reaction mixture was filtered and the solvent was 
evaporated to afford ester 109 as a very viscous colourless foam (0.640 g, 
quantitative). 
  From compound 117: A 1 N solution of NaOMe (34 µL, 0.03 mmol) in MeOH 
was added to a stirred solution of 117 (0.036 g, 0.06 mmol) in MeOH (1 mL) 
at 0 °C. After 1 hour, previously activated Dowex-H+ resin was added until 
neutral pH. After filtration with MeOH and water, the solvent was removed in 
vacuum to yield 118 as a viscous colourless foam (0.026 g, quantitative). 
[α]20D = +135.6 (c = 2.03, H2O). 1H NMR (D2O): δ 5.26 (d, J = 3.4 Hz, 1H, H-1 
Glu), 5.09 (d, J = 1.3 Hz, 1H, H-1 Man), 4.52 (t, J = 3.8 Hz, 1H, CHCH2OH), 
4.03 (dd, J = 1.6 Hz, J = 3.6 Hz, 1H, H-2 Man), 3.91-3.90 (m, 2H, CHCH2OH), 
3.87-3.63 (m, 10H), 3.77 (s, 3H, CO2Me), 3.45 (t, J = 9.0 Hz, 1H) ppm. 13C 
NMR (D2O): δ 174.6 (CO2Me), 99.6 (C-1 Man), 96.8 (C-1 Glu), 77.9 
(CHCH2OH), 76.3, 75.2, 74.7, 73.5, 72.8, 72.4, 71.8, 69.1, 64.9 (CHCH2OH), 
63.4, 62.9, 55.3 (CO2Me) ppm. HRMS: calcd. for C16H28O14Na+ [M+ + Na] 
467.1371; found 467.1372. 
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Experiment 93. Synthesis of Potassium (2R)-2-O-α-D-mannopyranosyl-
(1→2)-α-D-glucopyranosyl-2,3-dihydroxypropanoate (101) 
  A solution of 2 M KOH (320 µL) was added to a stirred solution of ester 118 
(0.026 g, 0.06 mmol) in H2O (1 mL). After all of the starting material had been 
consumed, the pH was adjusted to 7 with 10% HCl and the solvent was 
evaporated to afford 1 as a viscous colourless foam (0.027 g, quantitative). 
The NMR spectroscopic data were identical to those of a natural sample. 
[α]20D = +67.8 (c = 0.85, H2O). FTIR (film) υ máx.: 3315 (OH), 1655 (C=O) cm–1. 
1H NMR (D2O): δ 5.12 (d, J = 3.4 Hz, 1H, H-1 Glu), 5.06 (d, J = 1.12 Hz, 1H, 
H-1 Man), 4.13 (dd, J = 3.2 Hz, J = 7.0 Hz, 1H, CHCH2OH), 4.04-4.02 (dd, J = 
1.6 Hz, J = 3.2 Hz 1H, H-2 Man), 3.85-3.58 (m, 12H), 3.39 (t, J = 9.3 Hz, 1H) 
ppm. 13C NMR (D2O): δ 176.5 (CO2-), 97.1 (C-1 Man), 93.8 (C-1 Glu), 78.3 
(CHCH2OH), 73.9, 72.7, 71.8, 71.1, 70.1, 69.7, 69.5, 66.6, 62.9, 60.9, 60.5 
ppm. HRMS: calcd. for C15H26O14K+ [M+ + H] 469.09541; found 469.0954. 
 
Experiment 94. Synthesis of Phenyl 1-thio-β-D-glucopyranoside (110) 
  The synthesis of compound 110 was carried out according to the procedure 
described in the literature10. 
 
Experiment 95. Synthesis of Phenyl 3,4-di-O-(2,3-dimethoxybutane-2,3-
diyl)-1-thio-β-D-glucopyranoside (111) and Phenyl 2,3-di-O-(2,3-
dimethoxybutane-2,3-diyl)-1-thio-β-D-glucopyranoside (112) 
  The synthesis of compound 110 was carried out according to the procedure 
described in the literature11. 
 
Experiment 96. Synthesis of Phenyl 6-O-tert-butyldiphenylsilyl-3,4-di-O-
(2,3-dimethoxybutane-2,3-diyl)-1-thio-β-D-glucopyranoside (113) 
  TBDPSCl (1.28 mL, 4.92 mmol) was added to a solution of 111 (0.634 g, 
1.64 mmol) in dry DMF (5 mL) at r.t., followed by imidazole (0.391 g, 5.74 
mmol). After 12 h at room temperature, the reaction was quenched with H2O 
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(5 mL), extracted with CH2Cl2 (3x5 mL), and the combined organic phases 
were dried (MgSO4) and concentrated. Purification by flash column 
chromatography on silica gel (30:70 EtOAc/hexane) afforded the product 113 
as a white solid (0.908 g, 89%). [α]20D = +34.1 (c = 0.17, CH2Cl2). m.p. 69.2–
71.4 °C. FTIR (film) υ máx: 3496 (O–H) cm–1. 1H NMR (CDCl3): δ 7.67-7.72 (m, 
4H, Ph), 7.57-7.55 (m, 2H, Ph), 7.42-7.31 (m, 6H, Ph), 7.23-7.19 (m, 3H, Ph), 
4.57 (d, J = 9.3 Hz, 1H, H-1), 3.99-3.90 (m, 2H, H-6, H’-6), 3.82-3.73 (m, 2H, 
H-3, H-4), 3.59-3.52 (m, 2H, H-2, H-5), 3.31 (s, 3H, OMe), 3.19 (s, 3H, OMe), 
1.33 (s, 3H, Me), 1.28 (s, 3H, Me), 1.06 (s, 9H, t-Bu) ppm. 13C NMR (CDCl3): 
δ 135.8, 135.5, 133.7, 133.1, 132.8, 131.9, 129.6, 129.5, 129.0, 127.9, 
127.66, 127.63, 99.7 (CH3COCH3), 99.4 (CH3COCH3), 88.5 (C-1), 78.9 (C-5), 
73.7, 69.1 (C-2), 64.9, 61.9 (C-6), 48.2 (OCH3), 48.0 (OCH3), 26.9 (C(CH3)3), 
19.3 (C-Si), 17.7 (CCH3), 17.6 (CCH3) ppm. Anal. Calcd for C34H44O7SSi 
(624.86): calcd. C 65.35, H 7.10, S 5.13; found C 65.00, H 6.86, S 5.01. 
 
Experiment 97. Synthesis of Phenyl 2,3,4,6-tetra-O-acetyl-α-D-
mannopyranosyl-(1→2)-6-O-tert-butyldiphenylsilyl-3,4-di-O-(2,3-
dimethoxybutane-2,3-diyl)-1-thio-β-D-glucopyranoside (114) 
  Acceptor 113 (0.254 g, 0.41 mmol) was added to a solution of 
trichloroacetamidate 103 (0.250 g, 0.51 mmol) in dry CH2Cl2 (4 mL). The 
solution was cooled to -20°C and TMSOTf (92.30 µL, 0.51 mmol) was slowly 
added. When the reaction was completed, a saturated aqueous solution of 
NaHCO3 (2 mL) was added, followed by extractions with CH2Cl2. The 
combined organic phases were dried (MgSO4) and concentrated. The residue 
was purified by flash column chromatography on silica gel (20:80  
EtOAc/hexane) to afford 114 as a white foam (0.237 g, 58%). [α]20D = +54.1 
(c = 1.30, CH2Cl2). FTIR (film) υ máx:.1752 (C=O) cm–1. 1H NMR (CDCl3): δ 
7.73-7.70 (m, 4H, Ph), 7.55-7.53 (m, 2H, Ph), 7.43-7.19 (m, 9H, Ph), 5.51 (s, 
1H, H-1 Man), 5.35-5.33 (m, 3H, H-2 Man, H-3 Man, H-4 Man), 4.73-4.72 (m, 
1H, H-5 Man), 4.65 (d, J = 8.7 Hz, 1H, H-1 Glu), 4.29 (dd, J = 3.6 Hz, J = 12.0 
Hz, 1H, H-6 Man), 4.18-4.15 (m, 1H, H’-6 Man), 3.95-3.88 (m, 2H, H-6 Glu, 
H’-6 Glu), 3.79–3.76 (m, 3H, H-2 Glu, H-3 Glu, H-4 Glu), 3.55 (m, 1H, H-5 
Glu), 3.32 (s, 3H, OMe), 3.17 (s, 3H, OMe), 2.20 (s, 3H, Ac), 2.12 (s, 3H, Ac), 
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2.01 (s, 3H, Ac), 1.99 (s, 3H, Ac), 1.26 (s, 3H, Me), 1.25 (s, 3H, Me), 1.06 (s, 
9H, t-Bu) ppm. 13C NMR (CDCl3): δ 170.8, 169.9, 169.8, 169.6, 135.8, 135.5, 
133.9, 133.6, 133.0, 131.9, 131.5, 129.6, 129.5, 129.0, 127.6, 127.5, 99.9 
(CH3COCH3), 99.3 (CH3COCH3), 97.1 (C-1 Man), 88.7 (C-1 Glu), 78.5 (C-5 
Glu), 73.4, 72.8, 69.2, 69.1, 68.6 (C-5 Man), 66.0 (C-5 Man), 65.1 (C-2 Glu), 
62.0 (C-6 Glu, C-6 Man), 48.0 (CH3COCH3), 47.9 (CH3COCH3), 26.8 
(C(CH3)3), 20.9 (COCH3), 20.71 (COCH3), 20.70 (COCH3), 20.6 (COCH3), 
19.3 (C-Si), 17.6 (CH3COCH3), 17.3 (CH3COCH3) ppm. Anal. Calcd for 
C48H62O16SSi (955.15): calcd. C 60.36, H 6.54; found C 60.50, H 6.40. 
 
Experiment 98. Synthesis of Methyl 3-O-tert-butyldiphenylsilyl-(2R)-2-O-
[2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-6-O-tert-
butyldiphenylsilyl-3,4-di-O-(2,3-dimethoxybutane-2,3-diyl)-1-O-α-D-
glucopyranosyl]-2,3-di-hydroxypropanoate (115) 
  A suspension of thioglycoside 114 (0.387 g,0.40 mmol), glycerate 9 (0.143 g, 
0.40 mmol) and 4 Å molecular sieves in CH2Cl2 (3 mL) was stirred at r.t. for 1 
h. The solution was cooled to 0°C and N-iodosuccinimide (0.099 g, 0.44 
mmol) and TMSOTf (36 µL, 0.20 mmol) were added. After all of the starting 
material had been consumed, a 10% aqueous solution of Na2S2O3 (2 mL) and 
a saturated aqueous solution of NaHCO3 (1 mL) were added and the mixture 
was extracted with CH2Cl2; the combined organic phases were dried 
(MgSO4), filtered and the solvent was removed in vacuum. The crude product 
was purified by flash column chromatography (30:70 EtOAc/hexane) to afford 
glycoside 115 as a colourless viscous foam (0.286 g, 60%). [α]20D = +83.3 (c 
= 1.00, CH2Cl2). FTIR (film) υ máx: 1753, 1641 (C=O) cm–1. 1H NMR (CDCl3): δ 
7.68-7.62 (m, 8H, Ph), 7.42-7.30 (m, 12H, Ph), 5.46 (dd, J = 3.4 Hz, J = 9.9 
Hz, 1H, H-3 Man), 5.40-5.39 (m, 1H, H-2 Man), 5.29 (t, J = 10.0 Hz, 1H, H-4 
Man), 5.20 (d, J = 1.4 Hz, 1H, H-1 Man), 5.13 (d, J = 3.8 Hz, 1H, H-1 Glu), 
4.52-4.48 (m, 1H), 4.37 (dd, J = 5.2 Hz, J = 3.8 Hz, 1H, CHCH2OTBDPS), 
4.29-4.18 (m, 3H, H-6 Man, H’-6 Man, H-3 Glu), 3.97 (dd, J = 5.4 Hz, J = 10.5 
Hz, 1H, H-6 Glu), 3.91-3.83 (m, 2H, H’-6 Glu, H-2 Glu), 3.80-3.71 (m, 4H, H-4 
Glu, H-5 Glu, CHCH2OTBDPS), 3.72 (s, 3H, CO2Me), 3.28 (s, 3H, OMe), 3.17 
(s, 3H, OMe), 2.17 (s, 3H, Ac), 2.13 (s, 3H, Ac), 2.04 (s, 3H, Ac), 1.97 (s, 3H, 
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Ac), 1.27 (s, 6H, Me), 1.01 (s, 9H, t-Bu), 1.00 (s, 9H, t-Bu) ppm. 13C NMR 
(CDCl3): δ 170.7, 170.3, 169.8, 169.6, 169.5, 135.8, 135.6, 135.5, 135.4, 
133.7, 133.2, 132.7, 129.8, 129.7, 129.6, 129.5, 127.8, 127.7, 127.5, 127.4, 
99.6 (CH3COCH3), 99.5 (CH3COCH3), 94.6 (C-1 Man), 93.9 (C-1 Glu), 74.6 
(CHCH2OTBDPS), 70.9 (C-2 Glu), 70.4 (C-5 Glu), 69.6 (C-2 Man), 69.1 (C-3 
Man), 68.5 (C-5 Man), 67.8 (C-3 Glu), 66.3 (C-4 Man), 65.8 (C-4 Glu), 64.4 
(C-6 Man), 62.3 (C-6 Man), 61.7 (CHCH2OTBDPS), 51.9 (CO2CH3), 47.9 
(CH3COCH3), 47.8 (CH3COCH3), 26.7 (C(CH3)3), 26.5 (C(CH3)3), 20.9 
(COCH3), 20.7 (COCH3), 20.69 (COCH3), 20.67 (COCH3), 19.3 (C-Si), 19.1 
(C-Si), 17.6 (CH3COCH3), 17.6 (CH3COCH3) ppm. Anal. Calcd for 
C62H82O20Si2 (1203.49): calcd. C 61.88, H 6.87; found C 61.90, H 6.75. 
 
Experiment 99. Synthesis of Methyl (2R)-2-O-[2,3,4,6-tetra-O-acetyl-α-D-
mannopyranosyl-(1→2)-3,4-di-O-(2,3-dimethoxybutane-2,3-diyl)-1-O-α-D-
glucopyranosyl]-2,3-dihydroxypropanoate (116) 
  TBAF (1M in THF; 0.22 mL, 0.22 mmol) was added to a solution of 115 
(0.246 g, 0.20 mmol) in THF (3 mL) at room temperature. The reaction 
mixture was stirred for 3 h and then water was added. The mixture was 
extracted with EtOAc, dried (MgSO4) and concentrated to give a yellow 
viscous residue. Purification by column chromatography (EtOAc) afforded 
product 116 as a viscous colourless foam (0.103 g, 71 %). [α]20D = +155.2 (c 
= 1.82, CH2Cl2). FTIR (film) υ máx: 3463 (O–H), 1747, 1636 (C=O) cm–1. 1H 
NMR (CDCl3): δ 5.39-5.37 (m, 1H, H-2 Man), 5.35-5.28 (m, 2H, H-3 Man, H-4 
Man), 5.19 (d, J = 3.8 Hz, 1H, H-1 Glu), 5.13 (s, 1H, H-1 Man), 4.50-4.48 (m, 
1H, H-5 Man), 4.39-4.36 (m, 1H, CHCH2OH), 4.26-4.17 (m, 2H, H-6 Man, H’-6 
Man), 4.10 (t, J = 10.0 Hz, 1H, H-3 Glu), 3.95-3.81 (m, 5H), 3.75-3.67 (m, 2H), 
3.73 (s, 3H, OMe), 3.34 (s, 3H, CO2Me), 3.24 (s, 3H, OMe), 2.17 (s, 3H, 
OMe), 2.13 (s, 3H, Ac), 2.04 (s, 3H, Ac), 1.98 (s, 3H, Ac), 1.30 (s, 3H, Me), 
1.26 (s, 3 H, Me) ppm. 13C NMR (CDCl3): δ 170.7, 170.1, 169.9, 169.74, 
169.70, 99.8 (CH3COCH3), 99.7 (CH3COCH3), 94.9 (C-1 Man), 94.6 (C-1 
Glu), 75.4 (CHCH2OH), 71.4 (C-2 Glu), 70.0 (C-5 Glu), 69.3 (C-3 Man), 69.2 
(C-2 Man), 68.7 (C-5 Man), 67.4 (C-3 Glu), 66.0 (C-4 Glu), 65.8 (C-4 Man), 
63.3 (CHCH2OH), 62.1 (C-6 Man), 60.9 (C-6 Glu), 52.2 (CO2CH3), 47.9 
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(CH3COCH3), 47.8 (CH3COCH3), 20.8 (COCH3), 20.7 (COCH3), 17.6 
(CH3COCH3), 17.5 (CH3COCH3) ppm. HRMS: calcd. for C30H46O20Na+ [M+ + 
Na] 749.2475; found 749.2451. 
 
Experiment 100. Synthesis of Methyl (2R)-2-O-[2,3,4,6-Tetra-O-acetyl-α-
D-mannopyranosyl-(1→2)-1-O-α-D-glucopyranosyl]-2,3-
dihydroxypropanoate (117) 
  A mixture of TFA/H2O (5:1) (0.8 mL) was added to a solution of 116 (0.093 
g, 0.13 mmol) in CH2Cl2 (1 mL) at r.t. The reaction mixture was stirred until all 
of the starting material had been consumed and then it was concentrated to 
give a viscous residue. Purification by flash column chromatography (1:4, 
MeOH/CH2Cl2) afforded product 117 as a viscous colourless foam (0.055g, 
70%). [α]20D = +72.2 (c = 0.46, EtOH). FTIR (film) υ máx: 3460 (O–H), 1748 
(C=O) cm–1. 1H NMR (CDCl3): δ 5.43-5.42 (m, 1H, H-2 Man), 5.38 (dd, J = 3.2 
Hz, J = 10.0 Hz, 1H, H-3 Man), 5.26 (t, J = 10.0 Hz, 1H, H-4 Man), 5.20 (d, J 
= 3.6 Hz, 1H, H-1 Glu), 5.17 (d, J = 1.4 Hz, 1H, H-1 Man), 4.48 (t, J = 4.2 Hz, 
1H, CHCH2OH), 4.46-4.39 (m, 2H, H-5 Man, H-6 Man), 4.15-4.12 (m, 1H, H’-6 
Man), 3.88-3.68 (m, 7H), 3.69 (s, 3H, CO2Me), 3.43 (t, J = 9.4 Hz, 1H, H-4 
Glu), 2.18 (s, 3H, Ac), 2.09 (s, 3H, Ac), 2.06 (s, 3H, Ac), 1.98 (s, 3H, Ac) ppm. 
13C NMR (CDCl3): δ 173.7, 173.1, 172.8, 172.7, 172.0, 95.4 (C-1 Man), 94.8 
(C-1 Glu), 75.9 (CHCH2OH), 75.4 (C-2 Glu), 72.2 (C-5 Glu), 70.9 (C-3 Glu), 
69.7 (C-3 Man), 69.3, 68.4 (C-5 Man), 65.5 (C-4 Man), 62.3 (CHCH2OH), 61.8 
(C-6 Man), 60.3 (C-6 Glu), 52.7 (CO2CH3), 20.1 (COCH3), 20.0 (COCH3) ppm. 
HRMS: calcd. for C24H36O18Na+ [M+ + Na] 635.1794; found 635.2451. 
 
Experiment 101. Synthesis of 6-O-[Phenyl-3,4-di-O-(2,3-
dimethoxybutane-2,3-diyl)-1-thio-β-D-glucopyranosyl] Succinate (118) 
  Succinic anhydride (0.041 g, 0.41 mmol), followed by diisopropylethylamine 
(171 µL, 0.98 mmol) and a catalytic amount of DMAP were added to a 
solution of 111 (0.160 g, 0.41 mmol) in CH2Cl2 (2 mL) at 0°C. The reaction 
mixture was stirred as the temperature was allowed to rise to r.t. After 3 
hours, the reaction was quenched and washed with H2O. The aqueous phase 
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was extracted with AcOEt (3x 5 mL) and the combined organic phases were 
dried (MgSO4) and concentrated. Purification by flash column 
chromatography (80:20 EtOAc/hexane) afforded product 118 as a viscous 
colourless oil (0.180 g, 90 %). [α]20D = +110.5 (c = 0.19, CH2Cl2). FTIR (film) 
máx: 3488 (O–H), 1736 (C=O) cm–1. 1H NMR (CDCl3): δ 7.56–7.53 (m, 2H, Ph), 
7.33–7.29 (m, 3H, Ph), 4.52 (d, J = 9.3 Hz, 1H, H-1), 4.48 (dd, J = 1.9 Hz, J = 
11.8 Hz, 1H), 4.21 (dd, J = 5.4, J = 11.9 Hz, 1H), 3.77–3.71 (m, 2H), 3.59 (t, J 
= 9.8Hz, 1H), 3.48 (t, J = 9.32 Hz, 1H), 3.30 (s, 3H), 3.21 (s, 3H), 2.72–2.63 
(m, 4H), 1.32 (s, 3H), 1.28 (s, 3H) ppm. 13C NMR (CDCl3): δ 176.6, 171.8, 
133.5, 130.9, 128.9, 128.5, 99.8, 99.7, 88.0 (C-1), 75.7, 73.3, 69.0, 65.6, 62.8, 
48.05, 48.02, 28.7, 28.6, 17.6, 17.5 ppm. HRMS: calcd. for C22H30O10SNa+ [M+ 
+ Na] 509.1452; found 509.1454. 
 
Experiment 102. Synthesis of Resin-Bound 119 
  Thioglucoside 118 (0.130 g, 0.27 mmol) was dissolved in CH2Cl2 (2 mL) and 
cooled to 0°C. HOBt (0.036 g, 0.27 mmol) was added, followed by DIC (0.041 
mL, 0.37 mmol), and the solution was stirred at 0 °C for 10 min. The reaction 
mixture was transferred by cannula to Tentagel MB-NH2 resin (0.601 g, 0.24 
mmol) swelled in CH2Cl2 (2 mL), and the reaction was shaken at room 
temperature for 6 hours. The resin was filtered, and rinsed three times with 
DMF, MeOH and CH2Cl2, and dried in vacuum over phosphorus pentoxide. 
HR-MAS 1H NMR spectroscopy indicated successful coupling, with a 
theoretical resin loading of 0.32 mmol.g-1, as calculated from the resin weight 
gain. 
 
Experiment 103. Synthesis of Resin-Bound 120 
  Resin-bound thioglucoside acceptor 119 (0.711 g, 0.23 mmol) was swelled 
in CH2Cl2 (2 mL) with 4 Å molecular sieves. Donor 103 (0.340 g, 0.69 mmol) 
was dissolved in CH2Cl2, transferred by cannula to the reaction flask and 
shaken for 1 hour. The reaction was cooled to -20°C and TMSOTf (0.049 mL, 
0.27 mmol) was added. The solution phase was filtered after 15 min and the 
resin washed three times with DMF, MeOH, Et2O and CH2Cl2. The resin was 
dried in vacuum over phosphorus pentoxide. HR-MAS 1H NMR spectroscopy 
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indicated successful coupling, with a theoretical resin loading of 0.28 mmol.g-
1, as calculated from the resin weight gain. 
 
Experiment 104. Synthesis of Resin-Bound 121 
  Resin-bound donor 120 (0.350 g, 0.10 mmol) was swelled in CH2Cl2 (2 mL) 
with 4 Å molecular sieves. Acceptor 9 (0.280 g, 0.78 mmol) was dissolved in 
CH2Cl2, transferred by cannula to the reaction flask and the reaction mixture 
was shaken at r.t. for 1 h. The reaction was cooled to -20°C, NIS (0.037 g, 
0.12 mmol) and TMSOTf (0.013 mL, 0.07 mmol) were added, and the reaction 
shaken at -20°C for min. The solution phase was filtered out and the resin 
was washed three times with DMF, MeOH, Et2O and CH2Cl2. The resin was 
dried in vacuum over phosphorus pentoxide. HR-MAS 1H NMR spectroscopy 
indicated successful coupling with a theoretical resin loading of 0.186mmol.g-
1, as calculated from resin weight gain. 
 
Experiment 105. Cleavage from the Resin: Methyl 3-O-tert-
butyldiphenylsilyl-(2R)-2-O-[α-D-mannopyranosyl-(1→2)-3,4-di-O-(2,3-
dimethoxybutane-2,3-diyl)-1-O-α-D-glucopyranosyl]-2,3-
dihydroxypropanoate (122) 
  Resin 121 (0.430 g) was swelled in CH2Cl2 for 30 min and then suspended in 
MeOH. A 1 N solution of NaOMe (0.6 equiv.) was added and the reaction was 
stirred for 5 h at r.t. The resin was filtered and washed six times with CH2Cl2 
and MeOH. The solution phase was treated with previously activated Dowex-
H+, filtered with MeOH and concentrated under reduced pressure. Purification 
was accomplished by preparative TLC (1:9, MeOH/ CH2Cl2) to give the 
desired product 122 (2 mg, 18%). This product was very polar and for further 
characterization it was acetylated to afford 123. Compound 122: 1H NMR 
(CDCl3): δ 7.68-7.64 (m, 4H), 7.42-7.39 (m, 6H), 5.16-5.12 (m, 2H, H-1 Man, 
H-1 Glu), 4.41-4.39 (m, 1H), 4.15-3.58 (m, 14H), 3.75 (s, 3H), 3.21 (s, 3H), 
3.17 (s, 3H), 1.26 (s, 3H), 1.22 (s, 3H), 1.02 (s, 9H) ppm. 
 
Experiment 106. Synthesis of Methyl 3-O-tert-Butyldiphenylsilyl-(2R)-2-
O-[2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-6-O-acetyl-3,4-di-O-
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(2,3-dimethoxybutane-2,3-diyl)-1-O-α-D-glucopyranosyl]-2,3-
dihydroxypropanoate (123) 
  Acetic anhydride (5 µL, 5.3x10–2 mmol) and a catalytic amount of DMAP 
were added to a solution of 122 (2 mg, 2.5x10–3 mmol) in pyridine (0.5 mL) at 
r.t. After 12 hours, the reaction was quenched with H2O (1 mL), extracted with 
EtOAc (3x2 mL) and the combined organic phases were dried (MgSO4) and 
concentrated. Purification by flash column chromatography on silica gel 
(30:70, EtOAc/hexane) afforded product 123 as a viscous colourless oil (3 
mg, 100 %). [α]20D = +101.5 (c = 1.99, CH2Cl2). FTIR (film) υ máx: 1747 (C=O) 
cm–1. 1H NMR (CDCl3): δ 7.70-7.66 (m, 4H, Ph), 7.43-7.42 (m, 6H, Ph), 5.45 
(dd, J = 3.4 Hz, J = 9.9 Hz, 1H), 5.39–5.37 (m, 1H), 5.30 (t, J = 10.0 Hz, 1H), 
5.18 (d, J = 3.7 Hz, 1H, C-1 Glu), 5.16 (d, J = 0.96 Hz, 1 H, C-1 Man), 4.50-
4.46 (m, 1H), 4.44 (dd, J = 6.0 Hz, J = 3.6 Hz, 1H), 4.23-4.10 (m, 5H), 4.07-
4.00 (m, 2H), 3.93-3.88 (m, 2H), 3.71-3.64 (m, 1H), 3.68 (s, 3H), 3.29 (s, 3H), 
3.19 (s, 3H), 2.17 (s, 3H),2.13 (s, 3H),2.04 (s, 3H), 2.03 (s, 3H),1.97 (s, 3H), 
1.27 (s, 3H), 1.26 (s, 3H), 1.04 (s, 9H) ppm. 13C NMR (CDCl3): δ 170.7, 170.6, 
170.0, 169.8, 169.7, 169.6, 135.6, 135.5, 133.1, 132.8, 129.8, 129.7, 127.9, 
127.86, 127.84, 99.8 (C-1 Man), 99.7 (C-1 Glu), 94.7, 94.2, 75.0, 70.8, 69.4, 
69.1, 68.5, 67.5, 67.4, 66.2, 66.0, 64.3, 62.1, 62.0, 60.3, 52.0, 47.8, 47.7, 
26.6, 20.9, 20.76, 20.71, 20.70, 20.6, 19.1, 17.6, 17.5, 14.1 ppm. 
 
Experiment 107. Synthesis of Methyl 3-O-tert-butyldimethylsilyl-(2R)-2-
O-(2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-2,3-dihydroxypropanoate 
(125) 
  Acceptor 9 (0.546 g, 1.52 mmol) was added to a solution of 
trichloroacetamidate 103 (0.750 g, 1.52 mmol) in dry CH2Cl2 (5 mL). The 
solution was cooled to 0°C and BF3.OEt2 (0.193 mL, 1.52 mmol) was slowly 
added. When the reaction was completed, a saturated aqueous solution of 
NaHCO3 was added, followed by extractions with CH2Cl2 (3x10 mL). The 
combined organic phases were dried (MgSO4) and concentrated. The residue 
was purified by flash column chromatography on silica gel (30:70, 
EtOAc/hexane) to afford 125 as a white foam (0.888 g, 85%). 1H NMR 
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(CDCl3): δ 7.71-7.67 (m, 4H, Ph), 7.45-7.41 (m, 6H, Ph), 5.49-5.45 (m, 2H, H-
2, H-3), 5.33-5.27 (t, J = 9.9 Hz, 1H, H-4), 5.04 (d, J = 1.3 Hz, 1H, H-1), 4.49 
(dd, J = 6.9 Hz, J = 3.4 Hz, 1H, CHCH2OTBDPS), 4.23-4.17 (m, 2H), 4.03-
3.99 (m, 1H), 3.97-3.90 (m, 2H), 3.72 (s, 3H, CO2Me), 2.16 (s, 3H, Ac), 2.07 
(s, 3H, Ac), 2.01 (s, 3H, Ac), 1.97 (s, 3H, Ac), 1.05 (s, 9H, t-Bu) ppm. 13C 
NMR (CDCl3): δ 170.6, 169.81, 169.68, 169.62, 169.52, 135.57, 135.47, 
132.70, 132.56, 129.94, 129.89, 127.92, 127.90, 96.3 (C-1), 75.6, 69.2, 69.0, 
68.7, 65.9, 64.4, 62.2, 52.3 (CO2CH3), 26.7 (C(CH3)3), 20.88 (COCH3), 20.71 
(COCH3), 20.69 (COCH3), 20.63 (COCH3), 19.1 (C-Si) ppm. 
 
Experiment 108. Synthesis of Methyl (2R)-2-O-(2,3,4,6-tetra-O-acetyl-α-D-
mannopyranosyl)-2,3-dihydroxypropanoate (126) 
  TBAF (1M in THF; 1.28 mL, 1.28 mmol) was added to a solution of 125 
(0.880 g, 1.28 mmol) in THF (6 mL) at room temperature. The reaction 
mixture was stirred for 3 hours and then water was added. The mixture was 
extracted with EtOAc, dried (MgSO4) and concentrated to give a yellow 
viscous residue. Purification by flash column chromatography on silica gel 
(80:20, EtOAc/hexane) afforded product 126 as a viscous colourless foam 
(0.511 g, 89 %). [α]20D = +73.2 (c = 4.27, CH2Cl2). FTIR (film) υ máx: 1751 
(C=O), 3493 (O–H) cm–1. 1H NMR (CDCl3): δ 5.43-5.37 (m, 2H, H-2, H-3), 
5.28 (t, J = 9.9 Hz, 1H, H-4), 5.06 (d, J = 1.6 Hz, 1H, H-1), 4.38 (dd, J = 5.8 
Hz, J = 3.4 Hz, 1H, CHCH2OH), 4.25 (dd, J = 12.3 Hz, J = 5.6 Hz, 1H, H-6), 
4.15-4.09 (m, 2H, H-5, H’-6), 3.98 (dd, J = 12.1 Hz, J = 3.4 Hz, 1H, 
CHCH2OH), 3.91 (dd, J = 12.1 Hz, J = 5.9 Hz, 1H, CHCH2OH), 3.78 (s, 3H, 
CO2Me), 2.16 (s, 3H, Ac), 2.10 (s, 3H, Ac), 2.05 (s, 3H, Ac), 2.00 (s, 3H, Ac) 
ppm. 13C NMR (CDCl3): δ 170.5, 169.68, 169.64, 169.55, 96.89, 96.85 (C-1), 
76.0, 69.28, 69.22, 68.8, 66.26, 66.21, 62.5, 52.4 (CO2CH3), 20.75 (COCH3), 
20.61 (COCH3), 20.58 (COCH3), 20.54 (COCH3) ppm. 
 
Chapter 7 
	  
	  
218 
Experiment 109. Synthesis of Methyl (2R)-2-O-(2,3,4,6-tetra-O-acetyl-α-D-
mannopyranosyl)-3-O-(6-O-acetyl-2,3,4-tri-O-benzyl-α /β-D-
glucopyranosyl)-2,3-dihydroxypropanoate (127) 
  A suspension of thioglucoside donor 1 (0.128 g, 0.24 mmol), acceptor 126 
(0.107 g, 0.24 mmol) and 4Å MS in diethyl ether (4 mL) was stirred for 1 h at 
room temperature then cooled to -60°C. N-Iodosuccinimide (0.069 g, 0.30 
mmol) and TfOH (1.42 µL) were added at -60°C and when the reaction was 
complete, 10% Na2S2O3 aqueous solution (2 mL) and saturated aqueous 
NaHCO3 solution (1 mL) were added. The mixture was extracted with CH2Cl2 
(3x6 mL), the combined organic phases were dried (MgSO4), filtered and the 
solvent was removed under vacuum. The crude product was purified by 
preparative TLC (50:50, EtOAc/Hex) to afforded product 126 as a viscous 
colourless foam (0.143 g, 65 %, α/β=4.6:1). FTIR (film) υ máx: 1745 (C=O) cm–
1. 1H NMR (CDCl3): δ 7.38-7.25 (m, Ph), 5.45-5.27 (m), 5.06 (d, J = 1.7 Hz, H-
1 Man (α, α)), 5.05 (d, J = 1.7 Hz, H-1 Man (α, β)), 4.99 (d, J = 10.7 Hz, 
CH2Ph (α, α)), 4.92 (d, J = 10.9, CH2Ph (α, β)), 4.91 (d, J = 10.9, CH2Ph (α, 
β)), 4.87-4.73 (m), 4.87 (d, J = 3.9 Hz, H-1 Glu (α, α)), 4.69-4.65 (m), 4.61-
4.57 (m), 4.54 (dd, J = 7.0 Hz, J = 3.2 Hz), 4.45 (d, J = 7.8 Hz, H-1 Glu (α, β)), 
4.35-4.31 (m), 4.29-4.17 (m), 4.16-4.09 (m), 4.02-3.93 (m), 3.90-3.83 (m), 
3.76-3.72 (m), 3.74 (s, CO2Me (α, α)), 3.70 (s, CO2Me (α, β)), 3.67-363 (m), 
3.55 (dd, J = 9.5 Hz, J = 3.6 Hz, H-2 Glu (α,α)),3.52-3.48 (m), 3.44 (dd, J = 
9.1 Hz, J = 7.9 Hz, H-2 Glu (α,β)), 2.154 (s, Ac (α, α)), 2.151 (s, Ac (α, β)), 
2.09 (s, Ac (α, β)), 2.07 (s, Ac (α, α)), 2.04 (s, Ac (α, β)), 2.03 (s, Ac (α, α)), 
1.97 (s, Ac (α, β)), 1.96 (s, Ac (α, α)), 1.82 (s, Ac (α, β)), 1.79 (s, Ac (α, α)) 
ppm.13C NMR (CDCl3): δ 170.7-169.2, 138.5, 138.3, 138.2, 138.1, 138.0, 
137.6, 128.4-127.6, 104.2 (C-1 Glu (α, β)), 97.5 (C-1 Glu (α, α)), 96.6 (C-1 
Man), 84.5 (α, β), 82.1 (α, β), 82.0 (α, α), 80.0 (α, α), 77.3 (α, β), 75.72 (α, β), 
75.70 (α, α), 75.0 (α, α), 74.9 (α, β), 74.7 (α, β), 73.9 (α, α), 73.0 (α, β), 72.9 
(α, α), 69.6 (α, β), 69.25 (α, α), 69.20, 69.15 (α, α), 68.95 (α, α), 68.8 (α, β), 
68.3 (α, β), 67.8 (α, α), 66.0 (α, β), 65.6 (α, α), 62.95 (α, β), 62.85 (α, β), 62.3 
(α, β), 62.1 (α, α), 52.5 (CO2CH3 (α, α)), 52.4 (CO2CH3 (α, β)), 20.87 (α, α), 
20.85 (α, α), 20.84 (α, β), 20.76 (α, β), 20.73 (α, β), 20.70 (α, α), 20.62 (α, α), 
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20.60 (α, β), 20.4 (α, α), 20.3 (α, β) ppm. HRMS: calcd. for C47H56O19Na+ [M+ 
+ Na] 947.3313; found 947.3303. 
 
Experiment 110. Synthesis of Methyl (2R)-2-O-(2,3,4,6-tetra-O-acetyl-α-D-
mannopyranosyl)-3-O-(2,3,4-tri-O-benzyl-6-O-chloroacetyl-α /β-D-
glucopyranosyl)-2,3-dihydroxypropanoate (128) 
  The glycosylation reaction of thioglucoside donor 3 (0.178 g, 0.313 mmol) 
and acceptor 126 (0.140 g, 0.313 mmol) was performed according to the 
procedure described in experiment 106. The crude was purified by 
preparative TLC (40:60, EtOAc/Hex) affording the product 128 as a viscous 
colourless foam (0.090 g, 30 %, α/β=6:1), and recovery of initial donor 3 
(0.085 g, 60 %) and of the hydrolysed donor in the anomeric position (0.017 g, 
10 %). FTIR (film) υ máx: 1753 (C=O) cm–1. 1H NMR (CDCl3): δ 7.37-7.24 (m), 
5.47-5.38 (m), 5.34-5.29 (m), 5.06 (d, J = 1.7 Hz, H-1 Man (α, α)), 5.05 (d, J = 
1.6 Hz, H-1 Man (α, β)), 4.99 (d, J = 10.7 Hz), 5.06-5.04 (m), 4.99 (d, J = 10.7 
Hz), 4.86 (d, J = 11.2 Hz), 4.81-4.73 (m), 4.64 (dd, J = 15.8, 11.6 Hz), 4.48-
4.25 (m), 4.18-4.09 (m), 4.06-3.93 (m), 3.90-3.84 (m), 3.76-3.67 (m), 3.76 (s, 
CO2Me (α, α)), 3.74 (s, CO2Me (α, β)), 3.63-3.46 (m), 2.17 (s), 2.16 (s), 2.12 
(s), 2.11 (s), 2.04 (s), 2.03 (s), 1.99 (s), 1.98 (s) ppm. 13C NMR (CDCl3): δ 
170.69, 170.58, 169.85, 169.82, 169.78, 169.72, 169.69, 169.58, 169.1, 
167.0, 138.4, 138.2, 137.9, 128.53, 128.46, 128.39, 128.07, 127.90, 127.88, 
127.87, 127.82, 127.71, 97.4, 96.6, 95.99, 95.93, 82.1, 80.0, 77.29, 77.28, 
75.7, 74.9, 73.8, 73.55, 73.49, 73.0, 69.31, 69.27, 69.22, 69.15, 69.02, 68.94, 
68.93, 68.6, 67.7, 66.05, 65.99, 65.6, 64.5, 62.35, 62.32, 62.22, 62.14, 52.56, 
52.41, 40.7, 37.89, 37.76, 23.96, 23.88, 23.83, 22.2, 22.0, 20.89, 20.86, 
20.81, 20.71, 20.69, 20.63, 20.4 ppm. 
 
Experiment 111. Synthesis of Methyl (2R)-2-O-benzyl-3-O-(2,3,4-tri-O-
benzyl-6-O-acetyl-α /β-D-glucopyranosyl)-2,3-dihydroxypropanoate (130) 
  The glycosylation reaction of thioglucoside donor 3 (0.009 g, 0.017 mmol) 
and acceptor 129 (0.005 g, 0.017 mmol) was performed according to the 
procedure described in experiment 106. The crude was purified by 
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preparative TLC (30:70, EtOAc/Hex) affording the product 130 as a viscous 
colourless gum (0.007 g, 54 %, α/β=2.8:1). FTIR (film) υ máx: 1741 (C=O) cm–
1. 1H NMR (CDCl3): δ 7.37-7.26 (m, Ph), 5.20 (d, J = 3.5 Hz, H-1 (α)), 4.98-
4.94 (m), 4.89-4.84 (m, 3H), 4.81-4.77 (m), 4.74 (d, J = 7.7 Hz, H-1 (β)), 4.70 
(d, J = 11.8 Hz, CH2Ph (α)), 4.57 (d, J = 10.8 Hz, CH2Ph (α)), 4.37-4.17 (m), 
4.10 (dt, J = 10.0, 3.2 Hz), 4.00 (t, J = 9.2 Hz), 3.72-3.67 (m), 3.59-3.48 (m, 
3H), 3.41 (dd, J = 9.1 Hz, J = 7.7 Hz), 2.04 (s, Ac (α)), 2.03 (s, Ac (β)) ppm. 
13C NMR (CDCl3): δ 170.8, 138.5, 137.77, 137.69, 128.52, 128.50, 128.45, 
128.16, 128.10, 128.08, 128.02, 127.87, 127.83, 127.76, 97.4 (C-1 (β)), 91.2 
(C-1 (α)), 84.5, 83.0, 81.6, 80.0, 77.26, 77.20, 75.78, 75.74, 75.06, 75.04, 
74.8, 73.3, 73.1, 68.9, 63.15, 63.08, 20.9 ppm. 
 
Experiment 112. Synthesis of Methyl (2R)-2-O-(α-D-mannopyranosyl)-3-
O-(2,3,4-tri-O-benzyl-α /β-D-glucopyranosyl)-2,3-dihydroxypropanoate 
(131) 
  A 1N solution of NaOMe (0.17 mL, 0.17 mmol) in MeOH was added to a 
stirred solution of 127 (0.264 g, 0.28 mmol) in MeOH (1 mL) at 0 °C. After 
complete conversion of the starting material, previously activated Dowex-H+ 
resin was added until neutral pH. After filtration with MeOH, the solvent was 
removed in vacuum. Purification by flash column chromatography on silica gel 
(40:10, CHCl3/MeOH) afforded the α (0.156 g, 76 %) and β (0.028 g, 14 %) 
products as viscous colourless gums. Alpha product: [α]20D = +83.9 (c = 
0.72, CH2Cl2). FTIR (film) υ máx: 1747 (C=O), 3384 (OH) cm–1. 1H NMR 
(CDCl3): δ 7.34-7.24 (m, 15H, Ph), 5.00 (s, 1H, H-1 Man), 4.91 (d, J = 10.9 
Hz, 1H, CH2Ph), 4.88 (d, J = 3.0 Hz, 1H, H-1 Glu), 4.81 (d, J = 11.2 Hz, 1H, 
CH2Ph), 4.76 (d, J = 11.0 Hz, 1H, CH2Ph), 4.68-4.57 (m, 3H), 4.52-4.50 (m, 
1H, CHCO2Me), 4.08 (bs, 1H, H-2 Man), 3.94-3.85 (m, 4H), 3.79-3.70 (m, 
5H), 3.68-3.54 (m, 2H), 3.64 (s, 3H, CO2Me), 3.47 (dd, J = 9.1, 3.6 Hz, 1H, H-
2 Glu), 3.41 (t, J = 9.3 Hz, 1H, H-4 Glu) ppm. 13C NMR (CDCl3): δ 170.3 
(CO2Me), 138.7, 138.1, 137.9, 128.47, 128.43, 128.35, 128.17, 128.03, 
127.94, 127.90, 127.85, 127.57, 98.9 (C-1 Man), 96.8 (C-1 Glu), 81.6, 80.1, 
77.4, 75.6, 75.0, 73.8 (CHCO2Me), 73.1, 72.8, 71.5, 71.2, 70.4, 67.27 
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(CH2CHCO2Me), 61.7, 61.1, 52.4 (CO2CH3) ppm. HRMS: calcd. for 
C37H46O14Na+ [M+ + Na] 737.2785; found 737.2775. Beta product: [α]20D = 
+42.6 (c = 2.51, CH2Cl2). FTIR (film) υ máx: 1747 (C=O), 3371 (OH) cm–1. 1H 
NMR (CDCl3): δ 7.34-7.20 (m, 15H, Ph), 5.02 (bs, 1H, H-1 Man), 4.86-4.73 
(m, 4H), 4.63-4.57 (m, 2H), 4.44 (bs, 1H, CHCO2Me), 4.37 (d, J = 7.7 Hz, 1H, 
H-1 Glu), 4.19 (bs, 1H, H-2 Man), 4.11-3.46 (m, 11H), 3.54 (s, 3H, CO2Me), 
3.38 (t, J = 8.4 Hz, 1H, H-2 Glu), 3.33-3.21 (m, 1H, H-5 Glu) ppm. 13C NMR 
(CDCl3): δ 170.3 (CO2Me), 138.8, 138.2, 138.0, 128.1, 127.77, 127.57, 
127.52, 103.9 (C-1 Glu), 99.8 (C-1 Man), 84.4, 82.0, 77.46, 75.6, 75.5, 74.6, 
74.3 (CHCO2Me), 73.1, 71.6, 71.0, 70.6 (CH2CHCO2Me), 70.4, 66.3, 61.3, 
60.8, 52.4 (CO2CH3) ppm. HRMS: calcd. for C37H46O14Na+ [M+ + Na] 
737.2785; found 737.2777. 
 
Experiment 113. Synthesis of Methyl (2R)-2-O-(α-D-mannopyranosyl)-3-
O-(α-D-glucopyranosyl)-2,3-dihydroxypropanoate (132) 
 
  Benzyl ether 131 (α anomer) (0.225 g, 0.31 mmol) in EtOH/EtOAc (0.1:2.9, 3 
mL) was hydrogenated at 50 psi in the presence of Pd/C 10% (0.25 equiv). 
After 8 hours, the reaction mixture was filtered and the solvent was 
evaporated to afford ester 132 as a viscous colourless foam (0.140 g, 
quantitative). 1H NMR (D2O): δ 4.93 (d, J = 1.2 Hz, 1H, H-1 Man), 4.88 (d, J = 
3.7 Hz, 1H, H-1 Glu), 4.70-4.67 (m, 1H, CHCO2Me), 4.08 (dd, J = 11.0 Hz, J = 
4.2 Hz, 1H, CHH’CHCO2Me), 4.01-4.00 (m, 1H, H-2 Man), 3.84-3.74 (m, 4H), 
3.75 (s, 3H, CO2Me), 3.71-3.52 (m, 5H), 3.48-3.40 (m, 2H), 3.32 (m, 1H, H-4 
Glu) ppm. 13C NMR (D2O): δ 172.0 (CO2CH3), 99.3 (C-1 Man), 98.1 (C-1 Glu), 
73.7 (CHCO2Me), 73.4, 73.0, 72.1, 71.3, 70.2, 69.7, 69.3, 67.6 
(CH2CHCO2Me), 66.6, 60.9, 60.3, 53.0 (CO2CH3) ppm. 
 
Experiment 114. Synthesis of Potassium (2R)-2-O-(α-D-
mannopyranosyl)-3-O-(α-D-glucopyranosyl)-2,3-dihydroxypropanoate 
(124) 
  A solution of 2 M KOH (0.29 mL) was added to a stirred solution of ester 132 
(0.130 g, 0.29 mmol) in H2O (2 mL). After all of the starting material had been 
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consumed, the pH was adjusted to 7 with 10% HCl and the solvent was 
evaporated to afford 124 as a viscous colorless foam (0.137 g, quantitative). 
[α]20D = +89.7 (c = 0.33, H2O). 1H NMR (D2O): δ 4.85 (d, J = 3.7 Hz, 1H, H-1 
Glu), 4.84 (d, J = 1.5 Hz, 1H, H-1 Man), 4.29 (dd, J = 5.1 Hz, J = 2.2 Hz, 1H, 
CHCO2-), 4.01 (dd, J = 3.3 Hz, J = 1.6 Hz, 1H, H-2 Man), 3.96 (dd, J = 10.6 
Hz, J = 5.2 Hz, 1H, CHH’CHCO2-), 3.85-3.76 (m, 3H), 3.71-3.56 (m, 7H), 3.44 
(dd, J = 9.8 Hz, J = 3.7 Hz, 1H, H-2 Glu), 3.31 (t, J = 9.6 Hz, 1H, H-4 Glu) 
ppm. 13C NMR (D2O): δ 176.1 (CO2-), 98.8 (C-1 Man), 97.7 (C-1 Glu), 75.7 
(CHCO2-), 73.16, 73.04, 71.71, 71.53, 70.3, 69.9, 69.6, 68.3 (CH2CHCO2-), 
66.9, 61.0, 60.4 ppm. HRMS: calcd. for C15H26O14K [M+ + H] 469.0960; found 
469.0940. 
 
Experiment 115. Synthesis of Ethyl 3-O-(6-O-acetyl-2,3,4-tri-O-benzyl-
α /β-D-glucopyranosyl)-3-hydroxybutyrate (136) 
  A suspension of thioglucoside donor 1 (0.815 g, 1.52 mmol), ethyl 3-
hydroxybutyrate 133 (0.197 mL, 1.52 mmol) and 4Å MS in CH2Cl2 (6 mL) was 
stirred for 1 h at room temperature then cooled to 0°C. N-Iodosuccinimide 
(0.434 g, 1.93 mmol) and TfOH (0.112 mL) were added at 0°C and when the 
reaction was complete, 10% Na2S2O3 aqueous solution (6 mL) and saturated 
aqueous NaHCO3 solution (3 mL) were added. The mixture was extracted 
with CH2Cl2 (3x6 mL), the combined organic phases were dried (MgSO4), 
filtered and the solvent was removed under vacuum. The crude product was 
purified by flash column chromatography on silica gel (20:80, EtOAc/Hex) to 
afforded product 136 as a viscous colourless foam (0.771 g, 84 %). FTIR 
(film) υ máx: 1736 (C=O) cm–1. 1H NMR (CDCl3): δ  7.36-7.26 (m), 5.03-4.96 
(m), 4.95-4.74 (m), 4.71-4.62 (m), 4.58-4.54 (m), 4.50 (d, J = 8.0 Hz, H-1 (β)), 
4.31-3.92 (m), 3.89-3.85 (m), 3.67-3.62 (m), 3.54-3.44 (m), 3.43-3.37 (m), 
2.86-2.80 (m), 2.74-2.68 (m), 2.68-2.62 (m), 2.48-2.35 (m), 2.02 (s), 1.33-1.16 
(m) ppm. 13C NMR (CDCl3): δ  171.2, 170.77, 170.75, 138.67, 138.66, 138.18, 
138.03, 137.95, 137.81, 128.41, 128.40, 128.36, 128.30, 128.17, 128.13, 
128.11, 128.10, 128.03, 127.99, 127.95, 127.92, 127.87, 127.85, 127.77, 
127.67, 127.64, 103.5 (C-1 (β)), 102.4 (C-1 (β)), 96.8 (C-1 (α)), 94.4 (C-1 (α)), 
84.7, 81.95, 81.79, 79.90, 79.80, 77.5, 77.3, 75.73, 75.72, 75.68, 75.1, 74.9, 
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73.3, 72.8, 72.1, 69.6, 68.92, 68.87, 63.16, 63.01, 60.55, 60.46, 42.1, 41.8, 
21.5, 20.8, 19.1, 14.20, 14.17, 14.14 ppm. 
 
Experiment 116. Synthesis of Ethyl 3-O-(6-O-acetyl-2,3,4-tri-O-benzyl-
α /β-D-galactopyranosyl)-3-hydroxybutyrate (137) 
  The glycosylation reaction of thiogalactoside donor 19 (0.638 g, 1.19 mmol) 
and ethyl 3-hydroxybutyrate 133 (0.170 mL, 1.31 mmol) was performed 
according to the procedure described in experiment 115. The crude was 
purified by flash column chromatography on silica gel (20:80, EtOAc/Hex) 
affording the product 137 as a viscous colourless gum (0.685 g, 95 %). FTIR 
(film) υ máx: 1736 (C=O) cm–1. 1H NMR (CDCl3): δ 7.39-7.26 (m), 5.08 (d, J = 
3.7 Hz, H-1 (α)), 4.98-4.93 (m), 4.90-4.86 (m), 4.83-4.64 (m), 4.61 (d, J = 11.5 
Hz), 4.46 (d, J = 7.7 Hz, H-1 (β)), 4.45 (d, J = 7.6 Hz, H-1 (β)), 4.27-3.95 (m), 
3.93-3.88 (m), 3.82-3.78 (m), 3.76-3.75 (m), 3.54-3.48 (m), 2.89 (dd, J = 15.5 
Hz, J = 5.2 Hz), 2.72-2.62 (m), 2.48-2.37 (m), 1.99 (s), 1.98 (s), 1.96 (s), 1.95 
(s), 1.35-1.17 (m) ppm. 13C NMR (CDCl3): δ 171.28, 171.18, 170.7, 138.76, 
138.64, 138.59, 138.48, 138.43, 138.27, 138.24, 138.19, 128.61, 128.56, 
128.41, 128.32, 128.31, 128.20, 128.15, 128.04, 127.99, 127.97, 127.81, 
127.74, 127.73, 127.66, 127.62, 127.60, 127.55, 127.54, 127.51, 127.44, 
127.42, 103.8 (C-1 (β)), 102.9 (C-1 (β)), 97.6 (C-1 (α)), 95.3 (C-1 (α)), 82.33, 
82.28, 79.4, 78.98, 78.95, 76.38, 76.32, 75.2, 75.0, 74.77, 74.70, 74.51, 
74.27, 74.22, 73.56, 73.47, 73.45, 73.42, 73.04, 72.98, 72.85, 72.00, 71.92, 
71.75, 69.4, 68.72, 68.56, 63.69, 63.60, 63.1, 62.9, 60.48, 60.41, 60.36, 
60.34, 42.7, 42.16, 42.05, 41.87, 30.9, 21.9, 21.4, 20.79, 20.77, 20.75, 20.4, 
19.1, 14.21, 14.18, 14.16, 14.13 ppm. 
 
Experiment 117. Synthesis of Dimethyl (2S)-2-O-(6-O-acetyl-2,3,4-tri-O-
benzyl-α /β-D-glucopyranosyl)-2-hydroxysuccinate (138) 
  The glycosylation reaction of thiogalactoside donor 1 (0.850 g, 1.58 mmol) 
and dimethyl (S)-malate 134 (0.208 mL, 1.58 mmol) was performed according 
to the procedure described in experiment 115. The crude was purified by flash 
column chromatography on silica gel (30:70, EtOAc/Hex) affording the 
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product 138 as a viscous colourless gum (0.949 g, 94 %, α/β=7:1). FTIR (film) 
υ máx: 1739 (C=O) cm–1. 1H NMR (CDCl3): δ 7.36-7.26 (m, Ph), 5.05 (d, J = 3.7 
Hz, H-1 (α)), 4.99-4.95 (m), 4.87 (d, J = 10.9 Hz, CH2Ph), 4.81 (d, J = 10.8 
Hz, CH2Ph), 5.06-4.50 (m), 4.77 (d, J = 10.8 Hz, CH2Ph), 4.72-4.62 (m), 4.56 
(d, J = 10.9 Hz, CH2Ph), 4.52 (t, J = 6.5 Hz, CHCH2CO2Me (α)), 4.30-4.26 
(m), 4.16-4.13 (m), 4.00 (t, J = 9.3 Hz, H-3 (α)), 3.74 (s, CO2Me (α)), 3.74 (s, 
CO2Me (β)), 3.67 (s, CO2Me (β)), 3.58 (s, CO2Me (α)), 3.55-3.48 (m), 2.94-
2.93 (m, 1H), 2.93 (d, J = 5.9 Hz, CHCH2CO2Me (β)), 2.83 (d, J = 6.5 Hz, 
CHCH2CO2Me (α)), 2.04 (s, Ac (β)), 2.01 (s, Ac (α)) ppm. 13C NMR (CDCl3): 
δ 171.2, 170.7, 170.4, 138.6, 138.1, 137.9, 128.49, 128.44, 128.31, 128.12, 
128.08, 127.95, 127.87, 127.74, 127.72, 127.63, 102.8 (C-1 (β)), 98.5 (C-1 
(α)), 81.6, 79.7, 75.7 (CH2Ph), 75.0 (CH2Ph), 74.6 (CHCH2CO2Me (α)), 72.7 
(CH2Ph), 69.5, 62.8 (C-6 (α)), 52.4 (CO2CH3), 51.9 (CO2CH3), 37.4 
(CHCH2CO2Me), 20.85 (Ac (α)), 20.83 (Ac (β)) ppm. 
 
Experiment 118. Synthesis of Dimethyl (2S)-2-O-(6-O-acetyl-2,3,4-tri-O-
benzyl-α /β-D-galactopyranosyl)-2-hydroxysuccinate (139) 
  The glycosylation reaction of thiogalactoside donor 19 (1.20 g, 2.23 mmol) 
and dimethyl (S)-malate 134 (0.294 mL, 2.23 mmol) was performed according 
to the procedure described in experiment 115. The crude was purified by flash 
column chromatography on silica gel (30:70, EtOAc/Hex) affording the 
product 139 as a viscous colourless gum (1.235 g, 87 %, α/β=5:1). FTIR (film) 
υ máx: 1740 (C=O) cm–1. 1H NMR (CDCl3): δ 7.41-7.25 (m, 1H, Ph), 5.10 (d, J = 
3.7 Hz, H-1 (α)), 5.01 (d, J = 10.8 Hz), 4.97-4.94 (m), 4.88-4.83 (m), 4.77-4.57 
(m), 4.56-4.53 (m), 4.22-4.16 (m), 4.12 (d, J = 7.1 Hz, H-1 (β)), 4.09-3.96 (m), 
3.93 (t, J = 1.2 Hz), 3.83 (dd, J = 9.7, 7.7 Hz), 3.75-3.71 (m), 3.72 (s, CO2Me), 
3.56 (s, CO2Me), 3.54-3.48 (m), 2.95 (d, J = 6.0 Hz, CHCH2CO2Me (α)), 2.82 
(d, J = 5.5 Hz, CHCH2CO2Me (β)), 1.98 (s, Ac), 1.96 (s, Ac) ppm. 
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Experiment 119. Synthesis of Methyl 3-O-tert-butyldimethylsilyl-(2S)-2-O-
(6-O-acetyl-2,3,4-tri-O-benzyl-α /β-D-glucopyranosyl)-2,3-
dihydroxypropanoate (140) 
  The glycosylation reaction of thiogalactoside donor 1 (0.300 g, 0.56 mmol) 
and acceptor 135 (0.200 g, 0.56 mmol) was performed according to the 
procedure described in experiment 115. The crude was purified by flash 
column chromatography on silica gel (10:90, EtOAc/Hex) affording the 
product 140 as a viscous colourless gum (0.463 g, 98 %, α/β>10:1). FTIR 
(film) υ máx: 1743 (C=O) cm–1. 1H NMR (CDCl3): δ 7.68-7.66 (m, Ph), 7.40-7.27 
(m, 3H), 5.22 (d, J = 10.8 Hz, CH2Ph (β)), 4.96 (d, J = 10.8 Hz, CH2Ph (α)), 
4.87-4.78 (m), 4.80 (d, J = 3.99 Hz, H-1 (α)), 4.67 (d, J = 12.2 Hz, CH2Ph (α)), 
4.58-4.53 (m), 4.29-4.25 (m), 4.15-4.06 (m), 4.02-3.92 (m), 3.75 (s, CO2Me 
(β)), 3.72 (s, CO2Me (α)), 3.51-3.44 (m), 2.00 (s, Ac (α)), 1.98 (s, Ac (β)), 1.03 
(s, t-Bu (α)), 1.01 (s, t-Bu (β)) ppm. 13C NMR (CDCl3): δ  170.9, 170.7, 138.7, 
138.05, 137.97, 135.63, 135.61, 135.58, 133.2, 132.8, 129.8, 128.55, 128.49, 
128.25, 128.13, 128.05, 127.97, 127.94, 127.88, 127.87, 127.84, 127.79, 
127.76, 127.71, 127.65, 98.7 (C-1 (α)), 81.7 (α), 79.9 (α), 79.3 (α), 77.3 (α), 
75.7 (α), 74.9 (α), 73.0 (α), 69.4 (α), 64.3 (α), 62.8 (α), 52.0 (CO2CH3), 26.70 
(C(CH3)3 (α)),, 26.62 (C(CH3)3 (β)), 20.9 (Ac), 19.2 (C-Si) ppm. 
 
Experiment 120. Synthesis of Methyl 3-O-tert-butyldimethylsilyl-(2S)-2-O-
(6-O-acetyl-2,3,4-tri-O-benzyl-α /β-D-galactopyranosyl)-2,3-
dihydroxypropanoate (141) 
  The glycosylation reaction of thiogalactoside donor 1 (0.300 g, 0.56 mmol) 
and acceptor 135 (0.200 g, 0.56 mmol) was performed according to the 
procedure described in experiment 115. The crude was purified by flash 
column chromatography on silica gel (10:90, EtOAc/Hex) affording the 
product 140 as a viscous colourless gum (0.463 g, 98 %, α/β>10:1). Alpha 
product: FTIR (film) υ máx: 1746 (C=O) cm–1.  1H NMR (CDCl3): δ 7.67 (d, J = 
6.8 Hz, 4H, Ph), 7.43-7.17 (m, 21H, Ph), 4.96-4.94 (m, 2H), 4.95 (d, J = 11.6 
Hz, 1H, CH2Ph), 4.95 (d, J = 3.6 Hz, 1H, H-1), 4.86 (d, J = 11.6 Hz, 1H, 
CH2Ph), 4.75-4.70 (m, 2H), 4.62-4.58 (m, 2H), 4.15-4.09 (m, 3H), 4.06-3.91 
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(m, 7H), 3.70 (s, 3H, CO2Me), 1.97 (s, 3H, Ac), 1.03 (s, 9H, t-Bu). 13C NMR 
(CDCl3): δ  171.1, 170.5, 138.8, 138.44, 138.28, 135.65, 135.57, 133.1, 132.9, 
129.8, 128.39, 128.37, 128.31, 128.27, 127.84, 127.72, 127.59, 127.51, 
127.42, 99.3 (C-1), 78.8, 78.4, 76.3, 74.62, 74.56, 73.5, 73.2, 69.1, 64.6, 63.0, 
51.9, 26.7, 20.8, 19.2 ppm. Beta product: FTIR (film) υ máx: 1744 (C=O) cm–1. 
1H NMR (CDCl3): δ 7.71-7.66 (m, 4H, Ph), 7.44-7.28 (m, 21H, Ph), 5.23 (d, J = 
10.8 Hz, 1H, CH2Ph), 5.00 (d, J = 11.6 Hz, 1H, CH2Ph), 4.88 (d, J = 11.7 Hz, 
1H, CH2Ph), 4.75 (m, 2H), 4.68 (d, J = 11.6 Hz, 1H, CH2Ph), 4.58-4.54 (m, 
1H), 4.75 (d, J = 7.6 Hz, 1H, H-1), 4.16-4.11 (m, 2H), 4.08-4.07 (m, 2H), 4.02 
(dd, J = 11.2 Hz, J = 6.2 Hz, 1H), 4.00 (dd, J = 11.2 Hz, J = 6.2 Hz, 1H), 3.76 
(s, 3H, CO2Me), 3.55 (dd, J = 9.7 Hz, J = 2.7 Hz, 1H), 3.51-3.48 (m, 1H), 1.94 
(s, 3H, Ac), 1.03 (s, 9H, t-Bu) ppm. 13C NMR (CDCl3): δ 170.7, 170.5, 138.9, 
138.6, 138.2, 135.6, 133.23, 133.09, 129.70, 129.66, 128.60, 128.50, 128.39, 
128.30, 128.14, 127.76, 127.67, 127.60, 127.4, 102.7 (C-1), 81.9, 79.2, 76.9, 
74.9, 74.3, 73.8, 73.1, 72.1, 65.0, 62.9, 51.9, 26.65, 26.63, 20.8, 19.2 ppm. 
 
Experiment 121. Synthesis of Potassium (2S)-2-(α-D-
glucopyranosyl)propanoate (142) 
  A solution of NaOMe 1N (0.443 mL, 0.443 mmol) in MeOH was added to a 
stirred solution of 10 (0.427 g, 0.74 mmol) in MeOH (4 mL) at 0 ºC. After 1 h 
the reaction mixture was neutralized with saturated aqueous NH4Cl. The 
aqueous phase was extracted with EtOAc and the combined organic extracts 
were dried (MgSO4), filtered and the solvent was removed. The crude product 
was purified by flash column chromatography on silica gel (30:70, EtOAc/Hex) 
to afford the α (0.310 g, 78%) and β-alcohol (0.027 g, 7%) as viscous 
colourless gums. 
  A solution of the α-alcohol (0.300 g, 0.56 mmol) in EtOAc was hydrogenated 
at 50 psi in the presence of Pd/C 10% (0.25 equiv). After 5 hours, the reaction 
mixture was filtered and the solvent was evaporated to afford the ester as a 
very viscous colourless foam (0.149 g, quantitative). A solution of 2 M KOH 
(0.28 mL) was added to a stirred solution of the ester (0.149 g, 0.56 mmol) in 
H2O (2 mL). After all of the starting material had been consumed, the pH was 
adjusted to 7 with 10% HCl and the solvent was evaporated to afford 142 as a 
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viscous colorless foam (0.162 g, quantitative). [α]20D = +107.2 (c = 0.60, 
H2O). 1H NMR (D2O): δ 4.93 (d, J = 3.9 Hz, 1H, H-1), 3.96 (q, J = 6.8 Hz, 1H, 
CHCH3), 3.75-3.68 (m, 5H), 3.44 (dd, J = 9.9 Hz, J = 4.0 Hz, 1H, H-2), 3.35 (t, 
J = 9.3 Hz, 1H, H-4), 1.28 (d, J = 6.8 Hz, 3H, CHCH3) ppm. 13C NMR 
(CDCl3): δ  181.0 (CHCO2-), 97.3 (C-1), 75.5 (CHCH3), 73.1 (C-3), 71.9 (C-5), 
71.5 (C-2), 69.4 (C-4), 60.1 (C-6), 17.5 (CHCH3) ppm. 
 
Experiment 122. Synthesis of Potassium (2S)-2-(α /β-D-
galactopyranosyl)propanoate (143) 
  The methanolysis of the acetate group of the galactoside 32 (1.720 g, 2.63 
mmol) was performed according to the procedure described in experiment 
121. The crude was purified by flash column chromatography on silica gel 
(40:60, EtOAc/Hex) affording the alcohol as a viscous colourless gum (1.350 
g, 96 %, α/β=3:1). After catalytic hydrogenation of the benzyl ethers (1.323 g, 
2.46 mmol) and hydrolysis of the methyl ester according to the procedure 
described in experiment 118, the compound 143 was obtained as a viscous 
colorless foam (0.715 g, quantitative, α/β=3:1). FTIR (film) υ máx: 1635 (C=O), 
3332 (O-H) cm–1. 1H NMR (D2O): δ 4.97 (d, J = 3.9 Hz, H-1 (α)), 4.58 (q, J = 
7.0 Hz, CHCH3 (β)), 4.37 (d, J = 7.7 Hz, H-1 (β)), 4.25 (q, J = 6.9 Hz, CHCH3 
(α)), 3.93-3.88 (m), 3.84-3.79 (m), 3.76-3.64 (m), 3.63-3.52 (m), 3.47 (dd, J = 
9.9, 7.7 Hz, ), 1.38 (d, J = 7.0 Hz, CHCH3 (β)), 1.35 (d, J = 6.8 Hz, CHCH3 (α)) 
ppm. 13C NMR (CDCl3): δ 187.3 (CHCO2-), 101.8 (C-1 (β)), 98.9 (C-1 (α)), 
75.2, 73.7, 73.1, 72.6, 71.4, 70.7, 69.21, 69.07, 68.5, 68.0, 60.84, 60.80, 
52.68, 52.62, 17.1 (CHCH3) ppm. 
 
Experiment 123. Synthesis of Potassium 2-(α /β-D- 
glucopyranosyl)acetate (144) 
  The methanolysis of the acetate group of the glucoside 13 (0.940 g, 1.66 
mmol) was performed according to the procedure described in experiment 
121. The crude was purified by flash column chromatography on silica gel 
(40:60, EtOAc/Hex) affording the alcohol as a viscous colourless gum (0.765 
g, 88 %, α/β=11:1). After catalytic hydrogenation of the benzyl ethers (0.715 
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g, 1.37 mmol) and hydrolysis of the methyl ester according to the procedure 
described in experiment 121, the compound 144 was obtained as a viscous 
colorless foam (0.378 g, quantitative, α/β=10:1). 1H NMR (D2O): δ 4.88 (d, J = 
3.8 Hz, H-1 (α)), 4.41 (d, J = 7.9 Hz, H-1 (β)), 4.22 (d, J = 15.6 Hz, CHH’CO2- 
(β)), 4.06 (d, J = 15.5 Hz, CHH’CO2- (α)), 4.03 (d, J = 15.8 Hz, CHH’CO2- (α)), 
3.88 (d, J = 15.5 Hz, CHH’CO2- (β)), 3.79-3.61 (m), 3.46 (dd, J = 9.8, 3.8 Hz), 
3.34 (t, J = 9.5 Hz) ppm. 13C NMR (CDCl3): δ 177.4, 102.3 (C-1 (β)), 98.3 (C-1 
(α)), 75.9 (β), 75.5 (β), 73.1, 71.9, 71.5, 69.5, 68.5 (CH2CO2- (β)), 66.8 
(CH2CO2- (α)), 60.61 (C-6 (β)), 60.43 (C-6 (α)) ppm. 
 
Experiment 124. Synthesis of Potassium 2-(α /β-D- 
galactopyranosyl)acetate (145) 
  The methanolysis of the acetate group of the galactoside 34 (1.079 g, 1.91 
mmol) was performed according to the procedure described in experiment 
121. The crude was purified by flash column chromatography on silica gel 
(40:60, EtOAc/Hex) affording the alcohol as a viscous colourless gum (0.800 
g, 81 %, α/β=2:1). After catalytic hydrogenation of the benzyl ethers (0.787 g, 
1.50 mmol) and hydrolysis of the methyl ester according to the procedure 
described in experiment 121, the compound 145 was obtained as a viscous 
colorless foam (0.416 g, quantitative, α/β=2:1). 1H NMR (D2O): δ 4.91 (d, J = 
3.9 Hz, H-1 (α)), 4.34 (d, J = 7.7 Hz, H-1 (β)), 4.24 (d, J = 15.6 Hz, CHH’CO2- 
(β)), 4.06 (d, J = 15.6 Hz, CHH’CO2- (α)), 4.03 (d, J = 15.6 Hz, CHH’CO2- (β)), 
3.92-3.84 (m), (d, J = 15.6 Hz, CHH’CO2- (α)), 3.75-3.71 (m), 3.69-3.58 (m), 
3.52 (dd, J = 10.0 Hz, J = 7.6 Hz, H-2 (β)) ppm. 13C NMR (CDCl3): δ  177.5, 
102.9 (C-1 (β)), 98.3 (C-1 (α)), 75.2 (β), 72.6 (β), 71.1 (α), 70.8 (β), 69.5 (α), 
69.2 (α), 68.6 (β), 68.5 (CH2CO2- (β)), 68.4 (α), 66.8 (CH2CO2- (α)), 61.15 (C-
6 (α)), 60.95 (C-6 (β)) ppm. 
 
Experiment 125. Synthesis of Potassium (2R)-2-O-(α /β-D-
galactopyranosyl)-2,3-dihydroxypropanoate (146, 147) 
  The methanolysis of the acetate group of the galactoside 35 (1.078 g, 1.29 
mmol) was performed according to the procedure described in experiment 
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121. The crude was purified by flash column chromatography on silica gel 
(20:80, EtOAc/Hex) affording the α (0.671 g, 66 %) and the β-alcohol (0.286 
g, 28 %) as viscous colourless gums. 
  TBAF (1M in THF; 0.83 mL, 0.83 mmol) was added to a solution of the 
α−galactoside (0.655 g, 0.83 mmol) in THF (4 mL) at r.t. The reaction mixture 
was stirred for 4 hours and then water was added. The mixture was extracted 
with EtOAc, dried (MgSO4) and concentrated to give a yellow viscous residue. 
Purification by flash column chromatography on silica gel (80:20, 
EtOAc/hexane) afforded the α-diol as a viscous colourless gum (0.457 g, 
92%). After catalytic hydrogenation of the benzyl ethers from the α-diol (0.140 
g, 1.50 mmol) and hydrolisis of the methyl ester according to the procedure 
described in experiment 121, the compound 146 was obtained as a viscous 
colorless foam (0.416 g, quantitative). Alpha product 146: [α]20D = +127.6 (c 
= 0.62, H2O). 1H NMR (D2O): δ 4.97 (d, J = 3.9 Hz, 1H, H-1), 4.13 (dt, J = 4.7 
Hz, J = 2.3 Hz, 1H, CHCH2OH), 3.99 (t, J = 6.2 Hz, 1H, ), 3.93-3.87 (m, 2H), 
3.81 (dd, J = 12.1, 3.2 Hz, 1H), 3.77-3.70 (m, 2H), 3.69-3.64 (m, 2H, H-6, H’-
6) ppm. 13C NMR (D2O): δ  177.1 (CHCO2-), 97.6 (C-1), 79.2 (CHCH2OH), 
71.3, 69.6, 69.3, 68.5, 63.1 (CHCH2OH), 61.2 (C-6) ppm. 
  The same strategy was applied for the deprotection of the β-galactoside 
(0.266 g, 0.34 mmol). After fluorolysis (0.140 g, 76%), catalytic hydrogenation 
of the benzyl ethers from the β-diol (0.340 g, 0.615 mmol) and hydrolisis of 
the methyl ester, the compound 147 was obtained as a viscous colorless 
foam (0.188 g, quantitative). Beta product 147:1H NMR (D2O): δ 4.42 (d, J = 
7.5 Hz, 1H, H-1), 4.11 (dd, J = 6.5 Hz, J = 3.2 Hz, 1H, CHCH2OH), 3.83-3.77 
(m, 2H), 3.73-3.67 (m, 2H), 3.64-3.53 (m, 4H) ppm. 13C NMR (D2O): δ  177.9 
(CHCO2-), 102.6 (C-1), 81.3 (CHCH2OH), 75.1, 72.6, 70.9, 68.7, 62.6 
(CHCH2OH), 60.9 (C-6) ppm. 
 
Experiment 126. Synthesis of Potassium 3-O-(α-D-glucopyranosyl)-3-
hydroxybutyrate (148) 
  The methanolysis of the acetate group of the glucoside 136 (0.823 g, 1.36 
mmol) was performed according to the procedure described in experiment 
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121. The crude was purified by flash column chromatography on silica gel 
(40:60, EtOAc/Hex) affording the α (0.594 g, 82 %) and the β-alcohol (0.066 
g, 9 %) as viscous colourless gums. 
  After catalytic hydrogenation of the benzyl ethers of the α-alcohol (0.516 g, 
0.94 mmol) and hydrolysis of the methyl ester according to the procedure 
described in experiment 121, the compound 148 was obtained as a viscous 
colorless foam (0.285 g, quantitative). 1H NMR (D2O): δ 4.98 (d, J = 4.0 Hz, H-
1), 4.97 (d, J = 4.2 Hz, H-1), 4.14-4.04 (m, CHCH3), 3.80-3.59 (m), 3.45-3.39 
(m, H-2), 3.34-3.28 (m, H-4), 2.47 (dd, J = 14.2 Hz, J = 6.9 Hz, CHCH2CO2-), 
2.40-2.22 (m, CHCH2CO2-), 1.21 (d, J = 6.1 Hz, CHCH3), 1.14 (d, J = 5.9 Hz, 
CHCH3) ppm. 13C NMR (D2O): δ 180.19, 180.16, 97.6 (C-1), 94.9 (C-1), 73.4 
(CHCH3), 73.15 (CHCH3), 73.06, 71.9, 71.51, 71.48, 71.32, 70.5, 69.62, 
69.56, 60.6 (C-6), 60.3 (C-6), 45.6 (CHCH2CO2-), 44.5 (CHCH2CO2-), 20.6 
(CHCH3), 18.0 (CHCH3) ppm. 
 
Experiment 127. Synthesis of Potassium 3-O-(α /β-D-galactopyranosyl)-
3-hydroxybutyrate (149) 
  The methanolysis of the acetate group of the galactoside 137 (0.709 g, 1.17 
mmol) was performed according to the procedure described in experiment 
121. The crude was purified by flash column chromatography on silica gel 
(40:60, EtOAc/Hex) affording the alcohol as a viscous colourless gum (0.584 
g, 88 %, α/β=3:1). After catalytic hydrogenation of the benzyl ethers (0.573 g, 
1.01 mmol) and hydrolysis of the methyl ester according to the procedure 
described in experiment 121, the compound 145 was obtained as a viscous 
colorless foam (0.309 g, quantitative, α/β=3:1). 1H NMR (D2O): δ 5.01 (d, J = 
3.9 Hz, H-1 (α)), 4.99 (d, J = 3.8 Hz, H-1 (α)), 4.42 (d, J = 8.4 Hz, H-1 (β)), 
4.40 (d, J = 8.1 Hz, H-1 (β)), 4.23-4.04 (m), 3.97-3.89 (m), 3.84 (t, J = 3.9 Hz), 
3.78-3.54 (m), 3.40 (dd, J = 9.6, 8.2 Hz), 2.54-2.44 (m), 2.40-2.22 (m), 1.22-
1.13 (m) ppm. 13C NMR (D2O): δ 180.3, 179.9, 101.9 (C-1 (β)), 101.1 (C-1 
(β)), 97.9 (C-1 (α)), 95.1 (C-1 (α)), 75.14, 75.10, 74.99, 74.0, 73.4, 72.79, 
72.65, 71.02, 71.01, 70.8, 70.52, 70.44, 69.58, 69.46, 69.30, 69.1, 68.72, 
68.56, 68.46, 68.2, 61.23, 61.09, 60.9, 45.75 (CHCH2CO2-), 45.57 
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(CHCH2CO2-), 44.5 (CHCH2CO2-), 20.6 (CHCH3), 19.3 (CHCH3), 18.0 
(CHCH3) ppm. 
 
Experiment 128. Synthesis of Potassium (2S)-2-O-(α /β-D-
glucopyranosyl)-2-hydroxysuccinate (150) 
  The methanolysis of the acetate group of the glucoside 138 (0.263 g, 0.41 
mmol) was performed according to the procedure described in experiment 
121. The crude was purified by preparative TLC (50:50, EtOAc/Hex) affording 
the desired alcohol (0.117 g, 48 %) as a viscous colourless gum, and 
recovery of the initial 138 (0.068 g, 26 %) and the product of the hydrolysis at 
the anomeric position (0.046 g, 25 %,). After catalytic hydrogenation of the 
benzyl ethers (0.565 g, 0.95 mmol) and hydrolysis of the methyl ester 
according to the procedure described in experiment 121, the compound 145 
was obtained as a viscous colorless foam (0.290 g, 94 %). 1H NMR (D2O): δ 
4.94 (d, J = 3.9 Hz, H-1 (α)), 4.39 (d, J = 7.9 Hz, H-1 (β)), 4.19 (dd, J = 10.4, J 
= 3.1 Hz, 1H, CO2-CHCH2CO2-), 3.80-3.63 (m), 3.45-3.28 (m), 3.21-3.15 (m), 
2.59 (dd, J = 15.1 Hz, J = 2.9 Hz, CHCH2CO2- (β)), 2.52 (dd, J = 15.2 Hz, J = 
3.2 Hz, CHCH2CO2- (α)), 2.42 (dd, J = 15.2 Hz, J = 10.4 Hz, CHCH2CO2- (α)) 
ppm. 13C NMR (D2O): δ 179.5, 179.1, 135.3 (C-1 (β)), 99.7 (C-1 (α)), 95.9, 
79.0, 75.92, 75.72, 74.1, 73.1, 72.2, 71.8, 71.4, 69.6, 69.2, 60.7, 60.0, 41.5 
ppm.  
 
Experiment 129. Synthesis of Potassium (2S)-2-O-(α /β-D-
galactopyranosyl)-2-hydroxysuccinate (151, 152) 
  The methanolysis of the acetate group of the galactoside 139 (1.215 g, 1.91 
mmol) was performed according to the procedure described in experiment 
121. The crude was purified by flash column chromatography on silica gel 
(50:50, EtOAc/Hex) affording the α (0.642 g, 57 %) and β-alcohol (0.176 g, 16 
%) as viscous colourless gums, and recovery of the starting material 139 
(0.020 g, 16 %) and the product of the hydrolysis at the anomeric position 
(0.067 g, 8 %). After catalytic hydrogenation of the benzyl ethers from the α 
(0.640 g, 1.07 mmol) and β-alcohol (0.159 g, 0.27 mmol) and hydrolysis of the 
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methyl ester according to the procedure described in experiment 121, the 
compounds 151 (0.401 g, quantitative) and 152 (0.100 g, quantitative) were 
obtained as viscous colorless foams. Alpha product 151: FTIR (film) υ máx: 
1634 (C=O), 3332 (O-H) cm–1. 1H NMR (D2O): δ 4.96 (d, J = 4.0 Hz, 1H, H-1) 
4.20 (dd, J = 10.3, 3.1 Hz, CO2-CHCH2CO2-), 4.05-4.02 (m), 3.94 (d, J = 2.8 
Hz), 3.86 (dd, J = 10.4 Hz, J = 3.3 Hz), 3.70-3.54 (m), 2.54 (dd, J = 15.2 Hz, 
3.2 Hz, 1H, CHCH2CO2-), 2.43 2.42 (dd, J = 15.2 Hz, J = 10.3 Hz, 1H, 
CHCH2CO2-) ppm. Beta product 152: FTIR (film) υ máx: 1736 (C=O), 3410 (O-
H) cm–1. 1H NMR (D2O): δ 4.52 (dd, J = 10.0 Hz, J = 3.1 Hz, 1H, CO2-
CHCH2CO2-), 4.33 (d, J = 7.5 Hz, 1H, H-1), 3.83-3.82 (m, 1H), 3.77-3.50 (m, 
5H), 2.62 (dd, J = 15.2, 3.1 Hz, 1H, CHCH2CO2-), 2.44 (dd, J = 15.2, 10.0 Hz, 
1H, CHCH2CO2-). 13C NMR (D2O): δ 179.4 (CO2-), 179.0 (CO2-), 102.0 (C-1), 
77.6 (CHCH2CO2-), 75.4, 72.8, 70.9, 68.8, 61.3 (C-6), 41.9 (CHCH2CO2-) ppm. 
	  
Experiment 130. Synthesis of Potassium (2S)-2-O-(α-D-glucopyranosyl)-
2,3-dihydroxypropanoate (153) 
  The methanolysis of the acetate group of the glucoside 140 (0.450 g, 0.54 
mmol) was performed according to the procedure described in experiment 
121. The crude was purified by flash column chromatography on silica gel 
(20:80, EtOAc/Hex) affording the α (0.299 g, 70 %) and the β-alcohol (0.030 
g, 7 %) as viscous colourless gums. 
  TBAF (1M in THF; 0.37 mL, 0.37 mmol) was added to a solution of the 
α-glucoside (0.290 g, 0.37 mmol) in THF (2 mL) at r.t. The reaction mixture 
was stirred for 4 hours and then water was added. The mixture was extracted 
with EtOAc, dried (MgSO4) and concentrated to give a yellow viscous residue. 
Purification by flash column chromatography on silica gel (80:20, 
EtOAc/hexane) afforded the α-diol as a viscous colourless gum (0.162 g, 
80%). After catalytic hydrogenation of the benzyl ethers from the α-diol (0.150 
g, 0.27 mmol) and hydrolysis of the methyl ester according to the procedure 
described in experiment 121, the compound 153 was obtained as a viscous 
colorless foam (0.077 g, quantitative). 1H NMR (D2O): δ 4.96 (d, J = 3.9 Hz, 
1H, H-1), 3.96 (dd, J = 3.3 Hz, J = 6.5 Hz, 1H, CHCH2OH), 3.79- 3.75 (m, 
3H), 3.72-3.63 (m, 3H), 3.48 (dd, J = 3.9 Hz, J = 9.9 Hz, 1H, H-2), 3.37 (t, J = 
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9.6 Hz, 1H, H-4) ppm. 13C NMR (D2O): δ  177.4 (CO2-), 99.2 (C-1), 81.4 
(CHCH2OH), 72.9, 72.2, 71.7 (C-2), 69.3 (C-4), 62.6 (CHCH2OH), 60.0 (C-6) 
ppm. 
	  
Experiment 131. Synthesis of Potassium (2S)-2-O-(α-D-
galactopyranosyl)-2,3-dihydroxypropanoate (154) 
  The methanolysis of the acetate group of the α-galactoside 141 (0.640 g, 
0.77 mmol) was performed according to the procedure described in 
experiment 121. The crude was purified by flash column chromatography on 
silica gel (30:70, EtOAc/Hex) affording the alcohol (0.572 g, 94 %) as a 
viscous colourless residue. 
   TBAF (1M in THF; 0.83 mL, 0.88 mmol) was added to a solution of the 
α−galactoside (0.695 g, 0.88 mmol) in THF (5 mL) at r.t. The reaction mixture 
was stirred for 4 hours and then water was added. The mixture was extracted 
with EtOAc, dried (MgSO4) and concentrated to give a yellow viscous residue. 
Purification by flash column chromatography on silica gel (80:20, 
EtOAc/hexane) afforded the diol as a viscous colourless gum (0.343 g, 71%). 
After catalytic hydrogenation of the benzyl ethers from the diol (0.310 g, 0.56 
mmol) and hydrolysis of the methyl ester according to the procedure 
described in experiment 121, the compound 154 was obtained as a viscous 
colorless foam (0.172 g, quantitative). 1H NMR (D2O): δ 5.01 (d, J = 3.9 Hz, 
1H, H-1), 4.28 (t, J = 4.2 Hz, 1H, CHCH2OH), 4.18-3.92 (m, 4H), 3.85-3.58 
(m, 4H) ppm. 
  
Experiment 132. Synthesis of Potassium (2S)-2-O-(β-D-
galactopyranosyl)-2,3-dihydroxypropanoate (155) 
  The methanolysis of the acetate group of the β-galactoside 141 (0.275 g, 
0.33 mmol) was performed according to the procedure described in 
experiment 121. The crude was purified by flash column chromatography on 
silica gel (40:60, EtOAc/Hex) affording the alcohol (0.243 g, 93 %) as a 
viscous colourless residue. 
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   TBAF (1M in THF; 0.83 mL, 0.44 mmol) was added to a solution of the 
β−galactoside (0.350 g, 0.44 mmol) in THF (3 mL) at r.t. The reaction mixture 
was stirred for 4 hours and then water was added. The mixture was extracted 
with EtOAc, dried (MgSO4) and concentrated to give a yellow viscous residue. 
Purification by flash column chromatography on silica gel (80:20, 
EtOAc/hexane) afforded the diol as a viscous colourless gum (0.151 g, 62 %). 
After catalytic hydrogenation of the benzyl ethers from the diol (0.140 g, 0.25 
mmol) and hydrolysis of the methyl ester according to the procedure 
described in experiment 121, the compound 146 was obtained as a viscous 
colorless foam (0.078 g, quantitative). 1H NMR (D2O): δ 4.38 (d, J = 7.4 Hz, 
1H, H-1), 4.28 (dd, J = 6.2 Hz, J = 2.9 Hz, 1H, CHCH2OH), 3.84 (dt, J = 7.2, 
3.8 Hz, 2H), 3.76-3.68 (m, 3H), 3.66-3.53 (m, 4H) ppm. 13C NMR (D2O): δ 
177.1 (CO2-), 102.5 (C-1), 81.4 (CHCH2OH), 75.3, 72.8, 71.0, 68.6, 63.2 
(CHCH2OH), 61.0 (C-6) ppm. 
	  
Experiment 133. Synthesis of Ethyl 3-O-(2,3,4,6-tetra-O-acetyl-α-D-
mannopyranosyl)-3-hydroxybutyrate (156)  
  Ethyl 3-dihydroxybutyrate (0.348 mL, 2.68 mmol) was added to a solution of 
trichloroacetamidate 103 (1.100 g, 2.23 mmol) in dry CH2Cl2 (6 mL). The 
solution was cooled to 0°C and BF3.OEt2 (0.0.282 mL, 2.23 mmol) was slowly 
added. When the reaction was completed, a saturated aqueous solution of 
NaHCO3 was added, followed by extractions with CH2Cl2 (3x15 mL). The 
combined organic phases were dried (MgSO4) and concentrated. The residue 
was purified by flash column chromatography on silica gel (40:60, 
EtOAc/hexane) to afford 156 (0.943 g, 91 %) as a viscous colourless residue. 
FTIR (film) υ máx: 1743 (C=O) cm–1. 1H NMR (CDCl3): δ 5.33-5.22 (m), 5.17 
(dd, J = 2.8 Hz, J = 1.8 Hz, ), 5.14 (dd, J = 3.3 Hz, J = 1.8 Hz), 4.99 (d, J = 1.6 
Hz, H-1), 4.96 (d, J = 1.6 Hz, H-1), 4.30-4.05 (m), 2.67-2.57 (m), 2.52-2.38 
(m), 2.16 (s), 2.15 (s), 2.11 (s), 2.09 (s), 2.04 (s), 2.03 (s), 1.99 (s), 1.98 (s), 
1.32-1.22 (m) ppm. 13C NMR (CDCl3): δ 171.0, 170.79, 170.75, 170.63, 170.1, 
169.93, 169.88, 169.76, 169.74, 98.2 (C-1), 94.8 (C-1), 73.5, 70.1, 69.78, 
69.69, 69.09, 69.00, 68.7, 66.4, 66.0, 64.2, 62.6, 62.3, 60.75, 60.67, 42.7, 
41.9, 22.4, 21.3, 20.93, 20.89, 20.75, 20.70, 18.7, 14.17, 14.14 ppm. 
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Experiment 134. Synthesis of Dimethyl (2S)-2-O-(2,3,4,6-tetra-O-acetyl-α-
D-mannopyranosyl)-2-hydroxysuccinate (157) 
  The glycosylation reaction of trichloroacetamidate donor 103 (1.540 g, 3.12 
mmol) and ethyl dimethyl dimethyl (S)-malate 134 (0.494 mL, 3.75 mmol) was 
performed according to the procedure described in experiment 133. The 
crude was purified by flash column chromatography on silica gel (30:70, 
EtOAc/Hex) affording the product 157 as a viscous colourless gum (1.359 g, 
88 %). [α]20D = +15.29 (c = 1.19, CH2Cl2). FTIR (film) υ máx: 1745 (C=O) cm–1. 
1H NMR (CDCl3): δ 5.39-5.29 (m, 2H, H-3, H-4), 5.23 (dd, J = 3.1, 1.8 Hz, 1H, 
H-2), 5.01 (d, J = 1.6 Hz, 1H, H-1), 4.58-4.52 (m, 1H, CHCH2CO2Me), 4.39-
4.35 (m, 1H, H-5), 4.28 (dd, J = 12.3, 4.6 Hz, 1H, H-6), 4.05 (dd, J = 12.4, 2.3 
Hz, 1H, H’-6), 3.84 (s, 3H, CO2Me), 3.74 (s, 3H, CO2Me), 2.92-2.79 (m, 4H, 
CHCH2CO2Me), 2.19 (s, 3H, Ac), 2.12 (s, 3H, Ac), 2.07 (s, 3H, Ac), 2.01 (s, 
3H, Ac). 13C NMR (CDCl3): δ 170.77, 170.72, 170.1, 169.89, 169.87, 169.76, 
99.5 (C-1), 75.0, 69.4, 69.0, 67.3, 65.8, 62.2, 52.5, 52.3, 38.5, 20.89, 20.78, 
20.74, 20.69. 
 
Experiment 135. Synthesis of Methyl 3-O-tert-butyldimethylsilyl-(2S)-2-O-
(2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-2,3-dihydroxypropanoate 
(158) 
  The glycosylation reaction of trichloroacetamidate donor 103 (1.30 g, 2.64 
mmol) and aceptor 135 (0.946 g, 2.64 mmol) was performed according to the 
procedure described in experiment 133. The crude was purified by flash 
column chromatography on silica gel (30:70, EtOAc/Hex) affording the 
product 158 as a viscous colourless gum (1.33 g, 73 %). 1H NMR (CDCl3): δ 
7.67-7.65 (m, 4H, Ph), 7.47-7.39 (m, 6H, Ph), 5.43-5.31 (m, 3H, H-2, H-3, H-
4), 5.01 (d, J = 1.4 Hz, 1H, H-1), 4.36 (ddd, J = 9.9 Hz, J = 4.3 Hz, J = 2.2 Hz, 
1H, H-5), 4.31-4.25 (m, 2H), 4.03 (dd, J = 12.3, 2.2 Hz, 1H), 3.94-3.93 (m, 
2H), 3.74 (s, 3H, CO2Me), 2.15 (s, 3H, Ac), 2.11 (s, 3H, Ac), 2.06 (s, 3H, Ac), 
2.01 (s, 3H, Ac), 1.04 (s, 9H, t-Bu) ppm. 
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Experiment 136. Synthesis of Potassium 3-O-(α-D-mannopyranosyl)-3-
hydroxybutyrate (159)  
  A solution of NaOMe 1N (0.36 mL, 0.36 mmol) in MeOH was added to a 
stirred solution of 156 (0.276 g, 0.60 mmol) in MeOH (3 mL) at 0 ºC. After 
complete conversion of the starting material, previously activated Dowex-H+ 
resin was added until neutral pH. After filtration with MeOH and water, the 
solvent was removed in vacuum to yield the deprotected mannoside as a 
viscous colourless gum (0.157 g, 90 %). 
  A solution of 2 M KOH (0.78 mL) was added to a stirred solution of the 
previously mannoside (0.431 g, 1.56 mmol) in H2O (4 mL). After all of the 
starting material had been consumed, the pH was adjusted to 7 with 10% HCl 
and the solvent was evaporated to afford 159 as a viscous colorless foam 
(0.446 g, quantitative). 1H NMR (D2O): δ 4.91 (d, J = 7.5 Hz), 4.18-4.09 (m, 
(CHCH3), 3.84-3.77 (m), 3.74-3.63 (m), 3.57 (t, J = 8.9 Hz), 2.43-2.21 (m, 
(CHCH2CO2-)), 1.20 (d, J = 6.1 Hz, CHCH2CO2-), 1.14 (d, J = 5.6 Hz, 
CHCH2CO2-) ppm. 13C NMR (CDCl3): δ 179.9 (CH2CO2-), 179.8 (CH2CO2-), 
99.7 (C-1), 96.5 (C-1), 73.4, 72.9, 72.5, 70.57, 70.52, 70.41, 70.29, 70.24, 
66.84, 66.72, 61.0 (C-6), 60.7 (C-6), 45.5 (CHCH2CO2-), 44.8 (CHCH2CO2-), 
20.8 (CHCH3) ppm.  
 
Experiment 137. Synthesis of Potassium (2S)-2-O-(α-D-
mannopyranosyl)-2-hydroxysuccinate (160) 
  The methanolysis of the acetate groups of the mannoside 157 (1.343 g, 2.72 
mmol) was performed according to the procedure described in experiment 
136. The crude was purified by column chromatography on silica gel (20:80, 
MeOH/CH2Cl2) affording the desired deprotected mannoside (0.685 g, 78 %) 
as a viscous colourless gum, and the product of the hydrolysis at the 
anomeric position, the D-mannopyranoside (0.100 g, 20 %). After hydrolysis 
of the methyl ester according to the procedure described in experiment 133 
compound 160 was obtained as a viscous colorless foam (0.0.786 g, 
quantitative). 1H NMR (D2O): δ 4.85 (t, J = 15.6 Hz, 1H), 4.85 (s, 1H, H-1), 
Experimental Procedures 
	  
	  
	  
237 
4.24 (dd, J = 8.2 Hz, J = 4.7 Hz, 1H), 3.90-3.58 (m, 5 H), 2.79-2.64 (m, 2H) 
ppm. 
 
Experiment 138. Synthesis of Potassium (2S)-2-O-(D-mannopyranosyl)-
2,3-dihydroxypropanoate (161) 
  TBAF (1M in THF; 0.38 mL, 0.38 mmol) was added to a solution of the 
158 (0.220 g, 0.32 mmol) in THF (3 mL) at r.t. The reaction mixture was 
stirred for 4 hours and then water was added. The mixture was extracted with 
EtOAc, dried (MgSO4) and concentrated to give a yellow viscous residue. 
Purification by preparative TLC (60:40, EtOAc/hexane) afforded the alcohol as 
a viscous colourless gum (0.103 g, 72 %). The methanolysis of the acetate 
groups of the alcohol (0.518 g, 1.15 mmol) was performed according to the 
procedure described in experiment 136. After complete conversion of the 
starting material, previously activated Dowex-H+ resin was added until neutral 
pH. After filtration with MeOH and water, the solvent was removed in vacuum 
to yield the deprotected mannoside as a viscous colourless gum (0.312 g, 96 
%). Hydrolysis of the methyl ester according to the procedure described in 
experiment 136, the compound 161 was obtained as a viscous colorless foam 
(0.300 g, quantitative). 1H NMR (D2O): δ 4.89 (d, J = 1.4 Hz, 1H, H-1), 4.02 
(dd, J = 7.1, 3.2 Hz, 1H, CHCO2-), 3.99 (dd, J = 3.4, 1.6 Hz, 1H, H-), 3.89 (dd, 
J = 9.5, 3.4 Hz, 1H), 3.79 (dd, J = 12.2, 3.1 Hz, 1H, H-), 3.74-3.61 (m, 5H) 
ppm. 13C NMR (CDCl3): δ 100.8, 80.6 (C-1), 73.2, 70.5, 70.1, 66.5, 62.5, 60.5 
ppm. 
 
Experiment 139. Synthesis of Dimethyl (2S)-2-O-(2-azido-3,4,di-O-benzyl-
6-O-chloroacetyl-2-deoxy-α-D-glucopyranosyl)-2-hydroxysuccinate (162) 
    A suspension of thioglucoside donor 91 (0.750 g, 1.32 mmol), methyl (S)-
malate 134 (0.197 mL, 1.52 mmol) and 4Å MS in CH2Cl2:Et2O (1:4, 20 mL) 
was stirred for 1 h at room temperature then cooled to 0°C. A solution of N-
iodosuccinimide (0.0.594 g, 2.64 mmol) and TfOH (0.027 mL) in CH2Cl2:Et2O 
(1:1, 20 mL) was added at 0°C. After complete conversion of the starting 
material, 10% Na2S2O3 aqueous solution (20 mL) and saturated aqueous 
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NaHCO3 solution (10 mL) were added. The mixture was extracted with CH2Cl2 
(3x20 mL), the combined organic phases were dried (MgSO4), filtered and the 
solvent was removed under vacuum. The crude product was purified by flash 
column chromatography on silica gel (30:70, EtOAc/Hex) to afforded product 
162 as a viscous colourless foam (0.672 g, 84 %). 
1H NMR (CDCl3): δ 7.39-7.26 (m, 10H, Ph), 5.05 (d, J = 3.8 Hz, 1H, H-1), 
4.91-4.85 (m, 3H), 4.60 (d, J = 11.2 Hz, 1H), 4.54 (t, J = 6.5 Hz, 1H, 
CHCH2CO2Me), 4.35-4.24 (m, 3H), 4.04-3.93 (m, 3H), 3.75 (s, 3H, CO2Me), 
3.73 (s, 3H, CO2Me), 3.55 (t, J = 9.2 Hz, 1H, H-4), 3.30 (dd, J = 10.4, 3.8 Hz, 
1H, H-2), 2.85 (d, J = 6.6 Hz, 2H, CHCH2CO2Me) ppm. 13C NMR (CDCl3): 
δ 170.8, 170.2, 166.9, 137.66, 137.51, 128.55, 128.53, 128.06, 128.04, 
128.00, 100.0 (C-1), 79.9, 77.3, 77.0, 76.7, 75.47, 75.33, 74.9, 69.7, 64.0, 
63.2, 52.5, 52.2, 40.7, 37.6 ppm. 
	  
Experiment 140. Synthesis of Methyl (2S)-2-(2-azido-3,4,di-O-benzyl-2-
deoxy-α-D-glucopyranosyl)propanoate (163) 
  A solution of NaOMe 1N (0.46 mL, 0.46 mmol) in MeOH was added to a 
stirred solution of 95 (0.470 g, 0.77 mmol) in MeOH (5 mL) at 0 ºC. After 1 
hour the reaction mixture was neutralized with saturated aqueous NH4Cl. The 
aqueous phase was extracted with EtOAc and the combined organic extracts 
were dried (MgSO4), filtered and the solvent was removed. The crude product 
was purified by flash column chromatography on silica gel (30:70, EtOAc/Hex) 
to afford 163 (0.355 g, 98%) as a viscous colourless gum. FTIR (film) υ máx: 
1753 (C=O), 2108 (N3) cm–1. 1H NMR (CDCl3): δ 7.39-7.27 (m, 10H, Ph), 4.96 
(d, J = 3.7 Hz, 1H, H-1), 4.90 (s, 2H, CH2Ph), 4.87 (d, J = 11.1 Hz, 1H, 
CH2Ph), 4.67 (d, J = 11.1 Hz, 1H, CH2Ph), 4.18-4.02 (m, 3H), 3.74-3.73 (m, 
3H, CO2Me), 3.72-3.71 (m, 2H, H-6, H’-6), 3.59 (t, J = 9.5 Hz, 1H, H-4), 3.29 
(dd, J = 10.4 Hz, J = 3.7 Hz, 1H, H-2), 1.48 (d, J = 6.8 Hz, 3H, CHCH3) ppm. 
13C NMR (CDCl3): δ 172.7 (CO2Me), 137.9, 128.52, 128.48, 128.04, 127.96, 
127.88, 99.0 (C-1), 79.8, 78.0 (C-4), 75.42 (CH2Ph), 75.23, 75.03 (CH2Ph), 
72.1, 63.2 (C-2), 61.5 (C-6), 52.2 (CO2Me), 18.3 (CHCH3) ppm. 
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Experiment 141. Synthesis of Methyl 2-(2-azido-3,4,di-O-benzyl-2-deoxy-
α-D-glucopyranosyl)acetate (164) 
  The procedure of experiment 140 was applied to compound 96 (0.500 g, 
0.94 mmol) affording compound 164 as a viscous colourless gum (0.393 g, 92 
%). FTIR (film) υ máx: 1757 (C=O), 2110 (N3) cm–1. 1H NMR (CDCl3): δ  7.39-
7.28 (m, 10H, Ph), 5.04 (d, J = 3.5 Hz, 1H, H-1), 4.93-4.84 (m, 3H, CH2Ph), 
4.67 (d, J = 11.1 Hz, 1H, CH2Ph), 4.27 (d, J = 16.3 Hz, 1H, CHH’CO2Me), 
4.18 (d, J = 16.4 Hz, 1H, CHH’CO2Me), 4.05 (t, J = 9.6 Hz, 1H, H-3), 3.85-
3.70 (m, 3H), 3.77 (s, 3H, CO2Me), 3.62 (t, J = 9.4 Hz, 1H, H-4), 3.42 (dd, J = 
10.3, 3.6 Hz, 1H, H-2) ppm. 13C NMR (CDCl3): δ 169.7 (CO2Me), 137.8, 
128.56, 128.50, 128.12, 128.09, 128.07, 128.02, 127.93, 97.9 (C-1), 80.0 (C-
3), 77.6 (C-4), 75.6 (CH2Ph), 75.1 (CH2Ph), 72.1 (C-5), 64.3 (CH2CO2Me), 
63.4 (C-2), 61.5 (C-6), 52.1 (CO2Me) ppm. 
 
Experiment 142. Synthesis of Methyl (2R)-tert-butyldimethylsilyl-3-(2-
azido-3,4,di-O-benzyl-2-deoxy-α-D-glucopyranosyl)-2,3-
dihydroxyropanoate (165) 
  TBAF (1M in THF; 1.14 mL, 1.14 mmol) was added to a solution of 97 (0.830 
g, 1.03 mmol) in THF (7 mL) at r.t. The reaction mixture was stirred for 4 
hours and then water was added. The mixture was extracted with EtOAc, 
dried (MgSO4) and concentrated to give a yellow viscous residue. Purification 
by flash column chromatography on silica gel (50:50, EtOAc/hexane) afforded 
the alcohol as a viscous colourless gum (0.401 g, 72%). The procedure of 
experiment 140 was applied to the alcohol (0.296 g, 0.55 mmol) affording 165 
as a viscous colourless gum (0.261 g, 92 %). FTIR (film) υ máx: 1739 (C=O), 
2108 (N3) cm–1. 1H NMR (CDCl3): δ  7.43-7.29 (m, 12H, Ph), 5.20 (d, J = 3.6 
Hz, 1H, H-1), 4.97-4.88 (m, 3H, CH2Ph), 4.69 (d, J = 11.0 Hz, 1H, CH2Ph), 
4.40 (dd, J = 5.3 Hz, J = 3.6 Hz, 1H, CHCH2OH), 4.08 (dd, J = 10.2 Hz, J = 
9.0 Hz, 1H, H-3), 4.00-3.92 (m, 2H, CHCH2OH), 3.88-3.77 (m, 2H), 3.83 (s, 
3H, CO2Me), 3.72 (dd, J = 12.1 Hz, J = 4.6 Hz, 1H, H-6), 3.63 (t, J = 9.5 Hz, 
1H, H-4), 3.43 (dd, J = 10.3 Hz, J = 3.7 Hz, 1H, H-2) ppm. 13C NMR (CDCl3): δ 
169.8 (CO2Me), 137.76, 137.59, 128.59, 128.56, 128.52, 128.12, 128.06, 
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128.04, 127.97, 96.9 (C-1), 79.8 (C-3), 77.7 (C-4), 75.67 (CHCH2OH), 75.52 
(CH2Ph), 75.3 (CH2Ph), 72.2, 63.34 (C-2), 63.32 (CHCH2OH), 61.5 (C-6), 
52.5 (CO2Me) ppm. 
 
Experiment 143. Synthesis of Dimethyl (2S)-2-O-(2-azido-3,4,di-O-benzyl-
2-deoxy-α-D-glucopyranosyl)-2-hydroxysuccinate (166) 
  The procedure of experiment 140 was applied to compound 162 (0.670 g, 
1.10 mmol) affording compound 166 as a viscous colourless gum (0.429 g, 73 
%). FTIR (film) υ máx: 1739 (C=O), 2107 (N3) cm–1. 1H NMR (CDCl3): δ  7.41-
7.29 (m, 10H, Ph), 5.11 (d, J = 3.8 Hz, 1H, H-1), 4.94-4.88 (m, 3H, CH2Ph), 
4.71 (d, J = 11.1 Hz, 1H, CH2Ph), 4.58 (dd, J = 7.2 Hz, J = 5.9 Hz, 1H, 
CHCH2CO2Me), 4.10-4.02 (m, 2H, H-3, H-5), 3.78 (s, 3H, CO2Me), 3.78 (s, 
3H, CO2Me), 3.75-3.74 (m, 2H, H-6, H’-6), 3.62 (dd, J = 9.8 Hz, J = 9.2 Hz, 
1H, H-4), 3.32 (dd, J = 10.4 Hz, J = 3.8 Hz, 1H, H-2), 2.91-2.89 (m, 2H, 
CHCH2CO2Me) ppm. 13C NMR (CDCl3): δ 171.0 (CO2Me), 170.2 (CO2Me), 
137.8, 128.52, 128.47, 128.02, 127.96, 127.88, 100.2 (C-1), 79.6 (C-3), 77.9 
(C-4), 75.49 (CHCH2CO2Me), 75.39 (CH2Ph), 75.0 (CH2Ph), 72.3 (C-5), 63.3 
(C-2), 61.4 (C-6), 52.5 (CO2Me), 52.2 (CO2Me), 37.6 (CHCH2CO2Me) ppm.  
 
	  
Differential scanning fluorimetry 
 
Materials	  
 
  Mannosylglycerate (MG), glucosylglycerate (GG), glucosylglucosylglycerate 
(GGG), mannosyl glycolate (MGly) and mannosyl lactate (ML) were obtained 
by chemical synthesis as described in literature2, 12. New synthetic 
compounds were obtained by chemical synthesis as described in Chapter 7. 
The desired compounds were purified by size exclusion chromatography on a 
Sephadex G-10 column eluted with water. The fractions containing the pure 
compounds were pooled, lyophilized. Purity and concentration of the 
compounds was assessed by 1H NMR spectra obtained at 500 MHz 
spectrometer in D2O. For quantification purposes, spectra were acquired with 
Experimental Procedures 
	  
	  
	  
241 
a repetition delay of 60 s with formate as concentration standard. Only 
samples with purity higher than 98% were used. Mitochondrial malate 
dehydrogenase from pig heart (MDH) was purchased from Roche, and hen 
egg white lysozyme from Sigma-Aldrich. These enzymes were used without 
further purification. Recombinant staphylococcal nuclease A (SNase) was 
produced and purified from Escherichia coli cells as described by Faria et 
al.13 Protein concentration was determined from UV absorbance at 280 nm, 
using 0.28 (mg/mL)-1cm-1 for the extinction coefficient of MDH14, 2.58 
(mg/mL)-1cm-1 for lysozyme15 and 0.93 (mg/mL)-1cm-1 for SNase16. 
 
 
DSF	  assay	  
 
  The protein melting temperature (TM) determination was performed by 
monitoring protein unfolding with the fluoroprobe SYPRO Orange dye 
(Molecular Probes), which although completely quenched in aqueous 
environment, emits fluorescence upon binding to protein hydrophobic 
patches. Such increase in fluorescence can be measured as a function of 
temperature. The thermal shift assay was performed on an iCycle iQ5 Real 
Time PCR Detection System (Bio-Rad), equipped with a charge-coupled 
device (CCD) camera and a Cy3 filter with excitation and emission 
wavelengths of 490 and 575 nm, respectively. This equipment can 
simultaneously detect the fluorescence changes in 96-well plates (low profile 
plate, Bio-Rad) and thus can be used for parallel thermal stability assays. The 
96-well plates are sealed with optical quality sealing tape (Bio-Rad) and 
centrifuged at 2500 g for 2 minutes immediately before the assay to remove 
possible air bubbles. The plates are subsequently heated from 20 to 90 ºC 
with stepwise increments of 1 ºC with a 60 seconds equilibration time, 
followed by the fluorescence read out. In a typical assay with a total volume of 
20 µL, a protein concentration from 0.14 to 0.21 mg/mL, and a dye 
concentration of 5 fold were used to guarantee the best signal to noise ratio. 
Protein stock solutions of SNase or MDH were prepared in phosphate buffer 
(20 mM of sodium phosphate, pH 7.6), and lysozyme was prepared in citrate 
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buffer (40 mM sodium citrate, 110 mM NaCl, pH 6.0). These stock solutions 
were extensively dialyzed against the same buffer before the assays. Protein 
concentrations approximately 1.9 µM were used for MDH, 12.4 µM for SNase 
and 13 µM for lysozyme. Solute solutions were prepared in water with the 
respective concentrations. The assay was prepared by adding 2 µL of protein 
to 8 µL of dye buffer solution, and 10 µL of solute solution, all prepared in the 
protein purification buffer except for the solutes solutions. Fluorescence 
intensities versus temperature are used to calculate the protein melting 
temperature (TM) by determining the first derivative (d(Rfu)/dT) to extract the 
exact transition inflection point. 
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